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QUILL ON SCALPEL
This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Survival After Hepatic Resection 
for Metastatic Disease
The article “ Hepatic resection for 
metastatic disease” by Olak and col­
leagues (Can J  Surg 1986; 29: 435-439) 
is important for several reasons: it deals 
with an issue that is of great interest to 
surgeons, it comes from a major aca­
demic institution whose credibility should 
not be in question, and the authors state 
that their data support the position that 
selected groups of patients with metastatic 
colorectal cancer will obtain long-term 
benefit from resection of liver metastases.
The core of the paper is a life-table 
analysis of the survival of 25 patients who 
had primary colorectal carcinoma and 
who underwent hepatic resection for 
metastases. For all patients surviving the 
hepatic resection, the 5-year survival 
projected by the analysis was 50.3%.
The life table is the best method for 
handling longitudinal data when patients 
enter a study at different times and at its 
conclusion have been observed for differ­
ent lengths of time. Its efficiency lies in 
the fact that the survival experience of all 
patients under study is included in the
analysis, not just of those who have died 
by the time the study is terminated. How­
ever, the authors do not seem to recog­
nize the limitations of life-table analysis. 
As Peto and colleagues1 pointed out, “ if 
few patients are at risk for more than a 
certain time and after that time none of 
these few happens to die, there will be an 
apparent plateau in the life table. Such 
plateaux at the ends of life tables are very 
common and should never be taken as 
evidence that after a certain time most 
patients are cured unless there are large 
numbers of patients still at risk at the time 
of the plateau.” In the Montreal study, 
there is a plateau after 30 months with 
fewer than five patients followed out to 
5 years as shown in Fig. 1 of Olak’s paper 
on page 437. The survival of 50.3% at 30 
months should therefore not be projected 
to 5 years and any comment on long-term 
survival is invalid.
Another crucial point is that the prob­
ability values that make up the life table 
are determinations calculated from a sam­
ple of patients. As such they are subject
to sampling variation that can be meas­
ured as standard error. By calculating the 
standard error of the probability of sur­
vival, we can answer the question, “With 
what precision does the survival of our 
sample of patients estimate the true sur­
vival o f the population from which our 
sample is drawn?” The tabulated data 
allow us to carry out our own analysis to 
include the standard error of the proba­
bility o f survival at each event (Table I). 
If we include the two operative deaths, 
which for some reason were omitted from 
the original analysis, the survival estimate 
at 36 m onths (the time of the last two 
deaths) is 43% with a 95% confidence 
interval of 17% to 69%. Thus, with a 
small sample of 25 patients, the estimate 
is imprecise and the true survival figure 
could be as bad as 17% or as good as 
69%.
From the methodologic point of view, 
this is a weak study. There is no concur­
rent control group of untreated patients 
and reliance is placed upon comparison 
with historical control groups described
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by other authors. For instance, Adson 
and associates2 reported that 20% of 
patients with solitary lesions that were not
resected lived for 3 years or more. This 
figure falls within the 95% confidence 
interval of the estimate at 3 years for
patients who underwent surgery in the 
Montreal study. Thus, from the purely 
statistical standpoint, the survival of the 
Montreal patients was not significantly 
different from that of Adson’s control 
group.
What information, therefore, can we 
glean from this paper? Simply that the 
survival of patients who undergo hepatic 
resection for metastatic disease may be 
anywhere between 17% and 69% at 3 
years. Whether or not patients will benefit 
from resection of liver metastases remains 
to be determined by larger studies that 
include the survival experience of a com­
parable group of untreated patients.
J o h n  F . G a tely , m b , b c h ir , 
FRCS(EDIN), FRCS, FRCSC
Department of Surgery,
McMaster University Medical Centre, 
Hamilton, Ont.
L8N 3Z5
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Table 1—Survival Analysis for 25 Patients After Hepatic Resection for Metastatic Colorectal Cancer 
(Adapted From Olak and Associates, Table II)
Kaplan—Meier survival analysis*
Time,
mo Died
Censored
patients Survival
Standard
error
No. patients 
remaining
0 2 0 0.920 0.054 23
1 0 2 0.920 0.054 21
3 0 1 0.920 0.054 20
4 0 1 0.920 0.054 19
9 1 0 0.872 0.070 18
10 0 1 0.872 0.070 17
11 2 1 0.769 0.092 14
13 1 0 0.714 0.100 13
16 1 0 0 .659 0.107 12
20 1 1 0 .604 0.111 10
29 0 1 0 .604 0.111 9
30 0 1 0 .604 0.111 8
33 0 1 0 .604 0.111 7
36 2 0 0 .432 0.130 5
45 0 1 0 .432 0.130 4
53 0 1 0.432 0.130 3
55 0 1 0.432 0.130 2
61 0 1 0.432 0.130 1
82 0 1 0.432 0.130 0
* All patients have been included (including the 2 operative deaths); 95% confidence intervals -  observed 
estimate of survival ± 2 standard errors.
Relationship Between Improved Angina 
and Left Ventricular Function  
Change After Aortocoronary Bypass Grafting
Coronary artery bypass surgery has 
proven to be an effective treatment for 
the relief of intractable angina. Improve­
m ents in surgical technique and 
myocardial protection have made it a safe 
and acceptable approach even in poor- 
risk patients with severe left ventricular 
dysfunction.
In this issue (pages 269 to 271), Morton 
and colleagues from Ottawa address 
the question of whether a correlation 
exists between symptomatic improvement 
in angina and changes in left ventricular 
function following bypass surgery in 
patients with moderate to marked left 
ventricular dysfunction preoperatively. 
They conclude that no such relationship 
exists but that substantial relief of angina 
can be expected in these patients regard­
less of what happens to left ventricular 
function postoperatively.
Although this study has several defi­
ciencies (it is retrospective, only a portion 
of the total group were restudied for vary­
ing reasons, and the assessment of symp­
tomatic improvement is imprecise), it 
does makes some important points.
Angina is a result of an acute but tran­
sient imbalance between myocardial oxy­
gen supply and demand. Fixed, signifi­
cant coronary artery stenosis leads to 
exertional angina when coronary flow 
cannot increase to meet oxygen demand. 
The goal of bypass surgery is to ensure 
an adequate coronary flow reserve. A suc­
cessful result is signalled subjectively by 
the elimination of exertional angina and 
objectively by the ability to achieve a 
higher external workload (heart rate mul­
tiplied by blood pressure product). Both 
goals are usually achieved after success­
ful bypass surgery regardless of resting 
left ventricular function preoperatively.
Improved left ventricular function 
postoperatively has, in contrast, been 
more the exception than the rule. As Mor­
ton and his colleagues speculate, the 
obscurity of this association may relate 
in part to perioperative damage to previ­
ously normal myocardium. In the present 
era of improved myocardial protection, 
however, this association is more likely 
related to method of assessment. Utiliz­
ing serial radionuclide ventriculography, 
we were able to demonstrate a modest, 
but consistent, improvement in left ven­
tricular function in patients with only 
mild to moderate impairment preopera­
tively.1 Much of the reduction in left 
ventricular function seen in patients with
more severe dysfunction, however, is 
likely due to myocardial necrosis and will 
not change with revascularization. The 
case for bypass surgery in these patients, 
therefore, depends upon whether or not 
there are substantial areas of myocardium 
that become ischemic upon exertion. This 
rationale is independent of left ventricu­
lar function and although the operative 
risk in such patients is undoubtedly 
greater, with proper selection the benefits 
o f surgery are, as Morton’s study con­
firms, very real, and the risk is quite 
acceptable.
J.F Sy m es , MD, FRCSC
Associate professor of surgery,
Division of Cardiovascular and 
Thoracic Surgery,
McGill University,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
H3A 1A1
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CORRESPONDENCE
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Fat Embolism and 
Total Knee Arthroplasty
To the editors.—I read with interest the 
article entitled “ Fatal fat embolism dur­
ing cemented total knee arthroplasty: a 
case report” by Orsini and colleagues in 
the September 1986 issue of the journal 
(pages 385 and 386). This type of com­
plication, although previously described, 
certainly warrants reporting. However, I 
think it was somewhat misleading to 
attribute the complication simply to 
“cemented total knee arthroplasty” as the 
title implies. In fact, the fatal fat embo­
lus was probably related to the introduc­
tion of a long stem into the medullary 
canal of the femur. For this reason, such 
a complication is more commonly 
observed after total hip arthroplasty. The 
prosthesis used in this patient, a Guepar 
II total knee arthroplasty, is generally 
regarded as obsolete. The indications 
for fully constrained hinged prostheses 
such as this are very limited. Moreover, 
modern resurfacing total knee arthro­
plasties rarely have intramedullary stems 
attached.
Notwithstanding this criticism, I 
thought the case was clearly and concisely 
reported. It is the title that was mislead­
ing, suggesting fat embolism was a com­
plication of total knee arthroplasty rather 
than the result of introducing a prosthetic 
stem into the medullary canal.
Kelly G. Vince, md, frcsc
Kerlan-Jobe Orthopaedic Clinic,
Ste. 300,
501 East Hardy St.,
Inglewood,
CA 90301,
USA
To the editors.—Dr. Vince correctly 
states that the total knee prosthesis 
associated with fatal fat embolism in our 
case report had a long intramedullary 
stem and that most contemporary total 
knee prostheses do not utilize intramedul­
lary stems. However, research in our 
laboratory has clearly demonstrated that 
it is the combination of the introduction 
of a long intramedullary stem and bone
cement that produces the high intra­
medullary pressures associated with fat 
embolism.1’2 This evidence, together 
with the infrequent association of the fat 
embolism syndrome with total knee 
arthroplasty, led to our choice of title. 
Perhaps a more accurate title would have 
been “ Fatal fat embolism during 
cemented long-stem  to tal knee 
arthroplasty” . Nevertheless, we wish to 
emphasize that this complication was 
associated with the use of bone cement 
rather than, as Dr. Vince suggests, sim­
ply the introduction of an intramedullary 
stem. We thank Dr. Vince for his com­
ments.
Robin R. Richards, md, frcsc
Assistant professor of orthopedic surgery, 
University of Toronto,
Ste. 800,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
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Surgical Management 
of Crohn’s Disease
To the editors.—The article “ New 
options in the surgical management of 
Crohn’s disease” (Can J  Surg 1987; 30: 
133-136) is very helpful and timely.
It is not uncommon to find at opera­
tion relatively short and often multiple 
strictures, but deciding which strictures to 
include and how long an excision should 
be has been very difficult in the past. 
Strictureplasty makes management much 
simpler.
I would recommend a variant of the 
technique described in the article. With 
relatively short strictures, the Finney tech­
nique with a GIA stapler is quick and sim­
ple. The technique is similar to that used 
for a Finney pyloroplasty, if one
envisages the stricture as the pylorus. I 
have used this technique, without any 
problems.
Douglas Aldridge, mb,
CH B, FRCSC, FACS 
Ste. 205,
345 Lakeshore Rd. E,
Oakville, Ont.
L6J 1J5
Determining and Rationalizing 
the Supply of Physicians
To the editors.—I was surprised to read 
in your March 1987 issue (pages 77 and 
78) that there is a move afoot to increase 
the number of training slots for general 
surgeons in Canada. The reasons given 
for this philosophy are twofold — that 
there will be an increasing number of 
general surgeons retiring in the future and 
that “ training takes a minimum of 4 
years so there’s no turn on, turn off 
mechanism” .
Before embarking on a project with 
such long-term ramifications, more than 
those two factors should be taken into 
consideration. Surgeons have been retir­
ing ever since the specialty was first 
instituted, so that is nothing new. Even 
though it may take 4 years to train a sur­
geon, he will stay in the pool for up to 
30 years making the “ turn on, turn off” 
mechanism even more difficult to 
manage. McPhedran talks of the difficul­
ties encountered in trying to increase the 
number of training slots. That is mere 
child’s play when compared to the 
difficulties encountered when trying to 
reduce the number of training slots 
because of many vested interests.
The figures quoted are based on sim­
ple historical population statistics. These 
do not take into account the fact that the 
number of surgical procedures is slowly 
being reduced. For example, until the 
1970s, peptic ulcer surgery was so com­
mon that even junior residents were given 
an opportunity to perform gastric and 
duodenal surgery. Then came H2 block­
ing agents. During that same era, rheu­
matic heart disease provided cardiac sur­
geons with an endless supply of patients
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requiring valve replacements. Today, they 
have to content themselves with doing 
coronary artery bypass surgery, for rheu­
matic heart disease has disappeared. In 
our hospital last year, the introduction 
and aggressive use of indomethacin 
intravenously in neonates with patent 
ductus arteriosus has made duct ligation 
a rare event. Over the last three decades 
the incidence of appendicitis has dropped 
to half what it was in the pre-antibiotic 
era. Since medical research continues at 
an ever-increasing pace, one can antici­
pate that the number of diseases requir­
ing surgery for their cure will continue to 
decline.
In the United States there is now an 
oversupply of surgeons. In 1974, the aver­
age number of surgical procedures per­
formed per individual surgeon was 217. 
It had decreased by 1979 to 176 and by 
1984 to 161.' This is an average of one 
procedure every other day. What an 
incredible waste of manpower. How are 
junior surgeons going to gain the 
experience and proficiency that are such 
a necessary part of their profession? It is 
stimulating and exhilarating to be busy 
and most surgeons are quite capable of 
handling a much greater caseload without 
difficulty. Concurrently, because of 
increased experience and practice, they 
may even perform better surgery.
Donald Nuss, mb, ch b, frcsc, facs
Ste. 200,
400 West Brambleton Ave.,
Norfolk,
Va. 23510-1193,
USA
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Value of Trauma Centres
To the editors.—The recently published 
article by Roy (Can J  Surg 1987; 30: 
17-22), regarding the value of trauma 
centres, points out clearly the difficulties 
faced by health-care planners, surgeons 
and politicians in assessing the impact of 
regional trauma centres on the care of the 
acutely injured patient. Unfortunately, as 
Roy has pointed out, a great deal of the 
often-quoted data is anecdotal or publi­
cations of case series, with few well- 
designed prospective trials. Moreover, an 
overwhelming number of these reports 
come from the United States where injury 
patterns are known to differ from those 
in Canada. To a certain extent, similar 
disparities already exist in Canada with 
respect to injury patterns and outcomes 
(e.g., quoted population differences 
between Sunnybrook Medical Centre and 
St. Michael’s Hospital in Toronto).
Several other factors relevant to the 
trauma-centre argument should be 
explored before any system of regional 
trauma care can be established in any 
region of Canada:
• An analysis of the morbidity of all 
trauma patients treated in trauma centres 
versus non-trauma centres.
• Mortality and morbidity of patients 
who are not identified as having major 
trauma (injury severity score greater than 
or equal to 16, trauma score less than or 
equal to 12).
• The incremental costs of trauma 
care in trauma versus non-trauma centres.
Such factors as these necessarily point 
to well-designed before-and-after studies 
of trauma patterns, which would then be 
followed by the development of regional 
trauma units (i.e., a true establishment of 
need in a given region).
I wholeheartedly support Dr. Roy’s 
argument that accurate well-designed 
provincial trauma registries (independent 
of hospital medical records) must be 
firmly in place to answer all of these ques­
tions.
However, I take some exception to Dr. 
Roy’s concluding remarks in this other­
wise excellent article. Just as there is 
inconclusive evidence in the medical liter­
ature regarding trauma centre designation 
and acutely injured outcomes, so I must 
ask the question, “ Is there evidence that 
the Advanced Trauma Life Support 
Course makes any difference to trauma 
care in these situations?” In addition, in 
my experience, emergency physicians no 
longer need further education in early 
trauma care. This needs to be directed to 
family physicians who infrequently take 
emergency calls in their community hospi­
tals, and to general and orthopedic sur­
geons who think that their FRCSC auto­
matically qualifies them as experts in 
resuscitation of traumatized patients.
M.J. G irotti, md, frcsc
Director of trauma services,
Toronto General Hospital,
200 Elizabeth St.,
Toronto, Ont.
M5G 2C4
To the editors.—All of Dr. Girotti’s 
points are well taken. As a group, emer­
gency department physicians in university 
teaching hospitals are probably the best 
providers of advanced trauma life support 
in Canada. By “ emergency physicians” 
I meant simply the providers of primary 
care, particularly at the periphery. This 
would, of course, include many family 
physicians who only do occasional emer­
gency department duty. This should 
definitely be the target group in any such 
educational program. That is not to say 
that an FRCSC should be interpreted as 
a licence to resuscitate. Many residency
programs, including our own, offer the 
Advanced Trauma Life Support Course 
as part of the program, and the McGill 
University Medical School offers it to all 
medical students at the clinical clerkship 
level.
I have no proof that the Advanced 
Trauma Life Support Course per se 
makes a detectable difference. It is merely 
a framework, a cookbook if you like, to 
be followed. However, I know of no 
other method that will efficiently teach a 
group of physicians in a short period the 
essentials that I feel are necessary for 
optimal resuscitation and treatment in the 
“ golden hour” .
Peter D. Roy, md, frcsc
Ste. 4128,
Ambulatory Care Centre,
Victoria General Hospital,
Halifax, NS 
B3H 2Y9
Knee Disassembly
To the editors.—The paper entitled “ Role 
of total knee replacement in failed knee 
fusions” in the January 1987 issue of the 
journal (pages 25 to 27) is pioneering. 
However, the statement that “nothing has 
yet appeared in the literature on disassem­
bly” is not correct.
A case1 treated by Wright was 
described as follows: a 26-year-old 
woman with previous knee fusion for 
tuberculosis at age 13 had a simple 
arthroplasty done, followed by spontane­
ous ankylosis, then a Walldius total knee 
replacement. One year later, loosening 
required revision with cementing. At 5 
years, the patient passively flexed (by 
gravity) to 80°, had no active extension, 
but by hand lifted her knee straight when 
getting up from a chair. The gait was 
acceptable and she was happy with the 
result to that point.
T.N. Siller, md, frcsc
Scarborough Grace General Hospital,
3030 Birchmount Rd.,
Scarborough, Ont.
M1W 3W3
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To the editors.—I should like to apolo­
gize to Dr. Siller for omitting mention 
of the case he describes in Cruess and 
Mitchell’s book on degenerative arthritis 
of the lower limb.
What is of interest in the case described 
by Siller is the lack of active extension. 
In the most recent fusion takedown I have
228 VOLUME 30, NO. 4, JU LY 1987 /  THE CANADIAN JOURNAL OF SURGERY
done, I found the patellar tendon exqui­
sitely thin and was very concerned about 
the possibility of rupture. I therefore rein­
forced it with a couple of wire loops 
extending from above the patella to drill 
holes in the tibia. This man has powerful 
extension, but is very, very slow in gain­
ing flexion.
The finding of a very thin patellar ten­
don suggests that the patient reported by 
Dr. Siller had in fact a patellar tendon 
rupture, which would explain her loss of 
active extension.
H ug h  U . Ca m eron , m b , ch  b , frcsc 
Ste. 318,
43 Wellesley St. E,
Toronto, Ont.
M4Y 1H1
Resection of the Liver
for Metastatic Disease
To the editors.—We are grateful for the 
opportunity to respond to Dr. Gately’s 
editorial.
We all recognize that, ultimately, the 
ideal study to decide the relative merit of 
alternative forms of therapy, is a prospec­
tively randomized double-blind controlled 
trial. Unfortunately, this is not a perfect 
world!
Since less than 15% of patients with 
colorectal cancer and liver metastasis will 
be candidates for resection, the experience 
of any one institution is going to be 
extremely small. Indeed, it was only by 
creating a registry and personally review­
ing the records and experience of a great 
many institutions across the country that 
Foster1 was able to suggest this was a 
viable and perhaps superior treatment 
option in the hands of experienced hepatic 
surgeons. The number of subsets to be 
analysed is also great. They include: stage 
of the primary tumour; age and sex of the 
patient; synchronous versus metachro­
nous hepatic metastasis; size and number 
of liver metastases; extent of hepatic 
resection required, etc. A large mul­
ticentre (if not multinational) trial with 
all its inherent difficulties and tremendous 
expense would be necessary. In addition, 
the difficulty in generating a concurrent 
control group of untreated patients is 
real. There is still a place, and indeed a 
necessity at this stage, for major institu­
tions and hospitals to report their experi­
ences to the surgical community at large.
Gately’s suggestion that “ the core of 
the paper is a life-table analysis of the sur­
vival of 25 patients who...underwent 
hepatic resection for metastases” is incor­
rect and myopic. Our article was entitled 
“ Hepatic resection for metastatic dis­
ease” and not “ Survival after hepatic 
resection...” as implied in Dr. Gately’s 
editorial comments. It was intended to
share and communicate our total experi­
ence with hepatic resection for metastatic 
disease including types of procedures, 
mortality and complications, and to relate 
outcome to the various subsets previously 
described, looking for apparent differ­
ences that might lead to better patient 
selection.
In reporting our observed survival, we 
have presented data in a form compara­
ble to that reported by other authors who 
also use life-table methods. Our epidemi­
ologists and statisticians at McGill were 
consulted before we collected our data 
and they agreed that this was the best 
method of presentation. We certainly do 
recognize the limitations of this method 
and have clearly indicated the number of 
patients under observation at each 
6-month interval on every life table 
reported in the article. Furthermore, we 
deliberately presented, in Table IV, 
“ Observed Survival (in Months)”  and 
have clearly stated throughout that the 
life-table curves generated only a 
“ projected survival figure” . Since 
patients were being entered in the study 
up to 1985, it goes without saying that 
most will not have been observed for 5 
years! Dr. Gately himself states that “ the 
life table is the best method for handling 
longitudinal data when patients enter a 
study at different times and at its conclu­
sion have been observed for different 
lengths of time” . If the life-table method 
is not the “ best-fit”  method for 
representing these data, Dr. Gately has 
not told us which method is. We have 
been careful to avoid making statistical 
conclusions or analyses based on 
projected numbers at 5 years.
Dr. Gately correctly notes that the two 
operative deaths were omitted from the 
original life-table analysis. We are 
attempting to look at the effect o f a sur­
gical intervention on the biology and 
natural history of hepatic metastases. 
This is not a cost-benefit analysis and 
operative deaths, of necessity, must be 
excluded in this context. That is not to say 
that operative mortality is unimportant. 
It is incumbent upon any surgeon and 
institution to prove that this operation 
can be accomplished with low morbidity 
and mortality and was a greater impetus 
for us to review and discuss our own data 
than to analyse survival.
With small sample size, estimates of 
long-term survival will be imprecise as Dr. 
Gately correctly emphasizes. All institu­
tions must continually update and report 
their survival figures with time and we are 
currently in the process of doing so with 
18 additional months of follow-up. To 
our dismay, recurrences are being seen as 
an ongoing event; however, regardless of 
the ultimate overall survival data, there 
is no question that in some patients sur­
vival is being prolonged with a potential 
for “ cure” in a few. At no time is “ reli­
ance...placed upon comparison with 
historical control groups described by 
other authors”  as Gately states. The fact 
that Adson and  associates2 reported that 
20% of patients who had unresected soli­
tary lesions lived 3 years or more does not 
detract from our report that 13 of 23 
patients at risk , taking all subgroups, 
were alive and free of disease a mean o f 
24 months after hepatic resection. How 
better to define and select the subgroup 
with greatest potential for gain is the 
present interest. This will come with 
newer and better methods of detecting 
subclinical extrahepatic metastasis prior 
to undertaking hepatic resection, not by 
more concurrent control groups o f  
untreated patients as suggested by Dr. 
Gately.
M arvin  J. W e x l e r , m d , frcsc  
J em i O lak, m d
Department o f  Surgery,
Royal Victoria Hospital,
McGill University,
687 Pine Ave. W,
Montreal, PQ  
H3A 1A1
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There’s method to our madness here. We’re dramatizing a point about Marcaine:* 
The point is, Marcaine lasts a lot longer than other local anaesthetics. Up to 
twice as long, in fact. (See Covino, B.G. and Scott, D.B. Handbook of Epidural 
Anaesthesia and Analgesia. Grune & Stratton. In Orlando, 1985; 70.)
Since Marcaine lasts twice as long, our ad is twice as long. We understand 
that you may not have the time at one sitting to read and digest the amount of 
information shown here. But if you’ve read this far, you have the main point 
about Marcaine, the reason why it is so well respected and so well used, and later 
we’d like to table some discussion points about additional uses for Marcaine, 
and perhaps reacquaint you with its other advantages, such as the degree of 
participation it allows the mother in labour, and the fact it is 95% plasma protein 
bound which limits the amount of drug transfer across the placental barrier to 
the  foetus.
Longer duration is the key benefit of Marcaine to the anaesthetist. It lasts 
up to twice as long as lidocaine which means that you can achieve optimum 
pain control during surgical procedures. It also saves the obstetric anaesthetist 
time because fewer top-ups are necessary with Marcaine (see Ostheimer, G.W., 
Regional Anaesthesia Techniques in Obstetrics, Breon Laboratories Inc., 1980, 
p.23). But another key point about Marcaine is that it separates sensory from 
motor block. Excellent sensory anaesthesia can be obtained with less motor 
block than any other local anaesthetic. This separation allows for complete pain 
relief during and after surgery, yet lessens immobility in the post-operative 
phase. In obstetrics, Marcaine can maintain the mother’s ability to bear down 
in labour while providing relief of pain. Greater involvement and cooperation of 
the mother are considered desirable in obstetrics for the 80’s. (The reference 
material in the above paragraph outlines data on this phenomenon as well as 
evidence for the duration of Marcaine.)
Indeed, the long duration of Marcaine (and in actual fact, Marcaine can 
last twice as long as other, injectable local anaesthetics) not only reduces the 
time you spend because of fewer top ups during a procedure, it produces an 
extended pain free period in the mother after the birth when perineal repair has 
been required. Unlike general anaesthesia, the mother is also conscious during 
and immediately after the delivery so bonding and breast feeding can occur 
earlier.
What are the advantages of Marcaine and epidural anaesthesia relative to 
general anaesthesia? First and foremost is the avoidance of one of the principal 
hazards of general anaesthesia, i.e. vomiting and aspiration of stomach contents. 
Secondly, consider the area of endocrine stress response to anaesthesia and 
surgery (Lindall, S., et al: Endocrine Stress Response during General and Epidural 
Anaesthesia for Elective Caesarean Sections, Acta Anaesthesiol Scand. 1983;
27:50-55). With inhalation anaesthesia maternal plasma levels of cortisol and 
ACTH - endocrine stress markers - are consistently higher. The foetus may have a 
higher endocrine stress response.
And the argument can be effectively summarized by this statement: 
“Bupivacaine (Marcaine) is currently established as the safest and most 
effective amide-linked local anaesthetic for obstetric anesthesia? (Bromage P.R: 
Choice of Local Anesthetics in Obstetrics. In Shnider, S.M. and Levinson, G. 
(eds.): Anesthesia for Obstetrics. The Williams & Wilkins Company, Baltimore, 
1979,113.) And this statement: “The clear advantages to the post-partum 
mother are sufficient grounds for encouraging the teaching and eventually the 
routine use of epidural anaesthesia for caesarean section on all suitable patients? 
(Morgan B.M., et al: Anaesthetic Morbidity Following Caesarean Section Under 
Epidural or General Anaesthesia. The Lancet. 1984: 328-330). We have already 
mentioned the longer duration of Marcaine and the additional benefit that 
Marcaine is 95% plasma protein bound which limits the amount of drug transfer 
across the placenta to the foetus. Marcaine also causes minimal foetal and neo­
natal depression of neuro behaviour and muscle tone.
At this point, please allow for a pertinent digression from the discussion 
on the longer duration of Marcaine and other benefits.
INDICATIONS: Peripheral nerve block, infiltration, sympathetic blockade, 
caudal, epidural, and pudendal blocks.
CONTRAINDICATIONS: Bupivacaine is contraindicated in persons with 
known sensitivity to local anesthetics of the amide type. The use of bupivacaine 
is contraindicated in the presence of sepsis near the site of proposed injection, in 
severe shock and in heart block.
WARNINGS: USAGE IN PREGNANCY: Decreased pup survival in rats and 
an embryocidal effect in rabbits have been observed when bupivacaine 
hydrochloride was administered to these species in doses comparable to nine 
and five times respectively the maximal recommended daily human dose 
(400 mg). There are no adequate and well-controlled studies in pregnant women 
of the effect of bupivacaine on the developing fetus. Bupivacaine hydrochloride 
should be used during pregnancy only if the potential benefit justifies the
potential risk to the fetus. This does not exclude the use of Marcaine 0.25% or 
0.50% at term for obstetrical anesthesia or analgesia.
OBSTETRICS: The highest (0.75%) concentration is not recommended for 
obstetrical anesthesia. There have been reports of cardiac arrest with difficult 
resuscitation or death following its use for epidural anesthesia in obstetrical 
patients. Due to the high risk to the fetus, paracervical block is no longer 
recommended. The obstetrician is warned that severe persistent hypertension 
may occur after administration of certain oxytocic drugs, if vasopressors have 
already been used during labor (e.g. in the local anesthetic solution or to correct 
hypotension). Until further experience is gained in children younger than 12 
years, administration of bupivacaine in this age group is not recommended. 
PRECAUTIONS: RESUSCITAnVE EQUIPMENT AND DRUGS SHOULD 
BE READILY AVAILABLE WHEN ANY LOCAL ANESTHETIC IS USED. 
The safety and effectiveness of local anesthetics depend upon proper dosage, 
correct technique, adequate precautions, and readiness for emergencies. 
Marcaine (bupivacaine) should be used cautiously in persons with known drug 
allergies or sensitivities, particularly to the amide-type local anesthetics. Caution 
is advised in administration of repeat doses of bupivacaine to patients with 
severe liver disease. The following precautions apply to all local anesthetics: 
Select needles of proper length and bevel for the technique employed. Inject 
slowly with frequent aspirations and if blood is aspirated, relocate the needle. 
Inadvertent intravascular injection may cause serious complications. Absorption 
is more rapid when injections are made into highly vascular tissues. In caudal or 
epidural anesthesia, abandon the method if the subarachnoid space has been 
entered, as shown by aspiration of spinal fluid. The lowest dosage that gives 
effective anesthesia should be used, to avoid high plasma levels and serious 
systemic side effects. Injection of repeated doses of bupivacaine may cause a 
significant increase in blood levels due to accumulation of the drag or its 
metabolites or slow metabolic degradation. Tolerance varies with the status of 
the patient. Debilitated, elderly and acutely ill patients may require reduced 
doses commensurate with age and physical condition. It should be remembered 
that solutions containing a vasopressor agent, e.g. epinephrine, should be used 
with caution, if at all, in patients who are receiving monoamine oxidase 
inhibitors or anti-depressants of the triptyline or imipramine type, because 
severe, prolonged hypertension may result. Dose-related cardiac arrhythmias 
may occur if preparations containing epinephrine are employed in patients during 
or immediately following the administration of chloroform, halothane, 
cyclopropane, trichloroethylene or other related agents. In deciding whether to 
use these products concurrently in the same patient, the combined action of 
both agents upon the myocardium, the concentration and volume of vasocon­
strictor used, and the time since injection, when applicable, should be taken into 
account. The decision to use a local anesthetic containing a vasoconstrictor in 
areas with a limited blood supply or in patients with peripheral vascular disease, 
will depend on the physician’s appraisal of the relative advantages and risks. 
Local anesthetics which contain preservatives, i.e. those supplied in multiple 
dose vials, should not be used for caudal or epidural anesthesia.
EPIDURAL USE: It is advised that a test dose, generally 2-3 mL of 0.5% 
bupivacaine (or other amide anesthetic) containing 1:200,000 epinephrine (10-15 
micrograms) be administered to check that the spinal canal or a blood vessel has 
not been entered while locating the epidural needle or catheter. In the event of 
spinal injection clinical signs of spinal block would become evident in a few 
minutes. In the event of intravascular injection a transient increase in pulse 
rate and possibly momentary increase in systolic blood pressure are usually 
detectable with a monitor. The other symptoms and signs of “epinephrine 
response” are less dependable. The effects of other medication the patient has 
received may modify this response. When reinforcing doses are required the test 
dose should be used again to check the catheter location.
ADVERSE REACTIONS: Reactions to bupivacaine are characteristic of those 
associated with amide-type local anesthetics. A major cause of adverse 
reactions to this group of drags is excessive plasma levels, which may be due to 
over-dosage, inadvertent intravascular injection, or slow metabolic degradation. 
Other causes of reactions to these local anesthetics may be hypersensitivity, 
idiosyncrasy, or diminished tolerance. Excessive plasma levels cause systemic 
reactions involving the central nervous system and the cardiovascular system. 
The CENTRAL NERVOUS SYSTEM EFFECTS are characterized by 
excitation or depression. The first manifestation may be nervousness, dizziness, 
blurred vision, or tremors, followed by drowsiness, convulsions, uncons­
ciousness, and possibly respiratory arrest. Since excitement may be transient or 
absent, the first manifestation may be drowsiness, sometimes merging into 
unconsciousness and respiratory arrest. Other central nervous system effects 
may be nausea, vomiting, chills, constriction of the pupils, or tinnitus. The 
CARDIOVASCULAR MANIFESTATIONS of excessive plasma levels may
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include depression of the myocardium, blood pressure changes (usually 
hypotension), and cardiac arrest. Recent clinical reports and animal studies 
suggest this may be more likely to occur with the long acting amide local 
anesthetics such as bupivacaine. .
ALLERGIC REACTIONS are characterized by cutaneous lesions (e.g. 
urticaria, edema) and other manifestations of allergy. Reactions following 
epidural or caudal anesthesia may include: high or total spinal block, urinary 
retention; fecal incontinence, loss of perineal sensation and sexual function; 
persistent analgesia, paresthesia, and paralysis of the lower extremities; 
headache and backache; and slowing of labor and increased incidence of forceps 
delivery. It should be noted that reactions due to systemic absorption may be 
slow or rapid in onset. Those of rapid onset include respiratory depression, 
cardiovascular collapse and cardiac arrest. This type of reaction necessitates a 
high degree of preparedness since it can occur with little warning.
In co-ordinated studies of 3200 procedures carried out by 15 investigators, 
there were 2 severe systemic reactions. Both patients experienced convulsions 
as a result of inadvertent vascular injection. Fetal bradycardia has been 
observed with the use of bupivacaine. Most cases, including a few fatalities, 
occurred when the paracervical route was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vasoconstric­
tion in unanesthetized areas which may last for several hours.
TREATMENT OF OVERDOSE AND SEVERE REACTIONS: Toxic effects of 
local anesthetics require symptomatic treatment; there is no specific cure. The 
physician should be prepared to maintain an airway and to support ventilation 
with oxygen and assisted or controlled respiration as required. Supportive 
treatment of the cardiovascular system includes intravenous fluids and, when 
appropriate, vasopressors (preferably those that stimulate the myocardium). 
Convulsions may be controlled with oxygen and intravenous administration, in 
small increments, of a barbiturate or muscle relaxant, as follows: preferably, an 
ultra short-acting barbiturate such as thiopental or thiamylal, if this is not 
available, a short-acting barbiturate (e.g. secobarbital or pentobarbital) or a 
short-acting muscle relaxant (succinylcholine). Intravenous muscle relaxants 
and barbiturates should only be administered by those familiar with their use. 
DOSAGE AND ADMINISTRATION: As with all local anesthetics, the dosage 
varies and depends upon the area to be anesthetized, the vascularity of the 
tissues, the number of neuronal segments to be blocked, individual tolerance, 
and the technique of anesthesia. The lowest dosage needed to provide effective 
anesthesia should be administered.
In recommended doses, bupivacaine produces complete sensory block, 
but the effect on motor function differs between the three concentrations.
0.25% when used for caudal, epidural, or peripheral nerve block, produces 
incomplete motor block. Should be used for operations in which muscle re­
laxation is not important, or when another means of providing muscle relaxation 
is used concurrently.
0.5% provides motor blockade for caudal, epidural, or nerve block, but 
muscle relaxation may be inadequate for operations in which complete muscle 
relaxation is essential.
0.75% produces complete motor block. This concentration is recommended 
only for epidural block (single dose) in abdominal operations requiring complete 
muscle relaxation without the aid of other medication. It is not recommended for 
epidural block in obstetrical patients.
The duration of anesthesia with bupivacaine is such that, for most pro­
cedures, a single dose is sufficient. Maximum dosage limit must be 
individualized in each case after evaluating the size and physical 
status of the patient, as well as the usual rate of systemic absorp­
tion from a particular injection site. Most experience to date is 
with single doses of bupivacaine up to 225 mg with epinephrine 
1:200,000 and 175 mg without epinephrine; more or less drug 
may be used depending on individualization of each case. At 
present there is insufficient clinical evidence with multiple 
dosage or intermittent dose techniques to permit precise re­
commendations for such procedures to be given. However 
limited clinical experience in this area of use indicates that 
bupivacaine may be repeated in 3 to 6 hours up to a maxi­
mum dose of400 mg in 24 hours. In most cases the duration 
of anesthetic effect"is prolonged by the addition of epine­
phrine. The following table is presented as a guide to the use 
of bupivacaine. The doses shown have generally proved 
satisfactory for the average adult. They may require adjust­
ment in relation to age and the physical condition of the 
patient.
RECOMMENDED CONCENTRATIONS AND DOSAGE FOR ADULTS
Type of Block Concentration mL mg Motor Blockl
Local Infiltration 
EpiduraP
EpiduraP 
Test Dose
Peripheral Nerves 
Sympathetic
0.25%
0.75% 2
0.50%
0.25%
0.50%
w/epi
0.50%
0.25%
0.50%
0.25%
0.25%
up to max 
10-20 
10-20 
10-20 
2-3
15-30
15-30
5-30
5-60
20-50
up to max 
75-150 
50-100 
25- 50 
10- 15 
(10- 15/ig 
epinephrine) 
75-150
37.5- 75 
25-150
12.5- 150 
50-125
Complete
Moderate to Complete 
Partial to Moderate
Moderate to Complete 
Moderate
Moderate to Complete 
Moderate to Complete
1. With continuous (intermittent) techniques in caudal and epidural block using 0.25 and 0.5% solutions, 
repeat doses increase the degree of motor block. The first dose of 0.5% may produce complete motor block 
in most intercostal nerve blocks for intra-abdominal surgery, the 0.25% concentration has produced 
satisfactory motor blockade.
2. For single dose use not for intermittent technique.
3. Use of an appropriate test dose is recommended prior to injecting the full epidural dose (see “Precautions”)
AVAILABILITY: ISOTONIC SOLUTIONS:
0.25%-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without 
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative) 
without epinephrine (boxes of 1).
0.50% -  3 mL single dose ampuls (without preservative) with epinephrine (boxes of
10).
-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without 
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative) 
without epinephrine (boxes of 1).
0.75% -  3 mL single dose vials (without preservative) without epinephrine (boxes 
of 5).
The solutions are made isotonic with NaCl and the pH is adjusted with 
NaOH or HC1. The pH range for solutions without epinephrine is 4.0-6.5 and 
for solutions with epinephrine is 3.4-4.5. Plain solutions may be autoclaved but 
those containing epinephrine may not. Each mL of solution with epinephrine 
contains 0.0091 mg epinephrine bitartrate with 0.5 mg sodium metabisulfite.
0.001 mL monothioglycerol, and 2 mg ascorbic acid as antioxidants, 0.002 mL 
60% sodium lactate buffer and 0.1 mg edetate calcium disodium as stabilizer. 
Product Monograph is available on request.
Marcaine allows better participation of the mother in labour. Marcaine is 
95% plasma protein bound which limits the amount of drug transfer across the 
placenta to the foetus.
But first and foremost, Marcaine offers longer duration of pain control 
needed for surgical and obstetrical procedures.
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What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
Fees and Benefits:
a Challenge to Universality of Medicare
The schedules of benefits paid for by 
provincial health insurance plans across 
Canada are likely to change markedly in 
the next few years, as Alberta joins BC 
as provinces that have disallowed some 
payments previously supported.
In Alberta in mid-May, the government 
cut back its list of “ basic health services” 
in an effort to save $40 million and asked 
the public to help save another $25 mil­
lion. When the Alberta government 
announced that it would no longer auto­
matically pay for, among others, gas­
troplasty, eye examinations, circumcision, 
sterilization (and reversal operations) or 
blepharoplasty, the country turned 
toward Ottawa to hear the federal 
response. Health and Welfare Minister 
Jake Epp replied a few days later that 
such cutbacks would not endanger trans­
fer payments as long as the services were 
not medically necessary.
In an open letter to Albertans, the 
Minister of Hospitals and Medical Care 
said, “ Since 1980 costs have more than 
doubled...we have seen the price tag for 
health-related services rise from $1.1 bil­
lion in 1980 to approximately $3 billion 
in 1986, or from under $600 for every 
Albertan...to $1300....” The letter, signed 
“ Marv Moore” , solicited public help: “ In 
order to meet our budgetary target of 
having no increase in the present expen­
diture of $694 million for the Alberta 
Health Care Insurance Plan, it will be 
necessary to save a further $25 million. 
If we all help by using our health care sys­
tem in a responsible manner and perhaps 
using the system one time less, then I 
believe we can save even more and suc­
ceed in preserving the quality of our serv­
ices for years to come.”
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, 
PO Box 8650, Ottawa, Ont. K1G 0G8.
The news release accompanying the 
announcement said, “ ...a new restruc­
tured Utilization Committee is being 
formed and will be working particularly 
in the area of reducing unnecessary med­
ical tests and x-rays which have escalated 
dramatically in recent years” .
At present, the concern about rising 
costs may be the only universal element 
in the provinces’ health systems despite 
the Canada Health Act. Efforts to 
increase the funds available to pay the bill 
included New Brunswick’s official ban of 
extra-billing at the end of March, thus 
making that province the last to become 
eligible for transfer payments withheld by 
the federal government.
Earlier this year the Manitoba govern­
ment refused a medical fee increase that 
was recommended by a three-lawyer 
arbitration team. The government later 
changed its position, citing ambiguity in 
the arbitrators’ report as the reason for 
its reticence in accepting the 5.6% 
increase in fees and the 0.9% increase 
anticipated for growth in utilization. The 
refusal came during the first test of an 
agreement between the province and the 
medical association to put an end to extra­
billing.
The recent move by Alberta, now given 
the federal nod, is likely to become 
popular.
A look at the different schedules for 
fees and benefits shows that some 
provinces have more freedom to maneu­
ver than others. For example, Ontario 
and Alberta have agreed to pay for one 
complete annual health examination for 
each resident, whereas this is not a benefit 
in many other provinces; Newfoundland 
has a clause permitting payment for con­
sultations required by law or statute 
“ presumably in the best interest of 
patients and hospitals” , but other 
provinces specifically forbid such pay­
ments.
The differences in benefits are likely to 
be closely scrutinized in future, as is the 
lack of parity in payments to practi­
tioners. Theoretically, accessibility is at 
risk for patients who come from a 
province where practitioners have fallen 
far behind in their fee increases.
A sampling of surgical procedures 
(Table I) for which payment is allowed 
in all the provinces indicates the great var­
iation in amounts paid; the preambles for 
the schedules in some instances offset the 
differences, in others increase them. 
Regular “ business” hours for physicians 
vary from 9 hours in Alberta, Newfound­
land and Saskatchewan to a high of 13 
for GPs in Quebec, where Saturday is 
considered part of the work week.
The fee for most surgical procedures in 
Quebec includes 90 days of preoperative 
care and 15 days of postoperative care. 
Although all the other provinces also 
include some preoperative and postoper­
ative care in the price of the procedure, 
most allow surgeons to charge a fee for 
the major consultation, include some 
premium for performing the procedure 
outside normal business hours or add a 
surcharge for special visits.
QMA Continues Bid 
to Negotiate Fees
The discrepancies in Quebec physi­
cians’ reimbursements when compared 
with practitioners in the rest of Canada 
prompted the Quebec Medical Associa­
tion to draft a new schedule for GPs in 
an attempt to gain negotiating power for 
the province’s physicians. Last year, the 
QMA’s bid for negotiating power for 
specialists was rejected by government 
primarily because it was presented dur­
ing fee negotiations with the Federation 
des medecins specialistes du Quebec. The 
QMA is appealing the decision, maintain­
ing that negotiations are continuous and 
text continued on page 307
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Table 1- Selected D ifferences in the Preambles and Fees Listed in Provincial Schedules
Quebec New New- Prince Nova Saskat-
GP Specialist Ontario Brunsw ick foundland Edward Island Sco tia chewan Manitoba A lberta Columbia
PREAM BLE
Working hours 08 :00 -21:00  07:00 -19:00  07 :00 -17:00 08:00 -18 :00 08:00-17:00 08 :00 -19:00 0 8 :00 -1 9 :00 08 :00 -17:00 nm 0 8 :00 -1 6 :59  0 8 :00 -18 :00
Special trip charge
$15 $23.35 $28 .25 -
Evenings - 19:00-24:00  17:00-24:00 - 17:00-24:00 19:00-24:00 17:00 -24:00 17:00 -24:00 nm 17:00 -22 :59  18 :00 -23:00
Premium +33% + 30% + 30% + 25% _
Special vis it fee - $36.20 $8.45 $32 .22 $22 $23.25 $39 .75 $29 .40
Night premium - + 50% +50% + 25% (mini- + 50% + 25% _
mum $25.80)
Special vis it fee $31.85 $54.30 - $32 .22 $22 $23.35 $79 .50 $41 .30
Work week M on -Sa t M on-Fri M on-Fri M on-Fri M on-Fri M on -Fri M on -F ri M on -Fri M on-Fri M on -F ri M on -F r i
Surg ical assistan t's  fee 21% of 25% of $8.47/15 min to 35% of $9.67/15 min to 20% (min- 25% (minimum $62.80/1 h; Procedures of $66 .25  for Procedures
major fee major fee 2 h; $16.94/ surgeon fee 2 h; $19.34/ imum $27.45) $15) $18/15 min < $ 1 32 .7 5  - 1 h; $16.50/ < $ 9 7 .5 0  -
+ 10% of + 10% of 15 min thereafter thereafter + units 25% if sur- thereafter $52.90 (+ 15 min $41.10;
others others + units for for procedure geon/referring $17.90 fo r every thereafter $ 9 7 .5 0 -2 9 1 -
procedure GP $88.05) $76.50; $291
-  485  -  $105
Asst, special trip - - $28.50 - - _ $32 .22 $15 $23.35
Evening $42.80 $36.20 $32 .22 $22 $23.35 $39 .75 $29.40
Night $42.80 $54.30 $32 .22 $30 $23.35 $79 .50 $41.30
Premium, evening - - +40% _ +40% _ _
night + 50% + 50%
Preoperative care All: A ll except All: A ll except A ll except All: A ll except A ll unless All: All:
included in 90 d major consul- 30 d major consul- major consul- 30  d major consul- documented 3 0  d 30  d
procedural fee tation tation tation tation
Postoperative care All: All: All: All: All: All: All: All: All: All;
included in fee 15 d 42  d 42  d 8 wk 30 d 30  d 42  d 42 d 42  d 42  d
SUBSEQUENT PROCEDURES, % of normal fee
Same anesthesia, 50 50 85 50 85 50 50 75 50 75 50
same incision
Same anesthesia. 50 50 85 75 85 50 65 75 75 75 75
new incision
Same anesthesia, nm 100 nm nm nm 100 nm nm 100 100 100
different surgeon
New  condition, nm nm 85 nm nm 100 nm nm
with in  14 d
PROCEDURES, S
Arthroscopy, hip 106.10 150 82.50 133.44 104.75 133.55 179 105 99.75 121 93
With biopsy + 26.50 175 + 9.25
With foreign 200
body removal
Arthrotomy, hip 238.70 225 256 258.24 325 356 .15 313 .25 265 293 362 351
Reduction, hip
Closed 103.95 98 227.25 147.84 288.50 133.55 134 .25 133 83 157.50 256
Open 206.85 195 344.60 295.68 437 .50 311 .65 313 .25 292 293 518 428
Bladder, cystectomy
Partial 265.20 250 313.50 295 .68 398 356 .15 358 299 427 249 341
With reimplant 371.30 350 453.70 398 .40 576 445 .20 483 .30 362 514 405 499
of ureter
W ith reimplant 636.55 600 602.60 nm 765 nm nm nm 514 572
of ureters
Urethroscopy 30.95 50 29.10 44.16 37 71.20 53.30 53 .60 29.85 129 .50 96 .50
With biopsy + 10.05 64.20 44.16 81.50 71.20 53 .30 nm nm
With foreign 77.40 75 140.20 110.40 178 133.55 133.25 92 119.50
body removal
Gastroscopy 51.60 50 74.80 88.32 95 133.55 134.25 83 97.25 103.50 96 .50
With biopsy, photo + 15.50 + 15 74.80 88.32 95 133.55 134.25 83 97.25
With foreign + 32 + 35 81.10 147.84 103 nm nm 128
body removal
Wedge resection 230 230 330 .80 292.80 420 320.45 331 .15 542 493 4 74 558
for ulcer
Total gastrectomy 620 620 773.50 650.88 982 712.25 626 .50 669 618 921 826
Gastroduodenostomy/ 254 .60 260 330 .80 292.80 420 320.45 322 .20 327 370 542 315
gastrojejunostomy
With vagotomy 350.10 370 + 130 407 .04 + 165 445 .20 429 .60 4 67 + 88.50 758 461
Pericardiectomy
One side open 297.05 350 519 .90 IC 660 356.15 358 542 688 610 582
Both sides open 488.05 460 819 .20 IC 1040 534.15 537 nm nm nm nm
Cardiotomy
With exploration 265.20 250 430 .10 IC 546 445 .20 537 440 558 469 4 28
With foreign 328.90 310 519 .90 IC 660 445 .20 447 .50 444 nm 836
body removal
nm -  not mentioned; 1C - independent consideration.
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Care of the Ureter in Pelvic Surgery
Maintaining the integrity of the ureter is 
crucial in pelvic surgery. The ureter is 
best safeguarded by routine intraopera­
tive exposure, which will also allow 
immediate recognition of injury to it. If 
doubts over possible injury persist, it is 
best to open the bladder. The flux of 
urine from the ureteric orifices or the 
retrograde passage of catheters will then 
confirm or deny clinical suspicions. If 
specialist help is unavailable, the pelvic 
surgeon must be able to perform simple 
ureteric repairs or temporize in a way 
that allows the safe delay of definitive 
surgery. End-to-end ureteric anastomosis 
and ureteroneocystostomy are straight­
forward procedures that all pelvic sur­
geons should be familiar with. If they 
cannot be performed safely, the situa­
tion may be salvaged by draining the 
proximal ureter through the lateral 
abdominal wall; later, definitive surgery 
can be performed.
En chirurgie pelvienne, il est crucial de 
maintenir I'integrite de I'uretere. Le meil- 
leur moyen de sauvegarder I'uretere con- 
siste a I'exposer de routine durant I'ope- 
ration, ce qui permet egalement de 
reconnaltre les lesions qui pourraient 
I'affecter. Si le doute persiste quant a 
des lesions possibles, mieux vaut ouvrir 
la vessie. L'ecoulement d'urine a partir 
des orifices ur^teraux ou le passage 
retrograde de catheters permettront alors 
de confirmer ou d'infirmer les soupcons 
cliniques. Si on ne peut compter sur 
Taide d'un specialiste, le chirurgien pel
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vien doit etre capable d'effectuer des 
reparations simples des ureteres ou de 
temporiser de facon a permettre de retar­
der I'operation definitive en toute secu­
rity. Les anastomoses ureterales bout-a- 
bout et les ureteroneocystostomies sont 
des interventions simples que tout chirur­
gien du bassin devrait connaTtre. Si elles 
ne peuvent etre pratiqu£es sans risque, 
on peut sauver la situation en drainant 
I'uretere proximale via le cote de la paroi 
abdominale; la chirurgie definitive pou- 
vant etre remise a plus tard.
Pelvic surgeons are concerned with main­
taining the integrity of the ureter, for, 
should injury occur, the postoperative 
course will often be complicated and fre­
quently secondary surgery will be needed. 
This review will detail the circumstances 
surrounding the occurrence of ureteric 
injury and its management. The discus­
sion of repair will be confined to that 
undertaken at the time of surgery; treat­
ment of ureteric injuries that are first 
recognized in the postoperative period 
need not be immediate, and there will be 
time to obtain specialist help.1"3
The Injury
Two-thirds of all iatrogenic ureteric 
trauma occurs during gynecologic sur­
gery, most often for abdominal hys­
terectomy or the excision of uterine 
adnexa.1,4 The hysterectomy is fre­
quently described as “ straightforward” 
and “ uncomplicated” .5 Pelvic inflam­
matory disease, endometriosis, uterine or 
ovarian tumours may displace the ureter 
and contribute to injury but not to the 
extent generally believed. Less common 
sources of injury are abdominoperineal 
or anterior resection of the rectum; the 
ureters are at risk near the point where 
the inferior mesenteric artery is 
ligated.6’7 Vascular surgery also accounts
for a number of ureteric injuries.1 
Hyperangulation and obstruction of the 
ureter may result from placing vaginal 
sutures more laterally than recommended 
during a Burch urethropexy.
The ureter is frequently injured while 
hemostasis is being obtained. Therefore, 
the more common sites of injury are deep 
in the pelvis, close to the point where the 
uterine artery crosses over the ureter and 
at the brim of the pelvis, where the ure­
ter and ovarian vessels converge. The 
usual mechanism of injury is a crush or 
cut of a small portion (less than 1.0 cm) 
of an otherwise normal ureter. In gyneco­
logic surgery for benign disease, the ure­
ter is never “ stripped” and thus its blood 
supply is rarely interrupted.8’9
Prevention
The traditional means of avoiding 
operative injury to the ureter is to stay 
well clear of it. For example, at hysterec­
tomy, dissection is confined to the area 
in close proximity to the uterus. There 
are, however, difficulties with this 
approach. At times, pelvic lesions may so 
distort the ureter’s pathway that a dissec­
tion, believed to be far from the ureter, 
may place it in jeopardy, or a pelvic mass 
may limit the surgeon to dissection in 
areas where direct contact with the ure­
ter is unavoidable. At other times, the 
ureter may be in its usual position, but 
landmarks are lost and the ureter is inad­
vertently clamped, incised or ligated.
The best way to avoid ureteral injury 
is to expose it through a retroperitoneal 
dissection.5 This dissection is not 
difficult and it allows an easier approach 
to pelvic surgery. A further advantage is 
the immediate discovery of any ureteric 
damage.1011
Retroperitoneal dissection is initiated 
by cutting the round ligament at its mid­
point. The peritoneum is incised in a cau­
dal direction for 4.0 cm and the incision
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extended cranially well above any pelvic 
disease. This cranial-directed incision is 
placed lateral to the ovarian vessels 
(infundibulopelvic ligament).
The medial edge of the cut peritoneum 
is grasped with two or three small curved 
forceps and elevated medially. Immedi­
ately beneath the peritoneum a conden­
sation of the endopelvic fascia will be 
seen; the small blood vessels in this layer 
are best cauterized on sight. This prevents 
staining of tissues and enhances the dis­
section. The endopelvic fascia is then 
incised for 3 to 4 cm, giving access to 
loose retroperitoneal tissue that is charac­
teristically free of adhesions. The 
retroperitoneum in this location can eas­
ily be divided with the forefingers.
It is emphasized that dissection must be 
directed both medially and posteriorly to 
avoid the common and internal iliac 
blood vessels. As the surgeon proceeds 
along the medial leaf of the peritoneum, 
the ovarian vessels are first encountered; 
just deep to them, the ureter will be found 
attached to the peritoneum. The ureter is 
usually easy to identify by the peristaltic 
movements, its “ macaroni-like” appear­
ance and the fine blood vessels that cover 
it. The ureter runs from the brim of the 
pelvis (which it enters by crossing above 
the bifurcation of the common iliac blood 
vessels) downward to the medial aspect 
of the lateral cervical ligament. It then 
enters the ureteric canal and passes 
beneath the uterine artery, advancing 
through the vesicouterine ligament into 
the bladder.
The whole course of the ureter (from 
the pelvic brim to the ureteric canal) can 
be traced, with little bleeding, in a few 
moments. A further advantage is that the 
location of the ovarian and uterine ves­
sels has been established.
Recognition
It should be emphasized that most ure­
teral injuries occur after uncomplicated 
surgery when injury to the ureter has not 
been considered.5 Less than one-third of 
injuries are recognized intraoperatively; 
delay compounds the potential complica­
tions. Immediate repair is usually 
straightforward and the postoperative 
result is generally good.1'7-12 
During surgery injury may be suspected 
if an unusual collection of fluid is noted 
in the pelvis or if dissection was especially 
difficult in the vicinity of the ureter.
When the surgeon suspects injury but 
is not willing to expose the ureters, fear­
ing dissection may in turn cause injury, the 
use of indigo carmine or methylene blue 
dye is called for. After the administration 
of 40.0 mg of furosemide (Lasix), a 5-ml 
intravenous injection of the dye is given. 
Discolouration of the fluid in the pelvis 
indicates ureteric injury. If the concern 
is one of ureteric occlusion, patency can
be established by opening the bladder 
through a vertical cystotomy and noting 
the escape of jets of blue urine from the 
ureteric orifices.
If uncertainty persists, the suspect ure­
ters should be catheterized; a no. 8 French 
infant feeding tube serves this purpose 
admirably. The catheterization may not 
be easy, for a mucosal flap can prevent 
passage of the catheter. In such an event, 
tension applied to a suture, temporarily 
placed in the middle of the interureteric 
bar, will straighten the intramural ureter 
and permit the catheter’s passage.
Repair of the Injury
Usually only a small portion of a nor­
mal ureter is damaged, but there is a 
regrettable tendency to underestimate 
such injuries.13’14 Segments crushed by 
suture or forceps should be excised and 
partial transections should be treated as 
though they were complete. Another mis­
take is failure to ensure that the repair 
performed is well clear of any pelvic 
disease.
End-to-End Anastomosis
This method of repair is an uncompli­
cated procedure that restores anatomy 
and preserves the normal vesicoureteric 
junction. Some years ago it was dis­
couraged because stenosis frequently 
occurred at the site of repair. This 
problem can be minimized by enlarging 
the anastomotic site and preventing the 
pooling of urine in the retroperitoneal 
space. Urine in this location excites a 
fibrotic response; this fibrosis outside the 
ureter and the scarring of the ureter itself 
at point of injury may result in obstruc­
tion of the ureter.
To reduce pooling of urine, the anasto­
mosis is made as watertight as possible 
and the area is drained with a Jackson- 
Pratt drain. Years ago it was taught that 
urine must be diverted away from the 
anastomotic site by a vertical relieving 
incision.15 It is now argued that in the 
absence of radiation injury or infection 
diversion is unnecessary.16
A recent introduction is the internal 
splint that not only provides a conduit for 
the urine and thus diminishes leakage but 
also gives support to the anastomosis 
itself. The malleable double-J ureteral 
catheter is particularly attractive because 
it is inert and retains its place in both the 
renal pelvis and the bladder. The use of 
such a stent can be seen as an added safety 
measure and its use is encouraged.
The following technique of anastomo­
sis is suggested. The ureter is first 
debrided to ensure viability and mobilized 
to prevent excessive tension on the suture 
line. The opposing ends are spatulated to 
enlarge the circumference of the anasto­
mosis, and a double-J ureteral catheter is
inserted. A watertight anastomosis is then 
performed using interrupted 5-0 poly- 
glycolic acid sutures through the full 
thickness of the ureteral wall. A 
Jackson-Pratt drain is placed close to the 
anastomotic site and brought out through 
a separate incision.
Ureteroneocystostomy
The ureteral injuries that occur at hys­
terectomy are most often deep in the 
pelvis where limited access makes end-to- 
end anastomosis technically difficult and 
increases the risk of ischemic damage to 
the distal segment of the ureter. In these 
circumstances ureteroneocystostomy, 
using an antireflux technique, is advised. 
Urologists have become increasingly con­
fident with this technique as a result of 
their renal transplant experience.
The principles of repair are similar to 
those already mentioned. The ureter must 
be viable and the anastomosis with the 
bladder must be tension-free and tun­
nelled, but need not be in the region of 
the trigone. Tension-free anastomosis is 
best achieved by mobilizing the bladder, 
as in the Burch procedure, but dissection 
of the proximal portion of the ureter 
should be limited. After viability of the 
ureter is ensured by resection of the 
damaged end, it is brought through the 
muscle wall of the bladder by means of 
a submucous tunnel — the length of the 
tunnel should be five times the diameter 
of the ureter. A mucosa-to-mucosa 
anastomosis is performed between the 
ureter and bladder. A double-J ureteral 
catheter is inserted and a Jackson-Pratt 
drain placed retroperitoneally, close to the 
anastomotic site.
Anastomotic disruption is usually 
caused by tension, which can be avoided 
by mobilizing the bladder, but if adequate 
mobilization is not possible, a psoas hitch 
or the Boari-Ockerblad flap should be 
used.17 Both procedures permit upward 
extension of the bladder so it comforta­
bly reaches the injured ureter. Because of 
its simplicity and better results, the psoas 
hitch has generally replaced the Boari- 
Ockerblad flap.1418 The hitch is per­
formed by first mobilizing the bladder, 
and with two fingers in its interior, a horn 
is created which is sutured to the iliopsoas 
fascia. The site chosen is lateral to and 
above the external iliac artery; care is 
taken not to injure the genitofemoral 
nerve which overlies the psoas muscle in 
that area. Anastomosis with the ureter is 
carried out as described.
Other Maneuvers
There are circumstances in which the 
suggested repairs are not possible; for 
example, a large segment of ureter may 
be missing and a urologist is not availa­
ble. A procedure that allows renal
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drainage but does not place the other kid­
ney in jeopardy or compromise later 
definitive repair, is needed. In these cases, 
a double J ureteral catheter or an infant 
feeding tube is inserted into a linear ure­
terostomy well above the site of injury. 
The catheter or tube is secured and 
brought out through the abdominal wall. 
The ureterostomy is closed in a watertight 
manner and the retroperitoneum  
drained.14
Experienced urologists have other 
options, including transureterouretero­
stomy, ureteral replacement by a segment 
of ileum, mobilization of the kidney, 
renal autotransplantation and nephrec­
tomy. These procedures should not be 
attempted by the less-experienced sur­
geon, as further damage to the urinary 
tract may result.19 Simple ligation of the 
ureter for autonephrectomy should rarely 
be done, for infection and fistula forma­
tion frequently result.20
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Coronary artery disease accounts for 
more than half of the morbidity and mor­
tality associated with abdominal aortic 
surgery. To improve the results of vascu­
lar surgery, the risk of perioperative 
cardiac ischemia should be evaluated in 
each patient. Routine coronary angiogra­
phy demonstrated severe correctable 
coronary artery disease in 14% of 
patients who had no history or elec­
trocardiographic evidence of coronary 
artery disease. Exercise testing before 
abdominal aortic aneurysm repair will 
identify patients at high risk of cardiac 
ischemia. Dipyridamole-thallium imaging 
will identify high-risk patients before sur­
gery for aortoiliac occlusive disease. 
Some patients with symptomatic coro­
nary disease who are at extremely high 
risk should undergo preoperative coro­
nary revascularization. Others should 
have their vascular surgery deferred, 
because their cardiac risk may exceed 
the anticipated benefit of the vascular 
surgery. Patients at moderate risk may 
need more intensive intraoperative 
monitoring. Patients without evidence of 
cardiac ischemia with stress may 
undergo vascular surgery with a low risk
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of perioperative cardiac ischemia. Finally, 
patients who have evidence of ischemic 
heart disease should be considered for 
coronary revascularization following suc­
cessful vascular repair in order to 
prolong their survival.
La maladie arterielle coronarienne repre­
sente plus de la moitie de la morbidity et 
de la mortalite associees a la chirurgie 
aortique abdominale. Pour ameliorer les 
resultats de la chirurgie vasculaire, le ris­
que d'ischemie cardiaque perioperatoire 
doit etre evalue chez chaque patient. 
L'angiographie coronarienne de routine 
demontre une severe et corrigible mala­
die arterielle coronarienne chez 14% de 
patients sans antecedents ni evidence 
electrocardiographique de maladie arte­
rielle coronarienne. Des tests d'exercice 
avant correction de I'anevrisme aortique 
abdominal permettent d'identifier les 
patients presentant un risque elev& 
d'ischemie cardiaque. La visualisation au 
dipyridamole thallium permet d'identifier 
les patients a hauts risques avant chirur­
gie lors de maladie occlusive aortoilia- 
que. Certains patients atteints de mala­
die coronarienne symptomatique et 
presentant un risque extremement eleve 
doivent subir une revascularisation coro­
narienne preoperatoire. D'autres doivent 
avoir ieur chirurgie vasculaire retardee 
car le risque cardiaque peut exceder le 
benefice escompte apres la chirurgie vas­
culaire. Les patients a risque modere 
necessitent une surveillance intraopera- 
toire plus intensive. Les patients sans 
evidence d'ischemie cardiaque lors de 
stress peuvent subir la chirurgie vascu­
laire avec un risque minime d'ischemie 
cardiaque perioperatoire. Finalement, les 
patients presentant des evidences de 
maladie cardiaque ischemique doivent 
etre retenus pour une revascularisation 
coronarienne, suite a une chirurgie vas­
culaire reussie, afin de prolonger Ieur 
survie.
More than half the perioperative mor­
bidity and mortality associated with 
abdominal aortic surgery results from 
coronary artery disease.1-5 In addition, 
the poor long-term survival after success­
ful abdominal aortic surgery usually 
results from coronary artery disease.6-11 
The vascular surgeon must carefully 
assess the risks of perioperative cardiac 
ischemia in each patient before elective 
vascular surgery is carried out.
Improved techniques of intra- and 
postoperative management have 
decreased the risks of abdominal aortic 
surgery and have reduced the frequency 
of perioperative deaths from cardiac 
ischemia. However, the incidence of 
myocardial infarction postoperatively 
remains substantial,5 and a perioperative 
myocardial infarction may limit long­
term survival after vascular surgery.6’7 
Perioperative cardiac injury may also 
induce persistent cardiac symptoms 
postoperatively. Vascular surgeons there­
fore should attempt to minimize perioper­
ative myocardial ischemic injury.
Extent of Coronary Artery Disease
Hertzer and colleages12 performed 
routine preoperative coronary angiogra­
phy in 1000 patients who presented at the 
Cleveland Clinic between 1978 and 1983 
for consideration of elective vascular 
reconstruction. In patients with an 
abdominal aortic aneurysm, 6% had nor­
mal coronary arteries, 29% had mild to 
moderate coronary artery disease, 29% 
had compensated coronary artery disease, 
31 % had severe correctable coronary dis­
ease and 5% had severe inoperable dis­
ease. The Cleveland Clinic group care­
fully reviewed the coronary angiograms 
and the ventriculograms to develop these 
complex categories. They classified coro­
nary artery disease as mild when no lesion 
in a major coronary artery exceeded 70% 
stenosis. Coronary artery disease was
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advanced but compensated when a major 
coronary artery was stenosed but there 
was no immediate indication for 
myocardial revascularization either 
because the region at risk was adequately 
perfused by collateral vessels, or because 
it had already been replaced by a scar 
from a previous myocardial infarction. 
Coronary artery disease was considered 
severe but correctable when a severe coro­
nary artery stenosis supplied a region of 
functioning myocardium which was at 
risk for a myocardial infarction. They 
classified disease as severe and inoper­
able when there was diffuse distal disease 
or inadequate ventricular function.
The Cleveland Clinic group compared 
these results of coronary angiography to 
their suspicion of coronary artery disease 
from clinical examination (Table I). 
Among the 1000 patients (263 with 
abdominal aortic aneurysms, 381 with 
lower limb ischemia, 295 with cerebrovas­
cular disease and 61 with other vascular 
problems), 554 were suspected of having 
coronary artery disease before angiogra­
phy because of a history of myocardial 
infarction or angina pectoris and elec­
trocardiographic evidence of a previous 
infarction, ST- and T-wave changes or a 
left bundle-branch block. Severe correc­
table coronary artery disease was found in 
34% of those suspected of having coronary 
artery disease before angiography (Table 
I) compared with 14% of the patients who 
had no clinical evidence of coronary 
artery disease. Therefore, the patient’s 
history and an electrocardiogram may not 
provide a reliable guide to those at high- 
risk for perioperative ischemic injury.
At the Cleveland Clinic, 250 patients 
underwent coronary angiography before 
abdominal aortic aneurysm repair. Eighty 
patients (32%) had severe correctable 
coronary artery disease. Of the 250 
patients, 76 underwent coronary artery 
bypass grafting and 4 (5.3%) died; 206 
patients then underwent abdominal aor­
tic aneurysm repair and 7 (3.4%) died. 
Overall there were 282 operations, result­
ing in 11 deaths (3.9%). In the entire ser­
ies only one of the patients who had 
undergone coronary bypass grafting 
preoperatively died during or after 
peripheral vascular surgery.
From their experience, Hertzer and 
colleagues12 recommended a modified
approach to identify patients with severe 
but correctable coronary artery disease. 
They recommended preoperative coro­
nary angiography for those with clinical 
indications of coronary artery disease. If 
a major cardiac region was jeopardized 
by a critical stenosis, inadequately per­
fused by collaterals and not damaged by 
a previous infarction, they recommended 
preoperative coronary revascularization. 
In patients who had no clinical indication 
of coronary artery disease, they recom­
mended extensive noninvasive testing to 
identify the 14% of patients who will have 
severe correctable coronary artery disease.
Noninvasive Testing
Two-dimensional echocardiography 
will identify wall-motion abnormalities 
from a previous myocardial infarction but 
will not detect regions at risk of ischemia 
or infarction with stress. Patients with an 
abdominal aortic aneurysm can undergo 
exercise testing to evaluate their risk of 
perioperative ischemic injury. Exercise 
testing with or without thallium imag­
ing13 may identify the extent of inade­
quately perfused cardiac regions during 
exercise. Rest and exercise nuclear ven­
triculography will identify global or 
regional ventricular dysfunction with 
exercise suggesting severe correctable 
coronary artery disease.
Patients with aortoiliac occlusive dis­
ease usually cannot undergo standard 
exercise testing. Thallium imaging before 
and after intravenous administration of 
dipyridamole may identify patients at 
high risk of perioperative ischemic injury. 
Boucher and colleagues14 at the Mas­
sachusetts General Hospital evaluated 54 
patients with suspected coronary artery 
disease before they underwent peripheral 
vascular surgery. Six had abnormal thal­
lium test results and underwent coronary 
bypass surgery before the abdominal aor­
tic procedure, with no cardiac complica­
tions. Twenty patients had normal thal­
lium scans and 12 had persistent thallium 
defects (suggestive of a previous 
myocardial infarction); all 32 underwent 
vascular surgery without cardiac ischemic 
complications. Sixteen patients had evi­
dence of ischemia (thallium redistribu­
tion) with stress (dipyridamole) and 8
suffered cardiac ischemia perioperatively. 
Four patients had a myocardial infarction 
perioperatively and three of them died. 
Four had angina and transient elec­
trocardiographic changes and two under­
went successful coronary bypass surgery.
T herefore, exercise testing or 
dipyridamole-thallium imaging may iden­
tify patients who are at high risk for 
cardiac ischemia perioperatively, but the 
management of these high-risk patients 
remains controversial.
Preoperative Management 
of Coronary Artery Disease
Figure 1 illustrates the preoperative 
management protocol that we have used 
at the Toronto General Hospital to evalu­
ate patients before performing abdomi­
nal aortic surgery. After a complete his­
tory, a physical examination and an 
electrocardiogram, most patients can be 
divided into one of three groups: (a) a his­
tory of previous cardiac events, (b) likely 
to have a cardiac condition or (c) unlikely 
to have a cardiac condition. Preoperative 
evaluation should attempt to identify 
patients who are at high risk of ischemic 
injury perioperatively (severe stenosis in 
a vessel supplying a large segment of 
functioning myocardium) rather than 
identify patients with a cardiac condition. 
Those who have severe ventricular dys­
function but do not show evidence of 
ischemia with stress will require intensive 
monitoring intraoperatively, but they may 
not be at risk of ischemic events perioper­
atively and may not benefit from preoper­
ative coronary revascularization. Patients 
who have angina that is poorly controlled 
with full medical therapy should proba­
bly undergo coronary angiography 
preoperatively. The remaining patients 
should probably undergo noninvasive 
testing that includes an exercise test (with 
electrocardiographic monitoring or 
nuclear ventriculography) or a
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FIG. 1—Preoperative management pro­
tocol. Careful history, physical examination 
and electrocardiogram will determine likeli­
hood of cardiac disease, but noninvasive evalu­
ation may be required preoperatively to iden­
tify those patients who have evidence of cardiac 
ischemia with stress and severe, correctable 
coronary artery disease. Management of these 
patients requires careful assessment of risks and 
benefits of abdominal aortic surgery.
Table I—Angiographic Classification of Coronary Artery Disease 
ICAD) Before Vascular Surgery at the Cleveland Clinic
Angiographic classification
Suspected CAD,*
%
No indication 
of CAD, %
Normal 4 14
Mild 18 49
Compensated 34 22
Severe, correctable 34 14
Severe, inoperable 10 1
"Suspected CAD = cardiac history or an abnormal electrocardiogram.
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Referencesdipyridamole-thallium test (for those who 
cannot exercise). An echocardiogram may 
identify regional abnormalities of wall 
motion or dysfunction of the cardiac 
valve. A cardiology consultation may help 
in selecting the appropriate tests. Nonin- 
vasive testing may identify the 14% who 
have severe correctable coronary artery 
disease without a history of a cardiac con­
dition and the 34% with a history of a 
cardiac condition who have severe correc­
table coronary artery disease.
After preoperative noninvasive evalu­
ation, most patients can be classified into 
one of three groups: low, moderate and 
high probability of suffering cardiac 
ischemia perioperatively. Patients with a 
low probability should undergo routine 
abdominal aortic surgery. Those with a 
moderate probability may require exten­
sive intra- and postoperative cardiac 
monitoring. Experienced anesthetists 
employing intensive monitoring can pro­
vide excellent hemodynamic stability dur­
ing operation that may reduce possibil­
ity of cardiac ischemia. Patients who have 
evidence of myocardial ischemia with 
stress should have the risks and benefits 
of the vascular procedure carefully 
reviewed. Some should undergo vascular 
surgery with intensive monitoring. Some 
should be considered for coronary 
angiography and preoperative coronary 
bypass surgery. For some patients with 
severe coronary artery disease, the risks 
of the vascular procedure may outweigh 
the potential benefits. In these patients 
vascular surgery should be delayed.
Conclusions
Cardiac asssessment before abdominal 
aortic surgery may reduce the incidence 
of cardiac ischemic events perioperatively. 
Preoperative coronary angiography and 
bypass surgery should be reserved for 
patients with documented, severe ische­
mia in response to stress. Patients with 
compensated coronary artery disease or 
ventricular dysfunction can usually 
undergo vascular surgery with extensive 
intraoperative monitoring.
Finally, the long-term survival of 
patients after successful abdominal aor­
tic surgery may depend on the extent of 
their coronary artery disease.6-11 There­
fore, some patients who had evidence of 
myocardial ischemia on preoperative 
noninvasive testing should be referred for 
coronary angiography postoperatively. 
Patients with critical anatomy (stenosis of 
the left main coronary artery) and those 
whose ischemia cannot be controlled with 
medical therapy should be referred for 
late postoperative coronary revasculari­
zation. An increased awareness of the 
risks of coronary artery disease among 
vascular surgeons may improve the long­
term results of abdominal aortic surgery.
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2. Anesthetic Considerations in Abdominal Aortic Surgery
Contributions of the anesthetist to the 
management of patients requiring 
abdominal aortic surgery must comple-
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ment the roles of the cardiologist and 
vascular surgeon. Identification of risk 
factors and assessment of the degree of 
functional impairment of vital organs 
allows the anesthetist the best opportu­
nity to provide the vascular patient with 
as stress-free a surgical experience as 
possible.
Patient profiles, monitoring, induction 
and maintenance phases in the adminis­
tration of the anesthetic, and concerns 
of the early postoperative period are dis­
cussed from the anesthetist's perspec­
tive. General principles are emphasized. 
Specific details of assessment and 
management must be guided by local 
experience and resources.
Les contributions de I'anesthSsiste & la 
surveillance des patients n^cessitant une 
chirurgie aortique abdominale doivent
completer les roles du cardiologue et du 
chirurgien vasculaire. L'identification des 
facteurs de risques et I'etablissement du 
degr£ de deterioration fonctionnelle des 
organes vitaux permettent a I'anesthe- 
siste de fournir au patient de meilleures 
garanties d'absence de complications 
lors de la chirurgie vasculaire.
Les profils des patients, le monitoring, 
les phases d'induction et de maintien 
lors de ('administration de I'anesthesique, 
ainsi que la surveillance du stade pre- 
coce postoperatoire sont discutes sous la 
perspective d'un anesthesiste. Les princi- 
pes generaux sont degages. Les details 
specifiques devaluation et de controle 
doivent etre guides par ('experience 
locale et les ressources disponibles.
Mutual understanding of the respective 
contributions of medicine, surgery and
VOLUME 30, NO. 4, JU L Y  1987 /  THE CANADIAN JOURNAL OF SURGERY 239
anesthesia can benefit the patient who 
presents with abdominal aortic disease. 
Advances in technique and aggressive 
monitoring have become the benchmarks 
of anesthesia’s contribution.
This discussion will outline the extent 
of anesthesia’s role. I shall begin with 
some comments on patient profile and 
monitoring, then consider induction, 
maintenance and the early postoperative 
period.
Patient Profile
The medical profile of a patient sched­
uled to undergo abdominal aortic surgery 
has been well documented. Given its 
generalized nature and the host of 
predisposing factors contributing to its 
onset, patients with atherosclerosis who 
require abdominal aortic surgery may 
present with disease and functional 
impairment of the heart, lungs, kidneys 
and brain.
By interviewing the patient preopera- 
tively and reviewing the investigative data 
on the chart, the anesthetist can assess the 
functional reserve of the vital organs.
Myocardial function has repeatedly 
been demonstrated to be the most impor­
tant factor in determining patient out­
come after aortic surgery. Through a his­
tory of congestive failure or limited 
physical activity, the patient with func­
tional impairment of the left ventricle will 
be relatively easy to identify. The patient 
without an abnormal cardiac history 
presents a more difficult problem. Here, 
the extent of coronary artery disease is 
unknown, as is the likely response of the 
left ventricle to the critical events of the 
perioperative period. A normal resting 
electrocardiogram and an exercise elec­
trocardiogram that is limited by the phys­
ical constraints of peripheral vascular dis­
ease leave the question of functional 
reserve and myocardial ischemic risk 
unanswered. The expense and risks of 
coronary angiography preclude its routine 
use in patients scheduled for vascular sur­
gery. Dipyridamole-thallium scanning as 
reported by Boucher and associates1 
appears to offer a solution to this major 
gap in our knowledge. Patients may be 
separated, preoperatively, into low- and 
high-risk categories for myocardial ische­
mia and dysfunction. Their management 
would differ, but the objective of vascu­
lar surgery completed successfully with 
the least risk of perioperative myocardial 
ischemia and its sequelae could be 
achieved in a larger percentage of 
patients. If this imaging technique proves 
reliable, it may become a routine investi­
gation before major vascular surgery.
With the high rate of smoking in this 
group of patients, pulmonary dysfunction 
is common and may complicate the peri­
operative period. Altered response to
fluctuations in hydrogen-ion concentra­
tion and arterial oxygen content coupled 
with the depressant effects of anesthetic 
agents and narcotics can place these 
patients at greater risk than others. 
Increased pulmonary secretions and dis­
turbances in chest-wall mechanics con­
tribute to morbidity.
To cope with the stresses imposed dur­
ing the perioperative period, the kidneys 
must maintain three functions — a 
glomerular filtration rate adequate to 
maintain nonuremic blood chemistry, the 
ability to autoregulate intrarenal blood 
flow over a range of blood pressures and 
have tubules capable of controlling water 
and electrolyte fluxes. Consequently, the 
anesthetist will review the creatinine 
index, a range of the patient’s blood- 
pressure determinations and the specific 
gravity on a urine specimen taken before 
surgery.
Preinduction
Application of currently available 
monitoring techniques to patients who 
undergo abdominal aortic surgery allows 
the anesthetist to follow closely physio­
logical functioning intraoperatively. Limi­
tations of these monitoring techniques 
require extrapolation from actual infor­
mation provided and is accepted clinical 
practice in the management of such 
patients.
During electrocardiographic monitor­
ing, lead II will be adequate to interpret 
simple dysrhythmias but is considered 
inadequate for ischemia as only inferior 
wall events are chronicled. At a mini­
mum, leads II and V5 must be displayed. 
Addition of an esophageal lead would 
allow the posterior myocardium to be 
monitored for ischemia. One must real­
ize that ST depression is a late indicator 
of myocardial ischemia, and such changes 
on the oscilloscope are preceded by the 
following: regional myocardial dysfunc­
tion, decreased ventricular compliance 
with the appearance of new V waves on 
the wedge- or occlusion-pressure tracing, 
myocardial lactate production and angina 
pectoris in the awake patient.
Catheterization of the radial artery is 
universally accepted for monitoring, but 
its limitations must be appreciated in that 
both false high and false low pressures 
may be presented. For example, reverber­
ation in an inadequately damped system 
will give false high systolic pressures and, 
similarly, low pressures may be artefac- 
tual. The electronically derived mean 
arterial pressure is more consistent in 
representing true events. Devices are now 
available to adjust damping in the 
catheter-transducer system without alter­
ing natural resonating frequencies.
Right atrial catheterization should be 
performed to determine right ventricular
filling pressures. It also allows access to 
the central venous circulation for the infu­
sion of vasoactive drugs.
Pulmonary artery catheterization is 
now common in monitoring patients who 
undergo major vascular procedures, and 
multifunction catheters are available. The 
catheter should be placed in the awake 
but sedated patient, preferably several 
hours before the scheduled surgery. This 
allows time to observe the response of the 
left ventricle to volume challenging as well 
as the degree of relationship between the 
pulmonary artery diastolic pressure and 
the pulmonary artery occlusion pressure. 
Convincing arguments have been made to 
justify the use of the pulmonary artery 
catheter in patients with good left ventric­
ular function. Waller and associates2 
have shown that many hemodynamic epi­
sodes were missed or misinterpreted 
without the use of the catheter. Conners 
and colleagues3 showed that the 
hemodynamic status of critically ill 
patients could not be predicted on the 
basis of clinical signs. The occlusion pres­
sure was predicted correctly in only 42% 
of cases and the cardiac index in only 
44%. Further, in 48% of cases correct 
information obtained from the pulmo­
nary artery catheter monitoring prompted 
a change in drug therapy. Preoperative 
knowledge of the left ventricular ejection 
fraction appears not to predict a relation­
ship between central venous pressure and 
pulmonary artery occlusion pressure in 
patients who undergo abdominal aortic 
surgery. Ansley and colleagues4 sug­
gested that both pressures must be 
independently measured to assess the ven­
tricular filling pressures.
Ongoing assessment of renal function 
by observation of urine output is gener­
ally followed on an hourly or half-hourly 
basis. By convention, renal function is 
assumed to be normal if hourly flows 
greater than 0.5 ml/kg are maintained. 
During infrarenal cross-clamping, a rever­
sible, functional oliguria commonly 
develops. Frequently observed and inade­
quately explained, this oliguria is self- 
correcting if adequate intravascular 
volume and systemic pressures are main­
tained throughout the procedure and into 
the recovery period.
Induction
Induction of anesthesia leading up to 
surgery is the first critical event in 
intraoperative management of the 
patient. It is a time requiring the closest 
attention to any alteration in functions. 
With careful titration of selected induc­
tion agents and with airway management, 
the patient is prepared for intubation. By 
observing individual responses to a series 
of graded stimuli, ranging from loss of 
sympathetic tone with lapse into uncons-
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ciousness to the degree of pressor 
response to laryngoscopy without intuba­
tion, the anesthetist can judge both the 
level of anesthesia and degree of 
hemodynamic control. Dysrhythmias and 
severe hemodynamic changes are most 
likely to occur at this stage. Once intu­
bation is complete, stimulation is minimal 
until the surgical incision is made. 
Throughout the induction sequence it is 
essential that the anesthetist have availa­
ble the drugs necessary to treat detrimen­
tal alterations in hemodynamics (e.g., 
nitrates, inotropes, /3-blockers and cal­
cium antagonists).
Maintenance
The maintenance phase brings concerns 
in addition to preserving myocardial oxy­
gen balance, such as fluid replacement, 
rate of decline in body temperature, 
degree of accumulation of anesthetic 
agents and alterations of ventilation- 
perfusion ratios in the lungs. It is during 
the maintenance period that two other 
critical events take place — cross­
clamping and declamping of the aorta.
Fluid replacement for the majority of 
these patients requires a rigorous response 
to marked alterations in extracellular fluid 
and blood volume. Rate of replacement 
is guided by serial central venous and 
occlusion pressure readings, changes in 
the morphology of arterial waveform, 
urine output and ongoing estimates of 
blood loss. Crystalloid in the form of 
Ringer’s lactate solution or normal saline 
is employed initially and replaced with a 
more osmotically active solution, such as 
hetastarch or stored plasma, later in the 
procedure. It is common to administer 
more than 1 L /h  of crystalloid. Oxygen­
carrying capacity is supported with 
packed cells as indicated, on the basis of 
initial hematocrit value and blood loss.
A second problem, hypothermia, has 
numerous adverse effects that include 
alterations in functioning of the follow­
ing: anesthetic agents, the coagulation 
system, the oxyhemoglobin dissociation 
curve, performance of the myocardium 
and the ability to buffer or metabolize lac­
tic acid. Maintenance of normal body 
temperature is difficult in the intraoper­
ative period. The rate of decline of body 
temperature can be slowed by active 
warming of inhaled gases and intravenous 
fluids and must be considered part of the 
standard intraoperative care of these 
patients.
A third concern is the accumulation of 
anesthetic agents. Tissue uptake of fixed 
and volatile drugs, especially lipid-soluble 
drugs is a well-characterized component 
of anesthetic pharmacokinetics. The two 
main determinants of the rate and degree 
of tissue uptake are tissue blood flow and 
drug storage capacity. Constant doses of
fentanyl citrate or isoflurane throughout 
the operation will result in a large tissue 
store requiring metabolization and excre­
tion in the early postoperative period.
Problems accompany mechanical ven­
tilation of the lungs. Monotonous fixed- 
volume ventilation will allow a progres­
sive deterioration in ventilation-perfusion 
ratios, resulting in a progressive intrapul- 
monary shunt and subsequent impaired 
oxygenation. High peak airway pressures 
may result in a reduction in venous return 
to the heart. Positive end-expiratory pres­
sure may alter pulmonary artery pressures 
and position of the intraventricular sep­
tum, thereby disturbing left ventricular 
stroke volume, but ongoing attention by 
the anesthetist will minimize these haz­
ards. The anesthetist can manipulate ven­
tilator settings to provide optimum gas 
exchange with a minimum of deleterious 
effects, aided by either a mass spectrom­
eter or stand-alone oximeter and capnom- 
eter in conjunction with serial arterial 
blood-gas measurements.
Two critical events — cross-clamping 
of the aorta and subsequent declamping 
— require close cooperation between the 
anesthetist and the surgeon. Anticipation 
of these events allows for appropriate 
action to be taken to minimize the phys­
iologic sequelae to sudden drastic altera­
tions in peripheral vascular resistance and 
venous return. It is impossible to predict 
precisely the degree of response of either 
the myocardium or the myocardial oxy­
gen supply-demand ratio to aortic cross­
clamping. With information supplied by 
systemic and pulmonary pressure lines 
and close attention at the time of clamp­
ing, intervention with vasodilators or 
volume replacement, or both, will effec­
tively counter adverse hemodynamic con­
ditions. Declamping will again result in 
marked alterations in hemodynamic func­
tion. Vigorous volume replacement 
preceding declamping will counteract the 
hypotension commonly observed.
Early Postoperative Period
The hours immediately after abdomi­
nal aortic surgery are viewed by the 
anesthetist as a continuation of intraoper­
ative management. Requirements for 
volume replacement, warming and the 
administration of analgesia and sedation 
continue.
Problems such as oliguria, coagulopa­
thy or “ breakthrough” hypertension may 
occur in the later stages of the main­
tenance period or de novo in the early 
postoperative period.
Renal failure developing periopera- 
tively can seriously complicate the out­
come in these patients. Prompt aggressive 
dialysis may improve results, although the 
death rate remains exceptionally high. 
Prevention seems the best course, so the
anesthetist must constantly be concerned 
about renal function during the opera­
tion. Mechanisms available to prevent 
renal failure are similar, regardless of the 
etiology. These preventive measures 
include maintenance of renal blood flow, 
glomerular filtration rate and tubular 
flow. Urine volume remains the standard 
monitor of renal function intraopera- 
tively. The quality of this urine is not rou­
tinely measured (e.g., specific gravity, 
sodium concentration, urine-plasma 
ratios). In addition, a mental checklist of 
the major determinants of urine volume 
(mean systemic arterial pressure, antidi­
uretic hormone, sympathetic tone, tubu­
lar osmotic load and plasma oncotic pres­
sure) should be reviewed at intervals by 
the anesthetist. In response to a fall in 
urine output this checklist may suggest 
appropriate therapy (e.g., increase mean 
arterial pressure, crystalloid infusion or 
“ renal dose” dopamine).
As with other major problems asso­
ciated with this type of surgery, emer­
gence of a bleeding disorder is often 
predictable. Rarely is intraoperative 
coagulopathy due to an isolated defect in 
the clotting system; it is usually multifac­
torial. Early signs of trouble such as per­
sistent oozing from previously dry raw 
areas or failure to see clot formation in 
pooled blood will prompt the anesthetist 
to alert the blood bank to an anticipated 
increased need for blood and blood com­
ponents. Tests to be performed might 
include prothrombin, partial throm­
boplastin and activated coagulation 
times, platelet count and measurement of 
fibrinogen and fibrinogen-split products. 
Early consultation with the hematology 
service can facilitate a prompt response 
from laboratory and blood bank. More 
importantly, expertise will be provided 
should the problem persist or worsen, 
although the mainstay of therapy for 
acquired coagulopathies in the perioper­
ative period remains infusions of fresh- 
frozen plasma and platelets.
The appearance of an exaggerated 
hyperdynamic phase with hypertension 
and tachycardia early in the recovery 
period indicates that the patient has 
“ broken through” the sedation and 
analgesia. Prompt appropriate use of 
vasodilators, narcotics, /3-blockers and 
sedative hypnotics will prevent the poten­
tially deleterious effects of increased 
myocardial work and oxygen con­
sumption.
Conclusions
Postoperative care of the patient who 
has undergone abdominal aortic surgery 
will frequently pass from the anesthetist’s 
hands upon transfer to the intensive care 
unit. By virtue of the preoperative evalu­
ation and, more importantly, through
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several hours of direct observation and 
care, the anesthetist has accumulated con­
siderable information about each pa­
tient’s response to various physiologic 
stresses. A great deal of information on 
the intraoperative course of the patient is 
contained in the anesthetic record. Unfor­
tunately, interpretation of this record in 
the postoperative period is often difficult 
and sometimes impossible to those un­
familiar with the symbols and shorthand 
it contains. The result is either a poten­
tially hazardous misinterpretation of
intraoperative events or a disregard for 
information that may have a positive 
bearing on a postoperative problem. I 
would emphasize the need for direct com­
munication among all specialties involved 
in care of the patient in the perioperative 
period.
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3. Postoperative Management of Patients 
Who Undergo Aortic Surgery
Because patients with occlusive or 
aneurysmal disease of the aorta fre­
quently have coexisting disease in other 
important organ systems, complications 
after aortic surgery usually relate to the 
heart, lungs and kidneys. Postoperative 
care thus requires attention, in an 
intensive-care milieu, to respiratory, 
cardiac, renal and gastrointestinal sys­
tems, coagulation and, in rare instances, 
psychiatric problems.
Du fait que les patients souffrant 
d'occlusion ou d'anevrisme aortique sont 
frequemment atteints de maladies au 
niveau d'autres organes vitaux, les com­
plications apres chirurgie aortique sont 
g^neralement reliees au coeur, poumons 
et reins. La surveillance postoperatoire, 
en milieu de soins intensifs, necessite 
une attention particuliere aux systemes
From the Department o f  Surgery, New 
England Medical Center Hospital, Boston, 
Mass.
Presented as part of a symposium on the 
perioperative management o f  abdominal 
aortic surgery at the 8th annual meeting o f  
the Canadian Society fo r  Vascular Surgery, 
held in conjunction with the 55th annual 
meeting o f  the Royal College o f  Physicians 
and Surgeons o f  Canada, Toronto, Ont., 
Sept. 24, 1986
Accepted fo r  publication Dec. 18, 1986
Reprint requests to: Dr. A.D. Callow, 171 
Harrison Ave., Boston, MA 02111, USA
respiratoire, cardiaque et gastro­
intestinal, a la coagulation et, dans de 
rares cas, aux problemes psychiatriques.
The patient with occlusive or aneurysmal 
disease of the aorta is generally in an age 
group in which coexisting disease in one 
of several organ systems is common and, 
hence, complications after aortic surgery 
usually relate to the heart, lungs and kid­
neys, rather than to the arterial recon­
struction itself. Although the measure­
ment of central venous pressure is a 
relatively reliable guide to cardiac func­
tion and volume status under normal cir­
cumstances, it is often inaccurate during 
stress and in the presence of cardiac and 
pulmonary disease. Swan-Ganz catheteri­
zation is therefore relied upon in these 
patients for more precise measurement of 
fluid and blood replacement.
Postoperative complications associated 
with intraoperative problems include the 
following: injury to the inferior vena cava 
and iliac veins, ureteral injury, intraoper­
ative and postoperative thrombosis, 
intimal embolism, postoperative hemor­
rhage, stenosis or occlusion of an anasto­
mosis, spinal cord ischemia and paraple­
gia and ischemia of the left colon. These 
are specific problems that are usually eas­
ily recognized and, except for spinal cord 
ischemia, amenable to correction.
Postoperative care requires attention to 
the following: intensive care monitoring, 
respiratory, cardiac, renal and gastroin­
testinal (stress ulceration) systems, bleed­
ing and psychosis.
Monitoring
Initially the patient should be stabilized 
in an intensive care or recovery room 
where vital signs, urine output, cardiac 
rhythm and respiratory status can be con­
tinuously monitored for as long as neces­
sary. Systemic blood pressure, heart rate 
and rhythm and arterial blood gases 
should be measured promptly and a chest 
x-ray film obtained to check endotracheal 
tube position and adequate lung expan­
sion. Pre- and postoperative 12-lead elec­
trocardiograms should be compared. If 
myocardial ischemia or infarction is sus­
pected, blood samples should be submit­
ted for measurement of cardiac isoen­
zymes, hematocrit, serum electrolyte 
values, blood glucose, prothrombin and 
partial thromboplastin times and platelet 
count. The most commonly mismanaged 
postoperative problem involves fluid 
administration. This must be meticulous, 
for these patients do not tolerate fluid 
overload. During aortic surgery, the 
patient often requires a large amount of 
fluid, which is retained postoperatively. 
Much of this is sequestered in the inter­
stitial spaces where it remains until gradu­
ally mobilized and excreted in 48 to 72 
hours. Inappropriate secretion of antidi­
uretic hormone results in sodium and 
water retention. Therefore, intravenous 
fluids for maintenance should be limited 
to approximately 80 m l/h or 1 ml/kg 
body weight of 5% dextrose and half­
normal saline with 20 to 30 mmol/L of 
potassium chloride.
On arrival in the recovery room, these
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patients are usually cold and vasocon- 
stricted, and additional fluid may be 
necessary as rewarming and vasodilata­
tion occur. A decreasing urine output, 
reduced blood pressure, tachycardia and 
lower cardiac filling pressures indicate a 
need for additional fluids together with 
packed red cells or whole blood, if avail­
able, if the hematocrit is less than 30%. 
A balanced salt solution, such as Ringer’s 
lactate, is helpful.
We do not believe in early ambulation 
of patients after aortic or peripheral 
arterial reconstruction since many of 
them are hemodynamically unstable for 
several days. Incisional pain may be 
severe, causing tachycardia and hyperten­
sion, thus increasing the burden on the 
heart, and with the mobilization of excess 
fluid occurring 48 to 72 hours postoper- 
atively, there may be expansion of the 
intravascular volume creating additional 
cardiac stress. It must be remembered that 
myocardial infarction occurs most com­
monly 3 days after major surgery.1 Leg 
exercises against a foot board or other 
resistance-generating equipment improve 
venous emptying from calf muscles, 
increase blood flow to the legs and thus 
through the graft, maintain muscular tone 
and probably serve as prophylaxis against 
deep venous thrombosis.
Respiratory System
Support by a volume ventilator is 
generally necessary for several hours and 
sometimes several days. For the patient 
unable to breathe, controlled mechanical 
ventilation provides a preset tidal volume 
at a controlled frequency. For the patient 
who must remain intubated, an assist- 
control technique allows spontaneous 
breathing supplemented by assisted ven­
tilations, thus preventing hypoventilation 
and respiratory acidosis. Intermittent 
mandatory ventilation provides good 
assistance and control. Between manda­
tory ventilations, the patient may breathe 
spontaneously, so that the mandatory 
ventilations can be progressively 
decreased as the patient’s mechanics 
improve. Occasionally, those with 
reduced functional residual capacity will 
require continuous positive airway pres­
sure or positive end-expiratory pressure 
as well as assisted ventilation. It must be 
remembered that high pressures (more 
than 15 cm H20) can decrease cardiac 
output.2 Deep breathing and coughing 
are essential after extubation. Intermittent 
positive-pressure breathing is rarely neces­
sary unless bronchodilators or mucolytic 
agents are to be given. If endotracheal 
stimulation and suction are necessary, 
adequate oxygenation should be assured 
and the pulse be monitored because of the 
occasional occurrence of arrhythmias.
Cardiac System
Incisional pain, increased sympathetic 
tone, and some as-yet-unaccounted-for 
elevation of the renin angiotensin activity 
may explain why hypertension is fre­
quently associated with postoperative 
cardiac problems, producing excessive 
cardiac work. Cardiac work is the 
product of stroke volume, rate and sys­
tolic blood pressure. Thus, if hyperten­
sion is inadequately controlled, 
myocardial ischemia with failure may 
supervene. A useful guideline is to main­
tain systolic blood pressure within 15% 
above or below the preoperative level. 
Because arterial lines tend to record 
higher pressures than the sphygmo­
manometer, a comparison between the 
two should be made before an antihyper­
tensive medication is administered. Often, 
the relief of pain by a small dose of mor­
phine (2 to 5 mg) will moderate the hyper­
tension and the tachycardia.
For more immediate action, sodium 
nitroprusside may be given — 50-mg 
doses in 250 ml of 5% dextrose in water 
at a rate of 0.5 to 1.0 /ig/kg-min-1. 
This may be increased to a maximum of 
10 ^g/kg min"‘.3 Blood pressure must 
be monitored continuously, for, although 
this drug has a short duration of action, 
possibly not more than 10 minutes, it is 
a potent vasodilator. It must be used cau­
tiously in those with hepatic or renal 
insufficiency, either chronic or transient, 
inasmuch as it is metabolized to 
thiocyanate. Prolonged infusion or exces­
sively high doses may lead to cyanide 
intoxication.
The combination of tachycardia and 
hypertension is particularly stressful on 
the myocardium. Hypovolemia may be 
detected by decreased urine output, fall­
ing blood pressure, especially with deep 
inspiration, and low heart filling pres­
sures. If hypovolemia is not the cause, 
persistent tachycardia may be due to 
cardiac failure or increased sympathetic 
tone. A pulmonary capillary wedge pres­
sure greater than 18 to 20 mm Hg sug­
gests left ventricular failure for which 
digoxin may be administered. In the 
absence of hypovolemia and evidence of 
cardiac failure, tachycardia may be con­
trolled by the administration of 
propranolol 0.1 to 1.0 mg. Again, con­
tinuous electrocardiographic and blood- 
pressure monitoring should be main­
tained, for rapid slowing of the heart rate 
may occur. An occasional side effect, par­
ticularly in patients with chronic obstruc­
tive airway disease, is bronchospasm; this 
is less likely to be produced when patients 
are given the /3-blocker metoprolol 
(Lopressor), 50 mg orally twice daily. It 
should be used with care in the insulin- 
dependent diabetic for /3-blockade may 
mask sympathetic signs of hypoglycemia.
Low cardiac output and hypotension
must also be considered in association 
with hypovolemia, for pump failure or 
cardiogenic shock is a main cause of low 
cardiac output. Severe chronic cardi­
omyopathy or an intraoperative myo­
cardial infarction makes it a likely possi­
bility. So, too, must septic shock and 
cardiac arrhythmias be considered in 
determining the cause of low output. 
Cardiac output is a product of heart rate 
and stroke volume.4,5 The principal 
determinants of stroke volume are 
preload, afterload and myocardial con­
tractility.
Preload is the end-diastolic filling pres­
sures of the right and left hearts. Stroke 
volume is directly related to preload. 
Afterload is the resistance against which 
the left ventricle contracts — the force- 
resisting fibre contraction. It is inversely 
related to stroke volume.
Contractility describes factors such as 
/3-adrenergic agonists and antagonists that 
modify the force of contraction indepen­
dent of pre- and afterload. Systemic 
blood pressure depends directly on 
cardiac output and peripheral vascular 
resistance.
In the low-perfusion state, both blood 
pressure and urine output drop, one fre­
quently sooner or to a greater extent than 
the other. A 5- to 10-ml/kg bolus of fluid 
may^improve perfusion. Preload is meas­
ured by ventricular filling pressure at end 
of diastole, which means central venous 
pressure for the right ventricle and pul­
monary capillary wedge or left atrial pres­
sure for the left. Filling pressures should 
be brought into the normal range before 
administering drugs or mechanical sup­
port. The best drugs to improve cardiac 
output are the inotropic and /3-adrener­
gic group — isoproterenol or dopa- 
mine/dobutamine. Mechanical support 
may be necessary if these drugs fail. 
Cardiac output can also be increased by 
use of vasodilators to decrease afterload. 
A pulmonary capillary wedge pressure 
above 18 to 20 mm Hg may lead to pul­
monary congestion and a rise above 30 
mm Hg to frank pulmonary edema. It 
must be remembered that excessive posi­
tive end-expiratory pressure may falsely 
elevate central venous and pulmonary 
artery pressures, thus masking the true 
cause — hypovolemia. Nitroprusside or 
nitroglycerin, administered intravenously, 
may help to reduce afterload by vasodila­
tation. It may be maintained on a more 
sustained basis later in the postoperative 
period with hydralazine, captopril, 
nitrates and other parenteral vasodila­
tors.6 Myocardial contractility is most 
effectively enhanced by the inotropic 
drugs dobutamine, dopamine and 
digitalis. In acute cardiac failure, dobuta­
mine is the agent of choice, acting rapidly 
to decrease both preload and afterload.
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If bradycardia is the cause of the low out­
put state, the use of atropine may accen­
tuate the arrhythmias, making cardiac 
pacing necessary. Coronary perfusion 
may fall as a consequence of cardiac 
arrhythmias, and there may be associated 
diminished flow in other organ systems. 
There are a number of mechanisms that 
produce arrhythmias in the immediate 
postoperative course; hypothermia (quite 
common), hypoxia, hypo- or hyper­
kalemia, disturbances of acid-base 
metabolism and, of course, myocardial 
infarction. When premature ventricular 
contractions are common (often in the 
cold and acidotic patient) and occurring 
at a rate of more than 6/min, or 
associated with runs of ventricular 
tachycardia or bigeminy, treatment is 
required. Lidocaine (50 to 100 mg 
intravenously) administered as a bolus 
will often solve the problem. Rarely is a 
continuous infusion necessary.
Renal System
Renal failure in the absence of chronic 
renal insufficiency can usually be avoided 
by careful fluid management. The dia­
betic patient who has chronic renal 
insufficiency or is dehydrated is more 
likely to suffer failure postoperatively 
than the normal individual. An output of 
less than 15 ml/h in the presence of ris­
ing blood urea nitrogen and creatinine 
values makes for early recognition. In the 
high-risk patient, adequate preoperative 
hydration in the intensive-care unit, 
Swan-Ganz monitoring on the night 
before surgery and the administration of 
mannitol before infrarenal aortic clamp­
ing have been most effective in limiting 
this problem.7 The ideal urine output in 
the normal patient is 30 to 60 ml/h. High- 
output renal failure (more than 60 ml/h) 
in an intravascular-volume-depleted 
patient is occasionally seen and can be 
confirmed by the finding of a urine 
plasma-creatinine ratio of less than 10. 
Because the normal kidney retains sodium 
(urine value 20 to 40 mmol/L), a urine 
sodium value of 80 to 100 mmol is a 
second indicator of renal failure. Finally, 
failure to concentrate urine (specific 
gravity of 1.010) or a urine-plasma 
osmolarity ratio of less than 1.3 is an 
additional sign. Prerenal failure is usually 
due to inadequate intravascular volume 
or low cardiac output. Actual renal causes 
are usually a consequence of toxic 
influences such as antibiotics, other medi­
cations or the dye used at arteriography. 
Obstruction of the urinary collection sys­
tem is a cause of postrenal failure.
Gastrointestinal System
Postoperative problems in the gastroin­
testinal tract associated with reconstruc­
tive surgery revolve around peptic ulcer­
ation. Sepsis, prolonged hypotension, 
widespread tissue trauma, respiratory 
insufficiency, renal failure and advanced 
age are all risk factors.8,9 Usually, the 
body of the stomach is involved, but the 
small bowel, including duodenum, as well 
as the colon have suffered such ulcera­
tions. In most instances, nonoperative 
methods for controlling the bleeding are 
suitable but will not be effective if the 
underlying cause, as for example sepsis, 
continues. It should be remembered that 
the surgical death rate for stress hemor­
rhage in the stomach exceeds 50%.9 Fre­
quent administration of antacids through 
a nasogastric tube if necessary, with 
hourly check of gastric residuals to avoid 
the possibility of aspiration pneumonia, 
plus monitoring of the gastric juice pH, 
are all essential in prophylaxis and 
treatment.
Hemorrhage
Early reoperation is mandatory in the 
management of bleeding from an anasto­
mosis or an area of dissection such as the 
bed of an aortic aneurysm. Complications 
of bleeding are the development of infec­
tion in a hematoma and the late forma­
tion of a pseudoaneurysm at the anasto­
motic line. If more than two units of 
blood are needed to m aintain a 
hematocrit in the range of 30% ± 2% 
during the first 6 to 12 hours, intra­
abdominal hemorrhage must be consi­
dered. The usual causes of persistent peri- 
or postoperative bleeding are inadequate 
surgical hemostasis, a failure to reverse 
or excessive amounts of anticoagulants 
and, rarely, defects in clotting factors 
such as disseminated intravascular coagu­
lation and dilutional thrombocytopenia. 
Fresh-frozen plasma (10 ml/kg body 
weight) should be used to counteract the 
effect of heparin or Coumadin. The 
administration of large amounts of 
stored, packed, red blood cells may lead 
to dilutional thrombocytopenia, and fresh 
platelets should be available and 
administered with every six units of plate­
let concentrate. Spontaneous bleeding is 
rare with a platelet count of above 20.0 
x 109/L.
Massive blood transfusions, major 
transfusion reaction, widespread tissue 
trauma, extensive ischemia and sepsis are 
the most common causes of consumptive 
coagulopathy. Rarely, it is seen as an idi­
osyncratic reaction to systemically 
administered heparin.10 Disseminated 
intravascular coagulation involves con­
sumption of platelets and coagulation 
Factors VIII and V as well as fibrinogen. 
Thrombocytopenia, prolonged prothrom­
bin time and depressed fibrinogen levels
are the criteria for the development of dis­
seminated intravascular coagulation. The 
use of heparin should be reserved for 
when other efforts such as administration 
of platelets in fresh-frozen plasma fail to 
correct the problem.
Psychosis
The patient who undergoes reconstruc­
tive aortic surgery is generally elderly, in 
an age group susceptible to postoperative 
psychosis. Agitation, confusion, halluci­
nations, even combative behaviour are 
frequently seen. These changes are mild 
and generally resolve with no specific 
treatment. Sleep deprivation, unfamiliar 
surroundings, disturbances in physiology, 
such as hypoxia, hypoglycemia and 
hyponatremia, and the consequences of 
sepsis all play a role. A few may be suffer­
ing alcohol withdrawal. Narcotics may 
intensify the problem. Cimetidine has 
been implicated. Normal waking and 
sleeping patterns should be re-established 
if possible, normal sensory input provided 
and sedation, if used, must be carefully 
monitored. Haloperidol in doses of 0.5 
to 2 mg orally or intramuscularly may be 
useful as is Librium."
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Biologic Response to
Uncemented Madreporic Canine Hip Arthroplasty
The M adreporic hip arthrop lasty has 
provided encouraging clin ica l results. The 
surface o f the prosthesis is unlike other 
uncemented prostheses since the rough 
surface is form ed by m ultip le  1-mm 
diameter beads tha t are cast as an 
integral part o f the prosthesis and 
increase its surface area fou r times. 
Seven M adreporic hip arthroplasties were 
implanted in adult male mongrel dogs. 
Specimens were harvested 5, 6, 9, 12, 
20 and 52 weeks after insertion. One 
specimen became septic and loosened. 
The prosthesis was stabilized in itia lly  by 
fr ic tion  f it  between the prosthesis and 
the endosteal cortex o f the proximal 
femur. Dense, un iform ly organized, 
fibrous tissue surrounded the prosthesis 
at 5 weeks. The fibrous tissue appeared 
sim ilar to  Sharpey's fibres. C ircumferen­
tia l bone con tact increased from  26%  at 
5 weeks to 60%  at 52 weeks. Fluores­
cent labelling revealed active new  bone 
form ation w ith in  the in terstices o f the 
prosthesis w ith o u t evidence o f an inter­
vening soft-tissue membrane. Firm 
mechanical anchorage o f the Madreporic
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fem oral prosthesis w as dem onstrated in 
th is  study.
L 'arthrop lastie  Madreporique de la han­
d le  a fourn i des resulta ts cliniques 
encourageants. La surface de la prothese 
d iffe re  des autres protheses non consoli- 
des par le fa it que la surface rude est 
form ee de m ultip les grains de 1 mm de 
diametre constituan t une partie inte- 
grante de la prothese et augm entant de 
quatre fo is sa superficie. Sept arthroplas­
ties Madreporique de la hanche furent 
implantees chez des chiens mongrel 
adultes males. Des echantillons fu ren t 
recoltes 5, 6, 9, 12, 20 et 52 semaines 
apres insertion. Un echantillon devint 
septique et se decomposa. La prothese 
fu t stabilisee in itia lem ent par ajustement 
entre la prothese et le cortex endosteal 
du fem ur proxim al. Du tissu fibreux, 
dense, uniform em ent organise, entoura la 
prothese au bou t de 5 semaines. Ce 
tissu fib reux ressemblait aux fibres de 
Sharpey. Le con tact osseux peripherique 
augmenta de 26%  apres 5 semaines. a 
6 0 %  apres 52 semaines. Le marquage 
fluorescent revela une nouvelle fo rm ation  
osseuse active dans les in terstices de la 
prothese sans evidence d ’apparition 
d 'une  membrane de tissu mou. Un 
assemblage mecanique ferm e de la pro­
these femorale Madreporique a ete 
demontre au cours de ce tte  etude.
The long-term success of an arthroplasty 
depends on permanent anchorage of the 
prosthetic components within bone. 
Smooth-surfaced prostheses require bone 
cement for fixation. In spite of recent 
modifications in the use of methylmetha­
crylate to improve mechanical lon­
gevity,1'2 cemented arthroplasties fre­
quently loosen with time.3,4 Uncemented 
prostheses have been developed as an 
alternative. Rough-surfaced components
may allow biologic fixation that can 
respond to mechanical stresses over a long 
period without loosening.
There has been extensive clinical 
experience with the Madreporic (Benoist 
Girard, Paris; French manufacturing divi­
sion of Howmedica Inc.) hip arthroplasty 
developed by Lord.5' 7 This prosthesis 
utilizes a rough surface of 1-mm diameter 
beads that are cast as an integral part of 
the femoral component. The Madreporic 
surface increases the surface area of the 
prosthesis by a factor of four. The beads 
are cast in a single layer with an interbead 
space of between 1 and 3 mm. This differs 
from other uncemented prostheses which 
generally have the rough surface secon­
darily attached to the smooth prosthetic 
core by sintering or a similar process.8 
This surface takes the form of wire mesh, 
atomized alloy metal or a composite 
structure. The interbead distance of the 
Madreporic prosthesis far exceeds the 50 
to 400 /tm pore size recommended for 
porous coated prostheses.9 For these rea­
sons, the Madreporic surface cannot be 
compared to porous coated prostheses 
which have received a great deal of 
experimental investigation.10-15
Prosthetic canine hip arthroplasties
FIG. 1—Canine prosthetic hip arthroplasty 
components consisting of polyethylene 
acetabular component and femoral component 
with Madreporic surface.
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were used to study the biologic response 
to the Madreporic surface. The prosthe­
sis had an identical surface to that of the 
components used in human Madreporic 
hip arthroplasty. The purpose of the 
study was to determine the response of 
the proximal femur to the implantation 
of the prosthesis. Specifically, we sought 
to investigate the character of the inter­
face between the prosthesis and the sur­
rounding bone, and the presence of new 
bone formation within the proximal 
femur after insertion of the prosthesis.
Materials and Methods
Seven Madreporic hip arthroplasties 
were performed in adult mongrel dogs. 
The canine femoral component was tri­
angular in cross-section with the base 
medially and the apex laterally (Fig. 1). 
This differs from the circular cross- 
section of the human prosthesis. This 
design difference gave immediate rota­
tional stability without circumferential 
cortical contact.
The hip was exposed through an 
anterolateral incision. After capsulec- 
tomy, the joint was dislocated and the 
femoral head resected. The acetabulum 
was reamed and irrigated, and an 
acetabular prosthesis cemented in place 
using methylmethacrylate. The femur was 
reamed and the femoral component in­
serted, producing a snug fit to give ini­
tial mechanical stability (Fig. 2). Antibi­
otics were administered prophylactically 
for 48 hours postoperatively. The animals 
were not immobilized.
The dogs were given a single 
intravenous dose of xylenol orange,16 90 
mg/kg, 1 week before sacrifice by Nem-
FIG. 2—Postoperative view of canine 
Madreporic hip arthroplasty. Acetabular com­
ponent is cemented in place. Femoral compo­
nent is inserted without cement and is initially 
stabilized by friction fit.
butal overdose. Both the acetabulum and 
the proximal femur were harvested, but 
only the femoral components were 
studied. Specimens were obtained 5, 6, 9, 
12, 20 and 52 (two specimens) weeks fol­
lowing insertion.
The proximal femur was dehydrated, 
defatted and embedded in methyl­
methacrylate using a method similar to 
that of Jowsey and associates.17 Modifi­
cations in the technique were necessary 
due to the large size of the specimens.18 
Cross-sections 1-mm thick were cut 
through the proximal, middle and distal 
portions of the prosthesis using a Bueh- 
ler low-speed low-deformation saw. Fine- 
detail roentgenograms were obtained 
using Kodak XTL-2 mammography film 
and a Faxitron 805 (Hewlett Packard, 
Mississauga, Ont.). The sections were 
mounted on petrographic slides and 
ground with a rotary grinder to a thick­
ness of 250 /an. The sections were ana­
lysed by light, polarized and fluorescence 
microscopy.
The extent of bone ingrowth was meas­
ured for the proximal, middle and distal
cross-section of each prosthesis. A 20 x 
25-cm photographic enlargement was 
made of a whole-mount polarized pho­
tomicrograph of each entire cross-section 
(original magnification x 4). An area 
analyser was then used to determine the 
percentage of the prosthetic perimeter 
that lay in direct contact with bone. Since 
the prosthesis has a rough surface rather 
than a porous coating, it was possible to 
make these measurements accurately.
Results
In general, the animals were ambula­
tory within 48 hours of surgery. One 
animal stopped walking on the operated 
leg 6 weeks postoperatively. Radiologic 
examination did not reveal any abnormal­
ity, but the specimen was loose when har­
vested 52 weeks after insertion and puru­
lent material was present within the 
pseudocapsule of the hip joint. No other 
specimens could be manually extracted at 
the time of sacrifice. An undisplaced frac­
ture of the proximal femur occurred 
intraoperatively in two dogs whose speci-
Fig. 3a Fig. 3b
FIG. 3—(a) Polarized photomicrograph of proximal cross-section 5 weeks after insertion 
of prothesis. In this area there is no direct bone contact between prosthesis and endosteal cor­
tex. Intervening space is filled with fibrous tissue. Immature woven bone is advancing toward 
prosthesis. Intramembranous ossification is occurring within fibrous tissue (original magnifi­
cation x 20). (b) Polarized photomicrograph showing junction betw een woven bone and fibrous 
tissue surrounding prosthesis. Fibrous tissue is well organized and resembles Sharpey’s fibres, 
suggesting that it may be important for load transference while bone ingrowth occurs (original 
magnification X 52).
T a b le  l - P r o s t h e t ic  P e rim e te r W ith  Bone C o n ta c t (% )
W eeks P ro x im a l s tem M id d le  s tem D is ta l s tem M ean
5 1 8 2 0 4 0 2 6
6 4 8 2 7 5 4 4 3
9 1 3 7 8 2 6 3 9
12 4 3 2 9 41 3 8
2 0 5 8 4 8 4 6 5 0
5 2 6 4 5 7 61 6 0
5 2  (septic) 0 0 0
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mens were harvested 6 and 9 weeks after 
implantation; there was no difference in 
the recovery rate of these animals post- 
operatively.
Evaluation of the 5-week specimen 
demonstrated immature woven trabecu­
lar bone being formed along the endosteal 
cortical surface (Fig. 3a). Only a small
portion of the prosthesis had direct 
endosteal bone contact (Table I). The 
trabeculae ranged from 50 to 200 /tm in 
thickness (average 150 /mi). The trabec­
ulae were oriented at right angles to the 
prosthetic stem. Dense, fibrous tissue, 
oriented obliquely to the cross-section of 
the femoral component, filled the space
between the prosthesis and the endosteal 
cortical bone. The fibrous tissue was well 
organized with parallel fibres that resem­
bled Sharpey’s fibres (Fig. 3b). A longitu­
dinal section demonstrated that the 
fibrous-tissue fibres sloped downward 
from the endosteal bone to the prosthesis.
At 6 and 9 weeks the prosthetic
Fig. 4a Fig. 5a
F'g- 4b Fig. 5b
FIG. 4—(a) Polarized photomicrograph of cross-section of mid­
stem of prosthesis at 20 weeks. Fifty percent of prosthetic perimeter 
has direct bone contact. Bone growth into interstices of prosthesis and 
trabecular hypertrophy are both advanced at apices of prosthesis (origi­
nal magnification x 4). (b) High-power fluorescent photomicrograph 
of bone-prosthesis interface. New bone is forming within interstices 
of prosthesis and immediately adjacent to prosthesis without any evi­
dence of intervening soft tissue (original magnification x 52).
FIG. 5—(a) Polarized photomicrograph of cross-section of mid­
dle portion of specimen at 1 year. Mature trabecular bone lies in inti­
mate contact with prosthesis (original magnification x 20). (b) High- 
power fluorescent photomicrograph of bone-prosthesis interface 1 year 
after implantation. Active new bone formation continues deep within 
interstices of prosthesis without any evidence of intervening soft tissue 
(original magnification x 52).
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perimeter with direct bone contact had 
increased to 43% and 39% respectively. 
Predominantly woven bone was observed 
around the prosthesis. The intervening 
fibrous tissue remained well organized. 
The bone formation was concentrated at 
the proximal and distal ends of the 
prosthesis and also in cross-section at the 
apices of the triangular prosthesis. The 
split in the femur had healed in both 
specimens. At 12 weeks, 37% of the 
prosthetic perimeter had direct bone con­
tact. The lateral apex of the prosthesis 
demonstrated the greatest bone ingrowth 
and hypertrophy.
F ifty  percent of the prosthetic 
perimeter had direct bone contact at 20 
weeks (Fig. 4a). Bone ingrowth and 
trabecular hypertrophy were maximal at 
the apices of the prosthesis. New bone 
formation was observed in many of the 
interstices of the prosthesis (Fig. 4b). In 
these areas, the new bone formation 
approximated the prosthesis without evi­
dence of an intervening soft-tissue mem­
brane.
At 52 weeks, 60% of the prosthetic 
perimeter had direct bone contact. 
Mature trabecular bone was in contact 
with the prosthesis in many areas without 
intervening soft tissue (Fig. 5a). Fluores­
cent labelling demonstrated continued 
new bone formation deep within the inter­
stices of the prosthesis without interven­
ing soft tissue (Fig. 5b).
The septic specimen demonstrated no 
fibrous or bone ingrowth (Table I). The 
prosthesis was encircled by a reactive 
1-mm thick shell of endosteal new bone 
formation located approximately 2 mm 
from the edge of the prosthesis. The cor­
tical bone of the proximal femur had 
undergone cancellous change.
Discussion
Our study demonstrates that the 
Madreporic surface provided firm fixa­
tion of the femoral component of the 
prosthesis both initially and throughout 
the 1 year of the study. Immediately 
postoperatively, the prosthesis was 
anchored by friction fit. With time, well- 
organized fibrous tissue and new bone 
surrounded the prosthesis to stabilize it. 
Bone formation around the prosthesis 
was progressive, and in many areas no 
soft tissue intervened between areas 
o f new bone and the prosthesis. 
O thers11,19,20 have noted that initial 
friction fit is of paramount importance 
in allowing bone ingrowth. Micromotion 
is acceptable, but macromotion is not. 
This concerned us in our study since two 
undisplaced femoral fractures occurred at 
the time the prosthesis was inserted. The 
fractures healed without displacement, 
and bone ingrowth was not adversely 
affected. Longitudinal splitting of the 
femur at the time of prosthetic insertion
did not appear to have a deleterious effect 
on the quality or quantity of bone in­
growth, providing the initial friction fit 
was maintained.
Since the prosthesis was triangular and 
the canine endosteal canal is circular, only 
a portion of the prosthesis had direct con­
tact with the endosteal cortex at the time 
of insertion. In areas where the prosthe­
sis was in direct contact with the endosteal 
cortex, new bone formation was ob­
served, but fibrous tissue, fibrocartilage 
and hyaline cartilage were absent. Bone 
ingrowth was maximal at the apices of the 
prosthesis, which were often in direct con­
tact with the endosteal cortex. Progres­
sive trabecular maturation and hyper­
trophy were observed in the 20- and 
52-week specimens.
Fibrous tissue, which was obliquely 
oriented to the longitudinal surface of the 
prosthesis, formed in areas where the 
prosthesis did not touch the endosteal cor­
tex. This fibrous tissue attached to the 
endosteal bone and had the appearance 
of Sharpey’s fibres. This tissue, also 
similar in appearance to periondontal 
ligam ent, has been observed by 
others9,11,14,15,20,21 and was particularly 
prominent in the 5-, 6- and 9-week speci­
mens. We speculate that this well- 
organized fibrous tissue plays a role in 
load transference initially, while bone 
ingrowth occurs. Its presence did not indi­
cate loosening, since new bone formation 
was occurring within the interstices of the 
prosthesis in areas immediately adjacent 
to those with fibrous tissue.
Cameron and colleagues22 demon­
strated the inhibitory influence of early 
sepsis on bone ingrowth. Chen and 
colleagues13 observed a lack of bone 
growth into a cementless canine hip 
arthroplasty when non-weight bearing 
occurred secondary to a dislocation. We 
observed a total absence of tissue 
ingrowth of any kind in the single animal 
with sepsis. We are uncertain whether the 
absence of tissue ingrowth was due to a 
direct effect of sepsis or was secondary 
to the dog’s inability to bear weight. We 
think it was probably secondary to sep­
sis, because of the total absence of any 
type of tissue ingrowth.
The Madreporic prosthesis is not sub­
ject to damage by the shear forces that 
occur during insertion and that may dis­
rupt porous sintered surfaces.23 Sintered- 
particle migration does not occur and the 
large surface irregularities allow for the 
development of new bone between the 
endosteal bone and the prosthesis even in 
areas where there is no bone contact ini­
tially. Active new bone formation was 
observed at the bone-prosthesis junction 
throughout the study. Although only a 
small number of animals were studied and 
the important issue of stress shielding in 
the proximal femur was not addressed, 
this canine study demonstrates a favoura­
ble response to implantation of a femoral 
hip arthroplasty component with a 
Madreporic surface.
We acknowledge the assistance of Mrs. 
Isabella Urquhart, chief technologist in histol­
ogy, Princess Margaret Hospital, Toronto and 
Mr. A.K. Collins, director of medical photog­
raphy, St. Michael’s Hospital, Toronto.
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Posterior Wall Disruption of the 
Left Ventricle After Mitral Valve Replacement: 
Management of Bleeding and Cardiac Enlargement
Two patients who underwent mitral 
valve replacement sustained posterior 
left ventricular disruption postoperatively 
and survived. Management consisted of 
repair from outside the heart without 
removal of the mitral prosthesis. This 
was achieved with a running Prolene 
suture in the atrioventricular junction in 
one patient and pledgeted sutures in the 
other who had transverse midventricular 
disruption. Biologic glue was crucial in 
controlling hemorrhage after the repair in 
both cases. The patient with transverse 
midventricular disruption required place­
ment bilaterally of pectoralis muscle 
flaps to close the sternal wound because 
of swelling and dilatation of the heart.
Deux patients qui avaient eu un rempla- 
cement de la valvule mitrale ont subi en 
postoperatoire une desunion ventricu- 
laire gauche posterieure et ont survecu. 
Le traitement a consiste a reparer de 
I'exterieur du coeur sans enlever la pro- 
these mitrale. Ceci a ete accompli chez 
une patiente a I'aide d'une suture cou- 
rante de Prolene et, chez I'autre, qui 
avait une desunion meso-ventriculaire 
transverse, a I'aide de sutures en tam­
pon. Dans les deux cas, ('utilisation 
d'une colle biologique fut cruciale pour 
juguler I'hemorragie apres I'operation. La 
patiente qui avait subi une desunion
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meso-ventriculaire transverse a necessity 
des greffes bilaterales de lambeaux de 
muscles pectoraux pour refermer la plaie 
sternale a cause d'une inflammation et 
d'une dilatation du myocarde.
Ventricular disruption is a dreaded com­
plication of mitral valve replacement and 
is associated with a high death rate.1-4 
Most deaths are due to bleeding5-7 and 
heart failure.5,8 We have encountered 
two such cases and achieved successful 
surgical repair without removing the 
prosthesis. Besides suturing the disruption 
from outside the heart, biologic glue was 
found to be crucial in controlling residual 
hemorrhage. Bilateral pectoralis muscle 
flaps9 and bolstered skin traction o f the 
sternal edges were used in one patient to 
accommodate the dilated heart in the 
pericardial cavity.
Case Reports
Case 1
A thin 75-year-old woman underwent mitral 
valve replacement with a 27-mm Ionescu- 
Shiley prosthesis for calcific mitral stenosis and 
insufficiency. Cardiac catheterization before 
surgery revealed normal coronary arteries, 
severe mitral stenosis with a gradient o f 17 mm 
Hg across the mitral valve at rest, grade 3 
mitral insufficiency and calcific mitral annu­
lus with calcification extending posteriorly into 
the left ventricular myocardium. The annulus 
was decalcified but the posterior papillary mus­
cles were calcified and were left adherent to the 
ventricular myocardium. Pledgeted sutures 
were used to secure the mitral prosthesis. A left 
ventricular vent was not used. The operation 
was uncomplicated. Three hours after the 
procedure she suffered a severe hemorrhage 
requiring immediate exploration. A site of pro­
fuse bleeding was identified at the back of the 
heart. Under cardiopulmonary bypass the dis­
ruption was pinpointed at the atrioventricular 
junction (type I disruption10). In view of the 
heavy calcification noted at the time o f the ini­
tial operation, removal of the mitral prosthe­
sis and repair from within the ventricle were 
considered unwise. After induction o f cardi- 
oplegic arrest, a running 4-0 Prolene suture was
applied to the atrioventricular region avoiding 
the circumflex coronary artery. Biologic glue, 
made up of thrombin, cryoprecipitate, plasma 
and calcium,11 was applied to the area after 
suturing. The patient was weaned from bypass 
without difficulty. She made a smooth recov­
ery and was well on follow-up 15 months later.
Case 2
An obese 65-year-old woman underwent 
replacement of a 29-mm Omniscience mitral 
valve prosthesis which had been implanted 8 
months before for mitral stenosis and insuffi­
ciency. Malfunction of the prosthesis was evi­
dent; at catheterization the coronary arteries 
appeared normal. After opening the sternum, 
only the right side of the heart was dissected 
due to very dense adhesions over the left ven­
tricle. There was tissue ingrowth into the 
prosthesis with pannus formation in the atrial 
and ventricular sides of the prosthetic valve. 
The valve was removed and replaced with a 
29-mm lonescu-Shiley prosthesis using pledg­
eted sutures. A left ventricular vent was not 
used. The operation was difficult but weaning 
from bypass posed no problems. Two hours 
after surgery, she had severe hemorrhage with 
shock and was immediately explored. Profuse 
bleeding was observed from behind the heart. 
By the time bypass was instituted she had been 
hypotensive for approximately 30 minutes. 
After induction of cardioplegic arrest and dis­
section of the remaining pericardial adhesions, 
a 3- to 4-cm longitudinal disruption was found 
on the posterior midventricular region of the 
left ventricle (type III10). Finger exploration of 
the ventricular cavity through the tear revealed 
that the struts of the prosthesis did not appear 
to be the cause of the tear, so we elected to 
repair the tear without removing the prosthe­
sis. The defect was closed with pledgeted 
sutures of 3-0 Prolene placed longitudinally. 
Bleeding, which occurred after unclamping and 
heart ejection, ceased when biologic glue was 
applied to the posterior surface of the heart. 
She was weaned from bypass with the aid of 
the intra-aortic balloon pump. Due to pro­
found hypotension when attempts were made 
to close the sternum or skin, both were left 
open. Temporary closure of the latter was 
achieved with a Vidrape. The morning after 
surgery she was returned to the operating room 
and several attempts were made to close the 
sternum and skin, again without success due 
to profound hypotension. Three days later
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another attempt to close the sternum failed, but 
the skin was approximated. A final attempt at 
sternal closure was made 4 days later without 
success, so pectoralis muscle flaps were deve­
loped to fill the sternal wound. Stay sutures 
were needed to hold the sternal edges apart to 
prevent a tamponade-like effect while the mus­
cle flaps were applied to the sternotomy inci­
sion. They were removed 7 days postopera- 
tively. The intra-aortic balloon was removed 
a day later. She required prolonged ventilatory 
support and eventually a tracheostomy was 
performed 32 days after operation. The 
wounds healed without problems, but bactere­
mia occurred due to infection in a subclavian 
line used for hyperalimentation. She made a 
satisfactory recovery, with excellent cosmetic 
appearance o f the sternotomy incision. The 
follow-up is short (9 months), but she remains 
well and has had the tracheostomy tube 
removed.
Discussion
Left ventricular disruption after mitral 
valve replacement is rare (0.5% to 2% of 
all mitral valve replacements) and carries 
a high death rate.2-4 The condition was 
first reported by Roberts and Morrow in 
1967.12 Its cause is not completely under­
stood.10'12-15 Although spontaneous dis­
ruption o f the left ventricle without 
antecedent trauma may occur,15 most 
reports implicate a preceding traumatic 
event.16-23 Several hypotheses have been 
advanced to explain this complication. 
The atrioventricular groove is a “ weak” 
area in that the mitral annulus is only in 
continuity with the endocardium of the
left atrium4 without muscular continuity 
between atrium and ventricle. Thus, 
aggressive debridement or decalcification 
of this region may lead to atrioventricu­
lar separation. Similarly, insertion of 
sutures that penetrate the ventricular mus­
cle and are tied vigorously may result in 
tearing of the ventricular muscle with 
resultant weakening and subsequent sepa­
ration. This may explain type I injury. It 
has been suggested that type II injury is 
due to zealous excision of the papillary 
muscles with thinning of the ventricular 
wall followed by trauma from an adja­
cent prosthetic valve strut.8,10 Cobbs and 
colleagues15 and Spencer and associates8 
have hypothesized that type III injury is 
related to disruption of the posterior 
chordal attachments, predisposing the 
ventricle to a stretch injury, exacerbated 
by excessive ventricular relaxation during 
cardioplegic arrest. They suggest that 
preservation of the posterior mitral valve 
apparatus may eliminate this complica­
tion. In fact, the patient in our case 2 with 
a type III separation, did have excision 
of the posterior leaflets and chordae dur­
ing the original operation, thus predispos­
ing the ventricle to this type of separation. 
It must be noted, however, that confir­
mation of the mechanism of injury 
usually eludes the surgeon and, in view 
of this, particular care should be taken 
in the patient with a small ventricle, in the 
elderly and in the patient with previous 
mitral valve replacement who has had 
excision of the mural leaflet. Treatment
includes removal of the prosthesis and 
suture repair with or without a patch5 or 
repair of the tear without removal of the 
prosthesis.8 Bleeding5-8 and heart 
failure5,8 appear to be the most common 
complications leading to death after 
repair.
In our patients, repair was achieved 
from outside the heart either by running 
sutures in the atrioventricular groove 
avoiding the circumflex coronary artery 
(case 1) or with pledgeted sutures on the 
ventricular myocardium (case 2). In both 
cases, profuse bleeding in inaccessible 
areas occurred after repair. Biologic glue 
allowed complete hemostasis after the 
repair and was life-saving. This type of 
physiologic glue11 is readily available in 
any operating room.
Bleeding, edema and dilatation of the 
heart in the patient with type III disrup­
tion posed a considerable problem. 
Although bleeding was eventually con­
trolled with biologic glue, cardiac swell­
ing and dilatation precluded approxima­
tion of the sternum and skin. This 
problem was solved by the use of bilateral 
pectoralis muscle flaps to accommodate 
the heart in the pericardial cavity.9 The 
sternal edges had to be held apart with 
bolster sutures to prevent cardiac com­
pression when the flaps were laid over the 
sternal defect.
Conclusions
Bleeding and cardiac edema are major
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problems when posterior left ventricular 
disruption occurs after mitral valve 
replacement. The surgeon should consider 
repair without removal of the prosthesis 
and the use o f  biologic glue to achieve 
hemostasis subsequently. Mobilization of 
muscle flaps to accommodate an edema­
tous dilated heart should also be consi­
dered if sternal closure is impossible. It 
may become necessary to hold the ster­
nal edges apart with stents or suture bol­
sters to avoid compressing the heart until 
swelling decreases with time.
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Conservative Management of Renal Lacerations
in Blunt Trauma
Controversy in the treatment of blunt 
renal trauma is largely focused on 
immediate surgery versus conservative 
management for parenchymal lacera­
tions. A retrospective analysis of 133 
cases of blunt renal trauma at the Vic­
toria General Hospital in Halifax over a 
10-year period revealed 26 cases of 
renal laceration. The conservative 
approach to radiologic diagnosis and 
treatment options is discussed. Our 
experience confirms a low rate of 
both nephrectomy and secondary compli­
cations using conservative management.
Le debat entourant le traitement des 
traumatismes renaux fermes oppose sur- 
tout les tenants d'une chirurgie imme­
diate a ceux qui preconisent un traite­
ment conservateur des lacerations du 
parenchyme. L'analyse retrospective de 
133 cas de contusions renales vus au 
Victoria General Hospital d'Halifax au 
cours d'une periode de 10 ans a revele 
26 cas de lacerations renales. On com- 
mente I'approche conservatrice avec le 
diagnostic radiologique et les diverses 
options therapeutiques. Selon notre 
experience, on constate que le traite­
ment conservateur est accompagne d'un 
faible taux de nephrectomie et de com­
plications secondaires.
Despite increased experience over the last 
30 years with the treatment of renal lacer­
ations from blunt trauma, the issue of 
immediate surgery versus conservative 
management remains controversial. 
Advocates of immediate surgical debride­
ment maintain that primary repair and 
drainage allow for primary healing and 
early rehabilitation of the patient.1-4 
Advocates of a conservative approach 
think that a high percentage of renal inju­
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ries will heal spontaneously, precluding 
the need for any renal surgery.5-10
At our institution, clinically stable 
patients with severe renal lacerations have 
been managed conservatively and a 
review of our experience appeared ger­
mane to the controversy of immediate 
versus expectant surgery.
Patients and Methods
A retrospective analysis at the Victoria 
General Hospital in Halifax of 133 
patients who had suffered blunt renal 
trauma between 1975 and 1984 revealed 
26 cases of severe renal lacerations. Rou­
tine intravenous pyleography was done on 
admission for all patients with suspected 
renal injury, except those requiring emer­
gency surgery. Renal arteriography was 
performed when no renal lesion or a 
poorly defined one was seen on intra­
venous pyelography or, occasionally, as 
part of aortography to delineate intra­
abdominal bleeding. Nuclear scanning 
and intravenous pyelography were used 
on follow-up to assess renal function.
Renal lesions were classified in two 
groups — parenchymatous and hilar. 
Under parenchymatous lesions, contusion 
was diagnosed when there was minimal 
functional or anatomical change on 
intravenous pyelography; laceration was 
defined as a deep parenchymal tear 
extending at least to the corticomedullary
junction, with or without calyceal disrup­
tion (Fig. 1); a shattered kidney implied 
multiple lacerations. Hilar injuries were 
subdivided into pedicle injury, referring 
to renal arterial occlusion or laceration 
resulting in nonvisualization and failure 
of kidney perfusion, and pelvic injury, 
referring to a disrupted renal pelvis.
The clinical state of the patient decided 
the initial management of a renal lacera­
tion. If the patient was hemodynamically 
unstable because of severe renal hemor­
rhage at the time of admission, despite 
resuscitation, laparotomy was performed 
immediately. The clinically stable patient 
was treated conservatively with bed rest, 
frequent abdominal examinations and 
monitoring of vital signs, hydration, anal­
gesics, serial complete blood count and 
follow-up renal scanning or intravenous 
pyelography. Renal exploration was done 
if there was persistent severe hemorrhage, 
massive or increasing urinary extravasa­
tion or renal sepsis.
Findings
Renal lacerations accounted for 18% 
of blunt renal injuries in our institution 
and 80% of them resulted from traffic 
accidents (Table I). In this adult popula­
tion, 75% of the patients were under 30 
years of age and 90% were men (Fig. 2). 
Emergency intravenous pyleography was 
performed on 25 patients; emergency
FIG. 1—Intravenous pyelogram and corresponding arteriogram of renal laceration.
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laparotomy precluded one patient from 
undergoing intravenous pyelography and 
the laceration was diagnosed at surgery. 
Fifteen patients had renal arteriography 
for more accurate definition of the renal 
laceration. There were three additional 
cases in which arteriography, used to 
define an associated abdominal injury, 
outlined the renal laceration. The 
intravenous pyelogram and arteriogram 
were congruous except in three patients 
in whom the intravenous pyelogram was 
suggestive of a contusion but the arterio­
gram showed a renal laceration.
Three patients required immediate 
renal exploration and nephrectomy for 
severe hemorrhage. Surgery (nephrec­
tomy) was indicated in four other patients 
initially treated conservatively, three for 
persistent severe bleeding and one for 
renal sepsis. All kidneys removed immedi­
ately or after expectant treatment showed 
shattering.
Two (8% of the group of 26 with lacer­
ations) patients requiring nephrectomy 
had associated renal anomalies. One had 
a pelvic kidney and required immediate 
nephrectomy for severe hemorrhage. The 
other had a hydronephrosis secondary to 
an obstruction at the ureteropelvic junc­
tion; the obstruction initially was 
managed expectantly, but persistent severe 
bleeding necessitated nephrectomy.
There were no postoperative complica­
tions in the three patients requiring 
immediate nephrectomy. One patient 
with a delayed nephrectomy required re­
exploration of the renal bed 24 hours after 
operation because of hemorrhage, seem­
ingly from a slipped ligature.
In addition to the renal laceration, 
major associated injuries (Table II) were 
present in 17 patients, an average of 1.8 
injuries per patient. There were three 
deaths but none due to renal causes. 
Excluding the three patients who died of 
non-renal causes and three patients who 
required immediate nephrectomies, 20 
patients were managed expectantly. Four 
(20%) later needed nephrectomy. Those 
managed successfully showed improved 
renal function on follow-up renal scan­
ning or intravenous pyelography by the 
time of discharge. For patients with major 
injuries associated with the renal lacera­
tion, the average time in hospital was 20 
days. When the renal laceration was the 
main injury responsible for hospitaliza­
tion, the average stay was 10 days. Six 
patients underwent intravenous pyelogra­
phy at 6 months and one at 3 years; all 
showed completely healed kidneys. None 
suffered hypertension during a follow-up 
of 2 to 6 years. The remaining 13 could 
not be traced because of the transient 
patient population.
Discussion
In blunt renal trauma, renal contusion 
accounts for 80% of the injuries; the con­
tusions are treated conservatively as heal­
ing usually occurs without complica­
tions.11 Immediate surgical intervention 
is advised for hilar pedicle and pelvic inju­
ries and renal laceration in patients who 
are hemodynamically unstable.12 The 
controversy in the management of blunt 
renal trauma is thus focused on the less 
than 20% of patients with renal trauma 
who present with parenchymal lacera­
tions.1' 10,13
In accurately delineating the renal 
injury, infusion intravenous pyelography 
with tomography has an excellent (90%) 
correlation with both selective renal
arteriography and the lesion seen at explo­
ration.14' 16 Unfortunately, tomography 
is not available to every emergency 
department, and intravenous pyelography 
alone is said to have a correlation of 50% 
to 70% .14,15,17 In this series, the 
intravenous pyelogram provided adequate 
information about the renal laceration in 
22 of 25 cases for a false-negative result 
of 12%. On the other hand, arteriogra­
phy confirmed the diagnosis of renal 
laceration whenever it was suspected on 
intravenous pyelography.
Renal arteriography is the most 
accurate study for defining the nature of
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the renal injury. Lang18 recommended its 
use in all patients with hematuria and 
renal trauma, citing its low morbidity, 
accuracy and assessment of associated 
intra-abdominal injury. However, it can 
be argued that if a conservative approach 
to managing renal laceration is the policy 
and the indication to explore is based on 
clinical criteria, establishing a function­
ing kidney on the intravenous pyelogram 
is all that is necessary, since knowing the 
extent of laceration will not influence the 
course of management. Arteriography 
should, therefore, be reserved for possi­
ble surgical intervention when there is 
clinical deterioration. Advocates of a 
more liberal use of renal arteriography 
could argue that the procedure may be 
unsafe or not feasible by the time clini­
cal deterioration has occurred. It should 
be emphasized that the arteriographically 
defined renal injury may be more exten­
sive than the patient’s clinical condition 
indicates and the severity of the anatom­
ical injury per se should not be an indi­
cation for surgery.
Recent reports19'20 suggest that com­
puterized tomography provides precise 
anatomical details of renal injuries and 
has been used in preference to renal arteri­
ography. Computerized tomography has 
been advocated as the primary diagnos­
tic modality in patients suspected of sus­
taining major renal and other organ inju­
ries.21 Although there is a possibility that 
a laceration may be missed because the 
slice taken by the scanner may not go 
through the site of the renal injury, 
enhancement of the renal parenchyma has 
the added advantage of ruling out a major 
vascular injury. Routine intravenous pye­
lography and selective use of arteriogra­
phy still have their merits, particularly if 
renal surgery is contemplated.
In reviewing various series (Table 
III2-4’9’10’13'14’22) in which the policy of 
immediate surgical repair for all renal 
lacerations is applied, even with the tech­
nique of controlling the vascular pedicle 
before renal exploration, the nephrec­
tomy rate is equivalent to that of conser­
vative management. The merits of either
approach thus seem to centre on immedi­
ate and long-term patient morbidity. Our 
experience and that of others indicate 
spontaneous healing and resolution 
without side effects in a large proportion 
of cases even when the laceration seems 
severe on arteriography. Immediate sur­
gical management has been recommended 
for shattered kidneys with multiple lacer­
ations in order to avoid morbidity, but 
invariably a nephrectomy is neces­
sary.4'23 Even in these most severe paren­
chymal injuries, a conservative approach 
has been used successfully with minor 
complications7 and is recommended for 
the patient who can be stabilized clini­
cally.
Classification of renal injuries has 
varied from a simple categorization into 
mild and severe to one of 15 subdivisions 
based on anatomic and topographic 
criteria.11 We prefer the classification 
that separates the parenchymatous from 
the hilar lesions and attempts to catego­
rize the extent of the parenchymatous 
lesion. In our opinion such classifica­
tion is practical and has therapeutic 
implications.
There is a good correlation between the 
extent of trauma and the severity of the 
associated injuries. These extrarenal inju­
ries frequently dictate the immediate 
management and account for the mor­
bidity and mortality. The incidence of 
associated injuries in this study is com­
parable to those of previously reported 
series.4'13’24 Mendez12 reported that shock 
was present in 14% to 30% of trauma 
patients with renal injuries compared 
with 20% in our series. The frequency of 
associated major injuries could make the 
conservative approach more desirable.
Advocates of immediate surgical inter­
vention have suggested that the expectant 
approach prolongs the hospital stay.1'13 
The length of stay in our series was found 
to be more a reflection of the associated 
injuries. For patients whose renal lacera­
tion was the main injury, we believe an 
average length of stay of 10 days is an 
acceptable figure when compared with 
that from surgical series.
Table Ill-Frequency of Nephrectomy in Series of Renal 
Lacerations Caused by Blunt Trauma
Series No. of patients %
Immediate surgery
Cass and Ireland, 19733 22 68
Peters and Bright, 197713 ? 18
Cass, 19792 17 15
Cass and Luxenberg, 19834
lacerations 31 6.5
shattered 14 100
Expectant treatment
Morrow and Mendez, 197014 21 22
Cass and Ireland, 1973s 16 6
Thompson and associates, 19779 44 2
Wein and associates, 197710 42 2
Gibson and associates, 198 222 28 19.6
Present series 20 20
Conclusions
Emergency intravenous pyelography 
with renal arteriography in selected cases 
continues to be the method of choice in 
the initial evaluation of patients with renal 
injury. Conservative management of 
renal lacerations carries a low morbidity, 
an acceptable nephrectomy rate and we 
believe may obviate the need for surgery 
in many such cases. Major associated 
injuries frequently play an important role 
in the management of patients with renal 
lacerations.
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Simultaneous Occurrence of Chylothorax and 
Subarachnoid Pleural Fistula After Thoracotomy
A left chylothorax complicated elective 
left posterolateral thoracotomy and emer­
gency decompressive laminectomy car­
ried out on a 32-year-old woman with a 
benign neurofibroma. Failure of conser­
vative therapy necessitated ligation of 
the thoracic duct and this in turn 
unmasked the concomitant subara­
chnoid-pleural fistula. Surgical repair and 
lumbar subarachnoid drainage were 
required to close the second fistula. The 
clinical setting, diagnosis and manage­
ment of this uncommon condition are 
reviewed.
Un chylothorax gauche est venu compli- 
quer une thoracotomie posterolaterale 
gauche non urgente et une laminectomie 
de decompression d’urgence pratiquees 
chez une femme de 32 ans souffrant 
d'un neurofibrome benin. L'echec d'un 
traitement conservateur a necessity une 
ligature du canal thoracique qui, a son 
tour, mit en evidence une fistule pleuro- 
sous-arachnoidien. La reparation chirurgi- 
cale et le drainage sous-arachnoldien 
lombaire ont du etre pratiques pour refer- 
mer la seconde fistule. Le tableau Clini­
que, le diagnostic et le traitement de 
cette rare affection sont passes en 
revue.
Chylothorax and subarachnoid-pleural 
fistula are uncommon complications of 
thoracotomy. Their simultaneous occur­
rence, a rare event,1 must be considered 
in certain settings when treatment of a 
chylothorax is unsuccessful.
Case Report
A previously healthy 32-year-old woman was
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found to have an asymptomatic left posterior 
mediastinal mass on a routine chest film. Com­
puterized tomography demonstrated its origin 
from the left T6 nerve root, erosion of the outer 
lip of the interverteral foramen and no dumb­
bell extension into the spinal canal (Fig. 1). At 
another hospital a benign plexiform neuro­
fibroma was electively excised through a left 
posterolateral thoracotomy. The patient awoke 
with a left Brown-Sequard syndrome, which 
progressed rapidly and required emergency 
decompressive laminectomy late that night. 
Excessive serous pleural drainage was noted 
postoperatively. The chest tubes were eventu­
ally removed and the patient transferred to our 
hospital 2 weeks after operation for treatment 
and rehabilitation of a left lower extremity 
paralysis.
On admission, the clinical diagnosis of a 
large left pleural effusion was confirmed radi- 
ologically. Thoracentesis was done, and exami­
nation of the milky fluid revealed a triglycer­
ide content eight times that of plasma. A 
low-lying left intercostal drainage tube was 
inserted. The patient was placed on an elemen­
tal diet, but dietary intolerance required the 
institution of total parenteral nutrition (TPN). 
In spite of re-expansion of her left lung, ade­
quate dependent drainage and “ thoracic duct 
rest” , the fistulous drainage persisted at a rate 
of 600 to 1200 ml/d. The left chest tube was 
repositioned and then replaced, with no effect.
A contrast lymphangiogram (Fig. 2) and a 
nuclear lymphangiogram (Fig. 3) demonstrated 
disruption of the thoracic duct with extrava­
sation into the left pleural space. A left sub­
clavian venogram confirmed a patent subcla­
vian vein, thus ruling out venous occlusion as
a cause for the persistent chylothorax. Twenty- 
seven days after admission, after the patient 
was given 200 ml of cream 6 hours preopera- 
tively by nasogastric tube, supradiaphragmatic 
ligation of the thoracic duct was performed 
through a right posterolateral thoracotomy.
Postoperatively, the chest tube drainage 
decreased to 200 to 600 ml/d. A repeat nuclear 
lymphangiogram showed successful treatment 
of the chylothorax. However, persistent left- 
chest-tube drainage necessitated a left 
posterolateral thoracotomy 3 weeks later. A 
subarachnoid-pleural fistula was identified at
FIG. 2—Contrast lymphangiogram demon­
strates chylous leak in vicinity of T6 vertebra 
(closed white arrow). Contrast material then 
flows freely into left pleural space after travers­
ing paramediastinal cavity containing air-fluid 
level (open white arrow).
FIG. 1—Computerized tomogram (coronal view) of T6 vertebra showed neurofibroma aris­
ing from left T6 nerve root (closed white arrows). Erosion of superior and inferior lips of inter­
vertebral foramen can be seen (open white arrows), but no dumb-bell extension into spinal canal.
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the site of the previous excision. Dural closure 
could not be obtained, so a pedicled pleural 
patch was sutured to the tissue edges about the 
intervertebral foramen, using interrupted 3-0 
silk sutures. The left lung was decorticated, the 
parietal pleura abraded and the subarachnoid 
space decompressed by continuous closed lum­
bar subarachnoid drainage. Postoperatively, 
the patient remained on bed rest with limited 
elevation of the head of the bed. The left-chest- 
tube drainage diminished considerably. Four 
days postoperatively the lumbar drain was
FIG. 3—Nuclear lymphangiogram demon­
strates left chylothorax (closed black arrows). 
Some contrast material reaches supraclavicu­
lar nodes (open black arrows). Infradiaphrag- 
matic uptake is in liver and spleen.
FIG. 4—Nuclear myelogram demonstrates 
left subarachnoid-pleural fistula (closed black 
arrow). Contrast material drains through chest 
tube into reservoir on patient’s chest (open 
black arrow).
FIG. 5—Chest film at time of discharge 
from hospital shows minimal left pleural thick­
ening, blunting of right costophrenic angle and 
surgical clips at site of fistulas.
removed and the chest tube drainage promptly 
increased to 200 to 400 ml/d. A nuclear myelo­
gram (Fig. 4) demonstrated a persistent left 
subarachnoid-pleural fistula. Continuous 
closed lumbar subarachnoid drainage was rein­
stituted and after 1 week the fistula had closed. 
When the lumbar drain was removed the 
patient became febrile and had the signs and 
symptoms of meningitis. Culture of the 
cerebral spinal fluid grew Pseudomonas aer­
uginosa. The infection promptly responded to 
ceftazidime, which was continued in a dosage 
of 2 g every 8 hours for 2 weeks. The patient 
was transferred to our rehabilitation unit and 
was discharged home 14 weeks after transfer 
to our hospital, walking unaided with a 
minimal left foot drop. Fler discharge chest x- 
ray film showed left pleural thickening (Fig. 5).
Comments
Chylothorax
The anatomy of the thoracic duct is 
extremely variable. Its “ normal” course 
is rarely seen (Fig. 6). The thoracic duct 
originates as the efferent vessel of the 
cisterna chyli, adjacent to the L3-T10 ver­
tebral bodies. It lies to the right of the 
aorta, passing into the posterior mediasti­
num through the aortic hiatus. Here, in 
possibly the most constant location in the 
thorax, it is situated anterior to the ver­
tebral bodies, posterior to the esophagus, 
to the left of the azygos vein and to the 
right of the aorta. At approximately the 
level of the T5 vertebral body, the duct 
passes behind the aorta, to lie on its left. 
At the apex of the thorax (root of the 
neck) the duct passes behind the carotid 
sheath and then arches anteriorly to enter 
the venous system at the junction of the
left internal jugular and left subclavian 
veins. Along this course there are rich col­
laterals and anastomoses. This allows for 
safe ligation without sequelae.
Injury to the thoracic duct occurs most 
frequently during surgery about the 
thoracic aorta or esophagus but can com­
plicate any thoracic procedure. Aware­
ness of the variable anatomy of the duct 
is most important in preventing a 
chylothorax. Careful dissection about the 
probable course of the duct and 
meticulous control of suspected chylous 
leaks at operation are essential. If 
damaged, the duct may be safely ligated2 
or repair attempted.3 In our hands liga­
tion has been simple, safe and effective.
The diagnosis of a chylothorax is well 
documented.2 Fluid analysis measuring 
total lymphocyte count, chylomicrons 
and triglyceride and cholesterol concen­
trations is helpful. Contrast studies are 
the mainstay of diagnosis. We have found 
nuclear lymphangiography, using tech- 
netium-99m antimony colloid to be a 
new, but useful, diagnostic tool. It is easy 
to  adm inister, well to lerated  and 
eliminates the potential pulmonary com­
plications of standard contrast lymphan­
giography. In this case, nuclear lymphan- 
giograms verified the presence of the 
chylous fistula and recorded its closure. 
Precise localization of the fistulous site 
can be difficult but if required, as in our 
case, standard contrast lymphangiogra­
phy should be done.
Nonoperative m anagem ent o f a 
chylothorax includes an elemental diet or 
total parenteral nutrition. Administration 
of total parenteral nutrition through the 
left subclavian vein can be complicated
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FIG. 6—Typical course of thoracic duct. Its most constant portion within thorax is depicted 
on right.
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by venous thrombosis and paradoxically 
delayed fistula closure. For this reason we 
try not to use the left subclavian vein 
when treating a chylothorax and perform 
subclavian venography when conservative 
therapy fails.
We prefer the supradiaphragmatic 
approach for ligation of the thoracic 
duct.2 Generally, a right thoracotomy is 
used; however, concomitant or persistent 
disease in the left pleural space may neces­
sitate a left thoracotomy. In our case, an 
unsuspected subarachnoid-pleural fistula 
was masked by the chylous fistula, which 
was managed by a right-sided approach. 
Later, a left thoracotomy was needed to 
manage the subarachnoid-pleural fistula.
Subarachnoid-Pleural Fistula
This fistula is an uncommon entity. It 
occurs most frequently after blunt or 
penetrating trauma1,4-9 but is rarely seen 
after thoracotomy.10' 12 The fistula may 
be suspected on plain films of the 
skull,12 thoracic spine or chest. It may be 
demonstrated by myelography,4,5,7,8,10 
but if high-viscosity material is used there 
may not be free flow throughout the 
subarachnoid space, thus precluding the 
dem onstration of a small fistu la .13 
Radionuclide myelography is use­
ful.4’9,10’12,13 Analysis of the cerebrospi­
nal fluid collected from the pleural space 
may be misleading, for a “dialysis effect” 
may alter its typical composition.
Treatment of a subarachnoid-pleural 
fistula by intercostal tube drainage alone 
may be successful.6,7'11 Operative 
management may be conducted through 
a posterior laminectomy4,5,8,10 or thora­
cotomy, or both.1,4,9,12 Direct suture 
closure,4,8,10 fascial grafting,5 placement 
of a pleural flap,1,4 intercostal and other 
muscle grafting (free or pedicled),4 use 
of thrombin-soaked Gelfoam4 or methyl 
methacrylate seal,9 and thoracoplasty12 
have all been successful. The use of 
subarachnoid drainage is controversial.14 
In this case the continuous closed lumbar 
subarachnoid drain was a major factor in 
obtaining fistula closure. However, a 
Pseudomonas meningitis was uncovered 
on removal of the drain. This dreaded 
complication, which previously carried a 
55% to 85% death rate, was successfully 
treated with ceftazidime.15
The simultaneous occurrence of a 
chylothorax and a subarachnoid-pleural 
fistula has been described after blunt 
traum a,1 the diagnosis being made at 
thoracotomy. In our case, which occurred 
after thoracotomy, the diagnosis was 
made in stages. The simultaneous occur­
rence of these two fistulas should be con­
sidered in a patient with a chylothorax 
and a persistent neurologic defect, who 
presents after suffering trauma or under­
going thoracic neurosurgery. When the 
chylothorax fails to respond to standard
258
therapy, in this setting, a diagnosis of a 
simultaneous subarachnoid-pleural 
fistula should be considered. Diagnosis by 
analysis of thoracentesis fluid is difficult 
because of contam ination of the 
cerebrospinal fluid by chyle. Contrast and 
nuclear studies of each individual fistula 
are most useful. Staged surgical manage­
ment was successful in our case; however, 
a single procedure is desirable.
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Correction
In the May 1987 issue, page 220, there 
was a printing error in the book review 
entitled “ Treatment of shock” . The 
short fourth paragraph of this review 
should read “The text is in three parts: 
treating the microcirculatory lesions, 
supporting the vital organs and treat­
ing the underlying cause.” We apolo­
gize to Dr. Downs, the reviewer, for 
this error.
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ANTIBIOTIC
ACTION
In v itro  studies demonstrate that the 
bactericidal action of cefoxitin, a cephamycin 
derived from cephamycin C, results from the 
inhibition of bacterial cell wall synthesis. 
Evidence suggests that the methoxy group in 
the 7a position is responsible for the 
resistance of cefoxitin to degradation by 
bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - Gynecological in fections such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections 
Appropriate culture and susceptibility studies 
should be performed to determine the 
susceptibility of the causative organism(s) to 
MEFOXIN*. Therapy may be started while 
awaiting the results of these tests, however, 
modification of the treatment may be required 
once these results become available. 
Organisms particularly appropriate for 
therapy with MEFOXIN* are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci 
Gram negative (beta-lactamase producing 
and non-producing strains)
£. coli
K l e b s i e l l a  species ( in c lu d in g  K. 
pneumoniae)
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN* may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria. 
Clinical experience has demonstrated that 
MEFOXIN* can be administered to patients 
who are also receiving carben ic illin , 
gentamicin, tobramycin, or amikacin (see 
PRECAUTIONS and ADMINISTRATION). 
Intravenous Administration 
The intravenous route is preferable for 
pa tien ts w ith bacterem ia, bacteria l 
septicemia, or other severe or life-threatening 
infections, or for patients who may be poor 
risks because of lowered resistance resulting 
from such deb ilita ting  conditions as 
malnutrition, trauma, surgery, diabetes, heart 
failure, or malignancy, particularly if shock is 
present or impending.
PROPHYLACTIC USE
MEFOXIN* may be administered periopera- 
tively (preoperatively, intraoperatively and 
postoperatively) to patients undergoing 
vaginal or abdominal hysterectomy and 
abdominal surgery when there is a significant 
risk of postoperative infection or where the 
occurrence of postoperative infection is 
considered to be especially serious.
In patients undergoing cesarean section, 
intraoperative (after clamping the umbilical 
cord) and postoperative use of MEFOXIN* 
may reduce the incidence of surgery related 
postoperative infections.
Effective prophylactic use depends on the 
time of administration. MEFOXIN* usually 
should be given one-half to one hour before 
the operation. Prophylactic administration 
should usually be stopped within 12 hours. It 
has been generally reported that continuing 
administration of any antibiotic beyond 
*®Trademark
24 hours follow ing surgery increases the 
possibility of adverse reactions but, in the 
majority of surgical procedures, does not 
reduce the incidence of subsequent infection. 
If signs of postsurgical infection should 
appear, specimens for culture should be 
obtained for identification of the causative 
organism(s) so that appropriate therapy may 
be instituted.
CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics. 
WARNINGS
Before therapy with MEFOXIN* is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
s e n s it iv ity  re a c tio n s  to  M E F O X IN ', 
cephalosporins, penicillins or other drugs. 
MEFOXIN* should be given with caution to 
penicillin-sensitive patients.
There is some clinical and laboratory evidence 
of partia l c ro s s -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam 
antibiotics, penicillins and cephalosporins. 
Severe reactions (including anaphylaxis) have 
been reported w ith  m ost beta-lactam  
antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed 
with caution in individuals with a history of 
gastrointestinal disease, particularly colitis. It 
is important to consider a diagnosis of 
pseudomembranous colitis in patients who 
develop diarrhea in association with antibiotic 
use. While studies indicate that a toxin 
produced by Clostridium difficile is one 
primary cause of antibiotic-associated colitis, 
other causes should also be considered.
Any patient who has demonstrated some form 
of allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN* with caution. 
If an allergic reaction to MEFOXIN* occurs, 
a d m in is tra tion  o f the drug shou ld  be 
d iscontinued. Serious h ypersens itiv ity  
reactions may requ ire  trea tm ent with 
epinephrine and other emergency measures. 
PRECAUTIONS
The total daily dosage should be reduced 
when MEFOXIN* is administered to patients 
with transient or persistent reduction of 
urinary output due to renal insufficiency (see 
DOSAGE AND ADMINISTRATION) because 
h igh and p ro longed  serum a n tib io tic  
concentrations can occur from usual doses.
In patients treated with MEFOXIN* a false­
positive reaction to glucose in the urine may 
occur with Benedict’s or Fehling’s solutions 
but not with the use of specific glucose 
oxidase methods.
Using the Jaffe Method, falsely high creatinine 
values in serum  may o ccu r if serum 
concentrations of cefoxitin exceed 100 ug/mL. 
Serum samples from patients treated with 
MEFOXIN* should not be analyzed for 
creatinine if withdrawn within two hours of 
drug administration.
Increased nephrotoxicity has been reported 
follow ing concomitant adm inistration of 
ce p h a lo s p o rin s  and a m in o g ly c o s id e  
antibiotics.
The safety of MEFOXIN* in the treatment of 
infections during pregnancy has not been 
e s tab lished . If the  a d m in is tra tio n  of 
MEFOXIN* to pregnant patients is considered 
necessary, its use requires that the anticipated 
benefits be weighed against possible hazards 
to the fetus. Reproductive and teratogenic 
studies have been performed in mice and rats 
and have revealed no evidence of impaired 
fertility or harm to the fetus due to MEFOXIN*. 
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient's condition 
is essential and if super-infection occurs 
during therapy, appropriate measures should 
be taken. Should an organism become 
resistant during antibiotic therapy, another 
antibiotic should be substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN* (100 m g/kg/day and 
above) have been associated w ith  an 
increased incidence of eosinophilia and 
elevated SGOT.
ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse 
reactions rare ly required cessation  of 
treatment and usually have been mild and 
transient.
Local Reactions
T h ro m b o p h le b itis  has o c cu rre d  w ith  
intravenous administration. Some degree of 
pain and tenderness is usually experienced 
after intramuscular injections using water. 
Induration has occasionally been reported. 
Allergic
M aculopapular rash, urticaria , pruritus, 
eosinophilia, fever and otherallergic reactions 
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported 
rarely.
Blood
T ra n s ie n t e o s in o p h ilia ,  le u k o p e n ia , 
neutropenia, hemolytic anemia, and thrombo- 
cy to p e n ia  have been repo rted. Some 
individuals, particularly those with azotemia, 
may develop positive direct Coombs tests 
during therapy with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDFI, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure 
has been reported rare ly. The role  of 
MEFOXIN* in changes in renal function tests 
is d i f f ic u l t  to  assess, s ince  fa c to rs  
predisposing to prerenal azotemia or to 
impaired renal function have often been 
present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN* can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN* may be adm inistered in tra ­
venously or intramuscularly when required. 
(See complete monograph for full details on 
ADMINISTRATION and RECONSTITUTION.) 
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1g or 2g of 
MEFOXIN* every 6 to 8 hours. Dosage and 
route of administration should be determined 
by severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of
of infection I
Daily
Dosage
Frequency 
and Route
Uncomplicated 
forms* of in­
fections such as 
pneumonia, 
urinary tract 
infection, soft 
tissue infection
3-4 g 1 g every 6-8 h 
I.V. o r I.M.
Moderately 
severe or severe 
infections
6-8 g 1 g every 4 h
or
2 g every 6-8 h I.V.
Infections 
com monly 
needing anti­
biotics in higher 
dosage (e.g. gas 
gangrene)
12 g 2 g every 4 h
or
3 g every 6 h I.V.
’ In c lu d in g  p a t ie n ts  
a b s e n t o r  u n lik e ly
in  w h o m i b a c te re m ia  is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infectionsshould be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving 
a collection of pus, surgical drainage should 
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with 
reduced renal function but a reduced dosage
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. 
A fte r  a lo a d in g  dose , th e  fo l lo w in g  
recommendations for maintenance dosage 
may be used as a guide:
RENAL CREATININE
FUNCTION CLEARANCE D O SE F R E Q U E N C Y
m L /m in
Mild
impairment
Moderate
50-30 1-2 g every 8-12 h
impairment
Severe
29-10 1-2  g every 12-24 h
impairment
Essentially
9-5 0.5-1 g every 12-24 h
no function < 5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1 -2 g  should be given after 
each hemodialysis, and the maintenance dose 
should be given as indicated in the Table 
above.
Neonates (Including Premature Infants), 
Infants and Children (See WARNINGS for 
Neonates under ADMINISTRATION in the 
complete monograph.)
P rem atu re  In fa n ts  
w ith  B o dy W e ig h ts  
A bove 1500 g 20-40 mg/kg every 12 h I.V.
N eonates
0- 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
In fan ts
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
C h ild re n 20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN* is not recommended for the ther­
apy of meningitis. If meningitis is suspected,
an appropriate antibiotic should be used.
At present there is in su ffic ie n t data to 
recommend a specific dosage for children 
with impaired renal function ."However, if the 
administration of MEFOXIN* is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for 
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN is recommended as follows: 
Vaginal or abdominal hysterectom y and 
abdominal surgery
2 g a d m in is te re d  in tra m u s c u la r ly  o r 
in tra v e n o u s ly  ju s t p r io r  to  s u rg e ry  
(approximately one-half to one hour before 
initial incision).
The second and third 2 g doses should be 
administered at 2-6hour intervals after the 
initial dose.
Cesarean Section
The first dose of 2 g should be administered 
intravenously as soon as the umbilical cord 
has been clamped. The second and third 
2g doses should be given intravenously or 
intramuscularly four hours and eight hours 
after the first dose.
AVAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst 
Std.) is supplied as sterile powder in boxes of 
10 vials:
No. 3356 1 g cefoxitin as sodium salt 
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored 
below 30° C.
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Preservation of Platelets and Blood Products 
by Intravenously Administered Dipyridamole in Patients 
Who Undergo Coronary Artery Bypass Grafting
The combination of dipyridamole and 
acetylsalicylic acid has been proven 
effective in preventing coronary artery 
bypass graft occlusion, but the benefits 
of dipyridamole alone have not yet been 
evaluated. In order to assess the value of 
dipyridamole alone, the authors ran­
domized 24 patients (age range from 47 
to 76 years) who underwent coronary 
artery bypass grafting to treatment with 
either dipyridamole (120 mg/d) by cons­
tant intravenous infusion or isotonic dex­
trose solution. They recorded platelet 
counts and aggregates, hemoglobin 
levels, total blood loss, blood products 
and intravenous fluids given and 
dipyridamole plasma levels, starting 8 
hours before operation and continuing 
for 3 days after.
The two groups were similar with 
respect to pump time, cross-clamp time 
and baseline demographic factors. Plate­
let counts during cross-clamping and 1 
hour postoperatively were similar, but 
those on days 1, 2 and 3 postoperatively 
were significantly (p = 0.01 to 0.02) 
higher in the dipyridamole group. Mean 
blood losses in this group were 22%  to 
30%  lower, but the difference was not 
significant. However, administration of 
erythrocytes and plasma was 49%  to 
58%  less in the dipyridamole group (p = 
0.005 to 0.048) over the same period. 
Dipyridamole plasma concentrations 
varied from 0.37 /ig/ml before and during 
bypass to 1.5 ;tg/ml in the 3 days after.
The authors conclude that dipyridamole
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administered intravenously to patients 
who undergo coronary artery bypass 
grafting may preserve hemostatically 
effective platelets so that fewer blood 
products are required.
L'association dipyridamole/acide acetyl- 
salicylique a demontre son efficacite 
dans la prevention de I'occlusion des 
pontages aortocoronariens. Toutefois,
I'utilite du dipyridamole seul n'a pas ete 
evaluee. Dans le but d'evaluer I'effet du 
dipyridamole, les auteurs ont soumis au 
hasard 24 patients (ages de 47 d 76 
ans) qui ont subi un pontage aortocoro- 
narien a un traitement qui renfermait soit 
du dipyridamole (120 mg/j) en perfusion 
intraveineuse continue, soit une solution 
de dextrose isotonique. Ont 6te enregis- 
tres: le decompte et I'agregation plaquet- 
taires, le taux d'hemoglobine, la perte de 
sang total, les derives sanguins et les 
solutes intraveineux administres et les 
concentrations plasmatiques de dipyrida­
mole, de la 8e heure jusqu'au 3e jour 
apr£s I'operation.
Les deux groupes etaient comparables 
en ce qui a trait au temps de pompe, au 
temps de clampage et aux facteurs 
demographiques de depart. Les decomp- 
tes plaquettaires ont ete similaires pen­
dant la clampage et a la premiere heure 
apres I’operation; toutefois aux jours 1,
2 et 3 apres I'operation, ils etaient signi- 
ficativement plus eleves (p = 0.01 a 
0.02) dans le groupe dipyridamole. Les 
pertes sanguines dans ce groupe ont ete 
de 22% S 30%  inf^rieures mais cette 
difference n'est pas significative. Cepen- 
dant, pendant cette meme periode 
I'administration de sang entier et de 
plasma a ete de 49%  a 58%  moindre 
dans le groupe dipyridamole (p = 0.005 a 
0.048). Les concentrations plasmatiques 
de dipyridamole ont varie de 0.37 ^g/ml 
avant I'operation jusqu'a 1.5 /ig/ml dans 
les 3 jours qui suivirent.
Les auteurs concluent que I'administra­
tion intraveineuse de dipyridamole aux 
patients qui subissent un pontage aorto- 
coronarien peut sauvegarder I'hemostase 
des plaquettes, reduisant de la sorte les 
besoins en derives sanguins.
Dipyridamole (Persantine; Boehringer 
Ingelheim [Canada] Ltd., Burlington, 
Ont.) is an inhibitor of platelet function 
and has been used in combination with 
warfarin and acetylsalicylic acid to pre­
vent thromboembolism associated with 
cardiac valve prostheses,1 stroke,2 coro­
nary bypass graft occlusion3 and myo­
cardial infarction.4 However, there have 
been little data establishing the effective­
ness of dipyridamole alone. Claimed bene­
fits over acetylsalicylic acid alone rest on 
indirect evidence4 or have yet to be sub­
stantiated.5,6 In order to determine 
whether dipyridamole alone affects plate­
lets in coronary artery bypass grafting, we 
gave the drug as an intravenous infusion 
and measured the number of platelets and 
degree of hemostasis in patients who 
underwent elective coronary artery bypass 
grafting.
Patients and Methods
The study population comprised 24 
patients (19 men, 5 women), ranging in 
age from 47 to 76 years, scheduled to 
undergo elective coronary artery bypass 
grafting. All had platelet counts in the 
normal range, had had no concomitant 
antiplatelet or anticoagulant treatment for 
at least 1 week before surgery and had no 
evidence of heart failure. Each patient 
gave informed consent. The protocol and 
consent forms were approved by the 
institutional Human Experimentation 
Committee. Only one of the authors, 
responsible for randomization and study 
organization, had access to the study 
code. Surgery, sample collection, 
postoperative patient management and 
assays were all carried out under blinded 
conditions.
The patients were randomized to two 
groups of 12 patients. One group received 
dipyridamole (120 mg/d), the other iso­
tonic dextrose. Intravenous dipyridamole 
or the placebo was started at least 8 
hours before operation and continued 
for 2 or 3 days postoperatively. The 
drug ampoules (Boehringer Ingelheim 
[Canada] Ltd., Burlington, Ont.) were 
mixed in a 5% dextrose in water solution
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and infused at a rate of 12 m l/h to a dose 
of dipyridamole of 120 mg/d. The iso­
tonic dextrose was infused at a rate of 12 
ml/h. Based on pharmacokinetic con­
siderations and oral bioavailability,7 we 
estimated that this regimen would yield 
plasma concentrations intermediate 
between peaks and troughs after oral dos­
ing of 75 mg three times daily and 
minimize variation due to absorption.
Anesthesia and cardiopulmonary 
bypass procedures were standardized. 
Anticoagulation intraoperatively was with 
heparin (3 mg/kg), cardioplegia was by 
cold potassium solution (25° to 28°C) and 
the bypass pump was primed asanguine- 
ously and operated with a bubble oxygen­
ator. The heparin effect was neutralized 
postoperatively with protamine sulfate (1 
mg/kg).
After operation all patients were 
managed routinely in the intensive care 
unit by the regular staff who had no 
knowledge of patient randomization. 
Hemoglobin concentrations were main­
tained at 100 g/L  or greater by the trans­
fusion of packed cells. Plasma, albumin
or crystalloid was used for volume 
replacement to maintain the left atrial 
pressure at 8 to 10 mm Hg. No patient 
in either group required reoperation or 
infusions of platelets or cryoprecipitate to 
manage bleeding.
Various venous blood samples were 
taken pre- and postoperatively and by 
arteria l catheter in traoperatively . 
Erythrocyte counts, platelet counts and 
hematocrit and hemoglobin levels were 
analysed by an automatic counter. Cir­
culating platelet aggregates were deter­
mined by the method of Wu and H oak,8 
and the aggregation index was calculated 
as the platelet count in plasma plus ethy­
lene diamine tetra-acetic acid (EDTA) and 
formalin divided by the platelet count in 
plasma plus EDTA. Blood samples were 
taken 24 hours preoperatively (before 
infusion), immediately preoperatively 
(after infusion achieved a steady level), 
intraoperatively (during cross-clamping), 
1 hour postoperatively (in the recovery 
room) and 24, 48 and 72 hours postoper­
atively. Intraoperative blood loss, 
postoperative fluid balance, blood losses
at 0 to 12 hours, 12 to 24 hours and 24 
to 48 hours postoperatively, and blood 
products (plasma, packed cells) and fluids 
given in the same postoperative periods 
were recorded. Dipyridamole plasma con­
centrations were determined by high- 
pressure liquid chromatography.9
Statistical Analyses
Statistical analyses were carried out 
using the BMDP statistical programs.10 
Analyses of variance techniques for a 
two-factor repeated-measures design with 
one grouping factor (drug) were em­
ployed. Unpaired f-tests were used for 
comparisons of individual time points and 
clinical variables. Absolute and percen­
tage changes from baseline were used as 
a measure of drug effect, when baseline 
measurements were comparable.
Results
Table I presents details of the bypass 
procedure. Hemoglobin and hematocrit 
values and erythrocyte count were all 
slightly higher in the dipyridamole group 
but were similar to the placebo group by 
1 hour postoperatively (Table II).
Changes in platelet counts and circulat­
ing platelet aggregates are plotted in Fig. 
1. Overall analysis of change from base­
line for platelet counts was significantly 
different (p = 0.023) for the two treat­
ment groups, but pairwise comparison of 
the time points confirms the impression 
from Fig. 1 that this is primarily due to 
differences at 1, 2 and 3 days postopera­
tively (p = 0.024, 0.019 and 0.020, 
respectively). There was no significant 
change in circulating aggregates.
Cumulative blood losses over 48 hours 
postoperatively and blood products 
administered are given in Table III, and 
losses in the first 12 hours are shown in 
Table IV. Only 18 patients had complete 
data. Patients treated with dipyridamole 
lost 20% to 30% less blood than the 
placebo-treated patients, but the differ­
ence was not statistically significant. 
Nevertheless, the amount of blood 
products needed by the treated group to 
maintain the standard hemoglobin level 
after operation was significantly less. 
Dipyridamole plasma concentrations are 
shown in Fig. 2.
Discussion
Activated by the trauma of cardiopul­
monary bypass, platelets adhere avidly to 
injured endothelium and synthetic sur­
faces. Once platelets have adhered, the 
sequence of activation, adhesion and the 
internal generation and release of bioac­
tive materials begins. The widespread 
platelet consumption and partial activa­
tion of other platelets deplete their abso­
lute number and leave many impaired
Table I - Surgical P ro file *
Dipyridamole Placebo p value fo r
Variable (n -  12 , 2  women) (n -  12 , 3 wom en) group d iffe re n c e t
Age, yr 5 4 .5  ± 6 .6 5 8 .4  ± 9 . 1 2 0 .5 8
(4 7  -  67 ) (4 8  -  76 )
Preoperative 142  ± 1 0 .3 1 3 3  ± 12.1 0 .0 8
hemoglobin, g/L (1 2 9  -  157 ) (1 1 3  -  15 4 )
Preoperative 2 2 8 .3  ± 3 8 .5 2 4 3 .2  ± 56 .1 0 .4 6
p latele t counts, (1 66  -  2 8 6 ) (1 6 8  -  3 7 9 )
X  1 0 9IL
Preoperative 1 .00  ± 0 .1 4 1 .0 7  ± 0 .1 4 0 .2 1
aggregate ratio (0 .7 6  -  1 .16 ) (0 .8 9  -  1 .28 )
Num ber of bypassed 3 .0 0  ± 0 .9 5 2 .6 0  ± 0 .51 0 .2 6
vessels (2 -  4 ) (2  -  4 )
Tim e on pump, min 8 9 .9  ± 2 5 .0 8 3 .0  ± 1 8 .8 0 .4 9
(5 4  -  131 ) (6 0  -  11 0 )
Aortic cross-clamp 3 5 .3  ± 18 .9 37 .1  ± 1 8 .7 0 .8 3
tim e, min (9 -  57 ) (1 0  -  60 )
Intraoperative 4 2 0 5  ± 5 1 4 3 7 1 7  ± 1 1 0 4 0 .2 5
fluids given, m lt (3 5 0 0  -  4 9 0 0 ) (2 2 5 0  -  5 3 0 0 )
Intraoperative 68 3  ± 5 1 0 6 4 8  ± 3 3 2 0 .8 7
blood loss, ml (2 5 0  -  19 00 ) (3 0 0  -  1 4 0 0 )
Postoperative fluid 4 3 3 0  ± 1 1 6 6 3 5 6 2  ± 1 1 7 2 0 .1 6
balance, m l§ (2 5 5 0  -  6 7 5 0 ) (2 4 0 0  -  6 0 5 0 )
'V a lu e s  are means w ith  standard deviations, num bers in brackets are value ranges.
tT e s t  of differences is unpaired /-tes t.
tS u m  of asanguineous pump prime plus packed cells.
§Blood products and crystalloids given minus blood loss and urine output.
Table I I—Hemoglobin C oncentrations (g /L)*
Sam ple Dipyridamole Placebo p v a lu e t
Preoperative, 2 4  h 1 4 2  ± 1 0 .3 1 3 3  ± 12.1 0 .0 8
Post drug, 1 h preop 140  ± 1 0 .3 131 ± 1 3 .5 0 .0 7
Intraoperative, on 8 2 .5  ± 1 0 .8 7 5 .7  ± 1 3 .0 0 .2 0
cross-clamp
Postop, 1 h 111 ± 1 5 .0 111 ± 1 6 .0 0 .9 1
Postop, 2 4  h 10 8  ± 6 .2 111 ± 1 3 .2 0 .5 0
Postop, 4 8  h 10 8  ± 16 .5 11 5  ± 13 .7 0 .2 8
Postop, 72  h 1 0 4  ± 9 .7 1 1 6  ± 15 .3 0 .0 4
'V a lu e s  are mean ± standard deviations.
tp  value is based on unpaired M e s t.
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residual platelets in the circulation. These 
residual circulating platelets respond 
abnormally when tested in vitro and thus 
may contribute, as does the diminished 
number of platelets, to postoperative 
hemorrhage.11
In our study, mean (±  standard error) 
hemoglobin concentrations dropped 
42.2% ± 1.7% (dipyridamole) and
43.9% ± 2.8% (placebo) during aortic 
cross-clamping compared with baseline 
values, and platelet counts dropped 
47.3% ± 2.8% and 49.2% ± 3.8% 
respectively. The proportionately greater 
loss of platelets confirms platelet seques­
tration or consumption. In patients 
treated with dipyridamole, the recovery 
of platelet counts was more rapid 
postoperatively than in patients not so 
treated. The time course of new platelet 
synthesis from megakaryocytes is in the 
order of 3 to 7 days after a thrombocyto­
penic stimulus, so that a stimulus to 
thrombopoiesis by dipyridamole is less 
likely than direct platelet-sparing.12
Intraoperative blood losses and blood 
products used (Table I) were quite simi­
lar in the two treatment groups, in agree­
ment with the findings of Chesebro and 
colleagues.3 During this period, patients 
received heparin anticoagulation, so the 
effects of an antiplatelet agent might not 
be detectable. After heparin reversal with 
protamine, both variables of platelet 
counts and usage of blood products 
separate by treatment group. A previous 
report13 studied postoperative blood 
losses and blood products given for 15 
hours after open-heart surgery in patients 
on dipyridamole and in a control series 
but detected no differences. However, the 
dipyridamole dose was 0.5 mg/kg given 
as a single dose into the heart-lung 
machine, about one-quarter of the dose 
given in this study.
The pattern of blood products used and 
blood losses in the recovery period mir­
ror the observations on platelet counts. 
This implies that the platelets preserved 
by dipyridamole are functional. The 
platelet-sparing and improved hemosta­
sis by dipyridamole in this study stands 
in marked contrast to the effects of simi­
lar drugs such as acetylsalicylic acid and 
prostacyclin, which may preserve plate­
lets but at the expense of increased risks 
of hemorrhage and bleeding complica­
tions.14'15
Other groups have recorded elevations 
of platelet counts after dipyridamole 
treatment and the thrombocytopenic 
effect of surgery, in both animals16'17 
and m an.13’18 Miyauchi and Isomura18 
also used an intravenous dose (1 to 2 
m g/kg daily) preoperatively, apparently 
without postoperative drug administra­
tion. None of these groups, however, 
monitored the postoperative use of blood 
products for 2 days. In one study in 
dogs,17 the difference in platelet counts
in dipyridamole versus control animals 
was paralleled by lower indium -Ill- 
labelled platelet deposition in the 
myocardial tissues of the dipyridamole 
group. This supports the suggestion of 
decreased platelet consumption in our 
study. In another animal study, Becker16 
obtained good results by adding dipyrida­
mole to the pump prime. The plasma con­
centrations of dipyridamole were not 
monitored in any of these studies, but all 
the positive results were associated with 
intravenous use of the drug.
The infusion rate of dipyridamole was 
calculated to produce plasma concentra­
tions near 0.5 g/ml and preoperative
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PIG. 1—Platelet counts are shown as percentage of baseline in dipyridamole (solid circles) 
and placebo (open circles) groups. Values are means with standard-error bars for 11 or 12 patients 
in each group. Asterisks indicate significant differences between treatments (*p = 0.02, **p 
= 0.01). Change in platelet aggregate ratio from baseline (means with standard errors) for 
dipyridamole (solid squares) and placebo (open squares) groups. Positive deviation indicates 
decrease in presence of circulating aggregates. None of differences between treatments are statisti­
cally significant.
Table III--Cumulative Blood Losses and Blood Products Given Postoperatively*
Measurement
Postop 
time, h
Dipyridamole 
(n = 10)
Placebo
(n -  8) p value
Blood loss, ml 0-12 366 ± 194 526 ± 294 0.183
0-24 638 ± 198 841 ± 406 0.183
0-48 738 ± 242 950 ± 511 0.261
Blood products 0-12 290 ± 222 688 ± 291 0.005
given, ml 0 -24 465 ± 493 909 ± 351 0.048
0-48 515 ± 494 1065 ± 459 0.28
'Values are mean ± standard deviations.
Table IV--Data for Transfusion and Blood Loss (ml) in 
the First 12 Hours Postoperatively
Dipyridamole Placebo
Control Transfusion Losses Control Transfusion Losses
b24 500 315 23B 250 300
P22 50 750 21 500 450
P19 200 750 20 500 750
P16 200 Nil 18 500 925
+ 14 500 775 17 250 430
P13 300 525 15 250 380
P12 200 340 11 250 450
P10 250 125 9 250 600
P8 200 400 7 500 425
P5 200 100 6 — 525
P3 40 325 2 — 325
P1 50 450
VOLUME 30, NO. 4, JU LY 1987 /  THE CANADIAN JOURNAL OF SURGERY262
concentrations were in this range (Fig. 2). 
This is in the middle range of concentra­
tions attained with a dose of 75 mg three 
times daily,19'20 a regimen used in long­
term trials of bypass graft occlusion3 and 
secondary prophylaxis of myocardial 
infarction.4 The variation among 
individuals with the intravenous infusion 
method here is much less than the 50 to 
100-fold range observed with the peaks 
and troughs of oral dosing. If one con­
siders the preoperative dose of 100 mg 
four times a day used by Cheseboro and 
colleagues,3 then infusion rates must be 
at least doubled over our regimen to 
attain dipyridamole concentrations in the 
1.0 fig/ml range.20
The postoperative changes in platelet 
counts in our study were associated with 
two to three-fold increase in dipyridamole 
concentrations. This accumulation 
phenomenon may be due to a post-bypass 
redistribution of fluid (there is a large 
positive fluid balance postoperatively), an 
acute phase increase in the production of 
cq-acid glycoprotein,21 which avidly 
binds dipyridamole, or a decreased biliary 
excretion of dipyridamole. From our 
data, we are unable to explain the 
mechanism of the accumulation and we 
cannot conclude whether the platelet and 
blood-product effects are due to the 
increased concentrations or to intraoper­
ative platelet preservation. We could find 
no correlation in this study between drug 
concentration and platelet effects. Others 
have correlated both aggregation and
platelet Factor IV in plasma with 
dipyridamole concentrations.22
The lack of significant effects on plate­
let aggregates is disappointing, but, since 
the publication of Wu and Hoak’s 
method,8 there have been only isolated 
demonstrations of antiplatelet effects of 
a drug using this end point.23 Dipyrida­
mole is particularly devoid of antiaggre­
gation effects using conventional platelet 
aggregation models.24 This is thought to 
be owing to the need for an intact in-vivo 
preparation for its mechanism of action 
to be seen. This mechanism has been var­
iously proposed as adenosine uptake inhi­
bition,24 prostacyclin production25 and 
phosphodiesterase inhibition.24 The ini­
tial observation of antiplatelet effects in 
man occurred at dipyridamole concentra­
tions of 3.75 jtig/ml after oral dosing.26 
Extremely high doses in ex-vivo animal 
models have been required to decrease 
platelet aggregation or adhesion.27
Clinical evaluations of dipyridamole 
have yielded variable results. A combina­
tion of dipyridamole and warfarin signifi­
cantly decreased the thromboembolic 
complications in patients with prosthetic 
heart valves compared with warfarin 
alone.1 The combination of dipyrida­
mole and acetylsalicylic acid significantly 
decreased the incidence of coronary 
occlusion for 2 years in patients suffer­
ing a previous infarction,4 but compari­
son with acetylsalicylic acid alone has not 
shown added benefit. The power of the 
latter comparison to detect an increase of
50% in effectiveness of acetylsalicylic acid 
alone is about 20%, so lack of benefit 
cannot be established in this indication. 
Chesebro and Fuster28 have used previ­
ous human data to establish the relevance 
of dipyridamole in bypass graft occlusion 
and H arajola and colleagues29 have 
shown separate and additive effects of 
acetylsalicylic acid and dipyridamole on 
occlusion rates of peripheral bypass 
g rafts. In co n trast, Brown and 
colleagues6 have shown no added effect 
of dipyridamole in coronary bypass graft 
occlusion, but both acetylsalicylic acid 
and dipyridamole were not started until 
2 days after operation.
Our data show that dipyridamole 
alone, infused preoperatively and for 3 
days postoperatively, preserves platelets 
and may thus decrease the necessity for 
transfusion of blood products in the 
postoperative period. The platelet-sparing 
activity of dipyridamole may well have 
important implications for reducing coro­
nary graft occlusion and the severity of 
perioperative myocardial ischemia.
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Successful Surgical Repair in a Patient With Mitral Stenosis, 
Calcified Left Atrium and Severe Tricuspid Regurgitation
With a Giant Right Atrium
Successful mitral valve replacement and 
tricuspid annuloplasty were performed on 
a 66-year-old woman who had a calci­
fied left atrium, giant right atrium, calci­
fied mural thrombus and normal pulmo­
nary pressures. Successful repair in such 
cases depends on an adequate preopera­
tive investigation and a surgical approach 
tailored to the individual.
On a pratique avec succes un remplace- 
ment de valvule mitrale et une annulo- 
plastie tricuspidienne chez une femme de 
66 ans qui avait une calcification de 
I'oreillette gauche, une hypertrophie de 
I'oreillette droite, un thrombus mural cal- 
cifie et des pressions pulmonaires norma- 
les. Dans de tels cas, le succes de la 
reparation depend d'un examen preope- 
ratoire adequat et d'un abord chirurgical 
individualise.
Calcification of the left atrium was first 
described by Oppenheimer in 19121 as 
seen at the autopsy of a patient who died 
of heart failure secondary to mitral valve 
disease. The literature was reviewed by
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Harthorne and colleagues2 in 1966, 
bringing the number of reported cases to 
88. A further computer search has turned 
up only 17 more cases — probably 
because the condition is no longer a med­
ical curiosity.3-5
There are several classic features of left 
atrial calcification:
• It is usually found in women (75%).
• With the exception o f one reported 
case,6 it is associated with mitral steno­
sis secondary to rheumatic valve disease.
• Atrial fibrillation is almost uni­
versal.
• Most patients have long-standing 
symptoms averaging 15 to 20 years.
•  The frequency o f embolism (pul­
monary or systemic) is about 50%.
The calcification is believed to result 
from one of two causes — repeated bouts 
of endocarditis with deposition of calcium 
or a regurgitant jet striking the posterior 
portion of the atrium (McCallum’s patch) 
causing deposition of lime salts in this 
area.
The overall incidence of left atrial cal­
cification is estimated to be 1% to 2% 
of patients with rheumatic valvular 
disease.7
The death rate from surgery has been 
reported at 25%2 and it is stressed that 
the outcome o f surgery is greatly 
improved by preoperative recognition of 
the disease. The major problems encoun­
tered are control o f hemostasis, difficulty 
entering the atrium and postoperative 
embolism.
We report an unusual case in which a 
huge right atrium, calcified left atrial 
thrombus and normal pulmonary artery 
pressures were all present in association 
with complete left atrial calcification.
Case Report
A 66-year-old woman had rheumatic fever 
as a child and first became symptomatic at 40 
years of age, requiring commissurotomy in 
1959. She was well maintained on low-dose 
digoxin until 1977 when mild pulmonary edema 
developed. A diuretic was added to her regi­
men. She refused to undergo surgery on several 
occasions and in 1983 presented with biventric­
ular failure. She was managed medically but 
in 1985 consented to a surgical opinion.
At that time she had severe dyspnea on mild 
exertion. She had a blood pressure of 130/80 
mm Hg and atrial fibrillation. Her jugular vein 
pressure was elevated to the angle of the jaw 
and prominent fibrillating waves were noted. 
A hepatojugular reflux was present. The 
cardiac apex was laterally displaced and heart 
sounds were variable with an occasional S3 
murmur. There was a grade 3/6 pansystolic 
murmur in the tricuspid area and a milder sys­
tolic murmur in the mitral area. The liver was 
palpable 8 to 10 cm below the costal margin. 
The lung fields were clear and the rest of the 
physical examination was unremarkable.
Preoperatively the hemoglobin level was 123 
g/L with normal indices. The alkaline phos­
phatase level was mildly elevated (134 U/L), 
the electrocardiogram showed left ventricular 
hypertrophy, right bundle branch block and 
atrial fibrillation at a rate of 80 beats/min. 
A chest x-ray film revealed cardiomegaly with 
a huge right atrium and enlarged left atrium
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with irregular dense calcification in the left 
atrial cavity (Fig. 1).
Angiography demonstrated mitral stenosis 
and regurgitation. Her pulmonary artery pres­
sures were 36/19 mm Hg. The left atrial cal­
cification was not thought to involve the mitral 
annulus and surgical treatment was advised.
Surgical Approach
The heart was exposed through a midline 
sternotomy. The large right atrium was very 
thin and the left atrium was totally calcified. 
The aorta and both venae cavae were cannu- 
lated and the patient was placed on cardiopul­
monary bypass. Through the right atrium a 
Dubost incision was performed to expose both 
the tricuspid and mitral valves, the former 
being grossly dilated but with no structural 
abnormalities. A calcified mass was removed 
from the left side of the interatrial septum and 
reported as a calcified mural thrombus. The 
mitral valve was replaced with a no. 29 
Ionescu-Shiley bioprosthesis. Tricuspid 
annuloplasty using a no. 34 Carpentier- 
Edwards ring was then performed. The patient 
was weaned from cardiopulmonary bypass 
without complication. The clamp time was 134 
minutes and bypass time 216 minutes.
Postoperatively, the woman required treat­
ment for heart failure. She responded well and 
was transferred from the intensive care unit on 
postoperative day 3. Later a symptomatic 
pleural effusion was removed by thoracente­
sis and she was discharged home to the care 
of her family physician on day 14.
Follow-up 6 months later revealed residual 
class II symptoms (New York Heart Associa­
tion classification). The patient complained of 
only mild dyspnea and there was no evidence 
of cardiac failure on the chest film.
Discussion
Our patient was unique in several ways. 
Although all o f the following have been 
reported in association with left atrial cal­
cification, there are no reports o f all three 
coexisting simultaneously.
FIG. 1—Chest x-ray film reveals cardi- 
omegaly with huge right atrium, enlarged left 
atrium and irregular dense calcification in left 
atrial cavity.
• A giant right atrium was reported 
by Roberts and associates8 in a series o f 
three patients. All died intraoperatively 
or soon after.
• Left atrial thrombus is not uncom­
mon in this condition, although complete 
calcification is less common.
•  Pulmonary artery pressures were 
normal. Although occurring in 20% of 
patients, this has never before been 
reported in a patient with a hugely dilated 
right atrium.
Proper preoperative evaluation is para­
mount in these patients. It must include:
(a) A chest x-ray film. The left atrium 
is seen just inferior to the carina. Well- 
penetrated films are best, and oblique and 
lateral projections most useful.
(b) Fluoroscopy. This is a more sen­
sitive modality, especially in delineating 
the extent of calcification.
(c) Catheterization, which will help 
differentiate calcification in the coronary 
arteries.
The information gained from these 
investigations allows the surgeon to plan 
alternative approaches, two of the more 
common being a right thoracotomy with 
an incision through the posterior inter­
atrial groove and a Dubost incision 
through the right atrium and interatrial 
septum.
The high incidence of embolism  
postoperatively can be minimized by 
removal o f thrombus and by long-term 
anticoagulation.
We may, therefore, conclude that with 
proper preoperative investigation and an 
individualized surgical approach, severe 
calcification and enlargement of the atria 
are not contraindications to surgery in 
patients with severe left atrial calcifi­
cation.
References
1. O ppenheimer  BS: Calcification and osteogenic change 
of the left auricle in a case of a auricular fibrillation. Proc 
N Y  Path Soc 1912; 12: 213-216
2. Harthorne j w , Seltzer r a , Austen WG: Left atrial 
calcification. Review of literature and proposed manage­
ment. Circulation 1966; 34: 198-210
3. SHAW DR, Chen JT, Lester RG: X-ray appearance and 
clinical significance of left atrial wall calcification. Invest 
Radiol 1976; 11: 501-507
4. BLOCH HM, STEENKAMP WF, ZlADY F: Calcification of 
the left atrium. S A fr  Med J  1977; 52: 184-186
5. DOLIOPOULOS T, BOUDIOUKOS G: Calcification of the 
left auricular wall in rheumatic mitral cardiopathy. (Report 
of three cases). Acta Cardiol (Brux) 1972; 27: 654-660
6. Wang K, AMPLATZ K, GOBEL FL: Isolated calcification 
in a dilated left atrial appendage in the absence of mitral 
stenosis. Am  J  Cardiol 1972; 29: 882-885
7. Baeyens J , Van Steenberge R, Billiet  I: Calcifica 
tion parietale de 1’oreillete gauche du coeur. J  Belg Radiol 
1960; 43: 479-493
8. Roberts w c , Humphries JO, Morrow  AG: Giant 
right atrium in rheumatic mitral stenosis. Atrial enlarge­
ment restricted by mural calcification. A m  Heart J  1970; 
79: 28-35
◄  PRESCRIBING INFORMATION ►
ANUSOL*-HC
ointment/suppositories 
hemorrhoidal preparations
INDICATIONS: For the relief of the pain and dis­
comfort following anorectal surgery of all types 
and that which is associated with the acute phase 
of common anorectal disorders. These include 
hemorrhoids, internal and external (including 
those accompanying pregancy) whether or not 
complicated by thrombosis and prolapse; pruritis 
ani; proctitis, cryptitis, fissures and incomplete 
fistulas; and other congestive allergic or inflam­
matory conditions.
CONTRAINDICATIONS: Should not be used in 
patients with a sensitivity to any of the compo­
nents. Not to be used in the presence of existing 
tuberculous, fungal and viral lesions of the skin. 
PRECAUTIONS: Until an adequate proctologic 
examination is complete and a diagnosis made, 
any preparation containing hydrocortisone 
should not be used. In addition, specific measures 
against infection, allergy and other causal factors 
must not be neglected. Prolonged use could pro­
duce systemic corticosteroid effects, although 
none have been noted to date. As with all medica­
tion that is applied locally, if idiosyncratic reactions 
occur, medication should be discontinued. The 
safe use of topical corticosteroids during preg­
nancy has not been fully established. Therefore, 
during pregnancy, they should not be used unne­
cessarily on extended areas, in large amounts, or 
for prolonged periods of time.
ADVERSE EFFECTS: Occasionally patients may 
experience burning upon application, especially 
if the anoderm is not intact. Local sensitivity reac­
tions have been rare.
OVERDOSE: The chances of overdosage are very 
rare, and no toxic reactions or side-effects have 
been reported. In case of accidental ingestion, 
perform gastric lavage followed by a purgative 
dose of magnesium sulfate.
DOSAGE: OINTMENTS: Administer in the morn­
ing and again at bedtime, and after each bowel 
movement. Continue this treatment until the acute 
phase of pain and discomfort passes and the 
inflammation subsides.
SUPPOSITORIES: Insertl suppository in the morn­
ing and 1 suppository at bedtime and after each 
bowel movement. Continue this treatment until 
the acute phase of pain and discomfort passes 
and the inflammation subsides.
SUPPLIED: Ointment: Available in 15 g and 30 g 
tubes with a plastic applicator. Suppositories: 
Available in boxes of 12 and 24 suppositories.
INGREDIENTS: Suppositories Ointment
Zinc Sulfate
Monohydratef 10 mg 0.5%
Hydrocortisone
Acetate 10 mg 0.5%
TUCKS*
A soothing, cooling, medicated wet dressing and 
cleansing pad for hemorrhoids, feminine hygiene 
and personal itching problems.
DIRECTIONS: Gently wipe and cleanse affected 
area. For additional relief, apply Tucks for 15-30 
minutes, 3 to 4 times daily.
Soft pads medicated with Hamamelis water 50%, 
glycerin 10%, distilled water, q.s.
ANUSOL*-HC
*Reg. TM. of Warner-Lambert Canada Inc. 
Parke-Davis Canada Inc. auth. user 
TUCKS*
*Reg. TM. of Parke, Davis & Company,
Parke, Davis & Company, Ltd. Registered user
PARKE-DAVIS - -  n™i
Parke-Davis Canada Inc,Scarborough,Ontario I 1 1 CCTI* |
VOLUME 30, NO. 4, JU L Y  1987 /  THE CANADIAN JOURNAL OF SURGERY 265
.^ to ^ m ic m / ia /  in^ec/ionAs
DalacinC
Phosphate Sterile Solution
(clindamycin phosphate)
S/ct&£curvec£ effeclusefie&A' a ^ c u n A l
•  S/aclej<aideA- a n d  o/As*  anaejvde^
'
■ v  ■
^ V % v s - ;;v  f t\  ; i. sff
co m m o n  fia/A otpend in  fia/ym icj<o& uz/ 
tn fe c /ia n A '
i/ ia / iA i^ / o c o c c u A ' (
> /
P i  \
v  / n \ . m o d / com m ons ojt^anidm s in  /ta d l-o fi usounc/ in^ocHonA
■ w
to* Kedu£ey f/ies iiifie e d  
c a m f i/ d a / u x n A y
Upjohn
8704 REGISTERED TRADEMARK: DALACIN 
TRADEMARK: DALACIN C 
(5980.1 L) CE 903
THE UPJOHN COMPANY OF CANADA I Paab I
865 YORK MILLS ROAD/DON MILLS. ONTARIO l ccppl
-  y
4
4 >
i .  K
K *1
A  >'
* * \
(
4  J
* v
v  v -- ,  
y  *
Y
r  -* 
*  V
k
For prescribing information see page 294
H. St e r n , m d , f r c s c ; J.R. M a d r o n i c h , m d ; N . M c K e e , m d , f r c sc
Repair of Anorectal Incontinence in an 
Adolescent Boy With Neonatal Anal Atresia
Fecal continence, the ability to retain 
intestinal contents until evacuation is 
desired, requires the complex interaction 
of several factors. They include: the 
motor action of the sphincters, sensibil­
ity of skin and sphincters and function of 
the rectum and central nervous path­
ways. Appropriate and effective manage­
ment is available to treat many disorders 
of continence. However, the success of 
these treatments depends on careful 
delineation of the various contributing 
factors. The authors present the case of 
an 18-year-old boy with disabling fecal 
incontinence, secondary to neonatal anal 
atresia and its primary management, in 
order to illustrate the importance of care­
ful assessment of each of the contribut­
ing factors. His staged surgical treatment 
has been successful in returning him to a 
more normal state.
La continence anale, soit la capacity de 
retenir le contenu intestinal jusqu'E son 
Evacuation volontaire, exige I'interaction 
complexe de nombreux facteurs. Parmi 
ceux-ci, on compte Taction motrice des 
sphincters, la sensibilitE de la peau et 
des sphincters et le fonctionnement du 
rectum et des voies de transmission du 
systEme nerveux central. II existe des 
traitements appropriEs et efficaces pour 
paliier a plusieurs troubles de la conti­
nence. NEanmoins, le succEs de ces trai­
tements dEpend de ('identification 
soigneuse des divers facteurs en cause. 
Les auteurs dEcrivent le cas d'un jeune 
homme de 18 ans handicapE par une 
incontinence anale secondaire E une atrE- 
sie anale nEonatale et a son traitement 
initial. Ce cas leur permet d'illustrer 
('importance d'une Evaluation soigneuse
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de chacun des facteurs impliquEs. Un 
traitement chirurgical par Etape a permis 
E ce jeune homme un retour E une vie 
normale.
Complex derangements o f anal inconti­
nence can be managed in such a way as 
to benefit the patient. We describe the 
case of a teenage boy who presented with 
a severe sociosexual disability resulting 
from fecal incontinence. The derange­
ment o f the continence mechanism was 
complex and related to neonatal anal atre­
sia which was managed by dilatation. His 
condition was substantially improved by 
careful delineation of the abnormalities 
and an operative strategy to correct each 
one.
Case Report
An 18-year-old boy had congenital anal atre­
sia and an anal dimple. Treatment at birth had 
consisted of insertion of a probe through the 
dimple and dilatation. The sphincter was not 
incised. His mother was instructed to continue 
dilatations through his early childhood. His 
continence through childhood and adolescence 
was marginal. Control was achieved largely 
through buttock squeeze, dietary manipulation 
and frequent reconnoitering of accessible toi­
let facilities. Frequently he was unaware of the 
seepage. When we saw him his major problem 
was sociosexual, relating to his frequent leak­
age and fear of accidents. He refrained from 
all physical activities and had withdrawn from 
establishing any female relationships.
There were no obvious physical abnormali­
ties other than that pertaining to the anorec- 
tum. The anus was extremely patulous with a 
large anterior “ keyhole” defect and no observ­
able anoderm. The anal canal was 6 cm long, 
but the rectal mucosa was loose and an 
ectropion prolapsed 3 cm into the anal canal 
(Fig. 1). On digital examination a thickened 
rigid canal was noted which could easily admit 
two fingers. Squeeze was present in the 
posterior 120° of the puborectalis and exter­
nal sphincter. No squeeze could be effected 
anteriorly. Sigmoidoscopy and barium studies 
gave normal findings. Further investigations 
included intravenous pyelography which iden­
tified a horseshoe kidney, standard anal elec­
tromyography using a needle electrode which 
showed posterior activity but no activity in
67% of the anterior quadrants and anal 
manometry using three radially placed strain 
gauges (Narco Digitized Manometer; Narco 
Scientific Ltd., Health Dyne Co., Downsview, 
Ont.) (Table I).
A combined approach to the sphincter 
mechanisms and skin defects was designed. 
With the patient in the prone, jack-knife posi­
tion, a curvilinear incision was made in the 
anterior anal verge for approximately 180°. 
The healthy lateral margins of normal sphinc­
ter were first dissected out to a depth of
FIG. 1—Combination of defects including 
keyhole effect and mucosal ectropion.
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approximately 3 cm, the deep dissection was 
carried anteriorly to the scar. No intraopera­
tive electromyography was used since our 
preoperative results had been precise and the 
demarcation between healthy sphincter and 
scar was clear. The latter was quite attenuated 
and difficult to dissect, but once dissection was 
completed the scar was divided at its midpoint 
in preparation for a wrap as described by Gold­
berg and colleagues1 (Fig. 2). The scar ends 
were overlapped and sutured to the con­
tralateral healthy sphincter with interrupted 
absorbable sutures (Fig. 3).
After sphincter-muscle repair, the next stage 
was to re-establish the anoderm of the anal 
canal. This was accomplished by S-shaped skin 
and subcutaneous flaps, approximately 5 cm 
x 10 cm in dimension, which were created in 
the lateral quadrants and rotated into the anal 
canal. They were anchored with absorbable 
sutures and the lateral subcutaneous spaces 
drained with a small plastic suction apparatus 
(Fig. 4).
One week after operation the patient was 
continent to solid stools and at 6 weeks he was 
continent to both solid and loose movements, 
with occasional loss of control of flatus.
Subsequently, he experienced seepage of 
liquid stools and was operated upon again to 
remove a persistent mucosal ectropion.
He is now generally continent to solid stools 
but still has some difficulty with loose stools 
and flatus, although this occurs fairly infre­
quently and he is aware of the seepage. Con­
fidence in his continence mechanisms has been 
restored enabling him to begin an active social 
life. Despite significant clinical improvement, 
manometric improvement was minimal — 
approximately 20 mm Hg higher squeeze pres­
sures, radially.
Discussion
The frequency of anorectal atresia is 
between 1 in 1500 and 1 in 5000 live births 
and is more common in males.2-4 It is 
usually the result of incomplete separa­
tion by the urogenital septum of the 
cloaca into urogenital and anorectal com­
ponents. Less frequently it is caused by 
failure of the anal membrane to perforate 
normally at the end of 8 weeks’ gesta­
tion .2 Murken and Albert4 found a 
family history of anorectal atresia in 1 of 
169 patients with the abnormality.
The international classification of 
anorectal anomalies separates these 
defects into low (translevator), intermedi-
FIG. 2—Type of anterior dissection of exter­
nal sphincter (adapted from Goldberg SM, 
Gordon PH, Nivatvongs S1).
ate and high (supralevator), with many 
subdivisions according to sex and 
associated fistulas.5
Problems commonly associated with 
anorectal atresia include urinary inconti­
nence and sexual dysfunction which 
present a major psychosocial problem for 
the patient. Associated congenital 
genitourinary and skeletal anomalies are 
frequent.6,7 In 1272 children with imper­
forate anus Hasse6 found 323 urogenital 
malformations, 12 of which included 
horseshoe kidney.
The initial management of complete 
atresia has been directed at decompress­
ing the obstructed bowel and subse­
quently producing a socially necessary 
degree of fecal continence.8 In incom­
plete atresias, with an anal dimple, 
preliminary colostomy may not be neces­
sary. An early dilatation with repeated 
dilatations by one parent has been a com­
mon approach.5,9-13 Many other ap­
proaches have been advocated for higher 
fistulas, all of which are beyond the scope 
of this paper.8,14,15
The common factor in all forms of 
treatment is to provide long-term conti­
nence. Continence can be defined as the 
ability to retain intestinal contents until 
evacuation is desired. It requires the com­
plex interaction of several factors. 
Scharli16 has identified five main factors 
as the passive forces of continence: the 
motor action of the sphincters, the sensi­
bility of the skin and the sphincters, the 
function of the rectum and the central 
nervous pathways, which produce cons­
cious and unconscious coordination. 
Continence requires the ability to sense 
the need to defecate and to use the volun­
tary musculature to redirect stool prox- 
imally.17 A rigid anorectum may impede 
normal continence. Stelzner18 noted the
FIG. 3—Completed wrap of external sphinc­
ter with suture tags.
importance of the hypersensitive skin of 
the anal canal in sensing the intestinal 
contents.
Millard and Rowe15 identified the 
absence of a skin-lined anal canal from 
mucosal ectropion or rectal prolapse as 
common complications of early repair of 
imperforate anus, as in our patient. They 
noted that there is not enough skin avail­
able by push or pull to construct an ample 
skin-lined canal. They advocated skin 
flaps to eliminate tension at the border 
of mucosa and skin to correct the 
problem. They further suggested replace­
ment of insensitive ectropic mucosa with 
cutaneous sensory epithelium created by 
local flaps to provide essential perianal 
sensation. Our experience with gracilis 
muscle replacement for damaged sphinc­
ter muscle has been unrewarding.
Although we performed manometric, 
electromyographic and radiologic studies, 
we and others14 have found them in 
general to be of less benefit than clinical 
assessment. The one test of clinical use 
in our patient was electromyography 
which identified normal muscle and the 
extent of scar tissue.
We identified three deficiencies in our 
patient: a cutaneous sensory defect caused 
by the mucosal ectropion; anterior defi­
ciency of the anal sphincter, possibly 
caused by the initial dilatation “ missing” 
the anterior fibres; and anterior scarring 
of the anal canal, presumably due to 
repeated dilatations. Our surgical 
approach was designed to correct each of 
these deficiencies and was successful in 
restoring the young man to a near-normal 
state. Although we could find no similar 
reports using this combined approach, we 
speculate that, given the frequency of this 
problem, other patients exist who might 
benefit from such an approach.
FIG. 4—Completed wrap and graft 2 
months postoperatively.
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Do Symptoms Reflect a Change in Left Ventricular Function 
After Aortocoronary Bypass Grafting in Patients 
With Depressed Left Ventricular Function?
Seventy-nine patients with moderate to 
severe left ventricular dysfunction who 
underwent aortocoronary bypass grafting 
between 1971 and 1977 had follow-up 
heart catheterization at a mean interval 
of 3 years. Thirty-three patients (42%) 
had angiographic improvement in left 
ventricular function at follow-up and 18 
(25%) had a decrease in left ventricular 
end-diastolic pressure. Fifty-eight 
patients (73%) had improvement in 
angina of at least one New York Heart 
Association class at follow-up. There 
was no correlation between late 
improvement in left ventricular function 
and improvement in angina. Improvement 
in left ventricular function did not corre­
late with preoperative indices of severity 
of coronary disease or with indices of 
completeness of surgical repair.
Soixante-dix-neuf patients qui avaient 
souffert de dysfonctionnement ventricu-
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laire gauche moyen ou severe et qui ont 
subi un pontage aortocoronarien entre 
1971 et 1977 ont passe un catheterisme 
cardiaque de controle apres un intervalle 
moyen de 3 ans. Trente-trois patients 
(42%) montraient au suivi une ameliora­
tion angiographique de la fonction ventri- 
culaire gauche et 18 (25%) avaient une 
diminution de la pression telediastolique 
du ventricule gauche. Cinquante-huit 
patients (73%) presentaient une amelio­
ration de I'angine d'au moins une classe 
a I'echelle de la New York Heart Asso­
ciation. On n'a constate aucune correla­
tion entre une amelioration tardive de la 
fonction ventriculaire gauche et une 
amelioration de I'angine. L'amelioration 
de la fonction ventriculaire gauche n'a 
pas montre de rapport avec les indices 
preoperatoires de la severite de la mala- 
die coronarienne ou avec les indices 
d'achevement de la reparation chirur- 
gicale.
It has become clear over the past 15 years 
that symptoms of angina are relieved by 
aortocoronary bypass grafting for a long 
time in most patients,1 but the effect of 
such surgery on left ventricular function 
is contentious. Published studies have 
reported improvement,2'3 no improve­
ment4'5 and variable change6'7 in resting 
left ventricular function after successful 
bypass to myocardial segments with re­
versible ischemia.
One problem in analysing the results of 
grafting is that latent dysfunction of 
ischemic segments may be brought out 
only by stress such as exercise or pacing 
at study before or after surgery.5'8 
Another is that segments with normal 
contraction preoperatively cannot be 
expected to show better resting function 
postoperatively, but there is thf; potential 
for a loss of function due to periopera­
tive infarction. In our own experience, a 
comparison of segmental wall motion in 
50 patients before and after operation 
showed a decline in resting wall motion 
in 29 ventricular segments, improvement 
in 47 and no discernible change in 174. 
Mean ejection fraction for the group did 
not differ preoperatively and postopera­
tively (0.48 versus 0.49).9 On average, 
there appears to be modest improvement 
in ventricular function from aortocoro­
nary bypass grafting alone, but there is 
considerable individual variation.
We surveyed the results in our hospi­
tal of aortocoronary bypass grafting 
along with aneurysm repair in patients 
with depressed left ventricular function 
before operation. This subgroup admit­
tedly carries the greatest potential for a 
gain in ventricular function after surgery 
and we first wished to learn how fre­
quently such improvement occurred. We 
tried to assess whether functional 
improvement in such patients at follow­
up was manifested by better left ventricu-
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lar function. Further, we questioned 
whether improvement in systolic and 
diastolic left ventricular function neces­
sarily went together. When improvement 
did occur, we examined whether it could 
be predicted by, or associated with, cer­
tain characteristics of the patient or the 
operation.
Patients and Methods
Of 1831 patients who underwent aor­
tocoronary bypass grafting at the Ottawa 
Civic Hospital between 1971 and 1977, 
263 were considered to have class III or 
IV left ventricular dysfunction preoper- 
atively. This classification is a subjective 
and semiquantitative assessment of dys­
function used by our group that relates 
to the number of 25 percentiles of nor­
mally contracting ventricular circumfer­
ence at angiography (right anterior 
oblique projection). A class I ventricle has 
75% of the circumference contracting 
normally and a class II ventricle 50%. 
Thus, a class III ventricle has only 25% 
of its circumference with normal inward 
systolic motion and a class IV ventricle 
has no entire segment that contracts nor­
mally. Although subjective, the system 
has become fairly reproducible within our 
group. Where such measurements are 
available, patients with class III left ven­
tricles usually have ejection fractions 
between 0.25 and 0.45 and those with 
class IV ventricles less than 0.25.
This report is a survey of 98 of the 263 
patients who returned for a second heart 
catheterization at least 1 year after sur­
gery. In the first few years, many such 
patients returned because of recurrent 
symptoms. After 1978 some were studied 
in response to an invitation extended to 
all surviving patients. Complete pre- and 
postoperative catheterization data were 
available for 79 of the 98 patients. The 
interval between surgery and restudy was 
2.9 ± 1.4 years (mean ± SD). Compari­
sons were made of ventricular function 
preoperatively and postoperatively for 
each patient. Ventricular angiograms 
were reviewed by an experienced cardiac 
radiologist without knowledge of the clin­
ical results. Because left ventricular ejec­
tion fractions for both studies were avail­
able for only a few patients, systolic 
function was reported in terms of the 
above-noted classification. Left ventric­
ular end-diastolic pressure was measured 
before angiography through fluid-filled 
catheters, at the nadir of the “ a” wave. 
Change in ventricular function between 
the two studies and symptomatic 
improvement at follow-up were cor­
related, along with a number of preoper­
ative clinical and operative factors (Table 
I). Tests of statistical significance used 
were x2 analysis, Student’s t-test and 
Fisher’s exact test.
Findings
Of the 79 patients, 73 (92%) were men 
and the mean age at the time of surgery 
was 49 ± 8 years. Fifty patients (63%) 
had class III left ventricular dysfunction 
preoperatively and 29 (37%) class IV. No 
patient had a normal electrocardiogram 
before surgery; 64 (81%) manifested one 
or more previous infarctions, and the 
remainder had left bundle-branch block 
or ischemic ST abnormalities. Almost 
90% of patients had angina but only 18% 
had symptoms of uncompensated conges­
tive heart failure (Table II). At the time 
of operation, 17 patients (22%) had pli­
cation or resection of a ventricular 
aneurysm and the mean number of 
bypass grafts placed was 3.4 ± 1.1 per 
patient. These figures all closely resem­
ble those of the parent group, suggesting 
that patients restudied were a reasonably 
representative sample. The operative 
(30-day) death rate for the entire group 
of 263 patients was 8%.
Thirty-three patients (42%) were 
judged to have shown improvement, 
between studies, of at least one angio­
graphic class of ventricular contraction 
(Table III). The remainder did not 
improve or became worse.
Changes in left ventricular end-diastolic 
pressure between studies are outlined in 
Table IV. Although the mean value for 
the group overall did not change, there 
were subgroups in which there was a 
physiologically and statistically significant 
change in end-diastolic pressure. These 
groups were (somewhat arbitrarily) 
defined — one in which the pressure was 
more than 16 mm Hg preoperatively and 
fell by at least 6 mm Hg postoperatively 
(18 patients) and another in which the left 
ventricular end-diastolic pressure was 
more than 16 mm Hg postoperatively and 
at least 6 mm Hg more than the preoper­
ative level (21 patients). These subgroups 
of patients we have designated as 
“ LVEDP better” and “ LVEDP worse” 
respectively. In the remaining 40 patients 
there was no significant change.
A univariate analysis of preoperative 
clinical and operative factors thought 
likely to have a bearing on improved ven­
tricular function was done for the 33 
patients with improvement of one or 
more angiographic classes of left ventric­
ular function and the 18 “ LVEDP bet­
ter” patients. In no instance did any of 
these factors have a significant correla­
tion with such improvement (p > 0.10).
Improvement in angina at late follow­
up was compared with angiographic or 
hemodynamic improvement in left ven­
tricular function. The incidence of symp­
toms of uncompensated heart failure 
before surgery was too low (18%) for a 
meaningful difference to be present after 
surgery. Thus, improvement in angina 
was studied instead. Of the 18 “ LVEDP
better” patients, 10 (56%) had improve­
ment in angina of one or more NYHA 
class. However, 16 (76%) of the 21 
“ LVEDP worse” patients and 32 (80%) 
of the 40 whose left ventricular end- 
diastolic pressure did not change signifi­
cantly had similar degrees of improve­
ment. Similarly, 24 (73%) of the 33 
patients whose angiographic systolic left 
ventricular function improved had angi­
nal improvement while 34 (74%) of the 
46 whose left ventricular function was not 
better had similar improvement at 
follow-up.
Discussion
Many cardiac centres have avoided aor­
tocoronary bypass grafting in patients
Table I—Univariate Analysis of Hemodynamic 
or Angiographic Improvement 
Preoperative factors 
Presence of angina 
Presence of congestive heart failure 
Angiographic class of left ventricular 
function 
Cardiomegaly 
Hypertension
Extent of coronary disease 
Use of digoxin 
Use of diuretics 
Operative factors 
Number of grafts
Graft patency at angiographic follow-up 
Aneurysm repair
p >  0.10 for all factors.
Table II—Preoperative Clinical Status of Patients
Angina, Heart failure,
NYHA class no. |%) no. (%)
1 9 (11) 65 (82)
II 22 (28) 9 ( ID
III 28 (35) 3 (4)
IV 20 (25) 2 (3)
Table III--Change in Angiographic Class
of Left Ventricular Function
Class Preop Postop
Normal — 2
Class I - 1
Class II — 14
Class III 50 42
Class IV 29 20
Improvement in one or more class -  33 (42%).
Table IV-Change in Left Ventricular
End-diastolic Pressure
(LVEDP) (mean value ± SD)
Preop, Postop,
Group mm Hg mm Hg
Total group (n = 79) 15 ± 8 16 ± 8
LVEDP worse (n -  21) 12 ± 7 25 ± 6
LVEDP same (n -  40) 13 ± 7 13 ± 7
LVEDP better (n -  18) 24 ± 6 12 ± 4
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with severely depressed left ventricular 
function, especially those with a left ven­
tricular ejection fraction of less than 0.25 
(equivalent to our class IV). The ration­
ale has been that the high operative death 
rate and high attrition rate over the sub­
sequent few years negate the value o f such 
surgery. This has not been our philosophy 
at the Ottawa Heart Institute and the 
acceptable surgical mortality and late sur­
vival figures for patients with depressed 
left ventricular function bear this out. 
However, the changes in left ventricular 
function after grafting are much less 
clear-cut. That 42% of patients had a dis­
cernible improvement in angiographic left 
ventricular function must reflect reversi­
ble ischemia as a major component of 
hypokinesia preoperatively. It is surpris­
ing that none of the factors reflecting clin­
ical severity of coronary heart disease 
were predictive of improvement; it sug­
gests that patients need not be denied sur­
gery on that basis. It is more sobering that 
improvement in left ventricular function 
did not relate to those factors that usually 
express adequacy of surgery — number 
of grafts performed, number o f grafts 
patent at follow-up and repair of an 
aneurysm when present. It is possible that 
the beta error imposed by the number of 
patients in this study is responsible for the 
apparent lack of correlation and that
results in a much larger study might be 
different.
Of interest is the discrepancy between 
rates of improvement in systolic left ven­
tricular function (33 patients) and in 
diastolic function (18 patients, including 
9 of the above 33). As left ventricular end- 
diastolic pressure reflects not only end- 
diastolic volume but also end-diastolic 
chamber compliance, some ventricles 
must have experienced improved contrac­
tion without improvement in “ stiffness” 
upon filling. This may be the consequence 
of resid, al scarred myocardium or an 
absolute reduction in chamber size.
Lastly, it was interesting that 73% of 
patients had persisting improvement in 
angina at follow-up regardless of whether 
left ventricular function had observably 
improved, even when severely depressed. 
In particular, anginal improvement was 
equally likely to be present when the rest­
ing left ventricular end-diastolic pressure 
was higher after surgery than when it was 
lower. This attests to the complexity of 
reasons for improvement in symptoms 
and, most importantly, implies that relief 
o f angina following surgery in such 
patients does not necessarily indicate 
improvement in left ventricular function.
Clearly, aortocoronary bypass grafting 
can relieve angina in a majority of 
patients with depressed left ventricular
function. Improvement in left ventricu­
lar function per se is variable and not 
readily predictable; it cannot be inferred 
from improvement in angina alone.
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BOOK REVIEWS
ACUTE PERIPHERAL VASCULAR SUR­
GERY. Michael Staudacher. 165 pp. Must. 
Springer-Verlag New York, Inc., New 
York, 1985. $38.50 (US). ISBN 0-387- 
81874-X.
This monograph is designed for the general sur­
geon who may occasionally be required to pro­
vide emergency care for the patient with acute 
vascular problems.
The contents are well organized and the 
procedures well illustrated with coloured 
schematic diagrams. A very brief description 
is given of the pathologic features of some vas­
cular emergencies including arterial embolism, 
arterial thrombosis, venous thrombosis and the 
tourniquet syndrome. The descriptions of 
aneurysms and trauma are extremely brief.
Emergency instruments required for simple 
vascular repairs are adequately listed, but the 
description of the use of air in the Fogarty 
catheter will not be acceptable to most vascu­
lar surgeons.
The basic vascular surgical techniques are 
nicely illustrated, although the use of two stay 
sutures instead of the standard three triangu­
lation stay sutures for arterial end-to-end 
anastomosis is not generally practised. There 
are specific illustrations for the management 
of embolectomy, simple arterial puncture 
wound, severe femoral artery and vein injury 
and false aneurysm. Venous thrombectomy is 
described, but I do not think this is often indi­
cated and should not be done by the occasional 
operator.
Repair of the popliteal aneurysm is clearly 
described but oversimplified. Resectional ther­
apy is now seldom used. Iatrogenic vascular 
injuries are identified in hernia repair, mastec­
tomy and pelvic surgery. Although the manage­
ment is illustrated briefly, the prevention of 
these injuries is not addressed.
For the occasional vascular surgeon, it seems 
inappropriate to include a description of the 
extra-anatomical repair for an infected vascu­
lar wound in the groin.
The bibliography is limited to some German 
and American textbooks.
This monograph may be of value to the stu­
dent or junior resident as an introduction to 
vascular emergencies. The description of the 
basic vascular techniques of repairing arteries 
and veins will be of value to the general sur­
geon, but I think the operative descriptions of 
the emergency procedures lack the detail neces­
sary for the general surgeon who may be called 
upon to treat patients with these problems.
A.R. Downs, md, frcsc, facs
Professor of surgery,
University of Manitoba,
Head of Vascular Surgery Service,
GC405 Health Sciences Centre,
820 Sherbrook St.,
Winnipeg, Man.
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COLORECTAL CANCER. Current Concepts 
in Diagnosis and Treatment. Edited by 
Glenn Steele, Jr. and Robert T. Osteen. 366 
pp. Must. Marcel Dekker, Inc., New York, 
1986. $59.59 (US). ISBN 0-8247-7372-1.
COLORECTAL TUMORS. Edited by Oliver 
H. Beahrs, George A. Higgins and Jacob 
J. Weinstein. 334 pp. Must. J.B. Lippin- 
cott Company, Philadelphia, 1986. $57.50 
(US). ISBN 0-397-50677-5.
Approximately 138 000 new cases of colorec­
tal cancer were diagnosed in the United States 
in 1985. About half this number of people died 
of the disease in the same year. These statis­
tics establish colorectal cancer as the second 
most common cause of cancer-related deaths, 
and certainly a worthy subject for a compre­
hensive review in textbook form. Interestingly, 
two separate books on the subject, each with 
a quite different approach, have appeared on 
the market at the same time. Since even the 
most dedicated physician is unlikely to require 
or desire both books, a review of the individual 
and relative merits of the two would seem 
appropriate.
Beahrs and colleagues in their book Colorec­
tal Tumors have chosen a multiple-author for­
mat, with 42 contributors writing on their own 
areas of expertise, I gather, within the frame-
continued on page 308
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COUMADIN
(Warfarin sodium) ANTICOAGULANT
INDICATIONS: The prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary 
embolism, atrial fibrillation with embolization, and as an adjunct in the prophylaxis of systemic embolism 
after myocardial infarction. Some of the more common clinical disorders which may be associated with 
or predispose patients to the above indications are: Thrombophlebitis; Congestive heart failure; Surgical 
procedure or trauma associated with a high risk of thromboembolism; Myocardial infarction; Cerebral 
embolism . It may also be useful as an adjunct in the treatment of transient cerebral ischemic attacks due 
to intravascular clotting.
CONTRAINDICATIONS: Any localized or general physical condition or personal circumstance in which 
the hazard of hemorrhage might be greater than the potential clinical benefits of anticoagulation, such 
as: Pregnancy: COUMADIN' is contraindicated in pregnancy because the drug passes through the 
placental barrier and may cause fatal hemorrhage to the fetus in utero. Also, there have been reports 
of birth malformations in children born to mothers who have been treated with warfarin during pregnan­
cy. Women of childbearing potential who are candidates for therapy should be carefully evaluated and 
the indications critically reviewed with the patient. If the patient becomes pregnant while taking this drug, 
she should be apprised of the potential risks to the fetus, and the possibility of termination of the pregnancy 
should be discussed in light of those risks. Hemorrhagic tendencies or blood dyscrasias. Recent or 
contemplated surgery of: 1. central nervous system; 2. eye; 3. traumatic surgery resulting in large 
open surfaces. Bleeding tendencies associated with active ulceration or overt bleeding of: 
gastrointestinal, genitourinary or respiratory tracts; cerebrovascular hemorrhage; aneurysms -  cerebral, 
dissecting aorta; pericarditis and pericardial effusions; bacterial endocarditis. Threatened abortion, 
eclampsia and preeclampsia. Inadequate laboratory facilities or unsupervised senility, alcoholism, 
psychosis, or lack of patient cooperation. Spinal puncture and other diagnostic or therapeutic procedures 
with potential for uncontrollable bleeding. Miscellaneous: major regional, lumbar block anesthesia and 
malignant hypertension.
WARNINGS: The most serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis 
and/or gangrene of skin and other tissues. Risk of hemorrhage is related to the level of intensity and duration 
of therapy. Hemorrhage and necrosis have in some cases been reported to result in death or permanent 
disability. Necrosis appears to be associated with local thrombosis and usually appears within a few days 
of the start of therapy. In severe cases of necrosis, treatment through debridement or amputation of the 
affected tissue, limb, breast or penis has been reported. Careful diagnosis is required to determine whether 
necrosis is caused by an underlying disease. Therapy should be discontinued when warfarin is the 
suspected cause of developing necrosis and heparin may be considered. Although various ones have 
been attempted, no treatment for necrosis has been considered uniformly effective. See below for infor­
mation on predisposing conditions. These and other risks must be weighed against the risk of throm­
bosis or embolization in untreated cases. COUMADIN is a potent drug with a half-life of 2.5 days; therefore 
effects may become more pronounced as daily maintenance doses overlap. It cannot be emphasized 
too strongly that treatment of each patient is a highly individualized matter. Dosage should be con­
trolled by periodic determinations of prothrombin time or other suitable coagulation tests. Determina­
tions of whole blood clotting and bleeding times are not effective measures for control of therapy. Heparin 
prolongs the one-stage prothrombin time. When heparin and COUMADIN are administered concomitantly, 
refer to CONVERSION FROM HEPARIN THERAPY for recommendations. Caution should be observed 
when COUMADIN is administered in any situation or in the presence of any predisposing condition where 
added risk of hemorrhage or necrosis is present. Administration of anticoagulants in the following con­
ditions w ill be based upon clinical judgement in which risks of therapy are weighed against the risk of 
thrombosis or embolization in untreated cases. The following may be associated with these increased 
risks: Lactation. Severe to moderate hepatic or renal insufficiency. Infectious diseases or distur­
bances of intestinal flora -  sprue, antibiotic therapy. Trauma which may result in internal bleeding. 
Surgery or trauma resulting in large exposed raw surfaces. Indwelling catheters. Severe to moderate 
hypertension. Known or suspected deficiency in protein C: This hereditary or acquired condition, 
which should be suspected if there is a history of recurrent episodes of thromboembolic disorders in the 
patient or in the family, has been associated with an increased risk of developing necrosis following war­
farin administration. Tissue necrosis may occur in the absence of protein C deficiency. It has been reported 
that concurrent anticoagulation therapy with heparin for 5 to 7 days during initiation of therapy with 
COUMADIN may minimize the incidence of this reaction. Warfarin therapy should be discontinued when 
it is suspected to be the cause of developing necrosis, and heparin may be considered. Miscellaneous: 
polycythemia vera, vasculitis, severe diabetes, severe allergic and anaphylactic disorders. Patients with 
congestive heart failure may become more sensitive to COUMADIN, thereby requiring more frequent 
laboratory monitoring, and reduced doses. Concurrent use of anticoagulants with streptokinase or 
urokinase is not recommended and may be hazardous. (Please note recommendations accompanying 
these preparations.)
PRECAUTIONS: Periodic determination of prothrombin time or other suitable coagulation test is 
essential. Numerous factors, alone or in combination, including travel, changes in diet, environ­
ment, physical state and medication may influence response to anticoagulants. It is good practice 
to monitor the response with additional prothrombin time determinations in the period immediately 
after discharge from the hospital, and whenever other medications are initiated, discontinued or 
taken haphazardly. The following factors are listed for your reference; however, other factors may 
also affect the anticoagulant response.
The following factors, alone or in combination, may be responsible for INCREASED pro­
thrombin time response: ENDOGENOUS FACTORS: cancer, collagen disease, congestive heart failure, 
diarrhea, elevated temperature, hepatic disorders: (infectious hepatitis, jaundice), poor nutritional state, 
steatorrhea, vitamin K deficiency. EXOGENOUS FACTORS: a lcohol,t allopurinol, aminosalicylic acid, 
amiodarone HCI, anabolic steroids, anesthetics, inhalation, antibiotics, bromelains, chloral hydrate,! chlor­
propamide, chymotrypsin, cimetidine, clofibrate, COUMADIN overdosage, dextran, dextrothyroxine, diazox- 
ide, diflunisal, d iuretics,! disulfiram, ethacrynicacid, fenoprofen, glucagon, hepatotoxic drugs, ibuprofen, 
influenza virus vaccine, mefenamic acid, methyldopa, methylphenidate, metronidazole, miconazole, 
monoamine oxidase inhibitors, nalidixic acid, naproxen, narcotics, prolonged, pentoxifylline, 
phenylbutazone, phenytoin, pyrazolones, quinidine, quinine, ranitidine,! salicylates, sulfinpyrazone, 
sulfonamides, long-acting, sulindac, thyroid drugs, tolbutamide, trimethoprim/sulfamethoxazole, other 
medications affecting blood elements which may modify hemostasis. Also: dietary deficiencies, prolonged 
hot weather, unreliable prothrombin time determinations.
The following factors, alone or in combination, may be responsible for DECREASED prothrom­
bin time response: ENDOGENOUS FACTORS: edema, hereditary coumarin resistance, hyperlipemia, 
hypothyroidism. EXOGENOUS FACTORS: adrenocortical steroids, a lcohol,! antacids, antihistamines, 
barbiturates, carbamazepine, chloral hydrate,! chlordiazepoxide, cholestyramine, COUMADIN under­
dosage, diuretics,! ethchlorvynol, glutethimide, griseofulvin, haloperidol, meprobamate, oral contracep­
tives, paraldehyde, primidone, ranitidine,! rifampin, vitamin C. Also: diet high in vitamin K, unreliable PT 
determinations. Because a patient may be exposed to a combination of the above factors, the net effect 
on PT response may be unpredictable. More frequent laboratory monitoring is, therefore, advisable. 
Coumarins may also affect the actions of other drugs. Hypoglycemic agents (chlorpropamide, tolbutamide 
and glyburide) and anticonvulsants (phenytoin and phenobarbital) may accumulate in the body as a result 
of interference with either their metabolism or excretion.
ADVERSE REACTIONS: Potential adverse reactions may include: • Hemorrhage from any tissue or organ. 
This is a consequence of the anticoagulant effect. Signs and symptoms will vary according to the loca­
tion and degree or extent of bleeding. Therefore, the possibility of hemorrhage should be considered 
in evaluating the condition of any anticoagulated patient with complaints which do not indicate an ob­
vious diagnosis. Bleeding during anticoagulant therapy does not always correlate with prothrombin activity. 
(See SYMPTOMS AND TREATMENT OF OVERDOSAGE.) Bleeding which occurs when the prothrom­
bin time is within the therapeutic range warrants diagnostic investigation, since it may unmask a
previously unsuspected lesion, e.g. tumor, ulcer, etc. •  Necrosis of skin and other tissues. (SEE WARN­
INGS). • Other adverse reactions are infrequent and consist of alopecia, urticaria, dermatitis, fever, nausea, 
diarrhea, abdominal cramping, a syndrome called "purple toes,”  cholestatic hepatic injury, and hypersen­
sitivity reactions. •  Priapism has been associated with anticoagulant administration, however, a causal 
relationship has not been established.
DOSAGE AND LABORATORY CONTROL: Administration: Administration and dosage must be 
individualized. Adjust the dosage according to results of the one-stage prothrombin time (PT) with 
commonly used rabbit brain thromboplastin. There is ample evidence that prolongation of the prothrombin 
time 1.2 to 1.5 times control is sufficient for prophylaxis and treatment of venous thromboembolism, 
minimizing the risk of hemorrhage associated with more prolonged PT values. Where the risk of throm­
boembolism is great, such as with recurrent systemic embolism, a PT of 1.5 to 2.0 times control should 
be maintained. A ratio greater than 2.0 appears to provide no additional therapeutic benefit in most patients 
and is associated with a higher risk of bleeding.
Table of Recommended Therapeutic PT Ranges*
Clinical State Rabbit Brain PT Ratio**
Prophylaxis -  venous thromboembolism
High-risk surgery 1.2-1.4
Hip surgery 1.3-1.5
Treatment-deep vein thrombosis or pulmonary embolism 
Prevention of systemic embolism in patients with:
1.2-1.5
• atrial fibrillation,
•  tissue heart valves, or
• acute myocardial infarction 1.2-1.5
Recurrent systemic embolism 1.5-2.0
'M odified from Chest, ACCP-NHLBI National Conference on Antithrombotic Therapy, volume 89,
number 2, page 14S, 1986.
**For the three thromboplastins currently used in North America, a PT with rabbit brain thrombo­
plastin of 1.3 to 2.0 is equivalent to an International Normalized Ratio (INR) of 2.0 to 4.0. For other
thromboplastins the INR can be calculated as: INR = (observed PT).ISI 
Sensitivity Index) is available from the manufacturers of thromboplastin.
The ISI (International
INITIAL DOSAGE: Is commonly started above anticipated maintenance dosage levels. A commonly-used 
regimen is 10mg/day for 2 to 4 days, with daily adjustments based on the results of PT determinations. 
A large loading dose (i.e., 30mg) may increase the incidence of hemorrhagic and other complications, 
does not offer more rapid protection against thrombi formation, and is not recommended. Lower doses 
are recommended for elderly and/or debilitated patients and patients with increased sensitivity (see 
PRECAUTIONS). Maintenance: Most patients are satisfactorily maintained at a dose of 2 to 10mg daily. 
Flexibility of dosage is provided by breaking scored tablets in half. The individual dose and interval should 
be gauged by the patient's prothrombin response. Duration of therapy: The duration of therapy in each 
patient should be individualized. In general, therapy should be continued until the danger of thrombosis 
and embolism has passed. Treatment During Dentistry and Surgery: Management of patients who 
undergo dental and surgical procedures requires close liaison between attending physicians, surgeons 
and dentists. In patients who must be anticoagulated prior to, during, or immediately following dental or 
surgical procedures, adjusting the dosage to maintain the PT at the low end of the therapeutic range, 
may safely allow for continued anticoagulation. The operative site should be sufficiently limited and 
accessible to permit the effective use of local procedures for hemostasis. Under these conditions, dental 
and surgical procedures may be performed without undue risk of hemorrhage. Conversion from Heparin 
Therapy: Since the onset of COUMADIN'S effect is delayed, heparin is preferred initially for rapid anti­
coagulation. Conversion to COUMADIN may begin concomitantly with heparin therapy or may be delayed 
3 to 6 days. As heparin may affect the PT, patients receiving both heparin and COUMADIN should have 
blood drawn for PT determination, at least: • 5 hours after the last IV bolus dose of heparin, or • 4 hours 
after cessation of a continuous IV infusion of heparin, or • 24 hours after the last subcutaneous heparin 
injection. When COUMADIN has produced the desired therapeutic range or prothrombin activity, heparin 
may be discontinued.
SYMPTOMS AND TREATMENT OF OVERDOSAGE: Symptoms: Suspected or overt abnormal bleeding 
(i.e., appearance of blood in stools or urine, hematuria, excessive menstrual bleeding, melena, petechiae, 
excessive bruising or persistent oozing from superficial injuries) are early manifestations of anticoagulation 
beyond a safe and satisfactory level. Treatment: Excessive anticoagulation, with or without bleeding, 
may be controlled by discontinuing therapy and if necessary, by administration of oral or parenteral vitamin 
K, 2.5mg to 10mg. (Please see recommendations accompanying vitamin K, preparations prior to use.) 
Use of vitamin K, reduces responses to subsequent COUMADIN therapy. Patients may return to a pretreat­
ment thrombotic status following the rapid reversal of a prolonged PT. Resumption of COUMADIN ad­
ministration reverses the effect of vitamin K ,, and a therapeutic PT can again be obtained by careful dosage 
adjustment. If rapid anticoagulation is indicated, heparin may be preferable for initial therapy. If minor 
bleeding progresses to major bleeding, give 5 to 25mg (rarely up to 50mg) parenteral vitamin K,. In 
emergency situations of severe hemorrhage, clotting factors can be returned to normal by administering 
200 to 500mL of whole blood or fresh frozen plasma, or by giving commercial Factor IX complex. Packed 
red blood cells may also be given if significant blood loss has occurred. Infusions of blood or plasma 
should be monitored carefully to avoid precipitating pulmonary edema in elderly patients or patients with 
heart disease.
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Bacterial Colonization of Intestinal Urinary Conduit Diversion: 
a Morphologic and Bacteriologic Experimental Study
Cutaneous diversion of the urine through 
intestinal conduits results in bacteriuria 
with uropathogenic organisms in up to 
80% of patients, many of whom suffer 
pyelonephritis. Analysis of the bacterio­
logic data from daily sampling at multiple 
sites and scanning and transmission elec­
tron microscopic studies of sequential 
loop and autopsy specimens in rabbits 
with functioning colonic conduits indi­
cate that the pyelonephritis evolves in 
sequential stages of microbial coloniza­
tion. Using these data on the natural 
progression of bacterial infection, we can 
rationally test the ability of strains of 
bacteria indigenous to the conduit of this 
animal model to prevent uropathogenic 
colonization of the conduit.
La derivation cutanee de I'urine dans les 
canaux intestinaux resulte en une bac- 
teriurie avec organismes uropathoge- 
niques pour un pourcentage de malades 
allant jusqu'a 80%; de plus beaucoup de 
malades sont ensuite atteints de pyG- 
lonephrite. Les analyses des donnees 
bacteriologiques de pr£l6vements quoti- 
diens provenant d'emplacements multi­
ples, ainsi que des etudes utilisant micro­
scopes electroniques a balayage et a 
transmission avec de specimens d'anses 
successives et de specimens d'autopsie 
chez des lapins ayant des canaux du 
colon en bon etat, indiquent que revolu­
tion de la pyelonephrite se fait par 
etages successives de colonisation 
microbienne progressive. Si I'on se sert 
de ces donnees sur la progression 
naturelle des etages successives de I'in- 
fection bacterienne, il est possible de 
faire des essais rationnels de I'usage de 
I'interference bacterienne en utilisant des
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types de bact£ries indigenes stabilisees 
dans le canal intestinal de ce modele 
animal pour arreter les pathog&nes 
potentiels.
Cutaneous diversion of the urine is used 
to treat a variety of conditions that 
require surgical excision of the lower uri­
nary tract. The ileal loop, which uses an 
ileal segment into which both ureters are 
implanted for draining urine to the 
abdominal wall,1 has been used exten­
sively for the past 30 years. However, the 
operative procedure results in later 
development of infection; 80% of 
patients are reported to have bacteriuria 
caused by uropathogens.2-6 Acute and 
chronic pyelonephritis is common among 
the patients because of reflux of infected 
urine into the kidney resulting in progres­
sive renal deterioration.4'7,8 Colonic con­
duits incorporating a nonrefluxing ure- 
terocolic anastomosis have recently 
become popular. Long-term follow-up of 
patients having a colonic conduit revealed 
that there is still a high incidence of pye­
lonephritis and renal deterioriation.9 To 
reduce this incidence, antibiotics have 
been given preoperatively and postoper- 
atively, sometimes resulting in infection 
with yeast and resistant bacteria.2_6,l° 
Because of widespread clinical use of 
antibiotics, the natural history and 
progression of the bacterial populations 
associated with the intestinal urinary con­
duit is unknown.
Rozee and colleagues" have shown 
that the bacteria associated with the intes­
tinal surface are trapped within the mucus 
blanket. In a recent study, Bruce and 
colleagues10 showed virtually no bacteria 
adhering 13 the columnar cells of an intes­
tinal urinary conduit, even though the 
conduit mucus was heavily colonized with 
bacteria. It was suggested that use of 
indigenous bacteria to colonize the mucus 
biofilm of intestinal conduits might pre­
vent uropathogenic colonization. Before 
such a concept can be tested, a model 
must be developed to study the natural 
microbiologic progression of urinary con­
duit infections, and in which the protec­
tive effect of beneficial bacteria
introduced into the conduit can be 
assessed. In this investigation we deve­
loped an animal model for colonic con­
duit urinary diversion and undertook 
detailed microbiologic, ultrastructural 
and morphologic studies of the model to 
determine the etiology and natural 
progression of urinary conduit infections 
from the development of bacteriuria in 
the sterile conduit to the appearance of 
destructive pyelonephritis.
Material and Methods
Operative Procedure
After partial cystectomy colonic con­
duits were created in 10 young, female, 
New Zealand rabbits, each weighing 4 to 
5 kg, using a modification of the trigonal 
patch technique of Pond and Texter.12 
The animals were starved for 24 hours 
preoperatively and received saline infu­
sions preoperatively, intraoperatively and 
for 36 hours postoperatively. A single 
dose of veterinary penicillin-streptomycin 
was administered parenterally 12 hours 
before the operation. The animals were 
anesthetized with ketamine and the abdo­
men was opened through a midline inci­
sion. A 3 to 5-cm segment of descend­ing and sigmoid colon was mobilized and 
isolated by sharply transecting the prox­
imal and distal margins, being careful to 
preserve the mesenteric blood supply. 
Continuity of the colon was re-established 
by a one-layer anastomosis with inter­
rupted 4-0 chromic catgut sutures. The 
bladder, along with the ureters and the 
inferior vesical blood supply, was care­
fully dissected free. A subtotal cystectomy 
was performed, preserving the ureteral 
insertions into the trigone. The proximal 
urethra was oversewn with 4-0 chromic 
catgut. The isolated segment of colon was 
irrigated, first with a dilute piperacillin 
solution and then copiously by phos­
phate-buffered saline. The proximal end 
was spatulated and anastomosed to the 
trigonal patch with a running 4-0 catgut 
suture. A circular plug of abdominal wall 
was excised at the preselected stomal site 
and a nippled colonic conduit stoma con­
structed. After abdominal closure in
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layers, the rabbits were placed in incu­
bators with supplemental oxygen, in­
creased humidity and a temperature of 
29°C for 12 hours, after which they were 
returned to their cages. They received 
fluids parenterally for 36 hours postoper- 
atively, and then a regular diet.
Specimen Sampling and Preparation
Catheterized specimens of urine (with 
or without mucus) were taken daily from 
the stoma (distal 1 cm of conduit) and 
deep conduit (more than 1 cm proximal 
to stoma). Aliquots (0.1 ml) o f urine were 
spread plated on brain-heart infusion agar 
and  sheep-b lood  agar p la tes and 
incubated aerobically and anaerobically 
for 24 to 48 hours. Bacteria were quanti­
tated, isolated and identified using stan­
dard techniques. Bacterial counts greater 
than 104/m l were considered significant.6 
Mucus specimens extracted aseptically 
from the deep conduit were cultured in 
a similar fashion and were also prepared 
for transmission electron microscopy as 
described below.
All animals eventually became ill, 
stopped eating and drinking, became 
lethargic and had some degree of flank 
tenderness. With these symptoms a clini­
cal diagnosis of pyelonephritis was made 
and the rabbit was killed. At autopsy, 
urine was aseptically aspirated from the 
proximal conduit and the renal pelves of 
both kidneys and was cultured. Speci­
mens were taken from the stoma, prox­
imal and distal conduit, conduit mucus, 
ureters and kidneys for scanning and 
transmission electron microscopy. Renal 
cortical tissue was sectioned and bisected; 
one portion was homogenized and cul­
tured and the other stained with hematox­
ylin and eosin for histologic examination.
The specimens collected for scanning 
electron microscopy were fixed in 5% 
glutaraldehyde in cacodylate buffer (0.1 
M, ph 7.0) with 0.15% ruthenium red for 
2 hours at room temperature (22°C). The 
preparations were washed three times in 
the buffer and then “ metallized” , using 
osm ium  te tro x id e  a n d  th io carb o - 
h y d raz id e .13 This was follow ed by 
dehydration in ethanol and freon-113 
before critical point drying.14 The speci­
mens were then examined with a Hitachi 
S450 scanning electron microscope at an 
accelerating voltage of 20 kV.
The specimens collected for transmis­
sion electron microscopy were fixed as for 
scanning electron microscopy. They were 
then washed five times in buffer, post- 
fixed in 2% osmium tetroxide in buffer 
and dehydrated through a series of ace­
tone washes. All of the solutions used in 
processing the specimen, from the washes 
after gluteraldehyde fixation to dehydra­
tion with 70% acetone solution, con­
tained 0.05% ruthenium red. After fur­
ther dehydration in propylene oxide, the
Tab le  1— P o sto perative  T im e Elapsed Until B acte ria l C o lon izatio n  (1 0 4 bacteria/ml) 
o f S to m al and Deep Conduit Urine and the C lin ica l O ccurrence  of Pyelonephritis
T im e , d
Rabbit no. Stom a Deep Conduit Pyelonephritis
4 15 22 24
5 2 7 11
6 6 13 20
7 4 5 8
8 3 5 14
9 2 4 5
10 4 6 10
M e a n iS D  5.1 ±  4 .6  8 .9  ±  6 .5 13.1 ±  6 .7
'C l in ic a l  im pression confirm ed by b acterio lo gic au to p sy  stu d ies.
DAYS
0  2 4  6 8 10 12 14 16 18 2 0  22  2 4 2 6
No. 4 ---------------------------------------- © ---
4
S. •pidcrmidis
No. 5 ---- (§)--------- (IsK©---------®
. ♦ . 4 4 4
F. m«nigo»«pticum P. aeruginosa P. aeruginosa
P. aeruginosa
— -© — <®
4
S. spider midis
C pyogenes 
S. faecalis
S. epidermidis 
C. pyogenes 
S. faecalis
No. 6 
No. 7
No. 8
-----©-----
4
£  epidermidis
—dxc)----®
♦ t .  *
P. pneumotropica R pneumotropica 
| S. aureus 
P. pneumotropica
-<§>^Kc>-
♦ t ♦ecolis S f  
| S  c
faecalis
aureus
— © —
4
S. epidermidis
—© ----©Kk)
♦ * ♦
E. coli C. pyogenes
£  epidermidis 
S. xylosus 
S. aureus
E. coli
Bacteroides sp.
— ®
4
£  faecolis 
S. aureus
No. 9 — ® — <§>®
* * *S. aureus £  oureus 
S. foecalis £  faecalis  
A. Iwoffi A. Iwoffi
S. aureus
No. 10 — (D— ©-------- ®
4 4 4
E. cloacae E. cloacae E. cloocae
S. faecalis S. faecalis
FIG. 1—Bacteriologic data from stoma (S), deep conduit (C) and kidney (K) in seven rab­
bits after colonic conduit urinary diversion. Identification of organisms demonstrates sequen­
tial microbiologic colonization after operation, starting with stomal area and progressing to 
deep conduit and finally to kidney.
FIG. 2—Rabbit no. 7. Transmission electron photomicrograph of proximal portion of intes­
tinal conduit 7 days after operation. Note absence of bacterial colonization of both microvillar 
surface of colon and overlying mucus layer. Bars on all photomicrographs indicate 1 ^m.
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specimen was embedded in Spurr15 low- 
viscosity embedding resin. Sections were 
cut and stained with uranyl acetate and 
lead citrate,16 reinforced with evaporated 
carbon and examined with a Hitachi 6000 
transmission electron microscope at an 
accelerating voltage of 60 kV.
Results
The postoperative death rate was 30% 
— one animal died as a result of the 
anesthetic, another of pneumonia and the 
third of a pelvic abscess. In the remain­
ing seven rabbits a definite pattern of 
microbiologic colonization and infection 
was demonstrated. In all, there was a
progression from stomal colonization to 
deep conduit infection, followed by pye­
lonephritis. Table I shows the postoper­
ative time lapse until demonstrable 
colonization (greater than I04 bac- 
teria/ml) of stomal and deep conduit 
urine and clinical occurrence of pye­
lonephritis. The stomal urine was 
colonized by more than 104 bacteria/ml 
in a mean time (± SD)of5.1 ± 4.6 days, 
deep conduit urine infection followed 
3.7 ± 2.6 days later (range from 1 to 7 
days) and clinical evidence of pye­
lonephritis was confirmed a mean of 
4.3 ± 2.8 days (range from 1 to 9 days) 
after that. The clinical impression of pye­
lonephritis was confirmed in all cases by
autopsy cultures of renal pelvis urine and 
homogenized cortical tissue.
Identification of the organisms isolated 
from the urine specimens showed that in 
all animals bacteriuria developed with one 
or more of the following organisms: 
Staphylococcus epidermidis, Staphylo­
coccus aureus, Staphylococcus xylosus, 
Streptococcus faecalis, Pseudomonas 
aeruginosa, Corynebacterium pyogenes, 
Escherichia coli, Pasteurella pneumo- 
tropica, Acinetobacter Iwoffi, Entero- 
bacter cloacae, Flavobacterium meningo- 
septicum and Bacteroides sp. (Fig. 1). 
Analysis of the progressive data (Fig. 1) 
showed that organisms present in the 
stomal urine in the first stages of 
microbial colonization were usually 
involved in the further stages of conduit 
infection and pyelonephritis. In most 
animals polymicrobial populations deve­
loped in the later stages.
Scanning and transmission electron 
microscopic studies of sequential mucus 
specimens and autopsy biopsies of the 
conduits and kidneys again demonstrated 
the various stages of microbiologic 
colonization. For several days after the 
operation no microorganisms were found 
in the intestinal tissues or the mucus 
blanket (Fig. 2), but within a period of 
5 ± 4.6 days, the stomal area, including 
the mucus (Fig. 3) and cells from the 
mucocutaneous junction (Fig. 4), was 
heavily colonized by glycocalyx-enclosed 
microcolonies of bacteria. Within days 
the deep-conduit mucus and urine became 
thickly colonized with a similar mucus- 
associated population of bacteria, includ­
ing both gram-positive and gram-negative 
bacteria (Fig. 5). There was virtually no 
bacterial attachment to the microvillar 
surface of the columnar cells of the con­
duit (Fig. 6); however, bacterial coloni­
zation of the nearby mucus blanket was 
clearly demonstrated (Fig. 7). In all the 
animals, pyelonephritis (proven at 
autopsy) eventually developed. The inva­
sive and destructive nature of the renal 
infection was confirmed by positive cul­
tures of homogenized cortical tissue and 
histologic sections of the renal paren­
chyma.
Discussion
The development of pyelonephritis 
with renal deterioration is the major long­
term complication of intestinal conduit 
urinary diversion.2' 10 Our data indicate 
that the evolution of pyelonephritis fol­
lows sequential stages of progressive 
microbial colonization. Entry of bacteria 
into the conduit undoubtedly occurs when 
pathogenic bacteria adhere to the 
mucocutaneous junction of the stoma, 
and this is followed quickly by coloniza­
tion of the mucus and urine of the distal 
stomal zone. It took approximately 4 days 
in our animal mode! for the mucus and 
urine layer of the deep conduit to become
FIG. 3—Rabbit no. 4. Transmission electron photomicrograph of bacterial microcolony 
in mucus at site of stoma 16 days after surgery. Although cultures grew Staphylococcus epider­
midis, and many gram-positive cocci were seen, microcolonies of this gram-negative organism 
were commonly found in mucus. Ruthenium-red staining has revealed fine fibrous glycocalyx 
material surrounding these cells which also have thin electron-dense concentric element outside 
outer membrane of their cell walls.
FIG. 4—Rabbit no. 4. Transmission electron photomicrograph of epidermal cells from 
stoma 16 days after surgery. Cultures grew 5. epidermidis and direct microscopy showed that 
spaces between cells in this squamous epithelium were filled by gram-positive cocci growing 
in coherent glycocalyx-enclosed biofilm.
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colonized with a polymicrobial popula­
tion of pathogenic bacteria. It is likely 
that bacteria gain access to the kidneys 
through reflux of the infected urine from 
the conduit because reflux is present in 
this reconstructed urinary system.
It was interesting to note that a deep 
conduit urine infection did not develop 
immediately after colonization of the 
mucus and urine of the stomal zone of the 
conduit. The bacteria in the distal con­
duit were all present in the mucus/urine 
layer and none were seen attached to the 
intestinal cells. It would appear that the 
mucus produced by the goblet cells of the 
colonic conduit forms a dense flowing 
biofilm that entraps invading organisms 
and continuously forces them toward the 
stoma and out of the conduit. The mucus 
blanket might also be involved in prevent­
ing bacterial attachment to the conduit 
cell surface by pathogenic organisms. 
High levels of secretory immunoglobulin 
A within the conduit urine may also con­
stitute a host-defence mechanism against 
urinary tract infection in patients with 
conduits.17 However, this proposed 
defence mechanism is not totally effec­
tive, and pathogenic organisms eventually 
invade and reside in the mucus layer of 
the deep conduit. The presence of these 
pathogenic organisms in the proximal 
conduit exposes the animals to the risk of 
upper tract infection, which eventually 
develops in those subjected to this surgi­
cal modification.
Clinical studies2-10 appear to confirm 
our morphologic and bacteriologic inves­
tigation, although progression through 
the described stages is, of course, not 
documented. In most patients who 
undergo urinary diversion, bacteriuria 
develops within the conduit and this 
appears to precede the eventual develop­
ment of renal infection. The conduit 
mucus recovered from patients with ileal 
conduit bacteriuria also appears to be 
heavily colonized by uropathogens.10 It 
has been suggested10 that the establish­
ment of a nonpathogen (normal flora) 
within the urinary conduit may competi­
tively exclude pathogenic organisms from 
the conduit. Bacterial interference using 
indigenous strains of bacteria to inhibit 
potential pathogens has been successful 
in the intestines of human neonates,18 in 
the bovine udder,19 in the digestive tracts 
of newborn ruminants (unpublished data) 
and in the human vagina.20
In this investigation, the natural 
progression of the sequential stages of 
bacterial infection in the colon urinary 
conduit has been established in an animal 
model. We are planning to use this model 
in an attempt to stabilize indigenous bac­
teria such as Lactobacillus sp. in the 
mucus biofilm of the urinary conduit. In 
turn, we hope this may prevent subse­
quent stages of uropathogenic coloni­
zation.
FIG. 5—Rabbit no. 6. Transmission electron photomicrograph of mucus from deep (prox­
imal) area of colonic conduit 20 days after surgery. Both gram-positive and gram-negative bac­
teria were seen in mucus from this site, which grew wide variety of bacteria on culture. Gram­
negative rod-shaped cells are embedded in fine glycocalyx fibres and coarse fibres of dehydration- 
condensed mucus.
FIG. 6—Scanning electron photomicrograph of intestinal tissue from same proximal site 
as mucus sample seen in Fig. 5. When mucus is removed during processing, extensive examina­
tion of tissue surface shows very few bacteria and tissue appears normal in all morphologic 
respects.
FIG. 7—Rabbit no. 7. Transmission electron photomicrograph of tissue-mucus sample from 
deep (proximal) site in ileal conduit. Deep portion of this conduit was rapidly colonized 8 days 
after surgery and this sample grew both Pasteurella pneumotropica  and Staphylococcus aureus 
on culture. Microcolonies of both gram-positive and gram-negative (seen here) bacteria were 
seen in mucus layer but tissue surface was not colonized.
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Systemic Cystic Angiomatosis 
in a Woman With Hematuria and Splenomegaly
Cutaneous hemangiomas are frequently 
found on routine clinical examination and 
generally are not important. But when 
internal organs are involved, these vas­
cular tumours assume greater importance 
because of associated morbidity. A case 
is presented of multiple organ involve­
ment by angiomas in a woman with a 
history of flank hemangioma who was 
investigated for hematuria and 
splenomegaly. She subsequently under­
went splenectomy. The uncommon sys­
temic syndromes characterized by vascu­
lar tumours are discussed, and the case 
reported is appropriately classified. The 
clinical picture, pathologic features and 
investigations appropriate for systemic 
cystic angiomatosis are briefly reviewed. 
The authors recommend conservative 
management when there is splenic 
involvement unless the size of the spleen 
makes its rupture likely or when there 
are hematologic complications.
L'hemangiome cutane est frequemment 
retrouve a I'examen Clinique de routine
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et il est generalement sans importance. 
Toutefois, quand il y a atteinte des vis- 
ceres, ces tumeurs vasculaires prennent 
une importance plus considerable a 
cause de la morbidity qui y est associee. 
On presente ici le cas d'une femme 
ayant des antecedents d'hemangiome du 
flanc, examinee pour hematurie et sple- 
nomegalie, et chez qui on decouvrit de 
multiples atteintes angiomateuses visce- 
rales. Elle subit par la suite une splenec- 
tomie. On commente les syndromes 
systemiques rares caracterises par les 
tumeurs vasculaires et les cas signale s'y 
trouve classifie. On passe brievement en 
revue le tableau clinique. les caracteristi- 
ques pathologiques et les examens 
appropries dans les cas d'angiomatose 
kystique systemique. Les auteurs recom- 
mandent un traitement conservateur 
quand il y a atteinte de la rate & moins 
que la taille de celle-ci fasse soupconner 
une rupture possible ou quand il y a des 
complications hematologiques.
Although cutaneous hemangiomas are 
common and usually innocuous, they can 
be associated with a number of uncom­
mon systemic syndromes of potentially 
serious nature. In the latter context, they 
may serve as a clue to an underlying 
pathologic condition. We describe a case 
of the rare syndrome of systemic cystic 
angiomatosis, emphasizing the general­
ized nature of the disorder and the 
unusual presenting complaint of 
hematuria.
Case Report
A 44-year-old woman was admitted with a 
5-day history of painless hematuria and mild 
left-flank pain. Her medical history included 
surgical removal of a large left-flank heman­
gioma as a child.
Physical examination revealed mild left- 
flank tenderness and scarring and an enlarged 
spleen, palpable near the umbilicus medially. 
No other abnormalities were noted.
Laboratory investigations, including com­
plete blood count, differential count, platelet
FIG. 1—Abdominal x-ray film showing cal­
cific density near L3-4, splenomegaly with cal­
cifications and irregularity of heads of ribs at 
T10 and T il , consistent with arteriovenous 
malformations.
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count, blood smear, coagulation studies, liver 
transaminase determinations and creatinine 
measurement, were within normal limits. Uri­
nalysis showed 150 red blood cells per high- 
power field with negative cytologic findings 
and cultures. Intravenous pyleography showed 
no urinary tract abnormality, but there was 
radiologic evidence of splenomegaly, abdomi­
nal wall calcifications and enlargement of ver­
tebrae L3 and L4 (Fig. 1), findings consistent 
with arteriovenous malformation, and the left 
ribs appeared larger than the right on a chest 
x-ray film. Abdominal ultrasonography rev­
ealed multiple diffuse cystic lesions of the 
spleen and retroperitoneal area, believed to be 
hemangiomas (Fig. 2).
During cystoscopy, blood was seen to ooze 
from the left ureteric orifice, but a left retro­
grade pyelogram was normal. The hematuria 
stopped spontaneously after 5 days. Angiog­
raphy showed hemangiomatous involvement of 
the left chest wall and splenomegaly without 
evidence of hemangioma formation. A diag­
nosis of splenic hemangioma was made and 
splenectomy advised as a prophylactic meas­
ure, because its enlarged size made rupture 
resulting from minor trauma a possibility. At 
laparotomy a large spleen, mottled by calcifi­
cation, was removed. A large confluent heman­
gioma involved the left retroperitoneal area and 
encroached upon the left kidney. The liver and 
right kidney felt normal. No postoperative 
difficulties were encountered.
Pathological Findings
The spleen measured 16 x 13 x  7 cm 
and weighed 750 g. Multiple cystic and 
anastomosing vascular channels could be 
seen grossly, filled with blood and 
serosanguineous fluid (Fig. 3). These were 
lined by thin endothelium and surrounded 
by dense fibrous tissue. Some contained 
erythrocytes, others only proteinaceous 
material. Foci of calcification were 
present. The surrounding red and white 
pulp was displaced and distorted (Fig. 4). 
The diagnosis was lymphohemangioma.
giomatosis and multiple lymphangiecta- 
sis.1 The underlying pathologic features 
have remained similar, consisting of a net­
work of multiple cystic vascular and lym­
phatic channels.2 The rarity with which 
they occur as a multiorgan problem has 
prevented a uniform nomenclature.
In our case, pathologic changes 
involved the spleen, bones, skin, 
retroperitoneum and the left kidney. This 
involvement suggests the syndrome of 
systemic cystic angiomatosis, described by 
Seckler and associates.1 The differential 
diagnosis includes Klippel-Trenaunay 
syndrome (osteohypertrophic varicose 
nevus) characterized by hypertrophy of 
affected limbs, Osler-Weber-Rendu dis­
ease (multiple hereditary hemorrhagic 
telangiectasia), Sturge-Weber disease 
(encephalofacial hemangiomatosis), von
Flippel-Lindau disease (hemangiomato­
sis of the retina, brain stem and other 
organs) and M affucci’s syndrome 
(cutaneous hemangioma and enchon- 
droma of the bones). Similar splenic fea­
tures may be seen in lymphangioma of the 
spleen,3 lymphangioendothelioma of the 
spleen,4 and peliosis of the spleen (never 
found without coexisting peliosis hepa- 
tis).5 These all have features of our case 
and are a part of the differential diagno­
sis in patients with hemangioma.
Systemic cystic angiomatosis is a 
benign vascular tumorous formation that 
may be locally invasive. Only one case of 
truly malignant lymphangioma of the 
spleen has been described.6 Involved 
organs may include spleen, liver, lung, 
pleura, subcutaneous tissues (especially 
the neck and axilla), thymus, mediasti-
F1G. 3—Capsule of spleen (left) showing roughened pebble surface. Cut surface (right) 
shows cystic transformation by numerous blood-filled cavities.
Discussion
Vascular tumours have been described 
under a variety of names and syndromes: 
metastasizing benign angioma, angioma­
tosis, generalized lymphangioma, heman-
FIG. 2—Sonogram of enlarged spleen with 
multiple cysts of varying sizes, some with cal­
cific foci.
FIG. 4—Spleen shows numerous cysts lined by thin fibrous septae, some containing pro­
teinaceous fluid (upper right), others red blood cells. Splenic red and white pulp is displaced, 
distorted and diminished (hemalum-phloxine-saffron stain, initial magnification x 60).
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num, breast, retroperitoneum, kidney, 
skin and virtually any bone including the 
skull.1 The multisystem involvement may 
reflect the congenital origin of these 
tumours.7 The involvement of both lym­
phatic and vascular channels is more fre­
quent than either alone, and different 
organs may contain different types of 
lesions. The congenital nature is suggested 
by the severe neonatal forms of the dis­
ease such as diffuse neonatal heman­
giomatosis, generally a fatal condition.8 
In the older patient, the disease seems to 
progress more slowly.9
The absence of any family history and 
the age of our patient are not remarka­
ble, as she had had a cutaneous heman­
gioma as a child, suggesting that the other 
lesions may have been present since then. 
Hematuria is an unusual presentation in 
this syndrome, but hemangiomas are a 
well-described cause of urinary bleed­
ing.10 Although no lesion was identified 
radiologically, a hemangioma is assumed 
because of the other lesions present and 
the proximity of the pathologic changes 
in the left retroperitoneal area. Bleeding 
in this syndrome normally does not result 
from thrombocytopenia; only one such 
case has been reported.11 Despite the fre­
quent finding of splenomegaly (50%), 
hypersplenism is not usual. Bleeding 
usually results from local tumour effects 
such as bruising with a pathologic frac­
ture, hemoptysis with a lung lesion,9 
hemoperitoneum or bloody ascites from 
pleural or peritoneal angiomas.
No specific laboratory findings are 
present. However, various imaging proce­
dures, while not always in agreement, are 
on the whole diagnostic, as in this case. 
The skeletal survey may demonstrate the 
extent of disease. A simple abdominal x- 
ray film may reveal a soft-tissue density 
from splenic enlargement with cyst-wall 
calcifications or bony involvement. 
Technetium-99m-labelled heat-damaged 
erythrocytes for radioisotope scanning 
provide a specific splenic imaging 
agent.12 Ultrasonography may be espe­
cially helpful in splenic angioma, typically 
showing multiple echo-free lesions of var­
ious sizes. This is recommended as the 
method of choice for splenic imaging.13 
Some reviewers suggest angiography for 
definitive diagnosis, as a characteristic 
swiss-cheese appearance is pathogno­
monic. In our case, such an appearance 
was not seen. A picture of well-defined 
avascular lesions of varying size scattered 
throughout the spleen with no neovas­
cularity, arteriovenous shunting or 
venous pooling is typical.14
Splenic involvement in this case was the 
reason for surgery, and perhaps other 
patients with apparently isolated splenic 
lesions have multiorgan involvement that 
is not recognized. Angiomas of the spleen 
are uncommon even if isolated, and the
pathologic characteristics are essentially 
the same as in systemic angiomatosis.3 
The recognition of other lesions is not just 
of academic interest, as patients observed 
over time may show an increase in num­
ber and size of lesions.11 Four of 13 
patients in Seckler’s study1 died of local 
space-occupying effects and complica­
tions, including cervical cord compres­
sion, hepatosplenomegaly and chylous 
pleural effusion.
Therapy is primarily for local lesions 
and is surgical. Systemic therapy includ­
ing chemotherapy is ineffective. The ques­
tion of when to perform splenectomy 
might be guided by Halgrimson’s obser­
vation that these lesions are frequently 
calcified and thought to represent a late 
dormant stage in the natural history of 
hemangioma, suggesting that they are 
unlikely to lead to new symptoms, and the 
patient can safely be observed without 
surgery.15 Splenectomy is indicated when 
the spleen is greatly enlarged and trau­
matic rupture is considered likely with 
minor trauma, or if hematologic compli­
cations occur.
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SESAP V Question
315. A baby boy born with an imperforate anus treated by sigmoid colostomy has inter- 1 A
mittently required admission for watery diarrhea. Each hospitalization lasts three to five days,
and typical serum electrolytes are serum sodium, 135 mEq/L; serum potassium, 5.5 mEq/L; * *
serum chloride, 120 mEq/L; serum carbon dioxide content, 19 mEq/L, and pH, 7.27. The
contrast radiograph shown above was performed by injection of the distal colostomy stoma
when the baby was one year old. The most likely cause of this clinical picture is „
(A) obstructive uropathy . ^
(B) excessive loss of electrolytes due to gastroenteritis
(C) malabsorption caused by long-term administration of antibiotics
(D) excessive intake of liquids related to treatment of diarrhea
(E) urinary tract infection associated with passage of urine through the 
rectourethral fistula
For the incomplete statement above, select the one completion that is best of the five given.
4- V
For the critique of Item 315 see page 309.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and Self-Assessment 
Program No. 5. For enrolment in the Surgical Education and Self-Assessment Program No. 5, 
please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Unusual Presentation of a Pancreatic Pseudocyst:
a Case Report
Although pancreatic pseudocysts are 
usually found in the vicinity of the pan­
creas, there are reports of them ruptur­
ing into the peritoneal cavity, fistulizing 
into the thorax or bowel and occupying 
unusual sites such as the mesentery, 
mediastinum and spleen.
This is a report of a patient with pan­
creatitis and a pancreatic pseudocyst 
presenting as a swelling of the left thigh 
due to dissection of the pseudocyst into 
the psoas muscle.
Meme si les pseudokystes pancreatiques 
sont habituellement retrouves dans la 
region du pancreas, on retrouve des arti­
cles signalant leur rupture dans la cavite 
peritoneale, leur fistulisation dans le tho­
rax ou I'intestin ou leur presence dans 
des endroits inhabituels tels que le 
mesentere, le mediastin et la rate.
On signale ici le cas d'une patiente 
souffrant d'une pancreatite et d'un pseu- 
dokyste pancreatique qui est apparu 
sous la forme d'une tumefaction de la 
cuisse gauche, a cause de la dissection 
du pseudokyste dans le psoas.
A complication of pancreatitis is the for­
mation of pseudocysts, known to resolve 
spontaneously in about 41% of cases 
within 6 weeks.1 However, a substantial 
number may cause complications or 
appear at unusual sites. Weaver and 
colleagues2 noted that 80% of cases of 
pancreatic ascites resulted from pan­
creatic pseudocyst leakage. The pseu­
docysts were reported to rupture or track 
through the mediastinum into a pleural 
cavity3 or perforate into the colon and 
duodenum.4 They can present at unusual 
sites such as the spleen5 and dissect into 
the groin.6 We report another unusual 
presentation of pancreatic pseudocyst.
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Case Report
A 42-year-old woman was admitted with a 
swollen and painful left thigh; the symptoms 
had developed 1 month earlier. She was known 
to be an alcoholic with chronic pancreatitis. 
Previous operations included cholecystectomy 
and gastrojejunostomy with vagotomy for gas­
tric outlet obstruction secondary to pancrea­
titis, later converted to Roux-en-Y drainage 
because of bile reflux gastritis.
At examination the patient was in no distress 
but appeared older than her stated age. No 
mass or tenderness was detected on abdom i­
nal examination. Her left thigh was tender and 
markedly enlarged, with a circumference of 47 
cm at the mid-thigh level, compared with 41 
cm on the right side. The swelling was non- 
pitting and the skin had a bluish discoloura­
tion, most prominent near the groin.
Her hemoglobin level was 110 g/L, serum 
amylase level was 539 IU /L  (normal 20 to 120 
IU/L), alkaline phosphatase level was 498 
IU/L (normal 100 to 275 IU /L) and the serum 
albumin level was 25 g/L (normal 30 to 50 
g/L). The leukocyte count and blood urea, 
bilirubin, creatinine and aspartate aminotrans­
ferase levels were all normal.
A left lower limb venogram and lymphan- 
giogram were normal. A computerized tom o­
gram of the abdomen demonstrated diffuse 
pancreatic calcification and multiple radiolu- 
cent areas in an enlarged left psoas muscle (Fig. 
1). In the thigh, all muscle groups and adja­
cent soft tissue were enlarged, with oblitera­
tion of the tissue planes (Fig. 2).
At laparotomy, the whole left psoas sheath 
appeared distended. It contained 1500 ml of 
straw-coloured fluid having an amylase con­
tent of 37 800 units/L. With the fluid removed, 
a communication between the left psoas sheath 
and pancreatic bed was discovered. The pan­
creas was fibrotic and thickened with chronic 
inflammatory changes. A splenectomy and dis­
tal pancreatectomy were performed well medial 
to the site where the pseudocyst clinically
FIG. 1—Discrepancy in size between left (a) and right (b) psoas muscles.
appeared to communicate with the pancreatic 
duct. An intraoperative pancreatogram rev­
ealed an ectatic duct with free flow of the dye 
into the duodenum and no extravasation. The 
duct was suture-ligated and the pancreatic 
stump oversewn. Penrose and sump drains 
were placed in the pancreatic bed and left psoas 
sheath.
Pathological examination of the pancreas 
showed chronic nonspecific pancreatitis.
Postoperatively the patient had an external 
pancreatic fistula that drained, at its peak, 1400 
ml over 24 hours. Nasogastric suction and 
parenteral nutrition resulted in a substantial 
decrease in drainage. Three weeks postopera­
tively a left subphrenic fluid collection was 
drained surgically. She was discharged 3 weeks 
later in good condition, but with a persistent 
fistula draining up to 10 m l/d. The swelling 
of the left thigh had resolved at the time of dis­
charge.
Discussion
Pancreatic pseudocysts are uncommon 
but well-recognized complications of 
acute and chronic pancreatitis. They have 
the ability to enlarge and migrate,6 form 
an internal fistula3 and present in 
unusual locations.5,6
Our case illustrates a unique complica­
tion of pancreatitis. Although not radio- 
logically demonstrated, an internal fistula 
between the left psoas sheath and the pan­
creatic duct was presumably formed 
either directly or by way of a pseudocyst. 
Over time, pancreatic secretions collected 
in, and slowly enlarged, the psoas mus­
cle and sheath, eventually dissecting into 
the left thigh where the fluid diffused into 
the compartments causing swelling and 
pain.
The computerized tomogram was 
instrumental in diagnosing this particu-
FIG. 2—Swelling and increased size of left thigh muscles.
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lar problem. Ideally, endoscopic retro­
grade cholangiopancreatography would 
have been helpful in demonstrating the 
fistula between the pancreatic duct and 
pseudocyst, but unfortunately the previ­
ous surgery precluded this examination. 
We elected to perform distal pancreatec­
tomy because at laparotomy we believed 
that the changes in the psoas sheath were 
closely related to the posterior aspect o f
the distal pancreas with a communication 
between the left psoas sheath and pan­
creatic bed even though no definite duc­
tal disruption was visualized.
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Recognition and Management of Marlex Erosion 
After Horizontal Gastroplasty for Morbid Obesity
Between 1979 and 1 982 , 162 patients 
underw en t horizontal gastroplasty in 
w h ich  polypropylene mesh (Marlex) was 
used to  support th e  greater curve chan­
nel. There were no deaths and early 
w e igh t loss was good. The operation 
was stopped because o f late w e igh t 
gain. M arlex erosion w as recognized by 
endoscopy in 10 (6% ) patients between 
27 and 6 0  months a fte r operation. Tw o 
other patients w ith  Marlex erosion had 
the gastroplasty perform ed elsewhere.
The patients' sym ptom s were abdom i­
nal pain, vomiting or w e igh t gain. The 
M arlex w as often d iff ic u lt to  resect 
because the in flam m atory mass was 
adherent to  spleen or pancreas. Recon­
s truc tio n  by Roux-en-Y gastric bypass or 
ve rtica l banded gastrop lasty allowed con­
tinued  w e igh t loss and gastrogas- 
tro s to m y , although technica lly easier, 
resu lted in weight gain. The author con­
cludes th a t long-term fo llow -up  is neces­
sary a fte r any gastrop lasty or gastric 
bypass procedure especially when fo r­
eign m ateria l is used to  support the 
stom a.
De 1 9 7 9  a 1982, 162  patients ont subi 
une gastroplastie horizonta le au cours de 
laquelle de la toile de polypropylene 
(M arlex) a ete utilisee pour m aintenir le 
canal de la grande courbure. On n'a 
enreg istre  aucun deces et la perte de 
poids in itia te  fut bonne. On m it fin  a 
ce tte  operation & cause du gain de poids
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subsequent. A  I'endoscopie, on a iden ti­
f y  une erosion de la to ile  Marlex chez 
10 (6%) des patients de 27 a 60 mois 
apres (’operation. Deux autres patients 
qui avaient subi leur gastroplastie dans 
un autre centre presentaient aussi une 
erosion de la to ile  Marlex.
Les sym ptom es consistaient en douleur 
abdominale, vom issem ents ou gain pon- 
deral. La to ile  Marlex fu t souvent d iffic ile  
a resequer a cause de la masse inflam- 
matoire qui adherait a la rate ou au pan­
creas. Une reconstruction par derivation 
gastrique de Roux-en-Y ou par gastro­
plastie a sections verticales a permis de 
poursuivre la perte de poids alors que la 
gastro-gastrostom ie, bien que technique- 
ment plus facile , a resuite en un gain de 
poids. L 'auteur conclu t a la necessity 
d'une surveillance prolongee apres toute  
intervention de gastroplastie ou de deri­
vation gastrique, specialement quand des 
materiaux etrangers sont utilises pour 
soutenir le stoma.
Gastroplasty for morbid obesity is now 
a common operation, performed in many 
hospitals in North America. Late weight 
gain, often due to stomal dilatation, has 
been a problem after many types of gas­
troplasty and has led surgeons to support 
the stoma with materials such as poly­
propylene mesh (Marlex).
Over the last 5 years, Marlex erosion 
occurred in 12 of 162 patients who under­
went horizontal gastroplasty. The late 
appearance of this problem suggests that 
such cases will continue to be seen for a 
long time.
This report emphasizes the potential 
problems in the use of foreign materials 
around gastric stomas. Long-term follow­
up of patients who have had gas­
troplasties is recommended.
Patients and Methods
Between September 1979 and October 
1982, 162 consecutive gastroplasties were 
performed in 140 women and 22 men, 
using the technique illustrated in Fig. 1 
and described elsewhere.1 One double 
staple line was placed in 10 patients; in 
all the others, two double staple lines were 
placed 1 cm apart. Gastric pouch volume 
was less than 100 ml. Three staples were 
removed from the greater curve end of the 
long staple line and two from the same 
end o f the short staple line. The stapler 
was applied across the entire stomach. 
The resultant stoma was wrapped with a 
2 x  6-cm strip of Marlex mesh held in 
place with a 2-0 Prolene suture passed 
through the mesh 5 mm from each end 
and through the stomach just above and 
below the greater curve of the staple line. 
The suture was tied snugly but not tightly, 
effectively closing the blind space between 
the staple lines and securing the mesh to
FIG. X—Transverse gastroplasty as per­
formed between 1979 and 1982.
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the stomach. Omentum was placed over 
the mesh. A no. 18 nasogastric tube with 
extra holes above and below the staple 
line was passed through the opening and 
left in place for 48 hours.
Patients were at least 45 kg above ideal 
weight (mean 134 ± 20 kg) and between 
the ages of 17 and 58 years (mean 36 ± 
8 years). Treatable endocrine disorders 
were excluded by preoperative assess­
ment. Most of the 162 patients had poten­
tially reversible disorders related to 
obesity, such as diabetes, hypertension, 
osteoarthritis and infertility. All patients 
were assessed preoperatively by an inter­
nist and were required to stop smoking 
as a condition of acceptance for gas­
troplasty. Heparin (5000 units) was given 
subcutaneously to all patients before 
operation and cefazolin (1 g) was given 
intravenously once before and twice after 
operation. A fluid and pureed diet was 
advised for the first month postoper- 
atively and a soft diet for the second 
month. Patients were seen at monthly
intervals for the first 6 months and every 
3 months thereafter.
Revision gastroplasty was usually per­
formed by the techniques illustrated in 
Figs. 2 and 3. The GIA or TA-55 staplers 
were used for wedge excision of the 
eroded Marlex, and Roux-en-Y gastric 
bypass was performed by the technique 
of Pories and colleagues.2 For two of the 
later cases of staple-line disruption, ver­
tical banded gastroplasty3 was per­
formed after Marlex resection. No gas­
trostomy was carried out.
Results
Weight loss at 1 year was 33% of the 
initial weight. The low early failure rate 
rose progressively with time. There were 
no postoperative deaths. One leak 
occurred 5 days after gastroplasty and the 
patient recovered after drainage and 
removal of the Marlex. Five (3%) patients 
had stomal obstruction within 2 months
of operation. They required a gastrogas- 
trostomy. In these patients Marlex was 
not removed. Recovery was excellent but 
the patients gained weight.
The late problems with Marlex are 
documented in Table I. Ten of the 12 
patients were from our series while 2 had 
the initial operation elsewhere; 11 were 
women. Eight of the 12 patients had 
nausea and vomiting, 3 of these had com­
plete stomal obstruction, 6 had weight 
gain and 5 abdominal pain. An upper gas­
trointestinal series after a barium meal 
demonstrated stomal obstruction or 
enlargement but not Marlex erosion, 
endoscopy being the most useful proce­
dure. Eroded Marlex could be seen as a 
black mass adherent to the greater curve 
of the stomach. In three patients the 
stoma was completely obstructed. In 
eight, the staple line adjacent to the 
Marlex had disrupted leaving a large 
stoma, explaining the weight gain. Gas­
tric ulceration adjacent to the Marlex was 
unusual but was observed in one patient. 
In several cases, attempts were made to 
remove the Marlex with forceps and trac­
tion but it was too tightly adherent to the 
gastric wall.
Although stomal obstruction often 
occurred suddenly, other symptoms often 
persisted for months before the diagno­
sis of Marlex erosion followed by reoper­
ation. In several patients weight gain was 
the major sign and eroded Marlex was 
observed adjacent to a dilated stoma. 
Reoperation was carried out a mean of 
44 months after initial gastroplasty (range 
from 27 to 60 months). Since only 
patients with major weight gain or severe 
symptoms underwent endoscopy, it is 
possible that the frequency of this 
problem has been underestimated.
Preparation for reoperation was rou­
tine except in the three patients with 
stomal obstruction. They required 
nasogastric decompression and one 
patient with severe weight loss was given 
parenteral nutrition preoperatively. 
Stomal dilatation was attempted as previ­
ously described4 but was unsuccessful. 
At operation, the eroded Marlex was part 
of an inflammatory mass that was often 
difficult to resect. Although the Marlex 
had been covered by omentum in most 
cases, the mass was often adherent to 
pancreas or spleen. Careful dissection was 
necessary and bleeding was sometimes 
troublesome. In patient 6, splenectomy 
was necessary and discharge was delayed 
by hematoma formation in the left upper 
quadrant. Patient no. 10 underwent the 
original gastroplasty at another hospital. 
The Marlex did not appear to have been 
covered with omentum; it had retracted 
upward and was adherent to the 
diaphragm. The Marlex was left in place 
without apparent ill effect and the patient 
was well 4 months later. He requested the 
safest operation and underwent only a
HG. 2—Method of reconstruction in most patients after Marlex erosion.
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gastrogastrostomy. Stomach adjacent to 
the eroded Marlex was often thickened 
and inflamed. Care was necessary to get 
a secure staple line, and staple lines were 
usually oversewn. In two of the later cases 
the transverse staple line had disrupted 
almost completely allowing a vertical
banded gastroplasty to be performed. 
Care was taken to avoid constriction or 
obstruction o f the stomach at the point 
where transverse and vertical staple lines 
intersected. The appearance of the eroded 
Marlex is shown in Figs. 4 and 5. In 
patient 12, Marlex erosion was diagnosed
recently by endoscopy. Although the 
patient had been vomiting, the stoma was 
patent. So far, she has been willing to 
accept her symptoms because of the risks 
o f reoperation and the potential for 
weight gain.
Although the operations were often
Table I—Data for Patients With Marlex Erosion After Gastroplasty
Patient
no.
Age,
yr Sex
Preop
weight,
kg
Symptoms/
signs
Months 
to re- 
operation
Minimum
weight,
kg
Revision
weight,
kg Findings Treatment Complications
Present condition, 
weight (kgl/duration 
of follow-up (mo)
1 28 F 147 Vomiting,
stomal
obstruction
34
45
76 76
103
Marlex 
erosion, 
no stoma
Large
stoma
Marlex
resection,
gastrogas­
trostomy
Gastric
bypass
None
None
Weight gain, 103111 
Good, 85135
2 49 F 123 Vomiting,
stomal
obstruction
45 57 57 Marlex
erosion,
stomal
obstruction
Marlex
resection,
Roux-en-Y,
gastric
bypass
None Good, 82136
3 49 F 125 Left upper 
quadrant pain, 
weight gain
27 93 104.5 Marlex
erosion,
staple-line
disruption
Marlex
resection,
Roux-en-Y,
gastric
bypass
None Good, 86124
4 31 F 115 Abdominal
pain
46 76 76 Marlex
erosion,
gastric
ulceration,
staple-line
disruption
Marlex
resection
(refused
gastric
bypass)
Hematemesis, 
gastrectomy 
1 yr later 
(elsewhere)
Good, 61121
5 34 F 120 Vomiting, 
abdominal 
pain, weight 
gain
37 72 107 Marlex
erosion,
staple-line
disruption
Marlex
resection,
gastric
bypass
None Good, 80118
6 38 F 102.5 Vomiting 49 63 63 Marlex 
erosion, 
small stoma
Marlex
resection,
gastric
bypass
Left upper 
quadrant 
bleeding, 
splenectomy
Good, 69)14
7 33 F 119 Vomiting, 
abdominal 
pain, weight 
gain
35 81 103 Marlex
erosion,
staple-line
disruption
Marlex
resection,
gastric
bypass
None Good, 84113
8 52 F 115.5 Nausea, 
weight gain
60 88 107 Marlex
erosion,
staple-line
disruption
Marlex
resection,
gastric
bypass
None Good, 75112
9 37 F 111 Weight gain, 
abdominal 
pain, burping
47 77 93 Marlex
erosion,
staple-line
disruption
Marlex
resection,
vertical
banded
gastroplasty
None Abdominal pain, 
71)12
10 37 M 227 Vomiting,
stomal
obstruction
36 84 84 Marlex 
erosion, 
no stoma
Gastrogastro-
stomy
None Good, 9114
11 54 F 177 Heartburn, 
weight gain
58 89 145 Marlex
erosion,
staple-line
disruption
Marlex
resection,
vertical
banded
gastroplasty
None Good, 129.5)3
12 36 F 139 Vomiting 60 60 Marlex
erosion
None yet
Means 39.9 
± 9.1
135.0 
± 36.8
44.4 
± 10.5
76.3 
± 11.1
92.3 
± 25.1*
83.0 ± 17.71 
17.5 ± 11.3t
•Initial revision weight only for patient 1. 
tFinal weight and follow-up date only for patient 1.
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difficult, recovery was uncomplicated 
apart from the case of left upper quad­
rant hematoma after splenectomy. 
Weight loss was good with gastric bypass 
and satisfactory with vertical banded gas­
troplasty. Patient 1 with a gastrogas- 
trostomy had substantial weight gain 
which was controlled by gastric bypass. 
Patient 10 is doing well after gastrogas- 
trostomy although weight gain is 
expected.
Discussion
Erosion of the gastrointestinal tract by 
foreign materials ranging from sump 
drains to the Angelchik prosthesis5 has 
been described. It is not surprising that 
Marlex sutured to the stomach should 
sometimes erode, and our data suggest 
that erosion may not be recognized for 
many years after the initial operation. 
Symptoms and signs may vary widely 
from complete and surprisingly sudden 
stomal obstruction to abdominal pain and 
weight gain. Erosion of the Marlex at the 
end of a staple line appears to weaken it 
and may initiate the disruption. It is pos­
sible that erosion has occurred without 
symptoms in other patients who have not 
been subjected to endoscopy. The act of 
fixing the Marlex to the stomach with 
sutures penetrating the gastric wall may 
lead to erosion. In vertical banded gas­
troplasty the Marlex is passed through the 
circular window and fixed to itself. The
FIG. 4—Appearance of eroded Marlex after 
resection.
FIG. 5—Artist’s depiction of eroded Marlex.
lack of fixation to the stomach may 
reduce the likelihood of erosion.3
The reoperations proved difficult 
although there were no serious complica­
tions. The major problem was removal of 
the Marlex which was obscured by an 
inflammatory mass adherent to spleen or 
pancreas. The lack of symptoms after 
leaving the Marlex in place in one patient 
with stomal obstruction suggests that 
Marlex need not always be removed as 
long as obstruction is relieved. Even in 
those with a large stoma it may be possi­
ble to leave the Marlex below new staple 
lines, although staples may not hold well 
when placed in or near an inflammatory 
mass. Gastric bypass or vertical banded 
gastroplasty allow continued weight loss 
and can be performed safely, although 
gastrogastrostomy is a much easier oper­
ation for the high-risk patient and when 
technical difficulties occur. We did not 
use gastrostomy or jejunostomy but 
would recommend either procedure if the 
revision operation was particularly 
difficult.
Erosion of Marlex is not the only fac­
tor that can cause late obstruction and 
vomiting. Other possible causes include 
inflammatory adhesions to the Marlex 
mesh with torsion of the stomach, stomal 
ulceration, impaired emptying of the 
pouch due to pooling of contents in a 
large dependent pouch or poor motility 
and stricture formation under the mesh. 
Dilatation is the easiest way to manage 
stomal obstruction, but this may not be 
possible when the stoma is wrapped with 
Marlex.4
Summary and Conclusions
Marlex erosion has been detected as a 
late complication in 12 patients after 
transverse gastroplasty for morbid 
obesity. The symptoms included vomit­
ing, abdominal pain and weight gain. The 
problem was identified by endoscopy but 
not by upper gastrointestinal series. The 
patients were managed by Marlex resec­
tion and Roux-en-Y gastric bypass or ver­
tical banded gastroplasty, with good 
results. Horizontal gastroplasty is an 
unsatisfactory operation, and any patient 
with a gastric partition or gastric bypass 
requires long-term follow-up, especially 
when foreign materials are used to sup­
port the stoma.
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Giant Villous Adenoma of Second Portion of Duodenum:
Case Report
Villous adenomas of the duodenum are 
rare. In this report the authors describe 
the case of a 75-year-old woman who 
had an extensive adenoma involving the 
second portion of the duodenum and 
ampulla of Vater. The patient was suc­
cessfully managed by a pancreaticoduo­
denectomy. The authors describe the 
histopathology of the lesion and suggest 
guidelines for surgical consideration.
Les adenomes villeux du duodenum sont 
peu frequents. Ce rapport decrit une 
lesion tr6s etendue comprenant toute la 
deuxieme partie du duodenum ainsi que 
I'ampoule de Vater chez une femme de 
75 ans. L'investigation ayant mene au 
diagnostic, le traitement chirurgical et les 
conclusions histo-pathologiques sont 
presentes. Quelques pensees au sujet de 
la tenue a prendre envers ces lesions 
sont offertes.
Villous adenomas, although they are 
found throughout the gastrointestinal 
tract, are rare in the duodenum. Fewer 
than 75 such cases have been reported in 
the English medical literature since 
1893.1 These lesions have a propensity 
for malignant transformation, especially
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when they involve the duodenum and the 
ampulla of Vater simultaneously,1'2 and 
their detection is often incidental. The size 
of villous adenomas may or may not 
correlate with malignant change.3-5 
Jaundice,6 obstruction1 and bleeding7 
are the most frequent clinical features in 
patients with villous adenomas of duode­
num and ampulla of Vater.
The patient whose case is described in 
this paper was referred to the gastroin­
testinal service with vague abdominal dis­
tress and was found to have a large duo­
denal and ampullary villous adenoma, 
containing foci of both in-situ and inva­
sive adenocarcinoma.
Case Report
A 75-year-old white woman complained that 
she had had a vague gnawing sensation in the 
abdomen for more than 2 years. Physical 
examination and results of hematologic and 
biochemical studies failed to provide a diag­
nosis, but ultrasonography demonstrated a 
1.5-cm dilatation of the common bile duct. She 
underwent endoscopic retrograde cholan- 
giopancreaticography (ERCP), which demon­
strated an extensive lesion involving the entire 
mucosa of the second portion of the duode­
num and the ampulla of Vater, the orifice of 
which was obscured, preventing cannulation. 
Multiple biopsies were taken and later a bar­
ium study was performed to determine the 
extent of the lesion. Results o f liver function 
tests and amylase levels were normal. A com­
puterized tomogram demonstrated a thicken­
ing of the wall of the second part of the duode­
num and dilatation of the common bile duct. 
Selective celiac and mesenteric arteriograms 
showed a lesion of the second portion of the 
duodenum with increased vascular supply from 
branches of the gastroduodenal artery.
At laparotomy a diffuse soft mass was pal­
pated, filling the second portion of the duode­
num. There was no proximal dilatation. The 
gallbladder was thickened and distended, but 
the pancreas felt normal. The second portion 
of the duodenum and head of the pancreas 
were mobilized medially. Lymph nodes from 
the retroperitoneal space were examined by 
frozen section and no malignant cells were 
found. Once the common duct, portal vein and 
vena cava had been exposed, a pancreaticoduo­
denectomy was feasible and safely performed. 
The postoperative course was uncomplicated 
and the patient was discharged 11 days later.
Pathological Findings
The operative specimen showed a cir­
cumferential mucosal villous tumour, 8 
cm long, extending equidistant from the 
ampulla in the second portion of the 
duodenum. The wall of the ampulla of 
Vater was thickened, its orifice narrowed 
and the common duct distended to 1.5 cm 
in diameter (Figs. 1 and 2).
The tumour, a villous adenoma, was 
characterized by folds of hyperplastic sur­
face epithelium protruding into and nar­
rowing the duodenal lumen (Fig. 3). Mul­
tiple sections (32) revealed one focus of 
adenocarcinoma in situ, as demonstrated 
by a cribriform proliferation of the sur­
face epithelium with cellular atypism (Fig. 
3). In another zone of the adenoma was 
an area of submucosal invasive adenocar­
cinoma with marginal intramucosal car­
cinoma (Fig. 4).
The villous adenoma involved the
FIG. 1—Duodenal villous tumour involving 
entire circumference of mucosa of second por­
tion of duodenum and ampulla of Vater.
FIG. 2—Villous tumour located equidistant 
from papilla. Papilla and ampulla of Vater are 
thickened and common duct lumen (C) is 
slightly widened.
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ampulla of Vater (Fig. 5). No metastasis 
was noted in the 20 lymph nodes iden­
tified.
Discussion
Although villous adenomas have been 
observed in the first and third parts of the 
duodenum,3’6'8 the majority are located 
in the second portion,8-9 the number pos­
sibly being inflated by the inclusion of 
localized ampullar adenomas. Some 
observers believe that the incidence of 
malignant transformation in villous ade­
nomas of the duodenum and small intes­
tine parallels their increase in size. In a 
recent review, Perzin and Bridge5 
detailed a retrospective study of 51 
patients with adenomatous lesions of the
small bowel among 392 000 surgical 
pathological examinations. The benign 
adenomas were observed to have an aver­
age diameter of 2.65 cm versus 3.7 cm for 
adenomas incorporating a malignant 
component.
The type of surgical resection chosen 
for villous tumours of the duodenum 
depends on a number of factors: the 
demonstration of a focus of invasive 
adenocarcinoma within an existing 
predominantly villous adenoma, the loca­
tion and confines of the adenoma in the 
duodenum, the size and type (peduncu­
lated versus sessile), and on the simultane­
ous involvement of the duodenum and 
ampulla of Vater.
Although preoperative biopsies of the 
lesion in our case did not demonstrate
malignant change, the surgical procedure 
selected was a pancreaticoduodenectomy, 
a decision based on the size and extent of 
the tumour, its sessile rather than pedun­
culated nature, the involvement of the 
ampulla of Vater with radiologic evidence 
of luminal narrowing and, finally, the 
difficulty in demonstrating by frozen sec­
tion a possible site of invasive carcinoma 
in a lesion of this size.
Our case demonstrated the coexistence 
of focal, in situ, intramucosal and inva­
sive carcinoma, a finding that has fre­
quently been observed in large villous ade­
nomas of the duodenum.
In our patient the difficulty in making 
an early diagnosis related to a paucity of 
symptoms. The narrowing of the duo­
denal lumen did not lead to obstruction, 
the increased vascularity of the tumour 
did not cause bleeding and the ampullary 
involvement did not result in jaundice or 
cholangitis.
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FIG. 5—Villous adenoma also involving 
ampulla of Vater (hematoxylin and eosin, origi­
nal magnification x 69).
FIG. 3—Microscopic focus of adenocarcinoma within lesional alterations of villous ade­
noma. Surface epithelium forms cribriform proliferative pattern with evidence of intact basal 
layer (hematoxylin and eosin, original magnification x 67).
FIG. 4—Adjoining foci of villous adenoma, intramucosal adenocarcinoma and submucosal 
invasive carcinoma (hematoxylin and eosin, original magnification x 27).
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Radiocarpal Osteoarthritis Associated With 
Bilateral Bipartite Carpal Scaphoid Bones:
a Case Report
Bipartite carpal scaphoid is a rare con­
genital anomaly. The authors report on a 
56-year-old man who presented with 
bilateral wrist pain without a history of 
trauma. X-ray films demonstrated 
bilateral symmetric bipartition of the 
scaphoid into a large distal ossicle and a 
smaller proximal ossicle. There was 
degenerative change in the articulation 
between the distal ossicle and the radial 
styloid. The joint space between the 
proximal ossicle and the scaphoid fossa 
was preserved. The absence of peri- 
scaphoid degenerative change has been 
suggested as a criterion for the diagnosis 
of congenital bipartite scaphoid. This 
patient fulfilled all other criteria for the 
diagnosis and the authors suggest that 
degenerative change developed due to 
abnormally high contact force between 
the distal ossicle and the radial styloid. 
An identical pattern of degenerative 
change has been observed in long­
standing nonunion of the scaphoid, likely 
due to a similar mechanism. Radiocarpal 
osteoarthritis can develop in patients 
with congenital bipartition of the 
scaphoid and is similar to that observed 
in long-standing nonunion of the 
scaphoid.
Le scaphoi'de carpien bipartite est une 
anomalie conggnitale rare. Les auteurs 
commentent le cas d'un homme de 56
From the Division o f Orthopedic Surgery, 
Department o f Surgery, St. Michael’s 
Hospital and the University o f Toronto, 
Toronto, Ont.
*Assistant professor o f orthopedic surgery, 
University o f Toronto
fUpper extremity fellow, St. Michael’s 
Hospital and the University o f Toronto
XLecturer in orthopedic surgery, University 
o f Toronto
Accepted for publication Dec. 8, 1986
Reprint requests to: Dr. Robin R.
Richards, Ste. 800, 55 Queen St. E, 
Toronto, Ont. M5C 1R6
ans vus souffrant de douleurs bilaterales 
aux poignets alors qu'il n 'y avait pas 
d'ant6c6dent de traumatisme. Les radio- 
graphies ont d6montr6 une division en 
deux parties sym£trique bilaterale du 
scaphoi'de donnant lieu d un osselet 
proximal gros et a un osselet distal plus 
petit. On constatait une modification 
ddgdndrative de Tarticulation entre 
I'osselet distal et le styloide radial. 
L'espace articulaire entre I'osselet proxi­
mal et la fossette scaphoi'de n'dtait pas 
touchd. L'absence de changement ddgd- 
neratif periscaphoide a etd proposee 
comme critdre diagnostique du scaphoi'de 
carpien bipartite. Le malade qui nous 
occupe remplissait tous les autres enti­
res diagnostiques et les auteurs suggfe- 
rent que les changements ddgeneratifs 
observes dtaient dus a la force de con­
tact 6lev6e entre I'osselet distal et le 
styloide radial. Une Evolution identique 
des modifications ddgdndratives a deja 
et£ observde dans des cas d’absence 
d'ossification de longue date, probable- 
ment & cause de mdcanismes similaires. 
Une arthrose radio-carpienne peut appa- 
raftre chez les patients souffrant de sca­
phoi'de bipartite congenital et celle-ci 
ressemble a cede qu on observe quand il 
y a absence prolongde d'ossification du 
scaphoi'de.
Many authors113 have reported bipartite 
carpal scaphoid as a rare congenital 
anomaly. The condition may be isolated 
or it may occur in conjunction with other 
congenital anomalies of the hand or fore­
arm.14 The differentiation of scaphoid 
bipartition from nonunion of the 
scaphoid is important so that unnecessary 
immobilization and surgery can be 
avoided.13 Furthermore, accurate recog­
nition of the condition is important in 
compensation cases in order to avoid 
inappropriate judgements. The absence of 
periscaphoid degenerative change has 
been suggested as a criterion for the 
diagnosis of congenital bipartite 
scaphoid.10'1314 We recently treated a 
patient who had radiocarpal osteoarthri­
tis in association with bilateral bipartite 
carpal scaphoid bones.
Case Report
A 56-year-old right-handed male factory 
worker complained of bilateral wrist pain. The 
pain had developed spontaneously 2 years 
earlier. There was no history of trauma or other 
joint problem. On specific questioning, the 
patient denied any history of even trivial injury 
to or immobilization of either wrist joint. There 
was no family history of a joint problem in 
general or of the wrist in particular. The pain 
was aching in nature, exacerbated by activity 
and localized to the dorsal radial aspect of both 
wrists. The patient had been employed at a 
foundry for 15 years where he regularly had 
to push a heavy hopper down a track.
There was tenderness over the dorsal radial 
aspect of both wrists. The range of motion was 
45° dorsiflexion, 40° volar flexion, 15° ulnar 
deviation and 10° radial deviation bilaterally. 
Pronation and supination were full. Discom­
fort was felt at the extremes of motion. Maxi­
mum grip strength measured with a Jaymar 
dynanometer was at the third setting and meas­
ured 28 kg on the right and 18 kg on the left. 
Other findings on examination were within 
normal limits.
X-ray films demonstrated identical findings 
in both wrists (Fig. 1). The scaphoid consisted 
of two separate ossicles with smooth margins. 
The distal ossicle was larger than the proximal 
one. There was no evidence of cyst formation, 
increased density or osteoporosis. Lateral radi­
ographs (Fig. 2) showed no evidence of inter­
calary instability. The joint space between the 
radial styloid and the distal ossicle was narrow 
and the subchondral bone was sclerotic. The 
joint space between the proximal ossicle and 
the scaphoid fossa was preserved. A bone scan 
(Fig. 3) showed increased activity in the region 
of the scaphoid and lunate bilaterally consis­
tent with a degenerative process. Use of a non­
steroidal antinflammatory agent partially 
relieved the patient’s symptoms. Bilateral 
leather wrist gauntlets were prescribed to be 
worn at work. One year later the patient still 
complained of pain, but he had not changed 
his occupation.
Discussion
Bipartite carpal scaphoid is a rare con­
genital anomaly. Gruber15 found four 
bipartite scaphoid bones among 3007 dis-
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sections and Pfitzner1 found nine in 
1456. It has been proposed that scaphoid 
bipartition results from failure of the dis­
tal (radial) and proximal (ulnar) compo­
nents of the scaphoid to fuse. However, 
the very existence of scaphoid bipartition 
has been questioned.16 In view of the 
absence of a history of trauma and the 
symmetrical radiologic findings, we 
believe that our patient had congenital 
bilateral bipartition of the scaphoid. He 
fulfils Bunnell and Boyes’ criteria10 for
Fig. lb
FIG . 1—Posteroanterior views of (a) 
left and (b) right wrists of patient. Both 
scaphoids are bipartite. Distal ossicles are 
larger than proximal and edges are rounded. 
There is joint-space narrowing and subchon­
dral sclerosis between each distal ossicle and 
radial styloid. Joint space between proximal 
ossicle and scaphoid fossa is preserved.
the diagnosis, with the exception of 
degenerative change within the radiocar­
pal articulation. However, the presence 
of degenerative change in association with 
scaphoid bipartition is consistent with 
current knowledge of carpal biome­
chanics and the patient’s long history of 
manual labour. Others5,9,11’17 have stated 
that arthritic changes may occur with 
bipartite scaphoid.
Radiocarpal osteoarthritis is usually 
associated with chronic ligamentous insta­
bility,18 malunion of displaced intra- 
articular fractures19 and nonunion of the 
scaphoid.20,21 Watson and Brenner18 
noted that degenerative arthritis of the 
carpus develops when small cartilaginous 
contact surfaces are subjected to high 
shear loading. They also noted that the 
process of degenerative arthritis asso­
ciated with long-standing nonunion of the 
scaphoid begins between the radial styloid 
and the distal scaphoid fragment. In con­
trast, the proximal pole fragment in the 
scaphoid fossa is always spared. This 
radiographic pattern was observed in our 
patient, suggesting that degenerative 
arthritis associated with bipartition of the 
scaphoid develops by a mechanism simi­
lar to that observed in nonunion of the 
scaphoid. We suggest that scaphoid 
bipartition increased the contact force on 
the articulation between the radial styloid 
and the distal ossicle resulting in the 
development of degenerative arthritis. 
The radiographic pattern of arthritic 
change was identical to that observed in 
long-standing nonunion of the scaphoid.
Bone grafting of the scaphoid was not 
recommended in our patient because of 
the relatively advanced arthritic changes 
present when we saw him. It has been 
clearly shown that long-standing nonun­
ion of the scaphoid leads to progressive 
degenerative carpal arthritis.20,21 Since 
degenerative change also developed in our
Fig. 2a Fig. 2b
FIG. 2—Lateral views of (a) left and (b) right carpi do not show evidence of intercalary 
instability.
FIG. 3—Delayed technetium-99m bone scan demonstrating increased uptake affecting 
radioscaphoid articulation. Pattern of uptake is consistent with degenerative process.
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patient, bone grafting might be consi­
dered for patients with symptomatic 
scaphoid bipartition who present without 
degenerative changes. Although differen­
tiation of nonunion of the scaphoid from 
scaphoid bipartition is important diag­
nostically, it would appear, on the basis 
of this case report, that both conditions 
can result in identical patterns of carpal 
arthritis.
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St. Anthony’s Fire, Then and Now: 
a Case Report and Historical Review
A rare case of morbid vasospasm, 
together with striking angiographic find­
ings, is described secondary to the 
ingestion of methysergide by a 48-year- 
old woman. A brief review of the litera­
ture on similar cases is presented.
A discussion of the history of ergot 
includes its original discovery, the epi­
demics of gangrene that it has caused 
through the ages and its past and 
present role in the management of 
migraine headache. Despite the advent 
of calcium channel blockers and 0- 
adrenergic antagonists, ergot prepara­
tions continue to play a major role in 
migraine therapy, so that the danger of 
St. Anthony's fire persists.
On decrit un cas rare de vasospasme 
pathologique survenant de concert avec 
des modifications angiographiques mar­
quees chez une femme de 48 ans qui 
avait pris du methysergide. On fait une 
breve revue d'articles traitant de cas 
similaires.
Le commentaire sur I'histoire de I'ergot 
de seigle, porte sur sa decouverte origi- 
nale, les epidemies de gangrene dont il
From the Winnipeg Clinic, Winnipeg, Man.
Accepted fo r  publication Jan. 2, 1987
Reprint requests to: Dr. J.R. Tanner, Win­
nipeg Clinic, 425 St. Mary Ave., Winnipeg, 
Man. R3C 0N2
fut la cause a travers les ages et son 
role passe et actuel dans le traitement de 
la migraine. Malgre I'avenement des blo- 
queurs calciques et des antagonistes 0- 
adrenergiques, les preparations de deri­
ves de I'ergot continuent de jouer un role 
majeur dans la therapie de la migraine de 
sorte que, encore de nos jours, le danger 
du feu de Saint-Antoine persiste.
Epidemic gangrene has been recorded 
since the 9th century AD and a “ noxious 
pustule in the ear of grain” (i.e., ergoty 
rye) was described on an Assyrian tablet 
in 600 BC.1 Written records of epidemic 
gangrene appeared in the 10th and 11th 
centuries AD. The Greeks and Romans 
did not eat rye; it was the conquering Teu­
tons who popularized its consumption, 
and thus were responsible for the spread 
of ergotism throughout Western Europe. 
The connection with St. Anthony of 
Egypt (251-356 AD), “ patriarch of 
monks and healer of both men and 
animals” , developed some time later, 
probably with the translation of his relics 
and the establishment of a shrine at La 
Motte in the southeast of France around 
1100 AD.2 Victims of ergotism likely 
obtained relief at the shrine because of a 
change of diet. On modern French maps, 
there are two spots marked “ La M otte” 
in the Dauphinee region. Synonyms for 
the disease, such as “ mal des ardents” , 
“ ignis sacer” and “ feu sacre” , reflect this
French influence. Houses of the Order of 
St. Anthony, devoted to the care of the 
victims of epidemic gangrene, apparently 
had flame-red walls. Alternatively, the 
“ fiery” pain of peripheral vasospasm, 
which prompted sufferers to expose their 
limbs to the open air, and the subsequent 
development and bloodless separation of 
charcoal-like lesions on the extremities 
(i.e., dry gangrene) may also be respon­
sible for the name of the disease, St. 
Anthony’s fire.
In 1676, it was proven that epidemic 
gangrene was caused by the sclerotium of 
the fungus Claviceps purpurea (Fig. 1), 
which grows on rye, particularly in wet 
weather, and is now subject to strict pub­
lic health regulations. Despite these, the 
problem has persisted into the 20th 
century.
Isolated instances of morbid vaso­
spasm, on the other hand, may occur 
through the use of ergot preparations for 
treating migraine. They tend to follow 
one of three patterns:3
• Long-term ingestion with gradual 
increase to toxic levels.
• Acute excessive ingestion.
• Acute idiosyncrasy to a small dose.
The first pattern is the most common,
and ergotamine usually is the causative 
agent.
Methysergide, a semisynthetic drug 
that is structurally related to the natural 
ergot compound, has a relatively weak
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vasoconstrictive action and is less often 
implicated in vasospasm than ergotamine. 
Methysergide has some pharmacologic 
antiserotonin activity, which may account 
for its clinical prophylactic value against 
migraine. Moreover, vasospasm with 
methysergide has been overshadowed in 
importance by a graver complication — 
retroperitoneal fibrosis.4 The following 
report describes a case of methysergide- 
induced vasospasm, documented both by 
angiography and by noninvasive studies, 
which suggest that significant ergot-like 
activity is present in methysergide, in spite 
of synthetic alteration.
Case Report
A 48-year-old woman was referred with a 
1-month history of rest pain in the feet. One 
year before, pentoxifylline (Trental) had been 
prescribed for claudication, primarily in the 
left calf. For 2 years she had been taking 
methysergide as prophylaxis for migraine 
headache. Dosage ranged up to 16 mg/d, but 
she had two 3-month periods of abstinence on 
the advice of her physician. At the time of 
referral, however, she was taking close to her 
maximum dose. She had stopped smoking 5 
years before. Her history included hysterec­
tomy for fibroids in 1966 and an allergy to 
codeine.
The patient was a tired, anxious woman of 
medium build, who was having much difficulty 
walking. Carotid pulses were normal without 
bruits, femoral pulses were weak with bruits 
and there were no distal pulses in the lower 
limbs. The feet were pale, cold and slightly 
mottled, with elevation pallor and dependent 
rubor; ankle pressure was 30 mm Hg on the 
right, with no recordable Doppler signal on the 
left. Angiography (Fig. 2) demonstrated severe 
symmetrical narrowing in the superficial 
femoral and popliteal arteries, and multiple 
areas o f occlusion in the distal leg vessels.
Methysergide was discontinued. Within 48 
hours the feet were warm and pink, with 
bounding pulses and ankle pressure of 150 mm 
Hg (brachial pressure 145/80 mm Hg). Angiog­
raphy was not repeated. On follow-up 2 
months later, ankle pressures were normal, 
although there was some numbness in the dis­
tal part of the right foot. She was having inter­
mittent nocturnal headaches, satisfactorily con­
trolled with ice packs.
Discussion
Because, historically, epidemic gan­
grene involved such a large population, 
the epidemiology of ergotism was difficult 
to define. It became apparent that poor 
farmers were particularly vulnerable and 
that wet weather could be followed by an 
outbreak. The fact that ergot loses its 
potency with storage probably also con­
fused the picture. Once the connection 
was established between St. Anthony’s 
fire and ergoty rye, preventive public 
health measures were introduced. They 
have not met with unmitigated success: 
between 1889 and 1890, Kortneff 
observed over 2000 cases of ergot poison­
ing.5 A spectacular outbreak with con­
vulsions, psychoses and death occurred in 
rural France in the early 1950s when a 
baker used contaminated illegal rye to cir­
cumvent taxation, and, as recently as 
1979, an epidemic was reported in Ethio­
pia.6 Agriculture Canada7 grades rye on 
the basis of ergot content, from no. 1 
(0.05%) to no. 3 (0.33%). Higher con­
tents than this are labelled ergoty rye; this 
usually involves less than 1 % of rye in a 
normal year but up to 36% in a wet year. 
Other cereal and feed grains that are less 
susceptible to ergot infection than rye 
have similar limitations imposed by the 
Canadian Grain Commission.
The effect of ergot in pregnancy has 
been known for at least 2000 years. A 
quote from the sacred book of the Par- 
sees, written between 400 BC and 300 BC, 
translates as follows; “ Among the evil 
things created by Angro Maynes are nox­
ious grasses that cause pregnant women 
to drop the womb and die in childbed” .1 
The M oorish physician Avicenna 
(980-1037) apparently knew of ergot’s 
potential, although there is no direct men­
tion of it in his writings. In 1582, 
Lonicerus wrote of the painful effect of 
ergot on the uterus. In the early 1800s, 
Stearns, Akerly and Spalding described 
the use of ergot in parturition, and by 
1822 an enquiry into it? misuse resulting 
in stillbirth was conducted for the Medi­
cal Society of New York.5
In 1884, Dr. William H. Thomson of 
New York City described the use of fluid 
extract of ergot for frequent periodic 
headache.8 The dosage was 2 to 4 mg 
orally or rectally every hour for 3 hours 
or until effective, accompanied by quinine 
for nausea. According to Dr. Thomson,
FIG. 1—Three ears of rye on left of this 
early 19th-century drawing contain ergots, 
sclerotia of fungus Claviceps purpurea. First 
two ears contain great number of ergots, more 
detailed examples of which are shown in 
detached ergots. Third ear of stout rye contains 
only one large ergot. Ear at right, which also 
bears one ergot, is wheat, grain rarely contami­
nated by fungus. (From Prescott, O Jr: A Dis­
sertation on the Natural History and Medici­
nal E ffects o f  the Secale Cornutam, or Ergot, 
Cummings and Hilliard, Boston, 1813).
FIG. 2—Four films of translumbar aorto- 
gram demonstrate typical picture of ergot- 
induced vasospasm: symmetrical and diffuse 
narrowing, principally in superficial femoral, 
popliteal and limb arteries. Collateral vessels 
are frequently larger than main channels. Aorta 
and iliac arteries appear normal.
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it “ rarely fails” . Twentieth-century 
reports of ergotamine use in migraine 
appeared first in the French8 and 
German5 literature, but the definitive 
proposal for the mechanism of ergot’s 
beneficial effect was by Graham and 
Wolff9 in 1938: the long-acting vasocon­
striction produced by ergot prevents the 
vasodilatation of arteries of the scalp, 
which gives rise to the pain of migraine. 
H arrison’s Principles o f  Internal 
Medicine10 cites ergotamine as the prin­
ciple therapeutic agent for aborting an 
acute attack of migraine, and methyser- 
gide as the most useful drug in the 
prophylaxis of migraine. With such a tes­
timonial from one of the most popular 
and widely read medical textbooks in the 
world, one might infer extensive prescrip­
tion of ergot compounds.
Some of the most important investiga­
tions related to the actions and chemis­
try of the ergot alkaloids were carried out 
by Dale" and coworkers in the early 
1900s. Using the receptor protection tech­
nique, Innes12 demonstrated that ergota­
mine acts both as an a-adrenergic 
antagonist and as a partial agonist, in a 
variety of in-vitro animal smooth-muscle
FIG. 3—Structural formulae of ergotamine 
(left) and methysergide (right).
Table I—Iatrogenic Ergotism: 
Sites of Involvement15
Carotid vessels 
Retina 
Upper limb 
Coronary vessels 
Mesentery 
Kidney 
Lower limb
preparations. The a-adrenergic blocking 
effect was confirmed by Mikkelsen and 
associates13 who showed that ergotamine 
could block the effect of norepinephrine 
in human in-vitro mesenteric arteries har­
vested at cancer surgery. The partial 
agonist activity has been corroborated 
both in migraine patients and in normal 
volunteers,14 in whom there is a reprodu­
cible fall in ankle-to-brachial pressure 
ratio with intravenous administration of 
0.5 mg of ergotamine.
Goodman and Gilman1 have described 
ergot as a “ veritable treasure house of 
pharmacology” . As well as ergot, the 
sclerotium of Claviceps purpurea contains 
amines such as histamine, tyramine and 
acetylcholine; also quarternary ammonia 
bases, amino acids, carbohydrates, 
sterols, glycerides and inorganic com­
pounds. Ergot itself can be classified as 
follows: amino-acid alkaloids, amine 
alkaloids, and dihydrogenated com­
pounds of the above.
Ergotamine is an amino-acid alkaloid, 
whereas methysergide, which is more 
easily absorbed through the gastrointes­
tinal tract, is an amine alkaloid (Fig. 3). 
Dihydrogenation of ergotamine reduces 
its vasoconstrictive effect. All these com­
pounds are structurally related to lyser­
gic acid diethylamide (LSD).
The problem of iatrogenic ergotism, 
particularly in migraine sufferers, was 
first brought to the attention of the med­
ical community by Labbe and colleagues 
in 1929.5 Since then, over 100 case 
reports have appeared describing morbid 
vasospasm with the therapeutic use and 
abuse of ergot compounds.15 Table I 
outlines documented sites of involvement. 
A partial review of these case reports sug­
gests that the majority of patients recover 
completely. A few suffer minor tissue 
loss, the rare patient requires a major 
amputation, and when death ensues there 
is a complicating factor such as recent
Table II--Treatments for Iatrogenic Ergotism15
Vasodilatation (pharmacologic) Anticoagulation
a-adrenergic block Heparin
Phenoxybenzamine Streptokinase
Phentolamine
Tolazoline
Prazosin
Reserpine
^-adrenergic block
Propranolol
Dextran (?)
Direct action Volume expansion
Papaverine Dextran
Nitroglycerin Mannitol
Nitroprusside Crystalloid
Calcium channel block Vasodilatation (mechanical)
Nifedipine
Ganglionic block 
Epidural bupivacaine 
Cervical ganglionectomy 
Lumbar sympathectomy
Fogarty
Griintzig
major surgery. In a few cases, such as the 
one we described, the only treatment was 
withdrawal of the medication, but most 
physicians have felt obliged to institute at 
least some additional care (Table II). 
Since all these reports are anecdotal, the 
only control has been in patients in whom 
a constant intravenous infusion of 
nitroglycerin16 or nitroprusside17 has 
been interrupted with return of symptoms 
and signs. Otherwise, it is impossible to 
determine whether the relief of vasospasm 
is spontaneous or treatment-induced.
Migraine headache is an extremely 
common phenomenon, and its manage­
ment can be time-consuming, frustrating 
and moderately dangerous, as illustrated 
by this review. More recently there has 
been a trend to the use of /3-blocking 
agents18 and calcium channel blockers19 
in migraine therapy, although the sale of 
ergot preparations seems to be continu­
ing relatively unabated (Sandoz Ltd, 
Montreal: Personal communication, 
1986). Thus, the potential for St. 
Anthony’s fire is still with us, and likely 
will be for the forseeable future. It is 
important that the practising physician be 
aware of morbid vasospasm from ergot 
drugs, so that disasters can be averted.
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Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy 
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(See Dosage and Administration)
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600 mg 100 mL 20 min. *•
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MARLEX MESH IMPROVES THE RESULTS OF INCISIONAL 
HERNIA REPAIRS. P. Makarewicz, M. Al-Shehri, J. Freeman. Divi­
sion of General Surgery, Ottawa General Hospital, University of Ottawa, 
Ottawa, Ont.
One percent of all abdominal surgery is complicated by a postopera­
tive hernia and 8% of such repairs fail. Significant defects in muscle 
and fascia or infection cause failure after simple closure. Reinforce­
ment with prosthetic materials may reduce recurrence but increases risks. 
We established a hernia follow-up clinic to study recurrence and com­
plications in 116 patients with massive primary or recurrent hernias 
repaired with (60) or without (56) Marlex. There were 68 women and 
48 men aged 54 ± 14. The hernia was incisional in 91/116 (78%); 39 
of these 91 (34%) were recurrent. There were 58 upper, 41 lower abdomi­
nal hernias, 8 inguinal, 12 umbilical and 5 others. Thirty-six hernias 
were massive (greater than 8 x 8  cm). Fifty-nine patients were obese, 
25 had diabetes and 65 smoked. Postoperative drains were placed in 
64/116; local antibiotics were used in 43/116 and systemic antibiotics 
in 60/116. Patients were followed for 18 -  40 months. In the Marlex 
group, 10/60 (17%) complained of pain without objective findings while 
at least half of these were proven secondary to Prolene sutures subse­
quently removed. Two patients developed wound sinus necessitating 
removal of Marlex. Recurrent hernia occurred in 9/60 (15%). In those 
repaired without Marlex, 9/56 (16%) complained of pain and recur­
rence occurred in 22/56 (39%). There was a strong correlation between 
recurrence versus obesity, diabetes or previous surgery.
Marlex mesh repair of abdominal hernias is advisable for all large 
and/or recurrent hernias or in the presence of obesity. The recurrence 
rate with Marlex is lower compared to primary repair (15 versus 39%). 
Incisional pain is identical in patients with and without Marlex and may 
be secondary to Prolene knot granulomas.
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PRELIMINARY RESULTS OF COLOANAL ANASTOMOSIS. Denis 
Bernard, Daniel Tasse, Ramses Wassef, Stephen Morgan. Department 
of Surgery, University of Montreal, Division of Gastrointestinal Sur­
gery, Hopital St-Luc, Montreal, PQ
Coloanal anastomosis is the ultimate procedure to preserve the patients’ 
sphincters and avoid a permanent colostomy. Carcinomas (CA) of the 
midrectum and sometimes of the lower third do not require excision 
of the pelvic floor and sphincters for cure. Coloanal anastomosis was 
achieved in 29 patients after rectal excision for CA in 23, for adenomas 
in 4 and for 2 other conditions. Dukes’ staging of the CA were A: seven, 
B: six, C: nine and resection was palliative in one. The mean distance 
from the anus to the CA was 6.4 cm. A temporary defunctioning 
colostomy was established in all. There were no deaths and 52% (n: 
15) had postoperative complications (major: six, minor: nine). Mean 
follow-up is now 29 months (9-61 months). Only one had pelvic recur­
rence; one is alive with metastatic disease and one died of an unknown 
cause at 30 months with no evidence of recurrent disease. All others 
are alive and well. Colostomy was closed in all but two. Stenosis was 
the most common long-term problem: it occurred in 13 and required 
more than one dilatation in 8. Six months after the procedure the mean 
number of daily bowel movements is 4.3; 95% are continent to solid 
stools and 16% are incontinent to liquid stools or gas, but only one 
would prefer re-establishment of a colostomy. In selected cases with 
little or no extramural spread, we feel a resection and coloanal anasto­
mosis is a good alternative with acceptable functional results and a low 
rate of recurrent tumour comparable to complete rectal excision.
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PREVENTION OF INTRA-ABDOMINAL ABSCESSES WITH  
FIBRINOLYTIC AGENTS. O.D. Rotstein, J. Quinto, J. Kao. Depart­
ment of Surgery, University o f Toronto, Toronto, Ont.
Fibrin deposition during peritonitis predisposes to subsequent abscess 
formation by protecting bacteria from host defences. To determine 
whether the use of intraperitoneal (ip) fibrinolytic agents could prevent 
ip abscess formation, Wistar rats were implanted intraperitoneally with 
fibrin clots (100 mg/dl) containing either B. fragilis (BF, 2 x  109/clot) 
alone or E. coli (EC, 2 x  106) plus BF (2 x 108) and beginning at sur­
gery, animals received daily 5 ml ip injections of either phosphate- 
buffered saline (PBS), trypsin (TRYP 1.0 mg/ml or 0.5 mg/ml) or 
recombinant tissue plasminogen activator (t-PA, 0.25 mg/ml, Genen- 
tech Co). Abscess formation and bacterial numbers were assessed at 
5 days.
B. fragilis0 E. coli + B. fragilis
Treatment Abscess formation Mortality Abscesses
PBS 87% (n = 15) 8.3% (n = 12) 90%
TRYP (1 mg/ml) 20% b (n = 20) 25% (n = 12) l l % b
TRYP (0.5 mg/ml) 60% (n = 5) 16% (n = 12) 18%b
t-PA 0% (n = 15) ND ND
a: No mortalities occurred, b: p 0.01 versus PBS control, ND: not done.
The viable bacteria (log CFU/abscess) in BF abscesses were 7.7 ±  0.4 
(n = 6) in the PBS group versus 4.8 ± 2.5 (n = 4) in the TRYP I 
mg/ml group. In-vitro studies demonstrated no direct microbicidal 
activity of TRYP or t-PA on BF or EC, suggesting that enhanced bac­
terial clearance was responsible for reduced abscesses and bacterial num­
bers. Controlled fibrinolysis at operation may be a useful adjunct to 
surgery and antibiotics in preventing postoperative ip abscess formation.
R194
LOBULAR CARCINOMA OF THE BREAST. W.J. Orrom, B.M. 
Mielke, O.G. Thurston. Department of Surgery and Department of 
Pathology, University o f Alberta Hospital, Edmonton, Alta.
Lobular carcinoma of breast has distinct biological differences from 
other breast cancers affecting treatment, follow-up and prognosis. This 
study is a review of our experience with 22 cases of lobular carcinoma 
in situ and 136 cases of invasive lobular carcinoma seen at the Univer­
sity of Alberta Hospital, 1955 -  1985.
Lobular carcinoma totalled 10% of all breast cancers in this period. 
When compared to patients with invasive duct carcinoma, those patients 
with invasive lobular carcinoma were younger — 55 versus 58 years 
(p < 0.01) and had a higher incidence of bilaterality — 20% versus 
5% (p < 0.001). Actuarial survival was better for invasive lobular than 
invasive duct cancers (p <  0.001). The mean age of patients with lobu­
lar carcinoma in situ was 7 years younger than patients with invasive 
lobular carcinoma (p < 0.01) whereas patients with duct carcinoma 
in situ were similar in age to patients with invasive duct carcinoma. The 
surgical treatment of invasive lobular carcinoma was evenly distributed 
between radical, modified radical and simple mastectomy. There were 
no survival differences between the three groups.
The results of this study indicate a biological behaviour to lobular 
carcinoma that is significantly different than the more common duct 
carcinoma. The younger age, improved prognosis and higher frequency
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of bilaterality in patients with lobular carcinoma have important impli­
cations for treatment and follow-up. The 7-year lag between the in- 
situ and invasive forms of lobular cancer is strong evidence that this 
is a precursor lesion rather than a high-risk marker of invasive cancer. 
This is in contrast to duct carcinoma, where the in-situ and invasive 
forms appear virtually simultaneously.
R195
ENHANCEMENT OF CELLULAR KINETICS IN THE PROXIMAL 
SMALL INTESTINE OF THE RAT FOLLOWING RUMENEC- 
TOMY. R. Odze, B. Milmaker, P .H . Gordon. Lady Davis Research 
Institute, Department of Surgery, Sir Mortimer B. Davis-Jewish General 
Hospital, McGill University, Montreal, PQ
To determine the effect of excision of the rat rumen (forestomach) on 
the cellular kinetics of the proximal small intestine, young male 
Sprague-Dawley rats were randomly assigned to receive either control 
gastrotomy (Group A) or rumenectomy (Group B). After preliminary 
results indicated a proliferative response in Group B, the following two 
surgical groups were added to differentiate if this effect is dependent 
on luminal or extraluminal factors: pyloric ligation and gas­
trojejunostomy (Group C) and rumenectomy, pyloric ligation and gas­
trojejunostomy (Group D). Fourteen days following surgery each animal 
received an intraperitoneal injection of 3H-thymidine and was 
sacrificed 1 hour later. Radioautographic slides were prepared from 
sections o f duodenum and jejunum for determination of crypt column 
cell counts (CCC), villous column cell counts (VCC), crypt labelling 
index (Li) and proliferative index (Pi). In the duodenum, the results 
showed a CCC of 31.5 ± 0.3 (SEM) in Group A and 40.0 ± 0.4 in 
Group B (p < 0.01). Bypassed duodenum from Groups C (32.5 ± 0.3) 
and D (35.9 ± 0.4) showed no significant change in this parameter. 
In the efferent jejunum, the CCC showed no difference between Group 
A (30.9 ±  0.3) and B (33.1 ± 0.2) but significant increases were observed 
in both Groups C (40.3 ± 0.5) and D (46.9 ± 0.4) when compared 
to control (p < 0.01) and to each other (p <  0.05). The Li, Pi and 
VCC showed little variation between any surgical group. These results 
indicate that the intestinal mucosa in direct proximity to the stomach 
exhibits a luminal dependent crypt cell hyperplastic response follow­
ing excision of the rumen.
R196
RECONSTRUCTION OF THE TOTAL THORACIC ESOPHAGUS 
WITH REVASCULARIZED JEJUNUM: AN EXPERIMENTAL 
MODEL. J. Hobson, G. Pliagas, G. DeRose, R. Finley. Division of 
General Surgery and Division of Vascular Surgery, Victoria Hospital, 
University o f  Western Ontario, London, Ont.
Historically, total esophageal reconstruction with pedicled jejunum has 
proved to be unreliable. Ischemia of the proximal graft leads to anasto­
motic leakage and increased morbidity and mortality. Augmentation 
of the blood supply to the proximal jejunum should prevent these com­
plications.
A canine model was used to assess this technique of total esophageal 
reconstruction with autologous revascularized jejunum. Pedicled, 
isoperistaltic jejunum is passed retrosternally to the neck and 
anastomosed to the cervical esophagus and distally to the stomach. In 
the experimental groups (n = 15) the proximal jejunal arcade is revas­
cularized by anastomosing the artery to the side of the common carotid 
artery and vein to side of external jugular vein. The control group (n 
= 6) had no revascularization.
Successful revascularization occurred in 14/15 experimental animals. 
The esophagojejunal anastomosis leaked in 5/14 experimental (no stric­
tures) and 6/6 control animals (p < 0.01). None of the control animals 
were able to sustain an oral diet.
Using this technique, 10 other dogs (n = 10) underwent total thoracic 
esophageal reconstruction with revascularized jejunum. Regional mesen­
teric blood flow in the jejunum was measured using the radioactive 
microsphere technique (1-125 and Cr-51). Blood flow to the jejunum 
at the esophagojejunal anastomosis without revascularization measured 
0.011 ± 0.009 ml/g/min. With revascularization jejunal blood flow 
at the anastomosis measured 0.415 ± 0.129 m l/g/m in (p < 0.001).
Revascularization of the proximal jejunum in the neck does result 
in a statistically significant increase in blood flow to the jejunum at 
the esophagojejunal anastomosis and decreases the incidence of 
esophagojejunal anastomotic leakage in the neck.
R197
THE VALUE OF CURATIVE RESECTION FOR CARCINOMA OF 
THE ESOPHAGUS. F. Rubens, F. Shamji, S. Brown, H. Sachs. Divi­
sion of Cardiothoracic Surgery, University of Ottawa, Ottawa Civic 
Hospital, Ottawa, Ont.
We managed 71 patients with esophageal cancer between December 1983 
and February 1987. Thirty-two had squamous cell and 39 had adenocar­
cinoma of which 13 arose in Barrett’s esophagus. Using predefined 
criteria, 45 patients were considered operable. Thirty-seven of these were 
deemed resectable; 29 of these were curative and 8 were palliative.
Twenty-one of the 29 patients who had curative resection are alive 
1 to 36 months postoperatively (mean 20 months) whereas 6 of the 8 
patients who had palliative resection died 1 to 13 months (mean 4.8 
months) after surgery. Four of 45 operated patients died (8.9%); 3 of 
these were amongst the palliative resection group. However, only 1/29 
patients (3%) resected for cure died. The eight patients in the operable 
but unresectable group lived 2 to 24 months (mean 9). Eight of 26 inoper­
able patients are still alive 2 to 27 months (mean 11.5) after diagnosis.
Of the 32 patients with squamous cell cancer, 9 were inoperable or 
unresectable and were treated with 5-FU and radiation. Four of nine 
of these patients have survived longer than 13 months.
Conclusions: Curative resection of carcinoma of the esophagus results 
in mean 20-month survivorship which is superior to palliative or non- 
resectional therapy and has an operative mortality of 1/29 (3%). Con­
versely, palliative resection for carcinoma of the esophagus carries a 
high operative mortality with a low survival. Combination chemoradi- 
ation therapy provides reasonable palliation for patients with inopera­
ble squamous cell lesions.
R198
PALLIATIVE ND:YAG LASER THERAPY FOR OBSTRUCTING 
ESOPHAGEAL CANCER. K. Woolfson, C.D. Mercer. Hotel Dieu 
Hospilal, Kingston, Ont.
Nine patients with unresectable carcinoma of the esophagus (one 
hypopharyngeal, one Barrett’s adenocarcinoma, two squamous cell 
midesophageal and five adenocarcinoma of the gastroesophageal junc­
tion), ranging in age from 41 to 87 years (mean 68 years) underwent 
palliative vaporization of the tumour with the Nd:YAG Laser. Four­
teen treatments were required in these patients. A maximum of 7870 
joules (J) of energy was used in a single session (mean 4400 J). Pulse 
settings were energy 40 watts, pulse duration 0.5 seconds. Operative 
time ranged from 5 to 48 minutes. No intraoperative complications 
occurred. Postoperative morbidity occurred in two patients having previ­
ously undergone radiotherapy. (Procedure-related morbidity rate was 
14%.) One developed transient laryngeal edema requiring intubation 
and one developed a tracheoesophageal fistula controlled with an internal 
esophageal stent. Mean follow-up is 3 months (range 2 - 6  months). 
Significant improvement of dysphagia occurred in seven patients and 
one patient with a bleeding tumour was controlled with the laser. Two 
patients had minimal transient relief of dysphagia. Two patients died 
of metastatic disease during follow-up. The Nd:YAG Laser is an effec­
tive alternative to internal esophageal stenting and palliative resection 
or bypass in patients with obstructing esophageal malignancy.
R199
NORMOGLYCEMIA AFTER IMPLANTATION OF PURIFIED 
ISLETS OF LANGERHANS IN DOGS. G.L. Warnock, R.V. Rajotte. 
Department of Surgery and Department of Medicine, University of 
Alberta, Edmonton, Alta.
To promote clinical transplantation, effective methods for the isola­
tion of purified islets will be needed. Canine pancreata removed at total 
pancreatectomy were cannulated via the ducts and perfused with col- 
lagenase solution (1900 U/ml) at 37°C until mucoid. The gland was 
dissociated into a tissue suspension by teasing and trituration. Islets 
were separated on ficoll with gradient densities of 1.045, 1.075 and 1.085, 
which reduced the mean packed cell volume from 37 ± 2 to 1.1 ± 0.4 
ml (±  SEM, n = 15). Counts of islets identified at microscopy revealed 
a recovery of 103.6 ± 12 X 103 per pancreas. Mean islet diameter was 
128 ± 7 pm. Histology showed highly purified islets. A dose of > 3200 
purified islets/kg body weight was autoimplanted into splenic veins 
(six dogs) or embolized via the portal vein to the liver (five dogs). Por­
tal venous pressure was unchanged in the former and rose transiently
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by 3.4 ± 1.3 cm H20  in the latter group. Mean fasting plasma glu­
cose (PG, mg/dl) was 122 ± 4 at 1 week, 91 ± 6 at 1 month and 86 
± 4 at 6 months. During glucose tolerance tests, K values were nondi­
abetic (>  1.0) at 1.9 ± 0.2 (1 month) and 2.0 ± 0.3 (6 months). Six 
months after splenic implantation, basal splenic vein insulin was 20 ± 
4 mU/L versus 4 ± 1 in the artery; PG rose to > 350 after splenec­
tomy and immunohistology showed intrasplenic islets. In four other 
dogs, < 3200 islets/kg were refluxed into the spleen; PG rose to 235 
± 16 at 1 week. In three apancreatic controls, PG was 337 + 9. These 
data define the critical number of purified dog islets of constant size 
which is necessary to induce prolonged normoglycemia. Sufficient pure 
islets can be collected from a single dog pancreas to reverse diabetes 
after implantation into the liver or spleen.
R200
THE OPERATING ROOM: AN UNEXPLOITED UNDERGRADU­
ATE TEACHING RESOURCE. J.L. Provan, R. Cohen. Department 
of Surgery, University of Toronto, Toronto, Ont.
During the 1985-86 clerkship at the University of Toronto, 236 students 
completed the end-of-rotation Clerkship Assessment Form (CAF). The 
CAF contains 27 closed-ended (1 to 5 scale) items that assess the qual­
ity of the learning experience and the exposure to specific activities on 
all surgical clerkship rotations. Analysis of these data (correlation coeffi­
cients and stepwise multiple regression) revealed that six of the speci­
fied activities correlated well to moderately well with perceived success 
of the student’s learning experience, i.e., quality of time spent in the 
OR (r = 0.68), amount of scut work the clerk had to do (r = 0.53), 
frequency of review of histories and physical examinations (r = 0.46), 
opportunity to follow patients admitted previously to the OR (r = 0.45), 
amount of responsibility for patient care (r = 0.41) and the opportu­
nity to follow patients postoperatively (r = 0.33). Stepwise regression 
revealed that one activity, i.e., quality of time spent in the OR explained 
most of the variance on the dependent variable (perceived success of 
learning experience) for all surgical subspecialties: general surgery 45% 
(total variance explained 56%), neurosurgery 41% (total explained 61%), 
orthopedics 28% (total explained 51 %), thoracic 43% (total explained 
50%), urology 51% (total explained 65%), plastic surgery 53% (total 
explained 60%), and vascular surgery 44% (total explained 56%) at 
p < 0.001 (for all). The results of this study indicate that the quality 
of teaching students receive in the OR is important in determining the 
success of a surgical clerkship as a learning experience. Clerkship coor­
dinators need to give more attention to developing the OR as a struc­
tured undergraduate learning experience.
R201
COMPLICATIONS OF HICKMAN-BROVIAC CATHETERS. M.J. 
Monaghan, R.F. Pace. Department of Surgery, Queen’s University, 
Kingston General Hospital, Kingston, Ont.
The use of indwelling Silastic central venous catheters (Hickman- 
Broviac) has simplified many problems of long-term venous access. A 
review of 103 catheters in 79 patients (12 192 patient days) has disclosed 
a significant incidence of catheter-related morbidity, with occasional 
mortality. The indications for catheter use were chemotherapy adminis­
tration in 48, total parenteral nutrition in 19 and fluid or antibiotic 
administration in 12 patients. Mean catheter use in successfully catheter- 
ized patients was 120.7 days (range 1 to 827 days) and 11 patients 
required more than one catheter to complete therapy. Although 69% 
(71/103) of catheters functioned satisfactorily until elective removal, 
patient death or study conclusion, only 45% (46/103) were free from 
complication. Catheter removal was necessary in 31% (32/103) because 
of complications which did not respond to treatment, the most com­
mon indications for premature removal being catheter occlusion (6), 
subcutaneous tunnel infection (5) and catheter sepsis (10).
Although tunnel sepsis usually required catheter removal (5/7), the 
more ominous onset of catheter sepsis could often be controlled with 
intravenous antibiotics, and catheter removal was avoided in 14/24 cases. 
Coagulase-negative staphylococci predominated in cases of catheter sep­
sis (16/20 cases). Postoperative hemorrhage, venous thrombosis and 
catheter sepsis each contributed to one patient death and resulted in 
significant morbidity in surviving patients. Despite the high incidence
of complications associated with Hickman catheters, patient acceptance 
was high, and their use facilitated treatment in a high-risk patient group.
R202
RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE 
COLITIS AND FAMILIAL POLYPOSIS — THE CALGARY 
EXPERIENCE. J.A. Heine (R-II), J.M. Langevin, R.M. Preshaw, 
W.D. Wong. Division of General Surgery, Department of Surgery, 
Faculty of Medicine, University of Calgary, Calgary, Alta.
Fifty-five patients with ulcerative colitis (51 patients) or familial poly­
posis (4 patients) have undergone restorative proctocolectomy employing 
either an S or J ileal pouch-anal anastomosis. There were no postoper­
ative deaths. Major complications included small-bowel obstruction 
requiring laparotomy in two patients (4%) and pelvic abscess in three 
patients (5.5%). Minor complications included small-bowel obstruc­
tion managed conservatively in 10 patients (18%); “ pouchitis” in 11 
patients (20%); and anastomotic stenosis in 12 patients (22%), requir­
ing anal dilatation under general anesthesia in 5 patients (9%).
Patients were followed up for a mean of 14.7 months. Fifty-four 
patients (98%) could defecate spontaneously and mean stool frequency 
was 6.1 ± 1.9 bowel movements per 24-hour period. Four patients (7%) 
were having nine or more bowel movements per 24-hour period. Major 
daytime incontinence was a complaint of two patients (4%). Functional 
outcome was judged to be good to excellent in 50 patients (91 %). These 
results suggest that restorative proctocolectomy is a viable surgical alter­
native in selected patients requiring surgical management of ulcerative 
colitis or familial polyposis.
R203
SURGICAL TREATMENT OF CHRONIC PANCREATITIS (CP): 12 
YEARS’ EXPERIENCE. B.G. Karam, M.J. Wexler. Department of 
Surgery, Royal Victoria Hospital, McGill University, Montreal, PQ
Forty patients with cp underwent 42 operations between 1973 and 1984. 
Intractable pain or symptomatic cysts were the primary indications. Fifty 
percent were alcoholic, 23% diabetic and 18% had steatorrhea. All 
patients had ERCP or operative pancreatogram. Selection of proce­
dure was tailored to ductal pathology with attempts to preserve pan­
creatic tissue. Late results were classified as A, B or C: “ A ” = com­
plete relief of pain, no worsening of pancreatic function (pf); “ B”  = 
only occasional pain and/or controlled pf; “ C ” = failure to relieve 
pain or poorly controlled pf. Mean follow-up was 5.6 years. Three 
patients developed pancreatic carcinoma and four had late unrelated 
deaths. Perioperative mortality and morbidity rates were 2.5% and 15% 
respectively. Procedures and results are summarized:
# A B C
Whipple or total pancreatectomy 3 1 1
40-80% distal resection ± 17 3 5 5
retrograde drainage (Duval) 
Lateral pancreatojejunostomy 5 2 1 1
Internal cyst drainage 8 5 1
Sphincteroplasty Wirsung 8 5
Other 1 1
Relief of pain without iatrogenic worsening of pf can be achieved 
with 80% success and minimal morbidity and mortality, using a selec­
tive approach based on the ductal pathology. Results are poorest when 
major resectional procedures are required.
R204
IMPROVED SURVIVAL WITH SURGICAL TREATMENT OF 
PANCREATIC ABSCESS. R.G. Keith, J.R. Brow, H. Miller, J. 
McKee, R. Reid. Department of Surgery, University of Toronto, 
Toronto, Ont.
Twenty-two consecutive patients with pancreatic abscess were treated 
by operation designed to preserve maximal pancreatic tissue. Infected 
pseudocysts and aseptic necrosis were excluded from this study. All 
patients presented with sustained sepsis and nutritional failure; 10 
patients had single organ failure and 1 had multiple organ failure (MOF).
VOLUME 30, NO. 4, JULY 1987 /  THE CANADIAN JOURNAL OF SURGERY 297
Accurate localization of septic foci was obtained by diagnostic imag­
ing; CT scanning proved superior to ultrasound (sensitivity 90%:45%). 
Multiple abscesses were identified in 17 cases. Operation in each case 
was extensive debridement and drainage of all suppurative necrosis and 
abscess, specifically minimizing pancreatic resection. Postoperative 
intensive care was supplemented by mechanical ventilation in 9 cases 
and total parenteral nutrition in 15 cases.
There were only two deaths: 7 days from MOF; 60 days from 
myocardial infarction. Both had multifocal sepsis, preoperative organ 
failure but a short interval from diagnosis to operation (1:7 days).
Postoperative complications were common, correlating with multifo­
cal sepsis, but not with interval from diagnosis to operation. Fifteen 
patients developed 31 complications; 7 required reoperation, 2 for 
residual abscesses.
Follow-up of pancreatic function in 20 survivors at mean duration 
of 54 months documented preservation of endocrine (16/20 nondia­
betic) and exocrine (17/20) function, which correlated with intact whole 
organ on scanning (16/20).
Improved long-term survival is possible when debridement surgery 
conserving pancreatic parenchyma is effectively combined with inten­
sive perioperative care.
R205
THE RESTING ENERGY EXPENDITURE OF THE MORBIDLY 
OBESE. L.K. Tin, M. Gagner, H.M . Shizgal, R.A. Forse, L.D. 
MacLean. Royal Victoria Hospital, McGill University, Montreal, PQ
Previous reports on the resting energy expenditure (REE) of the mor­
bidly obese are inconsistent. This study was undertaken to determine 
the effects of obesity on the REE. In 18 morbidly obese patients, body 
composition was determined by multiple isotope technique, and the REE 
simultaneously measured by indirect calorimetry. Control data were 
obtained in 16 normally nourished volunteers. Resting energy expen­
diture was expressed as a function of body weight (BW), body surface 
area (BSA) and body cell mass (BCM). The degree of obesity was deter­
mined using an obesity index (OI) defined as body fat (FAT) per BCM 
representing the amount of fat supported for a given BCM.
____________BCM_________ FAT______ REE REE/BW REE/BSA REE/BCM_________ OI
Control 24.6 ±  1.6 16.7 ±  1.3 1427 ± 74 21.6 ± 0.7 789 ± 24 56.6 ± 1.7 0.70 ± 0.05
Obese 30.7 ±  1.4* 61.2 +  2.4* 1961 ± 77* 15.9 ±  0.5* 870 ± 6* 64.7 ± 2.4* 2.06 ± 0.10*
* Significantly different from control by unpaired Student’s t-test.
Morbid obesity is associated with an increased REE not only due to 
an increased BCM but also and separately due to the degree of obesity. 
A multiple linear regression equation was developed and was found to 
be significant (p <  0.0001, r = 0.89).
REE = 139.3 ± 47.0 (BCM) ± 180.5 (OI)
(p <  0.0001) (p <  0.001)
These data indicate that morbid obesity is associated with a hyper- 
metabolic state which is apparent when REE is expressed as a function 
of BCM, the metabolically active component of the body. The REE 
is related to the size of the BCM and the degree of obesity.
R206
POST NISSEN SYNDROME. D.E. Low, C.D. Mercer, E.C. James, 
L.D. Hill. Virginia Mason Medical Center, Seattle, WA.
Introduction: Nissen fundoplication (NFP) is the most common 
antireflux operation performed in North America. We reviewed 305 
patients who had undergone 356 previous antireflux procedures but 
required reoperation for recurrence or complication from 1964 to 1986. 
The 116 patients who required reoperation following NFP were specif­
ically examined for etiology of failure and complications. Results: Rea­
sons for reoperation included recurrent reflux ± stricture (80%), severe 
dysphagia (60%) and esophageal dysmotility (48%). Mean time inter­
val between failed NFP and remedial surgery was 51.4 months, but mean 
time to onset of recurrent symptoms was only 12.8 months. Prior to 
the patient’s original NFP, dysphagia was present in 23% compared 
to 60% of patients requiring remedial surgery. Analysis at operation 
demonstrated the cause of NFP failure to be “ slipped Nissen” (48%),
patulous repair (21%), complete (16%) and partial (13%) disruption, 
in addition to life-threatening complications including gastrobronchial, 
gastrocutaneous, gastropericardial and gastroaortic fistulas. Remedial 
surgery was individualized; however, most patients underwent Hill 
posterior gastropexy. Operative mortality was 2.6%. With a mean 
follow-up of 19 months, the overall results were rated excellent/good 
(86%), fair (11 %) and poor (3%). Summary: We suggest three reasons 
for recurrent symptoms and complications following NFP. (1) The 
procedure is done blindly with no attempt at intraoperative LES calibra­
tion, (2) it relies on sutures placed in the esophageal muscularis, (3) 
the wrap is not anchored and therefore is more prone to migration. 
The popularity of the NFP should be tempered due to these weaknesses 
in technique and increased risk of recurrence and serious complications.
R207
SUTURELESS BOWEL ANASTOMOSIS USING NDrYAG LASER. 
C.D. Mercer, B. Pauli. Department of Surgery, Hotel Dieu Hospital, 
Queen’s University, Kingston, Ont.
Phase 1: Nd:YAG Laser produced tissue-welded bowel anastomoses in 
rabbits. A 0.5-cm enterotomy was closed using sutures or non-contact 
laser energy. Small-bowel anastomoses (n = 84) were performed 15 
cm apart; bursting pressure (BP) of the occluded anastomotic segment 
was measured. Bursting pressures of laser anastomoses less than 300 
J were weaker (p < 0.001) than sutured anastomoses. Bursting pres­
sures of sutured and laser anastomoses using 300 -  500 J were similar. 
Phase II: Enterotomies were closed with sutures or laser at 400 J. All 
rabbits (n = 6) recovered without complication. At 7 or 14 days, all 
anastomoses were intact. Bursting pressures of sutured (mean 203 ± 
7 mm Hg) and laser anastomoses were not different (mean 200 ± 10 
mm Hg). Histology demonstrated fibrous union at 7 days but incom­
plete mucosal approximation with laser anastomosis. At 14 days, laser 
anastomoses were indistinguishable from normal bowel.
Technique N Energy (J) Mean BP ± SD (mm Hg)
Sutures 10 — 65.6 ± 15.3
Non-contact laser 7 100 29.1 ± 6.5
19 200 41.3 ± 11.9
21 300 50.2 ± 20.9
20 400 64.0 ± 25.7
7 500 65.0 ± 25.8
Nd:YAG Laser tissue welding is an effective method of anastomosing 
small-bowel enterotomies in rabbits.
R208
VOLVULUS OF THE COLON: EARLY LOCALIZATION OF SITE 
AN ESSENTIAL STEP FOR PROPER MANAGEMENT. E. Farkouh, 
M. Allard, H. Atlas, R. Denis. Department of Surgery, Sacre-Coeur 
Hospital, University of Montreal, Montreal, PQ
This paper summarizes our experience with this uncommon and seri­
ous form of intestinal obstruction over a period of 12 years, pointing 
out the importance of early recognition of the bowel segment involved 
for the selection of the appropriate treatment. Forty patients with colonic 
volvulus form the basis of this study, 24 male and 16 female, average 
age 59 years. They were divided into three groups according to site: 
1. Sigmoid volvulus (n: 24): Deflation by rectosigmoidoscopy was 
attempted on 20 patients. It was successful in 11 patients, and 5 of those 
had eventually elective surgery at a later date. Nine patients where defla­
tion failed had emergency surgery. Early in the series four patients had 
emergency surgery without attempt of deflation endoscopy. The type 
of operation used: sigmoid resection and anastomosis in eight, Hart­
mann’s procedure in five and simple detorsion in five. In this group 
the primary treatment recommended is deflation by rectosigmoidoscopy, 
with elective surgery at a later date. 2. Cecal volvulus (n: 13): All patients 
had emergency surgery, five had right hemicolectomy, six had detor­
sion and cecostomy, and two had cecopexy. 3. Transverse colon vol­
vulus (n: 3): Two patients had colon resection and anastomosis; and 
one patient had resection and ileostomy.
Groups 2 and 3 should be recognized early and subjected to immedi­
ate surgery to avoid early necrosis and perforation. In the three groups, 
seven patients died postoperatively (mortality rate 17.5%).
To lower this high mortality rate associated with colonic volvulus, 
early localization of the bowel segment involved and the immediate appli-
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cation of the appropriate treatment are essential. On the left side of 
the colon deflation endoscopy should be the primary treatment, while 
on the right side emergency surgery is the treatment of choice.
R209
IMMUNOSUPPRESSION WITH CYCLOSPORIN A (CsA) DOES 
NOT AFFECT RESISTANCE TO MURINE HEPATITIS VIRUS 
(MHV-3) IN A /J MICE. M. Abecassis, G.A. Levy, J.A . Falk, L. 
Makowka, R.E. Falk. Department of Medicine and Department of Sur­
gery, University of Toronto, Toronto, Ont.
It has been recently suggested that CsA is associated with a lower inci­
dence of viral infections when compared to conventional immunosup­
pressive therapy. These studies were designed to examine whether CsA 
alters innate T-cell dependent resistance to MHV-3 infection in the fully 
resistant A /J mouse. Mice, 6 - 8  weeks of age, were treated daily with 
cyclophosphamide (CY — 75 mg/kg), methylprednisolone (MP — 500 
mg/kg) or CsA (50 mg/kg) and were infected with MHV-3. Trough 
serum CsA levels were measured by radioimmunoassay 12 hours 
(4830 ± 650 ng/ml) and 24 hours (628 ± 315 ng/ml) following adminis­
tration, and CsA, at this dosage, prevented rejection of allogeneic skin 
grafts. Infected mice treated with CsA developed specific antibody (IgM 
and IgG) to MHV-3 and demonstrated no biochemical or histologic 
evidence of liver disease. In contrast, infected mice immunosuppreseed 
with either CY or MP developed both histologic and biochemical evi­
dence of fulminant hepatitis associated with failure to produce anti­
body to MHV-3 and 100% mortality. These results suggest that CsA 
does not alter innate resistance to MHV-3 in A /J  mice, whereas 
immunosuppression with either CY or MP results in conversion of 
resistance to susceptibility. We conclude that the increased incidence 
of viral infections associated with the use of CsA may be related to 
the concomitant use of other immunosuppressive agents.
R210
UTILITY OF INTRAOPERATIVE ULTRASONOGRAPHY IN THE 
SURGICAL TREATMENT OF HEPATIC TUMOURS. R. Lapointe, 
M. Lafortune, L. Lapointe, R. Dery, P. Lavoie. Department of Sur­
gery and Department of Radiology, Hopital Saint-Lue, Universite de 
Montreal, Montreal, PQ
Intraoperative ultrasonography was performed in 14 patients with var­
ious liver tumours: 9 colorectal metastasis, 3 nodular focal hyperpla­
sia, 1 hepatoma and 1 primary hepatic cystadenocarcinoma. All patients 
had preoperative work-up including ultrasonography of the liver as well 
as computerized tomography of the liver (13 patients) and selective 
hepatic arteriography (12 patients). At surgery, various kinds of liver 
surgery were carried out on these 14 patients after inspection, palpa­
tion and operative ultrasound examination of the liver had been per­
formed; segmentectomy in 4, hepatic lobectomy in 4, subsegmentec- 
tomy in 2 and biopsy in 4. Intraoperative ultrasonography proved to 
be a useful method not only for revealing and permitting guided biopsy 
of unsuspected preoperative tumours deep in the hepatic parenchyma 
but also for establishing the exact relationship between the vascular struc­
tures and the tumour. It is therefore an important exploration mean 
for therapeutic decision in liver surgery.
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SEPTIC STRESS AND THE ADIPOCYTE BETA-1 ADRENERGIC 
RECEPTOR. D. St. Vil, M. Gagner, R.A. Forse. Royal Victoria Hospi­
tal, McGill University, Montreal, PQ
Catecholamine exposure results in down-regulation of beta-adrenergic 
receptors (decreased response to stimulation in vitro). The object of 
this study was to determine if there were differences in the down- 
regulation of beta-1 receptors of adipose tissue from septic patients who 
survived (SURV) and those who died (NON-SURV). The adipose tis­
sue was biopsied from the abdominal wall and the intestinal mesentery 
during open abdominal dressing for peritonitis. Normal tissue was biop­
sied during elective surgery (Normal). Lipolysis was measured using 
an in-vitro dual isotope technique and expressed below as the lipolysis 
factor (LF). The beta-1 receptors were stimulated with isoproterenol 
(ISO). The maximal LF at any concentration was recorded as the Vmax 
The results are:
ISO
Mesentery
Normal
SURV
NON-SURV
5.3 ± 2.7 
5.6 £  5.6 
18.0 ± 2.1*
22.1 £ 7.3
26.4 ±  9.3
16.4 ± 5.2
51.3 £ 9.0 
43.7 ± 25.3 
5.9 ± 2.3*
Abdominal wall
Normal 7.6 ± 4.6
SURV 12.6 £ 4.9
NON-SURV 0.3 ± 3.2*
17.8 ± 4.4 40.5 £ 6.2
27.7 £  7.3 46.4 £ 15.3
14.2 ± 6.8 16.5 ± 4.2*
’ Significantly different from normal by analysis o f  variance.
50.7 ± 4.5
38.3 £ 14.0
10.4 £  8.4*
39.1 £  4.6
42.4 £  15.3
20.4 £ 12.3*
43.6 £ 5.8 
34.0 £ 9.6 
7.4 £ 6.2*
40.0 £  7.4 
42.3 £  9.2 
7.1 £  6.9*
62.1 £ 7.9
53.4 £  23.2
21.2 £ 0.4*
48.4 £ 6.5 
53.1 ± 23.2
25.5 £  9.9*
The LF at each ISO concentration and the Vmax were significantly 
decreased in the NON-SURV, reflecting the degree of catecholamine 
stimulation. The APACHE II and APS scores were similar between 
SURV and NON-SURV. The data thus indicate that the beta-1 recep­
tor of adipose tissue can provide an early measure of septic stress and 
be an early indicator of septic outcome.
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RESULTS OF PARKS’ SPHINCTEROPLASTY FOR POST TRA U­
MATIC ANAL INCONTINENCE. S. Morgan, D. Bernard, D. Tasse, 
R. Wassef. Department of Surgery, University of Montreal, Division 
of Gastrointestinal Surgery, Hopital St-Luc, Montreal, PQ
Surgical and obstetrical trauma is one of the commonest causes of fecal 
incontinence. Controversy still exists as to the type of repair and the 
need for a temporary diverting colostomy. We report on 45 patients 
(40 F, 5 M): 17 (38%) had one or more previous attempts at repair. 
Duration of incontinence following obstetrical trauma averaged 13 years 
versus 4 years following other trauma. Diverting colostomy was estab­
lished in every patient either shortly after the trauma for .he inconti­
nence or immediately before attempting repair and was closed 3 months 
after the repair in every case. Sphincteroplasty was performed accord­
ing to Parks’ technique by dissection o f the sphincters over half o f its 
circumference, dividing the centre of the fibrotic ring, and doing an 
overlapping type of repair and leaving the wound open for second- 
intention healing. There was no mortality. Results for incontinence were 
judged good to excellent in 82%, fair in 9% and failures in 9% (four 
cases). Three of the failures were repaired according to the same tech­
nique and the result was excellent in two and fair in the other. Previous 
reports mentioned three factors of increased risk of failure: age >  65, 
previous repairs and over 10-year duration of incontinence. Assessment 
of these risk factors reveals no difference in our results, possibly because 
of the presence o f a colostomy. The rate of failures was significantly 
higher in the first 15 cases (47%) than in the last 30 (3%) (p <  0.01). 
Sphincter repair following Parks’ principles is sound; a colostomy is 
recommended after major trauma or sepsis and should be considered 
when risk factors of failure are present.
R213
THE RESULTS OF TREATMENT USING COMPOSITE RESEC­
TION IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF 
THE ORAL CAVITY FOLLOWING FAILED IRRADIATION  
THERAPY. R.E. Robins, S. Schlagentweit. Cancer Control Agency 
of British Columbia and University o f British Columbia Medical School, 
Vancouver, BC
In our institution, the majority of patients with T1 and T2 NO and 
selected T3 and T4 NO squamous carcinoma of the oral cavity receive 
irradiation as primary therapy. There is close follow-up and surgical 
treatment for failure or recurrence. A retrospective study of 98 con­
secutive patients undergoing composite resection from 1971 to 1983 was 
done to determine and compare treatment results in those irradiated 
(76) and the total group including non-irradiated (22) patients. In the 
22 patients treated primarily by composite resection, 21 had T3 or T4 
lesions. All were followed at least 2 years and 84% more than 3 years. 
A computer-assisted analysis of the data was performed yielding product 
limit and actuarial survival curves.
The commonest sites were floor of mouth (35), tongue (19) and lower 
alveolus (19). There was no significant difference in the overall sur­
vival between the irradiated and total group. The 2, 3 and 5 years’ sur­
vival for all patients was 58%, 56% and 48%; for irradiated patients 
56%, 54% and 47%. There was also no difference in the behaviour 
of the irradiated group as compared to the total in comparison of tumour 
size, positive margins or node status. In both groups, 25% had posi­
tive margins at surgery. This was followed by ultimate failure as at 3 
years there were no survivors with positive margins; for clear margins 
there was 70% survival at 3 years and 61 % at 5 years. One-half of both
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groups had positive cervical nodes. Three and 5 years’ survival with 
negative nodes was 65% and 61%; with positive nodes 46% and 37%. 
The level o f nodal involvement was highly significant.
R214
SPECIFIC AND NONSPECIFIC IMMUNITY IN THE RESPONSE 
TO PSEUDOMONAS INFECTION FOLLOWING THERMAL 
INJURY. J.C. Marshall, H. Rode, D. Eshelby, J.L. Meakins, N.V. 
Christou. Department of Surgery, Royal Victoria Hospital, McGill 
University, Montreal, PQ
The role of specific and nonspecific immune mechanisms in the response 
to pulmonary infection with Pseudomonas following thermal injury was 
studied in a rat model. Male Lou/Lewis rats (mean weight 320 g), presen­
sitized to keyhole limpet hemocyanin (KLH), underwent a 30% TBSA 
scald burn or sham burn. Twenty-four hours later, animals were 
immunized IP with 10s heat-killed Pseudomonas aeruginosa. Seven 
days following immunization, blood was drawn for assay of specific 
anti-Pseudomonas IgG antibody using an ELISA to whole organisms, 
then animals were challenged intratracheally with 2 x  10® CFU live 
Pseudomonas. Animals were sacrificed 24 hours later, and the right 
lung was homogenized for quantitation of residual numbers of viable 
Pseudomonas. The mean diameter (mm) of the delayed-type hypersen­
sitivity (DTH) response to recall skin testing with KLH was used as a 
measure o f nonspecific immune responsiveness following the burn. 
Specific anti -Pseudomonas IgG was expressed in units/ml measured 
against a standard serum arbitrarily defined to have 10 U/ml of activity. 
Results follow (mean ± SEM).
24 h 72 h 1 wk Ami- Log10 CFU
Group DTH DTH DTH pseudo IgG pseudo/ml
Controls 6.8±0.3 10.2±0.2 9.0 + 0.3 69.5±11.0 1.97±0.1
Burn 1.8±0.5a 3.6±0.5a 4.2±0.3a 61.5± 7.7b 2.30±0.1°
ap < 0.001, bNS, cp = 0.01.
A 30% TBSA burn injury produced marked and persistent impair­
ment of nonspecific host defences; in contrast specific anti -Pseudomonas 
antibody production was normal. Pulmonary clearance of a bacterial 
challenge was depressed, despite an intact humoral immune response.
R215
SURGERY FOR CHRONIC CONSTIPATION. J. Engel, J. Duff, D. 
Grant, B. Taylor. Department of Surgery, University of Western 
Ontario, London, Ont.
We reviewed 25 patients who underwent surgery between 1976 and 1986 
for severe disabling constipation not controlled by laxative and enema 
regimens. There were 22 females and 3 males with a mean age of 43 
years (range 5-86). They had an average of 1.2 bowel movements per 
week (range 0-7). Additional symptoms included abdominal bloating 
22 (88%), abdominal pain 20 (80%), straining at stool for greater than 
5 minutes 14 (56%) and nausea 14 (56%). The preoperative diagnosis 
was colonic inertia in 23 (92%) and anal sphincter spasm in 2 (8%). 
Barium enemas performed in 22 patients showed: no abnormality -  8, 
megacolon -  7, dolichocolon -  6. Transit studies demonstrated colonic 
inertia in 14 and outlet obstruction in 2 patients.
The following operations were performed: subtotal colectomy with 
ileorectal anastomosis -  15 (60%), total colectomy with ileostomy -  4 
(16%), subtotal colectomy with ileosigmoid anastomosis -  3 (12%), 
extended internal sphincterotomy -  2 (8%) and partial colectomy with 
cecorectal anastomosis -  1 (4%). The mean follow-up was 19 months 
(range 1 - 6 0  months). Adhesive small-bowel obstruction occurred in 
five (20%) patients; three required reoperation. Constipation was com­
pletely relieved in 14 (56%) patients. Ten (40%) patients were improved: 
7 (28%) required regular laxatives and 3 (12%) required occasional lax­
atives. One patient remained constipated following an extended inter­
nal sphincterotomy. No one suffered from disabling diarrhea.
We conclude that total colectomy alleviates disabling constipation 
due to colonic inertia.
R216
HUM AN COLONIC MUCIN IN INFLAMMATORY AND  
NEOPLASTIC DISORDERS. B.E. Lukie. Department of Physiolog­
ical Sciences, University o f Newcastle-Upon-Tyne, UK
A mucus alteration of unknown significance has been observed in 
neoplastic and inflammatory disorders of the colon. The objective of 
this work was to characterize the molecular size distribution of this 
abnormal mucus. Mucus obtained from fresh colectomy specimens was 
solubilized and analysed by Sepharose CL-2B gel filtration chromatog­
raphy. Two glycoprotein peaks were regularly observed: a high molecular 
weight peak (mucin) which eluted at the void volume and extended to 
the initial included volume; a late-eluting low molecular weight peak 
(LMWP) of higher protein content. The distribution of glycoprotein 
between these two peaks was unaffected by prior heating at 100°C for 
10 minutes, incubation at 37°C for 48 hours or 10“ 3M phenylmethyl- 
sulfonyl fluoride. Both ulcerative colitis (UC) and cancer (CA) sam­
ples showed an increase in LMWP protein content when compared to 
a mucus from a patient with sigmoid volvulus. Mucin subunit which 
elutes between the mucin and LMWP peaks was not seen in any of the 
CA samples but was present in one of the two UC samples studied. 
Thus, CA and UC mucus are associated with an increased protein con­
tent of the LMWP. Mucin subunit formation was not detected in CA, 
but may be a feature of some cases of UC.
R217
MANAGEMENT OF MALIGNANT COLORECTAL POLYPS. D. 
Bernard, S. Morgan, D. Tasse, R. Wassef. Department of Surgery, 
University of Montreal, Division of Gastrointestinal Surgery, Hopital 
St-Luc, Montreal, PQ
Management of patients with endoscopically removed malignant intes­
tinal polyps remains controversial. The risk of residual disease, esti­
mated at 10.1% by Wilcox (Cancer 1986; 57: 160-171) should be assessed 
against the risk of a surgical operation. We report 30 cases of malig­
nant polyps (7.3% of 409 colonoscopically removed adenomas). Four­
teen contained carcinoma in situ and had no further treatment and 16 
had invasive carcinoma (5 sessile, 11 pediculated). Among these 16, 5 
were not submitted to surgery: because of old age in 1, minimal inva­
sion in 3 and low rectal location in the other. Eleven (3 sessile, 8 pedic­
ulated) underwent surgical resection and residual disease was present 
in 3 (27%), 1 with positive nodes. Reported criteria of increased risk 
of residual disease — CA in lymphatics or veins, incomplete excision, 
tumour at resection margin, sessile and villous — were present in seven. 
All three patients with residual disease had one or more of these criteria 
in their malignant polyps. Evidence of residual disease (10.1%) in the 
colonoscopy era studies comes from 14 series (Cancer 1986; 57:160-171), 
such as this one, totalling 188 cases. The presence of criteria of increased 
risk justifies surgical resection unless the patient is an otherwise poorer 
operative risk.
R218
SCINTIGRAPHIC BALLOON PROCTOGRAPHY FOR ASSESS­
MENT OF SEVERE CONSTIPATION. M.E. Pezim, J.H . Pember­
ton, S.F. Phillips. Department of Surgery and Gastroenterology Unit, 
Mayo Medical School, Rochester, MN
To determine why some constipated patients remain unchanged fol­
lowing colectomy and ileorectal anastomosis, we examined the role of 
the anorectal angle during defecation. Method: Fourteen subjects (5 
healthy controls, 9 severely constipated patients) were studied at rest 
and during defecation with an intrarectal balloon probe containing 5 
mCi 99mT c04- in 70 ml water, imaged by gamma camera. Patients in 
Group A (n = 5) often used digital evacuation or perineal compres­
sion to facilitate defecation. Patients in Group B did not. Results: Group 
A differed significantly from both controls and Group B by having a 
more acute resting anorectal angle, and a reduced ability to straighten 
the angle during defecation. In contrast, Group B resembled controls 
in both resting and defecation anorectal angles.
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Table: Anorectal Angle (°) (Mean ± SEM)
Rest Defecate Change
Control 113 ± 4 133 ± 5 20 ± 4
Group A 101 ± 4* 109 ± 4 8 ± 2**
Group B 118 ± 5 142 ± 6 23 ± 2***
*Group A vs Group B rest; p = 0.02. 
**Group A vs control change; p = 0.02. 
***Group B vs control change; NS.
Conclusion: Scintigraphic balloon proctography differentiates consti­
pated patients into two groups. Patients unable to straighten their 
anorectal angle during defecation have an expulsion disorder which 
would persist following colectomy. Those with normal anorectal angle 
dynamics have a colonic motility disorder for which colectomy is 
rational. Scintigraphic balloon proctography appears to be an impor­
tant too! in selecting patients for appropriate surgical treatment.
R219
STRICTUREPLASTY FOR CROHN’S DISEASE. P.J. Whelan, F.G. 
Saibil, L.B. Cohen, A .W . Harrison. Division of General Surgery and 
Gastroenterology, Sunnybrook Medical Centre, University of Toronto, 
Toronto, Ont.
The threat of short-bowel syndrome secondary to resectional surgery 
for Crohn’s disease has led us to test the safety and efficacy of stric­
tureplasty for the obstructive complications of Crohn’s disease.
In the past 21 months we performed strictureplasties on eight patients 
with Crohn’s disease. The main indication for operation in all was 
chronic obstruction. Six patients had a history of previous bypass and/or 
resection.
Thirty-two strictureplasties have been carried out, encompassing 55 
strictures. Two of the eight patients underwent limited resection con­
currently with multiple strictureplasties.
The length of follow-up ranges from 4 to 21 months. One patient 
has required reoperation for recurrence of an enterovesical fistula. Two 
patients had evidence of postoperative leaks; both responded to con­
servative management. All patients are able to ingest a full, normal diet 
despite discontinuation of steroids. The nutritional status of all patients 
has improved or continued in the normal ranges as determined by body 
weight, serum protein and hemoglobin.
Strictureplasty is a safe and effective therapy for Crohn’s disease.
R220
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) BY THE 
“ PULL” AND “ PUSH ” METHODS. M. Deitel, T. To, E. Spratt, 
C. Burul. Department of Surgery and Department of Nutritional 
Sciences, University o f Toronto, St. Joseph’s Health Centre, Toronto, 
Ont.
After 28 patients studied prospectively underwent PEG by the Ponsky 
“ pull” technique, a subsequent 28 patients underwent PEG by the Rus­
sell “ push” technique. These were compared with the prior 28 patients 
retrospectively who had undergone Stamm gastrostomy as an indepen­
dent operation by the same group of surgeons. All procedures were done 
within a 4-year period. “Pul!” Method: After gastroscopic insuffla­
tion, a suture or guidewire passed through a Medicut was snared and 
secured to the end of a phlanged 14F mushroom tube which was pulled 
retrograde out the abdominal wall. “Push” Method: Through a nee­
dle, a guidewire was inserted over which a dilator-sheath was rotated; 
the dilator was removed, and a lubricated 14F Foley was pushed through 
the intragastric-viewed sheath which was peeled away.
“ Pull” “Push”
Table: (n = 28 per group) Stamm PEG PEG
Age (x ± SD yr): 68 ± 12 69 ± 14 73 ± 15
Use: Neurologic diseases 15 16 14
Pharyngeal blockage 3 4 6
Cachexia, respiratory, 
burn
10 8 8
No. under local anesthesia: 5 13 17
Time for procedure (min): 55 ± 7 p <  0.001 27 ±8 p <  0.001 16 ± 3
Wound infection: 5 6 0
Death within 30 days: 4 2 2
Feeding was started 3 days after Stamm and 24 hours after PEG, 
initially elemental diet, progressed to non-digested liquid diet. “ Pull” 
PEG requires removal and reinsertion of the scope, and drags oral bac­
teria through abdominal wall which may account for peritubal infec­
tions. Percutaneous endoscopic gastrostomy was less costly than Stamm; 
“ push” PEG was simpler, faster and safer.
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EFFECTS OF PROLONGED INTESTINAL TRANSIT TIME ON 
BILIARY LIPIDS IN THE PIG. N. Causton, O. Thurston, K. Walker. 
The Surgical-Medical Research Institute, University o f Alberta, Edmon­
ton, Alta.
Previous studies indicate that cholesterol saturation of bile is associated 
with prolonged intestinal transit time (so-called colonic stasis) charac­
teristic of populations eating a low-fibre/high-refined-carbohydrate diet. 
This study was undertaken to determine the effect of prolonged intes­
tinal time on biliary lipids (cholesterol, phospholipid and total bile salts).
Young domestic pigs weighing 10 -  30 kg had an antiperistaltic loop 
of colon fashioned to prolong intestinal transit time mechanically, as 
measured by the passage of radiopaque markers. Gallbladder bile for 
determination of biliary lipids was obtained by needle aspiration at 
celiotomy prior to reversal of a 10- to 35-cm colonic segment and at 
4 and 8 weeks after reversal. The number of animals studied at 0, 4 
and 8 weeks was 19, 13 and 9 respectively. The animals were on a 
cholesterol-free diet throughout the study.
Intestinal transit time in control animals was 53.5 ± 23.1 hours (x 
± SEM) and was 175.2 ± 22.1 hours in animals with a reversed colonic 
segment (p <  0.001). Cholesterol saturation index of bile was 0.40 ± 
0.03 in the control period and 0.38 ± 0.03 and 0.33 ± 0.02 at 4 and 
8 weeks after colonic reversal. None of the observed differences was 
statistically significant.
Under the conditions of this study a marked prolongation o f intesti­
nal transit time did not increase the cholesterol saturation index of gall­
bladder bile. This result does not support the commonly held belief that 
prolonged intestinal transit time is a factor leading to cholesterol gall­
stone formation.
R222
THE EFFECT OF CYCLOSPORINE ON LIVER REGENERATION. 
R. Black, D. Grant, R. Zhong, W. Wall, P. Keown, J. Duff. Depart­
ment of Surgery and Department of Medicine, University o f  Western 
Ontario, London, Ont.
Liver regeneration can be critical to the success of orthotopic liver trans­
plantation when the donor organ has been compromised. Many drugs 
interfere with liver regeneration. The present study examined effect of 
oral cyclosporine (CsA) on liver regeneration. Thirty-two male Sprague- 
Dawley rats were placed into four groups after a standard 70% hepatec- 
tomy. The rats were sacrificed on the 10th postoperative day, and the 
following were measured: hepatic regenerative rate (RR), total food 
intake (FI) and the change in body weight (BW).
Treatment RR FI BW
Group 1 Olive oil 105% 186 g + 13%
Group 2 CsA 10 m g/kg/d 104% 159 g + 9%
Group 3 CsA 20 m g/kg/d 87 %* 124 g* -  5%*
Group 4 Olive oil/pair-fed 
with Group 4
86% * 124 g* -  3%*
* = p < 0.05 compared to Group 1.
The correlation coefficient between FI and RR was +0.75 (p <  0.001).
We conclude: (1) there is a significant correlation between FI and 
liver regeneration, (2) low-dose CsA does not impair liver regeneration, 
(3) high-dose CsA indirectly impairs liver regeneration by inducing 
anorexia.
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LONG-TERM RESULTS OF ENDOSCOPIC SCLEROTHERAPY 
FOR BLEEDING ESOPHAGEAL VARICES: EFFECTIVENESS, 
COMPLICATIONS, AND SURVIVAL. R.J. Tabah, M.J. Wexler, 
A .P .H . McLean. Department of Surgery, Royal Victoria Hospital, 
McGill University, Montreal, PQ
Endoscopic sclerotherapy as initial and primary treatment of sympto­
matic esophageal varices in 77 consecutive, unselected patients over a 
6-year period is reviewed in order to define the effectiveness, compli­
cations and survival associated with this form of treatment. Each of 
the 186 individual sclerotherapy sessions was performed through a 
Williams overtube under general anesthesia. Alcoholic cirrhosis was 
present in 69%. Of those with cirrhosis, 41 % were classified as Child’s
C. No specific additional treatment other than repeat sclerotherapy was 
required in 58%. Only 23% ultimately required surgery for control of 
recurrent variceal hemorrhage. The rate of rebleeding following an 
individual sclerotherapy session was 29%. Forty-one percent of recur­
rent bleeding occurred within 1 week following sclerotherapy. Com­
plications directly attributable to sclerosis were generally mild and well 
tolerated. These included superficial esophageal ulceration (11.8%) and 
fever (25%). Deep esophageal ulceration was observed in 17% of 
patients. Two deaths were directly attributable to sclerotherapy. Life- 
table analysis resulted in a 3-year survival of 71%, 63% and 27% in 
Child’s A, B and C patients managed under our protocol. Major causes 
of death included hepatic failure, sepsis and hemorrhage. We believe 
that endoscopic sclerotherapy as performed under general anesthesia 
is a safe, effective means of initial and long-term management of the 
patient with bleeding esophageal varices.
Canadian Society for Vascular Surgery
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CAROTID ENDARTERECTOMY: LATE RESULTS. C.R. Lye. 
University of Manitoba, Health Sciences Centre, Winnipeg, Man.
The late results of carotid endarterectomy have been assessed in a con­
secutive series of 380 patients who underwent 444 carotid repairs between 
1975 and 1986. Follow-up to date, subsequent stroke or death was 
obtained in 357 patients (94%).
There were 49 late deaths (30 cardiac, 7 cerebral), with a 7-year 
cumulative survival (life-table method) of 68.4%. There have been 18 
late strokes (7 fatal), of which 3 were ipsilateral to the original repair. 
Cumulative freedom from all stroke events (including operative stroke) 
at 1, 4 and 7 years was 94%, 90% and 81% respectively. Freedom from 
fatal or disabling stroke at the same intervals was 97%, 96% and 89% 
respectively. Only three patients have experienced late disabling non- 
fatal strokes.
Late angiograms have been obtained in 53 patients and have demon­
strated occlusion (5) and restenosis (6) o f the original repair as well as 
marked progression of disease in the opposite carotid (13).
Repair of recurrent stenosis was carried out in four patients, two of 
whom presented with recurrent symptoms. Late contralateral repair was 
performed in 13 patients, 8 of whom were symptomatic.
Although many patients die with intercurrent coronary artery dis­
ease, carotid endarterectomy can result in prolonged freedom from dis­
abling stroke. Late recurrent stenosis is less frequent and troublesome 
than contralateral disease progression.
R524
INFLUENCE OF SIZE ON SURVIVAL AFTER RUPTURED 
ABDOMINAL AORTIC ANEURYSM REPAIR. J.L. Murphy, G.G. 
Barber, N.V. McPhail, T.K. Scobie. Division of Vascular Surgery, 
Ottawa Civic Hospital, Ottawa, Out.
One hundred and seventy-two consecutive patients underwent repair 
of ruptured abdominal aortic aneurysms (AAA) between 1970 and 1985. 
There were 146 males and 26 females with an average age of 69.8 years. 
The overall mortality rate was 49.4%. Fourteen of 51 variables were 
clinically and statistically important, the most significant being urine 
output under 100 ml in the Operating Room, hypotension (<  90 mm 
Hg) in the OR, arrest, history of collapse and initial systolic BP (<  
90 mm Hg). Discriminant analysis correctly classified 90.2% of sur­
vivors with a false ( + ) rate of 9.8% and 83.7% of nonsurvivors with 
a false ( - )  rate of 16.3%. The principal contributors (F > 4) to the 
prognostic formulae were parameters of shock, not age or associated 
cardiopulmonary disease.
Size was documented in 133 aneurysms. Thirteen (9.8%) were less 
than 6.0 cm and 23 (17.8%) were 6.0 cm or less, while the average size 
of the larger (>  6.0 cm) AAA was 9.51 cm. The 13 smallest aneurysms 
(<  6.0 cm) were correctly diagnosed initially in only 46.2% compared 
to 76.7% overall (p < 0.05) and the time from arrival in the hospital 
to the Operating Room was 6.71 versus 2.37 hours for the rest (p < 
0.05). The mortality for these small aneurysms was 76.9% compared 
to 45.0% for the remainder (p < 0.06). Small aneurysms were known
to be present prior to rupture in 8/23 (34.8%) of cases, including 5/10 
aneurysms measured at 6.0 cm.
This review confirms the continuing poor results after ruptured 
abdominal aortic aneurysm repair and supports a more aggressive 
approach to diagnosis and treatment including abdominal aortic 
aneurysms between 4.0 and 6.0 cm in size.
R525
THE SELECTIVE MANAGEMENT OF SMALL ABDOMINAL 
AORTIC ANEURYSM WITH SERIAL ULTRASOUND SIZING. 
J.R. Gutelius, R. Pattenden, P.M. Brown. Division of Vascular Sur­
gery, Department of Surgery, Queen’s University and Kingston General 
Hospital, Kingston, Ont.
Management of the small asymptomatic abdominal aortic aneurysm 
is controversial. The authors have attempted to clarify this problem 
by a sizing program for all patients with asymptomatic aneurysms less 
than 5.0 cm in diameter.
In the past 6 years, 163 patients have entered the sizing program. 
After the initial ultrasound, repeat studies were done on a 6-month basis. 
Operation was performed if the aneurysm became symptomatic, 
increased more than 0.5 cm in diameter in 6 months, or reached 5 cm 
in greatest AP or lateral diameter. Twenty-eight patients have required 
surgery for symptoms (3), increase of greater than 0.5 cm in 6 months 
(5), and size of greater than 5 cm in diameter (20). There were no oper­
ative deaths and no patients ruptured prior to surgery. The operative 
patients were followed a mean duration of 17 months prior to surgery 
with a yearly increase in size of 1.1 cm.
One hundred thirty-five patients have been followed without surgery. 
Eighty-five of these patients have had two or more documented sizings 
with an average follow-up of 24 months. The mean yearly increase in 
size in this group was 0.2 cm. No ruptures occurred and there were only 
two deaths (CA of esophagus and myocardial infarction). Five patients 
were lost to follow-up.
Abdominal aortic aneurysm with a diameter of less than 5.0 cm can 
safely be followed. Even low-risk patients may be optimally managed 
conservatively and followed with serial ultrasounds with minimal risk 
of rupture.
R526
POPLITEAL ANEURYSMS: AN INDEX OF GENERALIZED VAS­
CULAR DISEASE. A.M. Thijssen, G.G. Barber, N.V. McPhail, T.K. 
Scobie, C. Wm. Cole. Division of Vascular Surgery, Ottawa Civic 
Hospital, Ottawa, Ont.
Experience with 59 popliteal aneurysms in 38 patients, accrued over 
10 years, was reviewed. Information is complete for 31 patients (50 legs) 
available for follow-up or who were followed until they died. Seven 
patients were lost to follow-up after several months and are included 
only so far as reliable information is known. Age at presentation ranged 
from 93 to 39 with the median age of patients with unilateral aneurysms 
being 5 years younger than those with bilateral disease (67 versus 72).
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There was only one female. Associated vascular pathology was noted 
with increasing frequency as age progressed including the development 
of a second popliteal aneurysm in patients presenting initially with 
unilateral findings. Two such patients were found to have developed 
an aneurysm in the opposite leg on subsequent follow-up 5 and 7 months 
after initial treatment. Seventeen patients with unilateral popliteal 
aneurysms remain asymptomatic with respect to the opposite leg, but 
the follow-up experience is considerably shorter than for the group who 
presented with bilateral disease. Initial management consisted of a bypass 
graft in 34/59, immediate amputation in 9/59, while 16/59 unrecon- 
structable but viable limbs were treated without surgical intervention. 
Bypass material was ePTFE in 2/34 and saphenous vein in the 
remainder. Thirty of 34 grafts were patent at last follow-up or were 
determined to be patent at the time of death. Four grafts occluded, one 
in the perioperative period and the others at 4, 5 and 32 months result­
ing in three amputations, only one of which was below-knee. These 
data illustrate that popliteal aneurysms may serve as a gauge of gener­
alized vascular disease, with a higher probability of occlusive as well 
as aneurysmal disease in other vessels when bilateral.
Vascular Pathology Associated With Popliteal Aneurysms
No. of patients 17 (unilateral) 21 (bilateral)
Age (median) 67 72
Follow-up (median) 21 (range 1-95 mo) 35 (range 1-96 mo)
Ml 24 (%) 33 (%)
CABG 6 10
Stroke 12 19
AAA 24 38
Fem/iliac aneurysm 18 29
R527
THE RATE AND DISTRIBUTION OF BLOOD FLOW FOLLOW­
ING PROLONGED SKELETAL MUSCLE ISCHEMIA. I. Forrest, 
T. Lindsay, A. Romaschin, I). Mickle, P. Walker. Division of Vascu­
lar Surgery, Toronto General Hospital, Toronto, Ont.
The pattern of muscle blood flow upon re-establishment of circulation 
to the lower extremity, following an acute arterial occlusion, is unclear, 
and yet may determine the extent of resulting necrosis. The purpose 
of this study was to document total blood flow and its distribution within 
the muscle, following prolonged periods of ischemia. The bilateral canine 
gracilis muscle preparation was used. Total blood flow was measured 
by timed venous collections. Distribution of blood flow was determined 
using a multiple microsphere technique. Measurements were made 
preischemia and during the reperfusion phase at 3, 18, 33 and 48 minutes 
following 4 (n = 8) and 5 (n = 8) hours of ischemia. Necrosis was 
quantitated using nitroblue tetrazolium staining in conjunction with com­
puterized planimetry. The muscles were divided into six slices and blood 
flow to each slice, as well as to the alive and dead portions, was calcu­
lated.
We demonstrated that preischemic flow is homogeneous through­
out the muscle (4.4 ± 0.02 ml/min/100 g). On reperfusion, total flow 
was 6-10 times higher and the distribution was preferentially to the mid­
dle slices. Blood flow in each slice was correlated to necrosis (r = 0.4) 
(p < 0.05). The degree of reactive hyperemia was greater following 
4 hours of ischemia than 5 hours (12.5 cc/min/100 g versus 20.3 
cc/min/100 g, p < 0.05) but there was no correlation between blood 
flow to alive versus dead portions, in each slice (p = NS).
We conclude that upon reperfusion muscle blood flow is no longer 
homogeneous. The rate of reactive hyperemia is inversely related to the 
length of ischemia. The extent of returning blood flow may not be the 
sole predictor of muscle viability.
R528
EVALUATION OF CEFAZOLIN AND CEEAMANDOLE TISSUE 
CONCENTRATIONS DURING AORTOFEMORAL BYPASS 
GRAFT PROCEDURES. A. Downs, T. Louie, C. Lye, D. Howard, 
G. Gray, H. Fong, W. Krulicki. Department of Medicine, Department 
of Medical Microbiology and Department of Surgery, University of 
Manitoba, Winnipeg, Man.
Coagulase-negative staphylococci (CNS), primarily S. epidermidis, are 
increasingly recognized as pathogens causing prosthetic graft infections. 
We measured serum and tissue concentraions of cefazolin (CFZ) or
cefamandole (CFM) during the surgical procedure. One gram of antibi­
otic was infused over 1 5 -2 0  minutes beginning 60 minutes prior to 
surgery. Aortic blood (for preclotting the Dacron graft), a biopsy of 
the aorta at the proximal anastomosis and soft tissue from the region 
of the distal anastomosis were obtained at approximately 100, 115 and 
150 minutes respectively, after initiating the antibiotic infusion. Results 
are shown below:
Mean Concentration ±  SE of Antibiotic (gg/ml Tissue Fluid)
Serum at Tissue, distal
preclotting graft Aorta anastomosis 
(90-100 min) (115-120 min) (140-150min)
Cefazolin, n = 16 43.3 ± 6.7 16.0 ±  3.6 15.2 ±  3.2
Cefamandole, n = 7 23.0 ± 4.9 8.7 ±  1.9 3.7 ±  0.8
Excluding isolates of S. hemolyticus, both CFZ and CFM were gener­
ally bactericidal for CNS. However, CFM was two- to fourfold more 
active on a weight basis with an MBCjo of 1.0 gg/ml whereas the 
MBCgo for CFZ was 4 ng/ml. Despite lower serum and tissue concen­
trations as compared to CFZ, CFM should be further evaluated as 
prophylaxis during vascular graft procedures since serum or tissue con- 
centration/MBC90 ratios suggest that CFM is an equivalent or superior 
drug as compared to CFZ. The results of an ongoing randomized com­
parison, including quantitative and qualitative cultures of graft material 
will be presented.
R529
IS AORTOPROFUNDA BYPASS A SUCCESSFUL OPERATION 
FOR MULTILEVEL OCCLUSIVE DISEASE? P.G. Kalman, M. Rae, 
K.W. Johnston, P.M. Walker. Division of Vascular Surgery, Toronto 
General Hospital, Toronto, Ont.
Proximal reconstruction is performed first in patients with combined 
aortoiliac and femoropopliteal occlusive disease. Profundoplasty of vari­
able length, however, may be required for providing adequate outflow. 
The purpose of this study was to determine whether aortoprofunda 
bypass is successful for multilevel occlusive disease. Aortoprofunda 
bypass was performed in 121 patients for disabling claudication (66%) 
and limb salvage (34°7o). The superficial femoral artery was occluded 
in 73% and diseased but patent in 27%. Fifty-seven (47%) had bilateral 
and 64 (53%) had unilateral profundoplasties — local in 16%, inter­
mediate (past one perforator) in 40%, and extended (past three perfo­
rators) in 44%. The cumulative graft patency, clinical success (patent 
and clinically improved) and hemodynamic success (patent and improved 
ankle/brachial index) were determined by life-table analysis (see table).
Cumulative (%) Standard Error
at 5 years (%)
Graft patency 97% *+ 1.3%
Clinical success 77%* 5.2%
Hemodynamic success 67% + 5.9%
*, + p < 0.01, log rank test.
There was no significant difference in success when patients were 
stratified for sex, preoperative grade (disabling claudication versus limb 
salvage), type of proximal anastomosis and extent of profundoplasty. 
No patients underwent concomitant distal revascularization and only 
four subsequent infrainguinal bypasses were required.
In conclusion, aortoprofunda bypass is a successful operation for 
the management o f multilevel peripheral occlusive disease with very few 
patients requiring subsequent distal revascularization. Despite continued 
patency, gradual subjective and objective deterioration occurs secon­
dary to progression of disease.
R530
FACTORS INFLUENCING RESULTS OF 136 ARTERIAL RECON­
STRUCTIONS FOR LOWER LIMB ISCHEMIA. F.M. Ameli, M. 
Stein, J.L. Provan. University of Toronto, Division of Vascular Sur­
gery, The Wellesley Hospital, Toronto, Ont.
We present a 5-year follow-up study of 136 arterial reconstructions for 
lower limb ischemia. A statistical analysis was performed using the stan­
dard life-table analysis, the log rank test, the Krusbal-Wallis analysis
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and the Spearman rank correlation coefficient. At 5 years of follow­
up, cumulative patency rate (CPR), limb loss rate (LLR) and cumula­
tive mortality were 52.3%, 15.8% and 30% respectively. The best predic­
tors of long-term mortality were age (p = 0.018) and operative com­
plications (p < 0.001). Over 5 years of follow-up CPRs were higher 
for claudicants than for limb salvage cases (p = 0.037). At 5 years, 
CPR of autogenous saphenous vein (ASV) grafts was 67.5% compared 
to 38.2% for prosthetic grafts (p = 0.016). Autogenous saphenous vein 
grafts had higher CPRs only for patients 64 years or younger (p = 
0.007). For patients older than 64 years, ASV and prosthetic grafts had 
similar CPRs. In patients with ASV grafts, good runoff was associated 
with significantly higher CPRs compared to poor runoff (p = 0.041). 
Claudicants lost only 2 limbs (3.9%) over the 5-year follow-up, com­
pared to 12 lost limbs (14.5%) for limb salvage patients (p = 0.038). 
Claudicants with ASV grafts had a 5-year LLR of 0% compared to 
21.3% for limb salvage (p = 0.039). However, claudicants with 
prosthetic grafts had a 5-year LLR of 17.8% compared to 20.1% for 
limb salvage patients with prosthetic grafts (p = 0.356). Postoperative 
smoking increased the probability of limb loss and adversely affected 
CPRs.
In conclusion, LLRs and CPRs are affected by multiple interactions 
with variables such as preoperative symptoms, graft material, age, runoff 
and postoperative smoking.
R531
REOPERATION WITHIN TWO YEARS FOLLOWING AORTO- 
FEMORAL BYPASS. J.G. Sladen, A. Gerein, J.L. Gilmour, T. 
Maxwell, R. Wong. University of British Columbia, St. Paul’s Hos­
pital, Vancouver, BC
This study was undertaken to assess the factors leading to early reoper­
ation following aortofemoral grafting. All data were recorded prospec­
tively. We analysed 269 consecutive primary aortofemoral grafts (523 
limbs) operated during the 5-year period prior to Dec. 31, 1983. Includ­
ing the initial hospitalization, 36 limbs (7%) had another lower extremity 
vascular operation within 2 years. Hospital morbidity included throm­
bosis with revision (2.2%), amputation (0.7%), and death (0.7%) which 
compares favourably with the National Vascular Audit.
Precursors to reoperation were: occluded superficial femoral (12%), 
gangrene (23%) and acute severe ischemia (40%). Operations performed 
were: redo 1; thrombectomy 1; embolectomy 1; femoral crossover 5; 
profundoplasty 1; femoropopliteal or tibial bypass 27. The reason for 
secondary operation was classified as: technical 13; disease “progress” 
5; insufficient improvement 6; “ opposite” leg 2; questionable selec­
tion or candidate for dilatation 10.
Inadequate management of an isolated profundus outflow was the 
commonest technical problem, preceding nine reoperations, five of these 
for thrombosis. Reoperation varied from 9 to 33% by surgeon. Although 
occlusion of the superficial femoral artery (SFA) is of statistical sig­
nificance with regard to reoperation (p = 0.001), 88% of the limbs with 
an occluded SFA did not require subsequent reconstruction within the 
first 2 years. Early reoperation can be reduced by identifying high-risk 
limbs and planning management and surgery more carefully in these 
patients.
R532
REVASCULARIZATION FOR RENAL FAILURE. S.J. Brister, J.R. 
Gutelius, P. Morrin, P.M. Brown. Department of Surgery, Kingston 
General Hospital, Kingston, Ont.
Between 1982 and 1987, 10 patients from our institution have under­
gone unilateral saphenous vein bypass (6), bilateral saphenous vein 
bypass (2), endarterectomy (1) or renal artery reimplantation (1) for 
renal failure. Six operations were done on an emergency basis for severe 
oliguria or anuria. Four patients were done on an elective basis for soli­
tary kidneys with high-grade arterial stenoses. Nine of 10 patients had 
atherosclerotic renal artery stenosis or occlusion. One patient had 
bilateral renal artery obstruction after rupture of a high recurrent 
abdominal aortic aneurysm. Eleven of 12 kidneys were greater than 10 
cm in length with the remaining kidney being 8.9 cm. Operations empha­
sized optimal exposure with rotation of viscera as required. Ischemic 
times at surgery varied from 20 minutes to 1 'h  hours with renal cool­
ing used in only one patient.
Of nine patients with atherosclerotic renal disease, two required tem­
porary dialysis postoperatively because of severe ATN. The patient with
occluded renal arteries secondary to his aneurysm repair 48 hours previ­
ously did not recover renal function. Eight patients were discharged 
with one late death attributed to pneumonia. In those discharged, creati­
nine fell from a median of 720 \ imol/L (range 160-1100) preoperatively 
to 290 /rmol/L (180-470) postoperatively. No patients discharged 
required dialysis.
Renal artery surgery for salvage may be done in those with severe 
renal occlusive disease and normal size kidneys with a high degree of 
success. Although operative mortality and morbidity is significant, the 
possibility of relative normal renal function justifies the risks of renal 
revascularization.
R533
AORTIC PROSTHETIC-ENTERIC FISTULA. A.R. Downs, C.R. 
Lye, H. Fong. Department of Surgery, University of Manitoba, Health 
Sciences Centre, Winnipeg, Man.
Aortic prosthetic-enteric fistula (APEF) is an uncommon but devastating 
complication of abdominal aortic surgery. Over the past 10 years, 14 
patients with APEF have been treated at our institution. There were
10 males and 4 females aged 50 to 82 years. The patients presented 3 
weeks to 23 years after their initial graft placement. Four patients had 
upper GI bleeding, 12 patients had melena. One patient presented with 
anemia and unexplained fever. Massive bleeding in two patients required 
emergency operation. Upper endoscopy was performed in eight patients. 
In only one case was a diagnosis suspected. Aortography was done in
11 patients and was helpful in 3 patients, demonstrating two false 
aneurysms and a leak into small bowel. An upper GI barium study was 
done in four patients and demonstrated the lesion in two. The original 
operation was for aortic aneurysm in nine patients. The proximal anasto­
mosis was end-to-end in 10 patients. One patient was operated upon 
for graft occlusion and the APEF was not discovered until postmor­
tem. One patient had local repair of the duodenum and the aortic anasto­
mosis. The remaining 12 patients had graft excision, omental patch and 
an extra anatomical bypass. Four patients died in the postoperative 
period and two patients died at 3 months and 4 months from aortic 
disruption. Eight patients have survived up to 4 years.
R534
IN-VIVO EXCIMER LASER ABLATION: ACUTE AND CHRONIC 
EFFECTS ON CANINE AORTA. D.L. Doyle, F. Litvack, W.S. 
Grundfest, A. Hickey, M. Fishbein, J. Forrester. Cedars-Sinai Medi­
cal Center, Los Angeles, CA
The lack of a fiberoptic delivery system has prevented in vivo excimer 
laser ablation. This is the first report of the acute and chronic effect 
of excimer laser on living arteries. We made 5 -  6 cm longitudinal 
anterior arteriotomies in the infrarenal aortas of 17 dogs. In 13, a 125 
mm2 rectangular segment of posterior intima was ablated by 85 ns 
pulsed, 308 nm excimer energy delivered via a 600 /im core 2 m optical 
waveguide. Four aortas were opened but not lased. Aortas were exa­
mined by light and scanning electron microscopy at 0, 1, 2, 24, 48, 72, 
106 hours; 1, 2, 3, 4 weeks.
Gross luminal thrombus developed in two control and one lased aorta. 
No aneurysms or fistulae developed. Excimer produced no thermal 
injury. Acutely, lased aortas had craters penetrating into the media. 
At 24 -  72 hours there were red cells in the media, localized fibrin depo­
sition and neutrophil infiltration. At 2 weeks the media had regener­
ated and the intima partially re-endothelialized. At 3 -  4 weeks the intima 
had completely healed and was indistinguishable from control.
In conclusion: (1) Excimer energy transmitted via fiberoptics precisely 
ablates in vivo without thermal injury. (2) Ablated arteries heal by 3 
weeks. (3) Excimer may be the technology of choice for laser angioplasty, 
especially for small-calibre thin-walled vessels.
R535
IS FASCIOTOMY NECESSARY FOLLOWING REVASCULARIZA­
TION FOR ACUTE ARTERIAL OCCLUSION? R. Corbisiero, A. 
Graham, B. de Varennes, R. Baffour, J. Symes. Cardiovascular 
Research Unit, McGill University, Montreal, PQ
Controversy exists as to the need for fasciotomy at the time of revas­
cularization for acute arterial occlusion. To address this issue we deve­
loped a unique canine model of compartment syndrome. Both hind limbs
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were completely devascularized at the popliteal level except for an iso­
lated pedicle of anterior tibial artery and vein. The right limb served 
as control while the left had both tibial vessels occluded for 8 hours 
then released for 16. Anterior compartmental pressures (CMP) were 
continuously monitored and popliteal venous effluent was collected for 
CPK, K, lactate and pH. Transfascial Pc^TFPOj) measurements 
were performed over the compartments. One hour after the onset of 
reperfusion 35 mCi of technetium-99m pyrophosphate (TcPYP) was 
injected systemically, and the uptake expressed as a ratio of the left 
limb to the right (L/R). Muscle necrosis was also graded histologically 
following the reperfusion period. In Group I (n = 7) no fasciotomy 
was performed while Group II (n = 7) underwent fasciotomy before 
reperfusion. Results: TFPo2 after arterial occlusion confirmed severe 
ischemia in both groups (mean 4 mm Hg). Data 1 hour after reperfu­
sion were:
CMP TFPOj Lactate CPK TcPYP
(mm Hg) (mm Hg) (mg/dl) (IU) (L/R)
Grp I 100 37 (±8.5) 22.85 (±5.5) 5072 (±3794) 8.14 (±2.7)
Grp It 15.7 84.3 (±24.5) 14.67 (±5.7) 1426 (±923) 2.16 (±1.3)
*p <  0.0001 *p <  0.005 *p <  0.01 *p <  0.01 *p <  0.002
♦Student’s /-test.
Elevation of CMP due to reperfusion significantly increases the extent 
of muscle necrosis following acute arterial ischemia. This study strongly 
supports the use of prophylactic fasciotomy in this setting.
R536
EARLY EXPERIENCE WITH IN-SITU SAPHENOUS VEIN 
BYPASS FOR LIMBS WITH CRITICAL ISCHEMIA. H. Fong, A.R. 
Downs, C. Lye. Department of Surgery, University of Manitoba, Win­
nipeg, Man.
Fifty-seven lower extremities in 55 patients (41 males, 14 females, mean 
age 69 years) underwent in-situ saphenous vein bypass for critical ische­
mia between 1985 and 1986. Indications for distal arterial reconstruc­
tion were ischemic lesions 56% and rest pain 44%. Associated medical 
conditions included hypertension 58%, angina 40%, old myocardial 
infarction 37%, congestive heart failure 25%, diabetes 40% and chronic 
smoker 68%. Regional anesthesia was used in 3/4 of patient group. 
Status of tibial vessel run-off by angiography were one vessel 68%, two 
vessels 25% and three vessels 7%. Proximal saphenous veins were 
anastomosed to common femoral artery 54%, superficial femoral artery 
35%, profunda femoral artery 4% and prosthetic graft 7%. Endarterec­
tomies to common femoral and superficial arteries were performed in 
nine extremities of which three had prosthetic patch angioplasty. Dis­
tal anastomoses were performed below knee in 56 extremities of which 
45% distal popliteal artery, 35% posterior tibial artery, 11% peroneal 
artery and anterior tibial artery 7%. There were four deaths, mortality 
rate 7%, of which three died of acute myocardial infarctions and one 
of respiratory failure. Other complications included leg edema 89%, 
wound complication 18%, acute graft occlusion 11% and acute hemor­
rhage 7%. There were six early and six late graft occlusions of which 
three extremities from each group required amputations respectively. 
Overall cumulative patency was 82% in 30 days, 81% in 3 months, 75% 
in 1 year and 72% in 2 years. We feel that for distal tibial arterial recon­
struction, in-situ saphenous vein bypass is a good procedure with accept­
able patency rate for limbs with critical ischemia.
R537
MANAGEMENT OF TRAUMATIC AORTIC DISRUPTION. C. 
Cina, R. Maggisano. University of Toronto, Sunnybrook Medical 
Centre, Toronto, Ont.
Fifteen patients have been managed for traumatic rupture of the aorta 
at Sunnybrook Medical Centre in the last 6 years.
While classic teaching is to operate immediately, a more deliberate 
plan of management was used. Cardiovascular hemodynamics were care­
fully monitored and pharmacologic hypotension was maintained in an 
intensive-care environment. Priorities for associated injuries were estab­
lished and often their treatment preceded that of surgical repair of the 
aorta. This was delayed until cardiorespiratory and CNS injuries were 
improved. Neither pump nor shunt was used in the operative repair. 
Six patients were not operated upon: two were dead on arrival; one
died of MI after 13 days; two refused operation (and are still alive); 
one died waiting for operation. The average cross-clamping time was 
36 ± 12 minutes. Tube-graft interposition was used in seven patients 
and direct repair in two. The overall mortality rate of this management 
approach is 23%, and the operative mortality 22%. One patient became 
paraplegic and one had a left vocal cord paralysis.
Prior to this experience a comparable group of patients were managed 
with urgent operative repair: three with direct cross-clamping and three 
with cardiopulmonary bypass. The mortality rate was 85%.
We conclude that delaying surgical repair until major cardiopulmo­
nary and CNS associated injuries resolve, will improve mortality and 
possible morbidity.
R538
CATHETER INJURIES OF PERIPHERAL ARTERIES: MANAGE­
MENT AND PREVENTION. T. Kieser, T. Wesley-James, G. Barber, 
N. McPhail, T.K. Scobie. Division of Vascular Surgery/ Ottawa Civic 
Hospital, Ottawa, Ont.
Fifty angiographic catheter injuries required surgical repair between 1977 
and 1985,0.3% of 12 244 cardiac and 0.25% of 2858 peripheral angio­
grams. Arteries involved included 21 common femoral, 10 superficial 
femoral and 4 profunda femoral. Injuries were thrombosis in 25, 
laceration-hematoma in 12, false aneurysms in 6, emboli in 5 and arterio­
venous fistula in 2. M ajor pathological lesions were laceration- 
perforation in 24, intimal damage in 3, significant atherosclerosis in 
9, hypoplastic arteries in 6 and no gross wall change in 8. Operative 
repair was thrombectomy and patch angioplasty in 18, primary repair 
in 9, thrombectomy in 8, formal bypass grafting and other procedures 
in 16. Rethrombosis requiring reoperation occurred in five patients, 
all of whom were successfully repaired. Four of 47 patients died.
Since common femoral artery catheterization is preferable to catheteri­
zation of major branches, 100 patients were assessed at the time of elec­
tive femoral artery surgery to demonstrate the level of common femoral 
bifurcation. The area was marked by a transverse line laterally from 
the pubic tubercle and in the groin skin crease. Ninety-one percent of 
femoral bifurcations were below the pubic tubercle confirming the value 
of this landmark for safe femoral artery catheterization.
The incidence of catheter injuries can be reduced by precise com­
mon femoral artery puncture and the avoidance of atherosclerotic and 
hypoplastic arteries. Results depend on prompt diagnosis and immedi­
ate surgery, thrombectomy with patch angioplasty providing optimal 
operative repair.
R539
RADIONUCLIDE ANGIOGRAPHY AT REST AND EXERCISE IN 
PREDICTING CARDIAC OUTCOME IN PATIENTS UNDERGO­
ING ABDOMINAL AORTIC RECONSTRUCTIVE SURGERY. W.P. 
Joyce, J.L. Provan, F.M. Ameli, P. McEwan. University of Toronto, 
Toronto, Ont.
Coronary artery disease (CAD) is the major cause of morbidity and 
mortality in patients undergoing elective abdominal aortic surgery. To 
identify this high-risk group of patients preoperatively, we have selected 
resting and exercise gated blood pool studies in 40 unselected and con­
secutive patients undergoing infrarenal abdominal aortic reconstruc­
tive surgery. Preoperatively, patients were allocated into two risk groups 
depending upon their left ventricular ejection fraction at rest (EFR). 
Patients with EFR <  50% (n = 11) were considered high risk and 
patients with EFR >  50% (n = 29) were considered low risk. Evidence 
of CAD was based on a history of myocardial infarction (MI), conges­
tive heart failure (CHF), or an abnormal preoperative ECG. Outcome 
was defined only in terms of cardiac complications and cardiac end 
points were taken as death, MI, CHF and pulmonary edema. Only four 
patients suffered a postoperative cardiac complication with one death 
(mortality 2.0%). These four patients had aneurysmal disease and a 
mean ejection fraction (EFR ± SD) of 27 + 5. Complications included 
pulmonary edema in three patients and cardiorespiratory failure and 
death in one patient. The clinical presence of CAD was significant in 
predicting outcome (p = 0.01) while information derived from stress 
electrocardiograms and exercise gated blood pool studies were not. Our 
preoperative assessment o f risk based on EFR <  50% was highly sig­
nificant in predicting outcome (p = 0.0004) while EFR alone was the 
best overall predictor of outcome (p = 0.0001).
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that the timing would never be suitable 
for an intervention. The debate in the 
appeals court is expected by the QMA to 
establish some criteria for the body that 
represents physicians and for the timing 
for changes.
The QMA recently released “ A New 
Contract for Health Care in Quebec” , 
which says among other things, “ ...the 
greater part of [health-related] expenses 
is blamed on physicians; only in appear­
ances can such an erroneous assumption 
be explained, not with facts and 
figures.... If we deduct the amount paid 
in 1984 by the RAMQ [Regie de 1’Assur­
ance Maladie du Quebec] for medical 
services, that is $882 772 551, or 12% of 
total expenses, we then obtain the total 
amount of $6 337 665 449 for all other 
expenses.
“ The Quebec physician is the one earn­
ing the lowest gross average income in 
Canada. In 1984, the gross average 
income was 40% lower than the Canadian 
average. Between 1971 and 1980, the con­
sumer price index increased by 108.4%, 
while the physician’s gross income was 
raised by a mere 48%. His purchasing 
power decreased by 30%; that of the 
salaried worker increased by 15%.
“ ...our Quebec physicians should be 
entitled to rates that compare to the 
Canadian average, to an updating of fees 
considering the technical difficulty, the 
rising costs of insurance, etc. They should 
be entitled to premiums for services ren­
dered evenings, nights, weekends and 
statutory holidays.”
Canada-wide statistics compiled by the 
federal government lend some support to 
the QMA’s contentions that the physi­
cians in that province are the lowest paid 
in the country. Criticized by medical 
associations as being a reflection of utili­
zation as much as differences in fees, the 
indices are based on a sample of the most 
highly utilized items in the schedules for 
each specialty, the fees paid for consul­
tations and an average price per service 
weighted by use patterns and total serv­
ices rendered. Using these statistics, the 
government establishes a “ median” fee 
for all services and gives it the value of 
100, valuing accordingly the “ all-services 
fee” for each province.
The indices for 1986 put Quebec’s 
general surgeons, urologists, ophthalmol­
ogists, and thoracic and cardiovascular 
surgeons as the lowest paid for their 
specialty in Canada.
New Chairman for General 
Surgery, U of Ottawa
Mark Dover, FRCSC, was recently 
appointed chairman for the division of 
general surgery at the University of 
Ottawa and chief of general surgery at the 
Ottawa Civic Hospital. Dover received his 
medical degree from the University of 
Ottawa in 1955 and took postgraduate 
training in Ottawa and New York.
M. Dover, MD, FRSCS
Casualties of War Treated 
in Canada
Simon Wren, FRCSC, a general sur­
geon in Kingston is chairman of the med­
ical committee of the local chapter of the 
Afghan Medical Relief Organization, and 
for the past few months has been coor­
dinating efforts in Canada to bring med­
ical help to casualties of the freedom 
fighting. He recently spoke to CJS about 
his work: “ We have had two objectives: 
one to transfer medical equipment to the 
refugee camps in Pakistan and to bring 
to Canada people who require reconstruc­
tive surgery for injuries sustained during 
the war.
“ At present at Hotel Dieu we have 
taken four patients — the first was a man 
who had chronic osteomyelitis caused by 
a gunshot wound to the tibia; the second 
had a malunion of the distal femur with 
consequent problems in the knee joint (he 
ended up with a fused knee). These 
patients were handled here by two ortho­
pedic surgeons, Michael Ashworth and 
Douglas Hedden. The third patient was 
a young girl who had injuries, I believe, 
from stepping on a mine. Her foot and 
ankle had healed but were malaligned and 
she couldn’t walk well. She has been 
treated with, in essence, an ankle and foot 
fusion and her foot has been straightened. 
The last one we treated here is a young 
girl who sustained shrapnel injuries to the 
head; she has retained some shrapnel in 
the brain tissue and has a partial right 
hemiparesis and partial aphasia. She’s 
here for some of the problems associated 
with the hemiparesis — problems to the 
right arm and leg.”
Wren has arranged for treatment of 
some of the patients elsewhere — in 
Toronto at the Toronto General, Western 
and St. Joseph’s hospitals.
“ All were patients in the refugee camps 
in Pakistan,” he said. “ I am coordinat­
ing the medical end of it; I get lists of 
patients from Pakistan with explanations 
of the problem; I relay the information 
to physicians who have elected to care for 
such patients. All the care is voluntary. 
The AMRO chapter has set up transla­
tion and home care services so these 
patients can be treated as outpatients.
“ The patients have adjusted well to a 
life that is very foreign to them; all will 
be going back after their care is complete. 
The intergovernmental committee for 
migration in Geneva coordinates the 
travel of these people from the camps to 
the various countries that are providing 
assistance. The committee arranges exit 
visas with the government in Pakistan.”
Amy Chouinard
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continued from  page 271
work of a related symposium. Most of the 
authors are well-respected, experienced physi­
cians, renowned for their clinical expertise. The 
text is divided into eight sections that include 
historical considerations, surveillance and 
detection, pathologic features, special diagnos­
tic techniques, management, adjuvant therapy, 
complications and follow-up procedures. The 
text is supplemented by beautiful illustrations 
and tables. The print is clear and easy to read.
Most of the book is well written. However, 
the multiauthor format has resulted in a weak 
and uneven style. Many of the chapters, par­
ticularly on surgical technique and radiation 
therapy, are of the “ how I do it”  type. There 
is frequently too little analysis of important 
recent trials or too much analysis of less- 
important issues (e.g., the no-touch technique). 
The chapters on radiotherapy are particularly 
poor in that regard. The results of major adju­
vant radiation studies are buried in the 
chemotherapy section. In particular, the chap­
ter dealing with preoperative radiotherapy and 
sphincter preservation contributes nothing to 
our knowledge. Similarly, there are two chap­
ters, dealing with urologic and vascular com­
plications, that are neither particularly com­
mon nor unique to colorectal cancer surgery. 
They seem, at best, to be filler. There are three 
separate chapters on polyps by four authors 
that, although not contradictory, are repetitive 
and still leave the reader confused.
The descriptive chapters on surgical tech­
niques are the strongest in the book. The chap­
ters on dysplasia in ulcerative colitis, prolifer­
ative defects and follow-up procedures are also 
excellent.
Steele and Osteen have selected fewer (14) 
contributors and used a much different format 
for Colorectal Cancer. They have established 
the controversial and key issues in each area 
of colorectal cancer and have asked the con­
tributors to provide all of the important rele­
vant data, analyses of them and their conclu­
sions. To a great extent they have been 
successful.
The chapter on screening is particularly good 
at eliminating the confusion created by a mul­
titude of studies. The chapters on surgical treat­
ment concentrate on the survival advantages 
for particular techniques in a variety of situa­
tions. The conclusions on management of anal 
cancer are somewhat controversial but are well 
supported. The section on polyps is a reasona­
ble analysis of the literature but does omit 
recent British literature which is at variance in 
some respects with the author’s conclusions. 
The chapters on radiation by Gunderson and 
adjuvant therapy by Mayer are much clearer 
in their interpretation of the literature than in 
Colorectal Tumors and provide more of an 
opportunity for the reader to evaluate their 
conclusions.
The major weaknesses of the book lie in the 
poor quality of editing and printing. The qual­
ity of reproductions in the surgical treatment 
section is particularly poor, and the tables are 
at times too cluttered to be interpreted easily. 
There are a number of grammatical and typo­
graphic errors throughout the book.
In conclusion, both texts are comprehensive 
studies of colorectal cancer. Beahrs and col­
leagues have produced a generally well-written 
text that would be of some use to the practis­
ing general surgeon or resident. However, it
has little to offer over and above standard Brit­
ish and American textbooks of colorectal sur­
gery. For the serious students of colorectal 
cancer, particularly those involved in con­
ducting clinical trials, Steele and Osteen have 
produced the better book.
H artley  S. St e r n , m d , frcsc
Department of Surgery,
University of Toronto,
Mount Sinai Hospital,
Ste. 1142,
600 University Ave.,
Toronto, Ont.
M5G 1X5
DIAGNOSTIC PATIENT STUDIES IN SUR­
GERY. Bernard Sigel. 449 pp. Illust. Lea 
&  Febiger, Philadelphia, 1986. $79.75. 
ISBN 0-8121-0996-1.
This excellent, concise textbook of commonly 
used diagnostic techniques provides rapid 
access to and selection of the most appropri­
ate test for a specific clinical situation. Many 
specialists in the fields of surgery, radiology 
and medicine have provided detailed reviews 
of patient diagnostic studies, which are defined 
as those “ requiring presence of the patient, not 
only specimen sent to the laboratory” .
Diagnostic investigations are initially divided 
into three groups: imaging, endoscopy and 
function studies, but the book is divided into 
two parts: part I — imaging and part II — 
endoscopy, function studies and magnetic 
resonance. This is somewhat confusing but for­
tunately is the only weak point in this book.
Part I contains nine chapters, giving detailed 
reviews of radiologic techniques, beginning 
with an interesting introduction to the basics 
and technique. This is followed by plain roent­
genography of the skeleton, chest and the 
abdomen. Then ultrasonography, computer­
ized tomography and radionuclide scanning are 
described. Finally, the more invasive luminal 
contrast studies of hepatobiliary and gastroin­
testinal systems and angiography are presented. 
Whenever indicated, emphasis is placed on the 
application of a particular study in trauma or 
some other emergency situation. Each chap­
ter is designed to present the background of 
the technique, indications, principles of diag­
nosis, complications and limitations of the test 
related to technique as well as to the examiner. 
Each overview is followed by a specific organ 
study, again with emphasis on indications, 
complications and limitations. In the chapter 
on plain-film roentgenography, the controversy 
regarding the use of preoperative chest x-rays 
is discussed. The chapters on ultrasonography 
and computerized tomography describe the 
indications for synchronized percutaneous 
biopsy. Percutaneous fine-needle biopsy is 
elaborated upon in more detail in part II.
Part II consists of 10 chapters dealing with 
the principles o f urologic, respiratory, upper 
and lower gastrointestinal endoscopies. Two 
chapters are devoted to the applications of 
diagnostic laparoscopy and paracentesis, with 
emphasis on trauma. Pulmonary function tests 
are outlined with detailed discussions on the 
indications, interpretation and even cost- 
effectiveness. In the chapter on cardiac assess­
ment, outlines of electrocardiography, cardiac 
catheterization and invasive bedside monitor­
ing techniques are presented. Continuous
esophageal pH monitoring, esophageal motil­
ity studies and gastroduodenal function studies 
are described. The efficacy of noninvasive vas­
cular techniques and technical problems 
associated with them in relation to both the 
venous and arterial systems are well presented. 
In the last chapter, applications for magnetic 
resonance imaging are dealt with.
In all chapters, numerous well-selected 
studies including controversial issues are 
quoted. Each topic is supported with well- 
selected illustrations of normal or pathologic 
states, sometimes with emphasis on diagnos­
tic errors. The endoscopy chapters lack illus­
trations, but these can be found in many text­
books and atlases.
Each chapter lists references from the cur­
rent literature as well as general reading on the 
subject.
This textbook is not a manual and does not 
pretend to teach one how to perform or inter­
pret a particular study. However, it gives very 
reliable reviews of most of the commonly used 
techniques with their rationale, indications and 
limitations. This book can be strongly recom­
mended to all medical and surgical residents. 
Surgeons, medical specialists and general prac­
titioners may use it as a reference guide to help 
them choose the proper study or to avoid inap­
propriate and costly tests in a particular clini­
cal situation.
J oel B. F reem a n , m d , fr csc , facs
Professor of surgery,
University of Ottawa,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6
FINE NEEDLE ASPIRATION FOR THE 
CLINICIAN. Joseph A. Linsk and Sixten 
Franzen. 337 pp. Illust. J.B. Lippincott 
Company, Philadelphia, 1986. Price not 
stated. ISBN 0-397-50678-3.
This book is based on the large experience of 
a consultant clinical oncologist who is an expert 
in fine-needle aspiration and works with a 
highly experienced cytopathologist. The 
authors rightly emphasize the lack of familiar­
ity of many physicians with the use of fine- 
needle aspiration to solve clinical problems.
In the introductory chapter, the pictures and 
text on technique are excellent and the hazards 
of the procedure are well documented. The 
remainder of the book is divided into sections 
that catalogue practically all visible and pal­
pable tumours in the human body, as well as 
those that can be imaged by various techniques. 
A short description of the clinical and patho­
logical findings of each is given, and the poten­
tial role of fine-needle aspiration in establish­
ing the diagnosis is considered. The section on 
the fine-needle aspiration of intrathoracic 
lesions, intra-abdominal lesions, the transrec- 
tal and transvaginal approach to pelvic lesions, 
and lesions of the skeletal system are of interest 
only to specialists in these areas and usually 
require the cooperation of an expert in diag­
nostic imaging.
The chapter on the breast includes a section 
on how masses may be discovered by a patient 
and an extensive section on the technique of 
clinical examination, both of which are not 
really germane to the central theme.
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The authors continually mention the impor­
tance of experience in the use of the technique 
by the clinican and the interpretation of the 
slides by the pathologist. However, they fail 
to give any indication of the percentages of 
false-negative and false-positive results in their 
own experience or in that from other clinics, 
which have been well documented in the liter­
ature. In the primary surgical treatment of 
breast cancer, they imply that positive cytologic 
findings may preclude the need for frozen- 
section confirmation of the diagnosis of cancer 
before embarking on a primary surgical proce­
dure. Most surgeons would forcefully disagree 
with this because false-positive findings have 
been reported.
This book contain^ a lot of extraneous infor­
mation which clouds the clarity of its message. 
It is not recommended for the average physi­
cian. It is a good reference for any person who 
is interested in developing his or her expertise 
in the technique of fine-needle cytology to help 
elucidate the diagnosis of palpable lumps in any 
area of the body.
Leo Mahoney, md, frcsc, facs
Associate professor of surgery,
University of Toronto,
Ste. 405,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
UPPER EXTREMITY REPLANTATION. 
Basic Principles, Surgical Technique, and 
Strategy. Viktor E. Meyer. 121 pp. Illust. 
Churchill Livingstone, Edinburgh; Aca­
demic Press Canada, Don Mills, Ont., 
1985. $58. ISBN 0-443-08448-3.
The author of this book on upper-extremity 
replantation has had extensive experience in the 
last decade in the management of patients with 
amputations of the finger, hand and forearm. 
The book presents a balanced, logical, thought­
ful approach to the subject, which is one of 
the most complex in hand surgery. There are 
many problems in the management of ampu­
tations. Patient selection, operative technique 
and postoperative care are among the most 
important considerations and one chapter is 
devoted to each of these. Of particular note 
is the chapter on personnel and organizational 
requirements for a replantation centre. This 
chapter should be seriously considered by any­
one thinking of doing solo replantation. Dr. 
Meyer’s team consists of four surgeons who 
can provide not only 24-hour service, but can 
back each other up for long procedures and 
assist in taking patients back to the operating 
room for revisions.
The chapter on indications is a most impor­
tant one and presents a balanced conservative 
approach with which I am in nearly complete 
agreement.
Surgical technique is well covered, with 
strong emphasis on skeletal fixation, which it 
rightly deserves. This chapter emphasizes tech­
nical principles and provides us with technical 
details that the author favours. Most replan­
tation centres would agree with the majority 
of the techniques used, but might favour a free- 
tissue transfer rather than a groin flap for 
major soft-tissue defects associated with upper 
limb replantation. Early mobilization and 
edema control by elevation is considerably eas­
ier with a free flap.
SESAP V  Critique
ITEM 315
This patient has an imperforate anus, better termed anorectal atresia with a 
rectourethral fistula. Patients with high-lying defects located above the leva­
tor sling mechanism are prone to urinary tract infection, primarily because of 
associated genitourinary malformations. In such patients the risk of infection 
prior to definitive pull-through operation and division of the rectourethral fistula 
is about 60%. Some patients have only sporadic difficulty, but others, partic­
ularly those with neurogenic bladders, develop chronic problems. In one series 
of 200 patients with various anatomic types of imperforate anus, 40% had some 
form of anomaly of the urinary tract, neurogenic bladder, significant urinary 
tract infection, or other forms of urinary complications. Metabolic acidosis 
may result from poorly functioning kidneys, further compromised by urinary 
tract infection. The reflux of urine through the fistula into the distal limb of 
the colostomy also causes acidosis, Chloride ions from the urine are reabsorbed 
through the bowel muscosa. Severe degrees of recurrent acidosis would neces­
sitate division of the fistula with or without completion of the rectoplasty.
E
References
315/1. Stephens FD, Smith ED (eds): Anorectal Malformations in Children. 
Chicago, Year Book Medical Publishers Inc, 1971, pp 293-303 
315/2. Wiener ES, Kiesewetter WB: Urologic abnormalities associated with 
imperforate anus. J Pediatr Surg 8:151-157, 1973
NOTICE OF CHANGE OF ADDRESS /
AVIS DE CHANGEMENT D ’ADRESSE
To ensure that you continue to receive the Canadian Journal o f Surgery without 
interruption, please fill in this form before you move.
Avant de demenager, assurez-vous de recevoir sans interruption le Journal cana- 
dien de chirurgie en completant le formulaire suivant.
Please print /  en lettres moulees, svp
Name /  nom ........................................................................................................
Royal College member number /  numero d’identite ......................................
Old address /  ancienne adresse .........................................................................
New address /  nouvelle adresse
Postal code /  code postal ..................................................................................
Date ......................................................................................................................
Royal College fellows please mail to: Royal College of Physicians and Sur­
geons of Canada, 74 Stanley, Ottawa, Ont. KIM 1P4.
Membres du College royal, veuillez expedier a: College royal des medecins et 
chirurgiens du Canada, 74 Stanley, Ottawa, Ont. KIM 1P4.
Subscribers please mail to: Information Systems, Canadian Medical Associa­
tion, PO Box 8650, Ottawa, Ont. K1G 0G8.
Abonnes, veuillez expedier a: Systeme de diffusion d’informations, 1’Associa­
tion medicale canadienne, CP 8650, Ottawa, Ont. K1G 0G8.
VOLUME 30, NO. 4, JULY 1987 /  THE CANADIAN JOURNAL OF SURGERY 309
CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f  Surgery is pleased to accept 
suitable classified advertisements. The deadline is 1 month before issue date. Regular 
classified rates (for each insertion): $40.00 for the first 40 words or less, additional 
words 50C each (additional $16.00 for frame). Special Display under 75 words, 1'A" 
x 2" $100.00. $6.00 charge (first insertion only) for CJS box numbers. Display rates 
available on request.
Copy should be mailed to the Canadian Journal o f  Surgery, PO Box 8650, Ottawa, 
Ontario K1G 0G8.
The section on postoperative care could be 
stronger. The author stresses the importance 
o f postoperative therapy but allows only one 
page for discussion o f postoperative therapy 
for the hand.
The reporting of results is a difficult area and 
the author is to be congratulated for his efforts. 
He has used the classification of Chen; unfor­
tunately, this includes the patient’s return to 
work, a factor that depends upon motivation, 
social support systems and the pre-injury job 
and does not really give us the information we 
would like — grip and pinch strength, manual 
dexterity, tactile gnosis and psychological adap­
tation to the injury. Nevertheless, the results 
section is useful, as it gives some idea of the 
levels o f amputations and types o f amputation 
injuries that are most likely to result in suc­
cessful replantation.
The book is written in a lucid style and the 
illustrations are excellent. Overall, it is a major 
addition to the microvascular literature and is 
necessary reading for all surgeons who are 
practising in this field, and residents who are 
training in hand surgery.
Ralph  T. Manktelow, md, frcsc
Division o f Plastic Surgery,
EN 10-236,
Toronto General Hospital,
200 Elizabeth St.,
Toronto, Ont.
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GENERAL SURGEON: MB — Prospective partner 
required to  replace retiring surgeon. The group 
services a productive economically stable region 
of 180 000, located in a university city of 42 000. 
Excellent schools, recreational and cultural facili­
ties. The clinic having a modern laboratory, x-ray 
and other diagnostic services is located adjacent 
to  a 220-bod acute care hospital. Interest in chest 
or vascular surgery an asset but not essential. 
Canadian fellowship is required. Contact: Mr. A.J. 
Lockhart, Administrator, Box 280, Brandon, MB 
R7A 5Z2. -S 8 7 -5 3
GENERAL SURGEON: ON — required immedi­
ately to serve the community of Arnprior and 
surrounding area. Sole practice draws from a 
community population of 6000 and a catch­
ment area of approximately 14 000. Current 
medical staff includes 9 GPs, 3 of which are 
GP anesthetists. Also available are weekly on­
site radiologic services for ultrasound and bar­
ium studies. A rnp rior hospital is fu lly  
accredited w ith  50 acute and 20 chronic care 
beds. We have 2 fully equipped operating 
rooms and an additional cysto/ortho room. 
Prospective candidates should have some 
training in orthopedic work as well as do emer­
gency and repeat ceasarean sections. Arnpri­
or is s itua ted  on the O ttaw a River 
approximately 70 km from downtown Otta­
wa. Our community offers excellent schools 
and recreational areas including golf courses, 
a curling club, a community sports centre with 
ski hills nearby. A ttractive grant available to 
assist w ith relocation and/or establishment of 
practice. For further information please con­
tact: R.J. Kedrosky, Administrator, Arnprior & 
District Memorial Hospital, 350 John St., N., 
Arnprior, ON K7S 3H4. Tel. (613) 623-3166.
-S 8 7 -4 5
GENERAL SURGEON: BC — required to move to 
the beautiful Sunshine Coast and relieve the local 
surgeon during his holidays. This is 10-12 weeks 
a year. Ideal position for a general surgeon near­
ing retirement. Apply to: Dr. E.J. Paetkau, Box 
638, Schelt, BC VON 3A0. -S 8 7 -5 4
SPECIALIST AND/OR CARDIOLOGIST: ON -
This exclusive seven storey building is located 
across from the Sutton Place Hotel at 984 Bay 
Street, corner of Bay and Wellesley. Currently we 
are 80% leased requiring only a few selected spe­
cialists to  fill out a full compliment. The building 
houses a large research oriented family practice, 
numerous specialists as well as radiology, ultra­
sound, pharmacy, laboratory, nuclear medicine 
and sports medicine facilities including tw o oper­
ating suites used primarily for cosmetic related 
surgery. For further leasing information call: 
Geoffrey Smith, (416) 243-9010.
-S 8 7 -5 6
UNIVERSITY OF BRITISH COLUMBIA -  Head, for 
the Department of Surgery in the Faculty of Medi­
cine at the University of British Columbia, (subject 
to final budgetary approval). The person appointed 
would be responsible for directing and developing 
the teaching, research and service programs of the 
department. A candidate should hold a specialty 
qualification in surgery and have substantial aca­
demic and clinical experience. Starting date and 
salary are subject to negotiation. The University 
of British Columbia offers equal opportunity for 
employment to  qualified male and female candi­
dates. In accordance w ith Canadian immigration 
requirements, this ad is directed to Canadian 
citizens and permanent residents and preference 
will be given to these individuals. Applications, ac­
companied by a detailed curriculum vitae and the 
names of three individuals for references should 
be directed to: Dr. Andrew Eisen, Associate Dean, 
Faculty of Medicine, Room 317, Instructional 
Resources Centre, University of British Columbia, 
2194 Health Sciences Mall, Vancouver, BC 
V6T 1W5. -S 8 7 -5 2
GENERAL SURGEON: US — required to practise 
in a 53-bed hospital and work in an office w ith  a 
cardiologist and general practice physician. Board 
certified or board eligible. Located in east central 
Alabama. Office rent free for 6 months. Please re­
ply to: Dr. Cecil P. Horn, PO Box 398, Ashland, 
Al 36251. —S87-55
CLINICAL FELLOWSHIP: ON -  position in 
orthopedic surgery for 1 year period beginning 
July 1, 1988. We have fellowships available 
in joint reconstruction, spine surgery, sports 
medicine and knee surgery, hand surgery and 
rehabilitation, each involving some aspect of 
trauma, due to Sunnybrook being the home of 
The Regional Trauma Unit. If interested please 
forward a letter of application stating your par­
ticular orthopedic interest, and include a copy 
of your curriculum vitae to: Dr. J. Schatzker, 
Chief, Division of Orthopedic Surgery, Room 
D5505, Sunnybrook Medical Centre, 2075 
Bayview Ave., Toronto, ON M4N 3M5. Please 
also state whether you will be self-funded or 
require support from Sunnybrook Medical 
Centre. -S 8 7 -4 6
MICROSURGICAL COURSE: -  The Department 
of Surgery, McMaster University is now offering 
one week, on-going courses in microsurgery, us­
ing animal facilities and videotapes. These courses 
are for anyone interested in small vessel anasto­
mosis, nerve repairs, vas and fallopian tube recon­
structions. The laboratory is organized to guide 
you through the basic microsurgical techniques to 
more advanced tasks w ith  the help of an assis­
tant on a one-to-one basis. Please call: Dr. A. Tho- 
ma at (416) 523-0019 for further information.
-S86-23
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MORE C O N F I D E N C E  IN A N T I T HR O MB O TI C  THERAPY
New Guidelines for 
Antithrombotic Therapy 
In Surgical Cases
The American College of Chest Physi­
cians and the National Heart, Lung and 
Blood Institute recently issued new 
guidelines for antithrombotic therapy.1 
There were four Grade A recom­
mendations for the use of warfarin (Coumadin®) in surgical oases. In each 
of these four (and other Grade A and B 
recommendations for Coumadin®) a PT 
ratio of 1.2-1.5 (rabbit brain) was 
emphasized for clinical efficacy and 
reduced side-effects risk.
INDICATIONS: Elective hip surgery/ 
surgery for fractured 
hips.
. patients undergoing elective hip surgery 
should be pretreated prophylactically with 
adjusted-dose heparin or moderate-dose war­
farin sodium . .
patients undergoing surgery for fractured 
hips should be treated prophylactically with 
moderate-dose warfarin.
INDICATION: Prophylaxis of venous 
thromboembolism.
"It is strongly recommended that the 
therapeutic range for prophylaxis . . . in high- 
risk medical or surgical patients should be 
equivalent to an INR of2.0-3.0(corresponding 
rabbit brain thromboplastin ratio 1.2-1.5)."
CONDITION: Bioprosthetic heart valves.
"  ■ • all patients with bioprosthetic heart valves 
in the mitral position be treated for the first 
three months after valve insertion with less 
intense warfarin . . ."
re believe these recommendationswill be of value to practicing physicians.
James E Dolen. M  D . F C  C  P , Jock H,rsh. M D . F R C P C .  Co-Cha.rm en A C C P -N H L B I Conference on Antithrombotic Therapy
ff
OUMADIN®
CONDITION: Prophylaxis of venous 
thromboembolism.
"It is recommended that anticoagulant therapy 
should be continued for three months using 
oral anticoagulants to prolong prothrombin 
tim e . . ."
^  *  -
(warfarin sodium)
for Antithrombotic Therapy
O F  V A L U E  I N  Y O U R  P R A C T  I C E
1. Chest 1986;89(2);1S-106S
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...now  comes the 
Even Greater Stapler
Ultra Light Compact 
disposable skin stapler
• Automatically released staples
• Improved staple visibility
• Proven reliability
• Allows for excellent accuracy
• Quality stapler supplied inexpensively
DAVIS+GECK A  T R A D I T I O N  O F  I N N O V A T I O N
Cyanamid Canada Inc. Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
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NEW PRE-CYDE
(Chtortiexidne Gluconate)
Pre-Cyde's broad antibacterial 
spectrum makes it an excellent 
bactericidal and fungicidal
Pre-Cyde is safe, virtually
Irritating,
pleasant
difference
New Pre-Cyde is the only germicidal antiseptic hand 
wash that combines all the 
effectiveness of chlorhexidine 
with a gentle emollient to 
sooth the skin.
Now a monofilament suture 
that is easy to handle and tie
supple, flexibleSoft
Resists kinki
e kn o tYields secur
Strong
the manageable monofilament
THE SMOOTH ONE
DEXON PLUS
Excellent knot security plus superior handling 
and smoother tissue passage.
